<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27914857</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6424</ISSN><JournalIssue CitedMedium="Internet"><Volume>221</Volume><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Environmental pollution (Barking, Essex : 1987)</Title><ISOAbbreviation>Environ. Pollut.</ISOAbbreviation></Journal><ArticleTitle>Imidacloprid induces various toxicological effects related to the expression of 3β-HSD, NR5A1, and OGG1 genes in mature and immature rats.</ArticleTitle><Pagination><MedlinePgn>15-25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0269-7491(16)31055-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.envpol.2016.08.082</ELocationID><Abstract><AbstractText>This study aimed to evaluate the adverse effects of the insecticide imidacloprid (IMI) on male spermatogenesis, steroidogenesis, and DNA damage in sexually mature and immature rats. Forty male rats (mature and immature) were equally divided into four groups: two mature and two immature groups. IMI groups of both ages were orally administered IMI in corn oil at a concentration of 1 mg/mL for kg BW/day, whereas their respective controls were orally administered corn oil only (1 mL/kg of body weight) daily for 65 days. On day 66, the rats were lightly anesthetized and then euthanized by cervical dislocation. Whole blood was collected for hemogram, serum for hormonal profile, semen for sperm profile, and testes for gene expression and histopathological, and immunohistochemical examinations. The obtained results revealed that both sexually mature and immature rats orally exposed to IMI showed serious abnormalities in sperm morphology and concentrations, with an imbalance of sexual hormones. There were increases in the level of serum 8-hydroxy-2'-deoxyguanosine and in the percentage of comet (tailed) sperm DNA in the IMI-treated groups. The results exhibited the upregulation of a DNA damage tolerance gene (8-oxoguanine glycosylase 1) and downregulation of the activity of steroidogenic genes (nuclear receptor subfamily 5, group A, member 1 and 3β-hydroxysteroid dehydrogenase). Immunohistochemical examination of the B-cell lymphoma 2-associated X apoptotic protein in testicular sections showed various degrees of apoptosis in the spermatogonial cells of the IMI-treated rats compared to the control groups. These damaging effects of IMI were more pronounced in the sexually mature rats than in the immature rats. In conclusion, despite using a low dose of IMI in the present study, there were noticeable harmful consequences on the reproductive system at different stages of sexual maturity in male rats.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdel-Rahman Mohamed</LastName><ForeName>Amany</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Forensic Medicine and Toxicology, Clinical Pathology and Biochemistry, Faculty of Veterinary Medicine, Zagazig University, 44511 Zagazig, Egypt. Electronic address: amanyrahman292@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Wafaa A M</ForeName><Initials>WAM</Initials><AffiliationInfo><Affiliation>Department of Forensic Medicine and Toxicology, Clinical Pathology and Biochemistry, Faculty of Veterinary Medicine, Zagazig University, 44511 Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khater</LastName><ForeName>Safaa I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Forensic Medicine and Toxicology, Clinical Pathology and Biochemistry, Faculty of Veterinary Medicine, Zagazig University, 44511 Zagazig, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Environ Pollut</MedlineTA><NlmUniqueID>8804476</NlmUniqueID><ISSNLinking>0269-7491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007093">Imidazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007306">Insecticides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073943">Neonicotinoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009574">Nitro Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054339">Steroidogenic Factor 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C515060">steroidogenic factor 1, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>3BN7M937V8</RegistryNumber><NameOfSubstance UI="C082359">imidacloprid</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>5614-64-2</RegistryNumber><NameOfSubstance UI="C024829">8-hydroxyguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.-</RegistryNumber><NameOfSubstance UI="D015096">3-Hydroxysteroid Dehydrogenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C483741">OGG1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015096" MajorTopicYN="N">3-Hydroxysteroid Dehydrogenases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007093" MajorTopicYN="N">Imidazoles</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007306" MajorTopicYN="N">Insecticides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073943" MajorTopicYN="N">Neonicotinoids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009574" MajorTopicYN="N">Nitro Compounds</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013091" MajorTopicYN="N">Spermatogenesis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013094" MajorTopicYN="N">Spermatozoa</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054339" MajorTopicYN="N">Steroidogenic Factor 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">8-OHdG</Keyword><Keyword MajorTopicYN="N">Bax</Keyword><Keyword MajorTopicYN="N">Comet</Keyword><Keyword MajorTopicYN="N">Neonicotinoid</Keyword><Keyword MajorTopicYN="N">Spermatogenesis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>08</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>08</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27914857</ArticleId><ArticleId IdType="pii">S0269-7491(16)31055-7</ArticleId><ArticleId IdType="doi">10.1016/j.envpol.2016.08.082</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27903453</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><PubDate><Year>2017</Year><Month>06</Month></PubDate></JournalIssue><Title>Free radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic. Biol. Med.</ISOAbbreviation></Journal><ArticleTitle>Repair of 8-oxo-7,8-dihydroguanine in prokaryotic and eukaryotic cells: Properties and biological roles of the Fpg and OGG1 DNA N-glycosylases.</ArticleTitle><Pagination><MedlinePgn>179-201</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0891-5849(16)31078-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2016.11.042</ELocationID><Abstract><AbstractText>Oxidatively damaged DNA results from the attack of sugar and base moieties by reactive oxygen species (ROS), which are formed as byproducts of normal cell metabolism and during exposure to endogenous or exogenous chemical or physical agents. Guanine, having the lowest redox potential, is the DNA base the most susceptible to oxidation, yielding products such as 8-oxo-7,8-dihydroguanine (8-oxoG) and 2-6-diamino-4-hydroxy-5-formamidopyrimidine (FapyG). In DNA, 8-oxoG was shown to be mutagenic yielding GC to TA transversions upon incorporation of dAMP opposite this lesion by replicative DNA polymerases. In prokaryotic and eukaryotic cells, 8-oxoG is primarily repaired by the base excision repair pathway (BER) initiated by a DNA N-glycosylase, Fpg and OGG1, respectively. In Escherichia coli, Fpg cooperates with MutY and MutT to prevent 8-oxoG-induced mutations, the "GO-repair system". In Saccharomyces cerevisiae, OGG1 cooperates with nucleotide excision repair (NER), mismatch repair (MMR), post-replication repair (PRR) and DNA polymerase η to prevent mutagenesis. Human and mouse cells mobilize all these pathways using OGG1, MUTYH (MutY-homolog also known as MYH), MTH1 (MutT-homolog also known as NUDT1), NER, MMR, NEILs and DNA polymerases η and λ, to prevent 8-oxoG-induced mutations. In fact, mice deficient in both OGG1 and MUTYH develop cancer in different organs at adult age, which points to the critical impact of 8-oxoG repair on genetic stability in mammals. In this review, we will focus on Fpg and OGG1 proteins, their biochemical and structural properties as well as their biological roles. Other DNA N-glycosylases able to release 8-oxoG from damaged DNA in various organisms will be discussed. Finally, we will report on the role of OGG1 in human disease and the possible use of 8-oxoG DNA N-glycosylases as therapeutic targets.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boiteux</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre de Biophysique Moléculaire, CNRS, UPR4301, rue Charles Sadron, 45072 Orléans, France. Electronic address: serge.boiteux@cnrs-orleans.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coste</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre de Biophysique Moléculaire, CNRS, UPR4301, rue Charles Sadron, 45072 Orléans, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castaing</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre de Biophysique Moléculaire, CNRS, UPR4301, rue Charles Sadron, 45072 Orléans, France. Electronic address: bertrand.castaing@cnrs-orleans.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029968">Escherichia coli Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>5614-64-2</RegistryNumber><NameOfSubstance UI="C024829">8-hydroxyguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C061738">mutY adenine glycosylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.23</RegistryNumber><NameOfSubstance UI="D043382">DNA-Formamidopyrimidine Glycosylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.23</RegistryNumber><NameOfSubstance UI="C468610">DNA-formamidopyrimidine glycosylase, E coli</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043382" MajorTopicYN="N">DNA-Formamidopyrimidine Glycosylase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029968" MajorTopicYN="N">Escherichia coli Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042822" MajorTopicYN="N">Genomic Instability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">8-oxoguanine</Keyword><Keyword MajorTopicYN="Y">8-oxoguanine-DNA glycosylases</Keyword><Keyword MajorTopicYN="Y">Base excision repair</Keyword><Keyword MajorTopicYN="Y">Fpg</Keyword><Keyword MajorTopicYN="Y">GO repair network</Keyword><Keyword MajorTopicYN="Y">OGG1</Keyword><Keyword MajorTopicYN="Y">Spontaneous mutations</Keyword><Keyword MajorTopicYN="Y">Therapeutic targets cancer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27903453</ArticleId><ArticleId IdType="pii">S0891-5849(16)31078-4</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.11.042</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27864332</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-3804</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>01</Month></PubDate></JournalIssue><Title>Mutagenesis</Title><ISOAbbreviation>Mutagenesis</ISOAbbreviation></Journal><ArticleTitle>Weak silica nanomaterial-induced genotoxicity can be explained by indirect DNA damage as shown by the OGG1-modified comet assay and genomic analysis.</ArticleTitle><Pagination><MedlinePgn>5-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/mutage/gew064</ELocationID><Abstract><AbstractText>In a previous study, 15-nm silica nanoparticles (NPs) caused small increases in DNA damage in liver as measured in the in vivo comet and micronucleus assays after intravenous administration to rats at their maximum tolerated dose, a worst-case exposure scenario. Histopathological examination supported a particle-induced, tissue damage-mediated inflammatory response. This study used a targeted approach to provide insight into the mode of action (MoA) by examining transcriptional regulation of genes in liver in a time and dose-dependent manner at 1, 2, 4, 8 and 24 h after intravenous administration of 15-nm silica NPs. DNA damage was assessed using the standard comet assay and hOGG1 glycosylase-modified comet assay that also measures oxidative DNA damage. Potassium bromate, an IARC Class 2B carcinogen that specifically operates via an oxidative stress MoA, was used as a positive control for the hOGG1 comet assay and gave a strong signal in its main target organ, the kidney, while showing less activity in liver. Treatment of rats with silica NPs at 50 mg/kg body weight (bw) caused small, statistically insignificant increases in DNA damage in liver measured by the standard comet assay, while a statistically significant increase was observed at 4 h with the hOGG1 comet assay, consistent with a MoA involving reactive oxygen species. Histopathology showed liver damage and neutrophil involvement while genomic analysis and response pattern of key genes involved in inflammation and oxidative stress supported a tissue damage-mediated inflammatory response involving the complement system for removing/phagocytising damaged cells. No changes were observed for histopathology or gene array for the low-dose (5 mg/kg bw) silica NPs. The results of this study confirm our hypothesis that the weak DNA damage observed by silica NPs occurs secondary to inflammation/immune response, indicating that a threshold can be applied in the risk assessment of these materials.</AbstractText><CopyrightInformation>© The Author 2016. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pfuhler</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Downs</LastName><ForeName>Thomas R</ForeName><Initials>TR</Initials></Author><Author ValidYN="Y"><LastName>Allemang</LastName><ForeName>Ashley J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Yuching</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Crosby</LastName><ForeName>Meredith E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Present address: AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mutagenesis</MedlineTA><NlmUniqueID>8707812</NlmUniqueID><ISSNLinking>0267-8357</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7631-86-9</RegistryNumber><NameOfSubstance UI="D012822">Silicon Dioxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020552" MajorTopicYN="N">Comet Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012822" MajorTopicYN="N">Silicon Dioxide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27864332</ArticleId><ArticleId IdType="pii">gew064</ArticleId><ArticleId IdType="doi">10.1093/mutage/gew064</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27816939</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>291</Volume><Issue>51</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>16</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>O-GlcNAcylation of 8-Oxoguanine DNA Glycosylase (Ogg1) Impairs Oxidative Mitochondrial DNA Lesion Repair in Diabetic Hearts.</ArticleTitle><Pagination><MedlinePgn>26515-26528</MedlinePgn></Pagination><Abstract><AbstractText>mtDNA damage in cardiac myocytes resulting from increased oxidative stress is emerging as an important factor in the pathogenesis of diabetic cardiomyopathy. A prevalent lesion that occurs in mtDNA damage is the formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG), which can cause mutations when not repaired properly by 8-oxoguanine DNA glycosylase (Ogg1). Although the mtDNA repair machinery has been described in cardiac myocytes, the regulation of this repair has been incompletely investigated. Here we report that the hearts of type 1 diabetic mice, despite having increased Ogg1 protein levels, had significantly lower Ogg1 activity than the hearts of control, non-type 1 diabetic mice. In diabetic hearts, we further observed increased levels of 8-OHdG and an increased amount of mtDNA damage. Interestingly, Ogg1 was found to be highly O-GlcNAcylated in diabetic mice compared with controls. In vitro experiments demonstrated that O-GlcNAcylation inhibits Ogg1 activity, which could explain the mtDNA lesion accumulation observed in vivo Reducing Ogg1 O-GlcNAcylation in vivo by introducing a dominant negative O-GlcNAc transferase mutant (F460A) restored Ogg1 enzymatic activity and, consequently, reduced 8-OHdG and mtDNA damage despite the adverse hyperglycemic milieu. Taken together, our results implicate hyperglycemia-induced O-GlcNAcylation of Ogg1 in increased mtDNA damage and, therefore, provide a new plausible biochemical mechanism for diabetic cardiomyopathy.</AbstractText><CopyrightInformation>© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cividini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and fcividini@ucsd.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Brian T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Anzhi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Wenlong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suarez</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Juarez</LastName><ForeName>Julieta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>the Department of Pharmacology, Instituto Nacional de Cardiología, Juan Badiano 41, Barrio Belisario Domínguez Secc XVI, 14080 Tlalpan, DF, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diemer</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casteel</LastName><ForeName>Darren E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dillmann</LastName><ForeName>Wolfgang H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, University of California, San Diego, La Jolla, California 92093-0671 and wdillmann@ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 HL066941</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 NS047101</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Life Sci. 2013 Mar 28;92(11):657-63</RefSource><PMID Version="1">23000101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2000 Feb;14(2):355-60</RefSource><PMID Version="1">10657991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2007;76:679-99</RefSource><PMID Version="1">17408359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Amino Acids. 2011 Mar;40(3):819-28</RefSource><PMID Version="1">20676904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 May 23;97(11):5735-9</RefSource><PMID Version="1">10801981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1994 Jul 29;269(30):19321-30</RefSource><PMID Version="1">8034696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Jul 16;279(29):30133-42</RefSource><PMID Version="1">15138254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Mar 30;276(13):9838-45</RefSource><PMID Version="1">11148210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2003 Jul;17(10):1195-214</RefSource><PMID Version="1">12832285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Rev Camb Philos Soc. 2004 May;79(2):235-51</RefSource><PMID Version="1">15191224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Life Sci. 2013 Mar 28;92(11):648-56</RefSource><PMID Version="1">22728715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2010 Feb 4;9(2):144-52</RefSource><PMID Version="1">20042377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aging Cell. 2012 Jun;11(3):439-48</RefSource><PMID Version="1">22314054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Dec 12;289(50):34449-56</RefSource><PMID Version="1">25336635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Nov 7;278(45):44230-7</RefSource><PMID Version="1">12941958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bioenerg Biomembr. 2011 Feb;43(1):25-9</RefSource><PMID Version="1">21286795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jun 07;33(10):3271-82</RefSource><PMID Version="1">15942030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2006 Apr 15;212(2):167-78</RefSource><PMID Version="1">16490224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2005 May 13;96(9):1006-13</RefSource><PMID Version="1">15817886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2227-36</RefSource><PMID Version="1">17208994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Regul Integr Comp Physiol. 2012 Oct 1;303(7):R689-99</RefSource><PMID Version="1">22874425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2016 Dec;1863(12 ):2977-2992</RefSource><PMID Version="1">27646922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2000 May 12;86(9):960-6</RefSource><PMID Version="1">10807868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Protoc Hum Genet. 2009 Jul;Chapter 19:Unit 19.1</RefSource><PMID Version="1">19582765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1988 Sep;85(17):6465-7</RefSource><PMID Version="1">3413108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Gerontol. 2010 Aug;45(7-8):478-88</RefSource><PMID Version="1">20096766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2004 Apr;1011:101-11</RefSource><PMID Version="1">15126288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Jun 1;32(11):1102-15</RefSource><PMID Version="1">12031895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 2011 Mar;32(3):125-30</RefSource><PMID Version="1">21216018</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2007 May 25;100(10):1415-27</RefSource><PMID Version="1">17525381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Mar;26(5):1654-65</RefSource><PMID Version="1">16478987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2010 Jul 23;107(2):171-85</RefSource><PMID Version="1">20651294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Oct 21;280(42):35537-44</RefSource><PMID Version="1">16105839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 May 12;112(19):6050-5</RefSource><PMID Version="1">25918408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Apr 4;272(14):9308-15</RefSource><PMID Version="1">9083067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Aug 24;287(35):30024-34</RefSource><PMID Version="1">22745122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2007 Apr 6;355(2):431-7</RefSource><PMID Version="1">17303074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Endocr Disord. 2002 Apr 25;2(1):2</RefSource><PMID Version="1">12003641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Aug 17;287(34):28882-97</RefSource><PMID Version="1">22692202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):514-9</RefSource><PMID Version="1">9012815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Apr 4;272(14):9316-24</RefSource><PMID Version="1">9083068</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 1999 Feb 9;1410(2):103-23</RefSource><PMID Version="1">10076021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 1993 Jul;9(7):246-9</RefSource><PMID Version="1">8379000</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2014 May 1;306(9):C794-804</RefSource><PMID Version="1">24553187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1977 Apr;74(4):1348-52</RefSource><PMID Version="1">266177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1984 Mar 10;259(5):3308-17</RefSource><PMID Version="1">6421821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Biochem Biophys. 1995 Feb 1;316(2):909-16</RefSource><PMID Version="1">7864650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Jan 2;284(1):547-55</RefSource><PMID Version="1">19004814</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058065" MajorTopicYN="N">Diabetic Cardiomyopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008929" MajorTopicYN="N">Mitochondria, Heart</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">8-oxoguanine glycosylase (OGG1)</Keyword><Keyword MajorTopicYN="Y">cardiomyopathy</Keyword><Keyword MajorTopicYN="Y">mtDNA; O-linked N-acetylglucosamine (O-GlcNAc)</Keyword><Keyword MajorTopicYN="Y">oxidative stress</Keyword><Keyword MajorTopicYN="Y">type 1 diabetes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>08</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27816939</ArticleId><ArticleId IdType="pii">M116.754481</ArticleId><ArticleId IdType="doi">10.1074/jbc.M116.754481</ArticleId><ArticleId IdType="pmc">PMC5159511</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27813497</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>47</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>22</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.</ArticleTitle><Pagination><MedlinePgn>77482-77494</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.13030</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To define the role of the DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1) in predicting the prognosis and chemotherapeutic response of non-small cell lung cancer patients receiving platinum-containing chemotherapy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our investigations found that serum APE1 level was significantly elevated in 229 of 412 NSCLC patients and correlated with its level in tissue (r2 = 0.639, p &lt; 0.001). The elevated APE1 level in both tissue and serum of patients prior to chemotherapy was associated with worse progression-free survival (HR: 2.165, p &lt; 0.001, HR: 1.421, p = 0.012), but not with overall survival. After 6 cycles of chemotherapy, a low APE1 serum level was associated with better overall survival (HR: 0.497, p = 0.010).</AbstractText><AbstractText Label="EXPERIMENTAL DESIGN" NlmCategory="METHODS">We measured APE1 protein levels in biopsy tissue from 172 NSCLC patients and sera of 412 NSCLC patients receiving platinum-based chemotherapy by immunohistochemistry and a newly established sensitive and specific enzyme-linked immunosorbent assay, respectively. APE1 levels in sera of 523 healthy donors were also determined as control.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our studies indicate that APE1 is a biomarker for predicting prognosis and therapeutic efficacy in NSCLC. The chemotherapy-naïve serum APE1 level, which correlated with its tissue level inversely associated with progression-free survival of platinum-containing doublet chemotherapy, whereas post-treatment serum APE1 level was inversely associated with overall survival.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shiheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Jinlu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xueqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaoyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongyi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology, Baylor University Medical Center, Dallas, TX 75246, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baugh</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology, Baylor University Medical Center, Dallas, TX 75246, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tell</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology and DNA repair, Department of Medical and Biological Sciences, University of Udine, Udine 33100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Laboratory of Molecular Gerontology, National Institute on Aging, Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>49DFR088MY</RegistryNumber><NameOfSubstance UI="D010984">Platinum</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 May 10;6(13):11575-84</RefSource><PMID Version="1">25865228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2011 Jun;10(6):M110.005330</RefSource><PMID Version="1">21474795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2012;19(22):3689-700</RefSource><PMID Version="1">22680928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2005 Oct 10;116(6):925-33</RefSource><PMID Version="1">15856462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 7;435(3):403-7</RefSource><PMID Version="1">23665318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1998 Jun 1;26(11):2771-8</RefSource><PMID Version="1">9592167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2014 Jan;34(1):493-501</RefSource><PMID Version="1">24403507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2009 Dec;66(3):298-304</RefSource><PMID Version="1">19324449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Chemother Pharmacol. 2014 Oct;74(4):777-86</RefSource><PMID Version="1">25107571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2012 Feb 14;9(3):144-55</RefSource><PMID Version="1">22330686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 1995 Mar;36(3):455-8</RefSource><PMID Version="1">7698709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2005 Dec 18;230(2):187-98</RefSource><PMID Version="1">16297705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 04;9(9):e106485</RefSource><PMID Version="1">25188410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1992 Aug 1;52(15):4168-74</RefSource><PMID Version="1">1322237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2013 Mar 21;368(12):1101-10</RefSource><PMID Version="1">23514287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Oct 17;502(7471):333-9</RefSource><PMID Version="1">24132290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2006 Apr;28(4):995-1002</RefSource><PMID Version="1">16525651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2002 Mar;8(3):752-8</RefSource><PMID Version="1">11895905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e58001</RefSource><PMID Version="1">23472128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2015 Jun 1;75(11):2133-8</RefSource><PMID Version="1">25931285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Sep 15;6(27):23383-98</RefSource><PMID Version="1">26125438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Korean Circ J. 2015 Sep;45(5):364-71</RefSource><PMID Version="1">26413103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2015 Oct;47(4):823-33</RefSource><PMID Version="1">25672588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2011 Nov 15;17(22):6973-84</RefSource><PMID Version="1">21908578</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="Y">Biomarkers, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010984" MajorTopicYN="N">Platinum</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">NSCLC</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">chemotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27813497</ArticleId><ArticleId IdType="pii">13030</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.13030</ArticleId><ArticleId IdType="pmc">PMC5340230</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27535970</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-8514</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>11</Month></PubDate></JournalIssue><Title>Molecular cancer therapeutics</Title><ISOAbbreviation>Mol. Cancer Ther.</ISOAbbreviation></Journal><ArticleTitle>Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.</ArticleTitle><Pagination><MedlinePgn>2722-2732</MedlinePgn></Pagination><Abstract><AbstractText>Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality in the United States. Aggressive treatment regimens have not changed the disease course, and the median survival has just recently reached a year. Several mechanisms are proposed to play a role in PDAC therapeutic resistance, including hypoxia, which creates a more aggressive phenotype with increased metastatic potential and impaired therapeutic efficacy. AP Endonuclease-1/Redox Effector Factor 1 (APE1/Ref-1) is a multifunctional protein possessing a DNA repair function in base excision repair and the ability to reduce oxidized transcription factors, enabling them to bind to their DNA target sequences. APE1/Ref-1 regulates several transcription factors involved in survival mechanisms, tumor growth, and hypoxia signaling. Here, we explore the mechanisms underlying PDAC cell responses to hypoxia and modulation of APE1/Ref-1 redox signaling activity, which regulates the transcriptional activation of hypoxia-inducible factor 1 alpha (HIF1α). Carbonic anhydrase IX (CA9) is regulated by HIF1α and functions as a part of the cellular response to hypoxia to regulate intracellular pH, thereby promoting cell survival. We hypothesized that modulating APE1/Ref-1 function will block activation of downstream transcription factors, STAT3 and HIF1α, interfering with the hypoxia-induced gene expression. We demonstrate APE1/Ref-1 inhibition in patient-derived and established PDAC cells results in decreased HIF1α-mediated induction of CA9. Furthermore, an ex vivo three-dimensional tumor coculture model demonstrates dramatic enhancement of APE1/Ref-1-induced cell killing upon dual targeting of APE1/Ref-1 and CA9. Both APE1/Ref-1 and CA9 are under clinical development; therefore, these studies have the potential to direct novel PDAC therapeutic treatment. Mol Cancer Ther; 15(11); 2722-32. ©2016 AACR.</AbstractText><CopyrightInformation>©2016 American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Logsdon</LastName><ForeName>Derek P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimard</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Meihua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahda</LastName><ForeName>Safi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pancreatic Cancer Signature Center, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yanlin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhangsheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zyromski</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pancreatic Cancer Signature Center, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schipani</LastName><ForeName>Ernestina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurofarba Department, Section of Medicinal Chemistry, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Supuran</LastName><ForeName>Claudiu T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Neurofarba Department, Section of Medicinal Chemistry, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korc</LastName><ForeName>Murray</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pancreatic Cancer Signature Center, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivan</LastName><ForeName>Mircea</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pancreatic Cancer Signature Center, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pancreatic Cancer Signature Center, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fishel</LastName><ForeName>Melissa L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana. mfishel@iu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pancreatic Cancer Signature Center, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 CA122298</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 CA075059</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001108</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA075059</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR065403</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS091667</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cancer Ther</MedlineTA><NlmUniqueID>101132535</NlmUniqueID><ISSNLinking>1535-7163</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000951">Antigens, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.1.1</RegistryNumber><NameOfSubstance UI="C089226">CA9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.1.1</RegistryNumber><NameOfSubstance UI="D000071231">Carbonic Anhydrase IX</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2009 Sep 8;16(3):259-66</RefSource><PMID Version="1">19732725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1853-67</RefSource><PMID Version="1">18627350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2013 Apr 30;52(17):2955-66</RefSource><PMID Version="1">23597102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncology (Williston Park). 2014 Jan;28(1):70-4</RefSource><PMID Version="1">24683721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Jun 1;18(11):3100-11</RefSource><PMID Version="1">22498007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vision Res. 2011 Jan;51(1):93-100</RefSource><PMID Version="1">20937296</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Sep 5;10(9):942-52</RefSource><PMID Version="1">21741887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2011 Jan 11;50(1):82-92</RefSource><PMID Version="1">21117647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</RefSource><PMID Version="1">17560642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2015 Sep;95(3):318-36</RefSource><PMID Version="1">25921418</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Pharmacol. 2013 Apr 30;4:56</RefSource><PMID Version="1">23641216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Hematol. 2010 Dec;38(12 ):1178-88</RefSource><PMID Version="1">20826193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2011 Sep;10(9):1698-708</RefSource><PMID Version="1">21700832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2015 Jan 1;75(1):111-9</RefSource><PMID Version="1">25385028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Pharm Sin B. 2015 Sep;5(5):378-89</RefSource><PMID Version="1">26579469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2014 Jun 16;25(6):735-47</RefSource><PMID Version="1">24856585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Enzyme Inhib Med Chem. 2016;31(3):345-60</RefSource><PMID Version="1">26619898</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Redox Biol. 2014 Feb 21;2:485-94</RefSource><PMID Version="1">24624338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aliment Pharmacol Ther. 2003 Oct 15;18(8):837-46</RefSource><PMID Version="1">14535878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2015 Sep;779:96-104</RefSource><PMID Version="1">26164266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Nutr. 2015 Mar 27;2:10</RefSource><PMID Version="1">25988138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Nov;28(9):885-95</RefSource><PMID Version="1">20919954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Jul 18;283(29):20473-83</RefSource><PMID Version="1">18482982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Oncol. 2015 Feb;42(1):19-27</RefSource><PMID Version="1">25726049</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Physiol. 2014 Jan 08;4:400</RefSource><PMID Version="1">24409151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 17;51(2):695-705</RefSource><PMID Version="1">22148505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2010 Aug 15;80(4):455-62</RefSource><PMID Version="1">20488164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Signal. 2013 Apr 02;6(269):pl1</RefSource><PMID Version="1">23550210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Histochem Cell Biol. 2000 Sep;114(3):197-204</RefSource><PMID Version="1">11083462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Pathol. 2012;40(1):18-32</RefSource><PMID Version="1">22131108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2011 Aug 1;12(3):198-207</RefSource><PMID Version="1">21613822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2014 Aug 28;20(32):11216-29</RefSource><PMID Version="1">25170206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2008 Jul;7(7):2012-21</RefSource><PMID Version="1">18645011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Molecules. 2015 Nov 19;20(11):20551-68</RefSource><PMID Version="1">26610437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2014 Aug;1846(1):152-60</RefSource><PMID Version="1">24821201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2014 Nov 30;5(22):10969-75</RefSource><PMID Version="1">25473891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2006 Feb 22;7:85</RefSource><PMID Version="1">16504059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2012 Jan;3(1):84-97</RefSource><PMID Version="1">22289741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2008 Jun;7(6):882-8</RefSource><PMID Version="1">18344687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Metastasis Rev. 2015 Mar;34(1):97-114</RefSource><PMID Version="1">25566685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Mar 30;149(1):63-74</RefSource><PMID Version="1">22464323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Sep 26;321(5897):1801-6</RefSource><PMID Version="1">18772397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2000 Jul;2(7):423-7</RefSource><PMID Version="1">10878807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2016 May;55(5):688-704</RefSource><PMID Version="1">25865359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e55313</RefSource><PMID Version="1">23418439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Aug 15;18(16):4266-76</RefSource><PMID Version="1">22896693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Jul 19;288(29):21197-207</RefSource><PMID Version="1">23740244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2014 Mar 27;33(13):1670-9</RefSource><PMID Version="1">23604114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2009 Apr;1795(2):162-72</RefSource><PMID Version="1">19344680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Metastasis. 2012 Aug;29(6):615-24</RefSource><PMID Version="1">22484976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2012 May;2(5):401-4</RefSource><PMID Version="1">22588877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 May 15;63(10):2649-57</RefSource><PMID Version="1">12750293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2009 Nov 2;8(11):1273-82</RefSource><PMID Version="1">19726241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Future Oncol. 2014 May;10(7):1215-37</RefSource><PMID Version="1">24947262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Drug Discov. 2015 Jun;10 (6):591-7</RefSource><PMID Version="1">25891195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2015 Jan 30;290(5):3057-68</RefSource><PMID Version="1">25492865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Subcell Biochem. 2014;75:181-98</RefSource><PMID Version="1">24146380</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2014 Feb 20;5:e1065</RefSource><PMID Version="1">24556680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Physiol. 2014 Apr 09;5:141</RefSource><PMID Version="1">24782785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2016 May;15(5):794-805</RefSource><PMID Version="1">26873728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Biol. 2016 Feb 19;11(2):308-18</RefSource><PMID Version="1">26730496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2015 Jul 15;75(14):2800-10</RefSource><PMID Version="1">25979873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47462</RefSource><PMID Version="1">23094050</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000951" MajorTopicYN="N">Antigens, Neoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071231" MajorTopicYN="N">Carbonic Anhydrase IX</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021441" MajorTopicYN="N">Carcinoma, Pancreatic Ductal</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051795" MajorTopicYN="N">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="N">STAT3 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018874" MajorTopicYN="N">Spheroids, Cellular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Mark R. Kelley has licensed APX3330 though Indiana University Research &amp; Technology Corporation to ApeX Therapeutics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>08</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27535970</ArticleId><ArticleId IdType="pii">1535-7163.MCT-16-0253</ArticleId><ArticleId IdType="doi">10.1158/1535-7163.MCT-16-0253</ArticleId><ArticleId IdType="pmc">PMC5097013</ArticleId><ArticleId IdType="mid">NIHMS810248</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27802207</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-8592</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Cancer biomarkers : section A of Disease markers</Title><ISOAbbreviation>Cancer Biomark</ISOAbbreviation></Journal><ArticleTitle>APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.</ArticleTitle><Pagination><MedlinePgn>313-322</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional enzyme that is involved in DNA repair and the redox regulation of transcription factors. Blocking these functions leads to cell-growth inhibition, apoptosis and other effects. Previous studies have demonstrated that high expression levels of the APE1 protein are associated with the progression and chemoresistance of cancers. We hypothesized that APE1 silencing in ovarian cancer cells might have anticancer effects mediated by cell-growth inhibition and an increase in drug-sensitivity.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In this study, we explored the consequences of APE1 silencing in ovarian cancer cells.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Immunohistochemistry (IHC) was used to detect the APE1 protein levels in tissue samples from twelve ovarian cancer (OC) patients and eleven non-OC patients. APE1 knockdown was achieved via the stable transfection of SKOV3 and A2780 cells with a construct encoding a short hairpin DNA directed against the APE1 gene. Then, cell proliferation, colony formation, cell cycle and apoptosis assays were performed to reveal the consequences of APE1 silencing in ovarian cancer cells. Additionally, the SKOV3 and A2780 cells were subjected to the treatment with camptothecin (CPT) and ultraviolet rays (UV) to assess the possible link between the APE1 protein and drug-resistance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our results revealed that the APE1 protein was overexpressed in OC tissues. APE1 knockdown in A2780 and SKOV3 cells reduced cell proliferation, arrested cell cycle progression, repressed colony formation and weakly promoted cell apoptosis through the BAX and BCL-2 apoptotic pathways. Additionally, the down-regulation of APE1 significantly enhanced the sensitivity of ovarian cancer cells to the CPT/UV treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study suggested that the APE1 protein is important for the proliferation and growth of ovarian cancer cells. APE1 silencing might enhance drug-sensitivity, and thus APE1 might serve as a novel anti-OC therapeutic target.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Renquan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Suhong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongling</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Jiajun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Cancer Biomark</MedlineTA><NlmUniqueID>101256509</NlmUniqueID><ISSNLinking>1574-0153</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="Y">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apurinic/apyrimidinic endonuclease 1</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">ovarian cancer</Keyword><Keyword MajorTopicYN="N">proliferation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27802207</ArticleId><ArticleId IdType="pii">CBM643</ArticleId><ArticleId IdType="doi">10.3233/CBM-160643</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27611085</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1551-4005</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>22</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>16</Day></PubDate></JournalIssue><Title>Cell cycle (Georgetown, Tex.)</Title><ISOAbbreviation>Cell Cycle</ISOAbbreviation></Journal><ArticleTitle>Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.</ArticleTitle><Pagination><MedlinePgn>3048-3059</MedlinePgn></Pagination><Abstract><AbstractText>Exposure of renal cells to high glucose (HG) during diabetes has been recently proposed to be involved in renal injury. In the present study, we investigated a potential mechanism by which AICAR treatment regulates the DNA repair enzyme, 8-oxoG-DNA glycosylase (OGG1) in renal proximal tubular mouse cells exposed to HG and in kidney of db/db mice. Cells treated with HG for 2 days show inhibition in OGG1 promoter activity as well as OGG1 and Nrf2 protein expression. In addition, activation of AMPK by AICAR resulted in an increase raptor phosphorylation at Ser<sup>792</sup> and leads to increase the promoter activity of OGG1 through upregulation of Nrf2. Downregulation of AMPK by DN-AMPK and raptor and Nrf2 by siRNA resulted in significant decease in promoter activity and protein expression of OGG1. On the other hand, downregulation of Akt by DN-Akt and rictor by siRNA resulted in significant increase in promoter activity and protein expression of Nrf2 and OGG1. Moreover, gel shift analysis shows reduction of Nrf2 binding to OGG1 promoter in cells treated with HG while cells treated with AICAR reversed the effect of HG. Furthermore, db/db mice treated with AICAR show significant increased in AMPK and raptor phosphroylation as well as OGG1 and Nrf2 protein expression that associated with significant decrease in oxidative DNA damage (8-oxodG) compared to non-treated mice. In summary, our data provide a novel protective mechanism by which AICAR prevents renal cell damage in diabetes and the consequence complications of hyperglycemia with a specific focus on nephropathy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Habib</LastName><ForeName>Samy L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>a Department of Cellular and Structural Biology , University of Texas Health Science Center , San Antonio , TX , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Geriatric Research, Education and Clinical Department , South Texas Veterans Health Care System , San Antonio , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Anamika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>a Department of Cellular and Structural Biology , University of Texas Health Science Center , San Antonio , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kidane</LastName><ForeName>Dawit</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>c Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute , Austin , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>d Division of Nephrology and Cancer Center, University of California at Davis , Davis , CA , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Sitai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Department of Cellular and Structural Biology , University of Texas Health Science Center , San Antonio , TX , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Cycle</MedlineTA><NlmUniqueID>101137841</NlmUniqueID><ISSNLinking>1551-4005</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D046912">Multiprotein Complexes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076226">Rapamycin-Insensitive Companion of mTOR Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076223">Regulatory-Associated Protein of mTOR</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012265">Ribonucleotides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C540162">Rptor protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C525637">rictor protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>360-97-4</RegistryNumber><NameOfSubstance UI="D000620">Aminoimidazole Carboxamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.31</RegistryNumber><NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>F0X88YW0YK</RegistryNumber><NameOfSubstance UI="C031143">AICA ribonucleotide</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2006 Nov 8;5(11):1337-45</RefSource><PMID Version="1">16861056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Renal Physiol. 2008 Jan;294(1):F281-90</RefSource><PMID Version="1">17989114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Clin Nutr Metab Care. 2002 Sep;5(5):561-8</RefSource><PMID Version="1">12172481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2006 May;168(5):1443-51</RefSource><PMID Version="1">16651612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2005 Nov;25(21):9554-75</RefSource><PMID Version="1">16227605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22</RefSource><PMID Version="1">9240432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2008 Oct;51(10):1761-4</RefSource><PMID Version="1">18696044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2012 Oct;23(10):1652-62</RefSource><PMID Version="1">22904348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2002 Jun;45(6):877-82</RefSource><PMID Version="1">12107732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2002 Jan;45(1):85-96</RefSource><PMID Version="1">11845227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2003 May;26(5):1507-12</RefSource><PMID Version="1">12716813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2003 Mar;24(3):573-82</RefSource><PMID Version="1">12663520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2010 Jun;59(6):1386-96</RefSource><PMID Version="1">20299472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2005 Jun;54(6):1615-25</RefSource><PMID Version="1">15919781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2002 Jun 21;294(4):798-805</RefSource><PMID Version="1">12061777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2008 Jan 24;7:10</RefSource><PMID Version="1">18218111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Dec 13;414(6865):813-20</RefSource><PMID Version="1">11742414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2010 Oct;46(15):2806-20</RefSource><PMID Version="1">20656472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):109-18</RefSource><PMID Version="1">11018584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S241-5</RefSource><PMID Version="1">12874439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Endocrinol Metab. 2013 Jan 1;304(1):E87-99</RefSource><PMID Version="1">23132297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2008 Oct;57(10):2626-36</RefSource><PMID Version="1">18599524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2010 Feb;30(4):908-21</RefSource><PMID Version="1">19995915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2004 Sep;567(1):1-61</RefSource><PMID Version="1">15341901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Obes Metab. 2011 Dec;13(12):1097-104</RefSource><PMID Version="1">21733059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Renal Physiol. 2006 Jul;291(1):F162-75</RefSource><PMID Version="1">16467130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 1976 May 7;72:248-54</RefSource><PMID Version="1">942051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Jul;29(14):3991-4001</RefSource><PMID Version="1">19451232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2010 Nov;31(11):2022-30</RefSource><PMID Version="1">20837600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Aug 12;280(32):29158-68</RefSource><PMID Version="1">15901726</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Biochem Biophys. 2007;47(3):332-47</RefSource><PMID Version="1">17652779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Jul;26(14 ):5336-47</RefSource><PMID Version="1">16809770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2008 Oct;51(10):1893-900</RefSource><PMID Version="1">18709353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12932-7</RefSource><PMID Version="1">19625624</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000620" MajorTopicYN="N">Aminoimidazole Carboxamide</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007687" MajorTopicYN="N">Kidney Tubules, Proximal</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076222" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046912" MajorTopicYN="N">Multiprotein Complexes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076226" MajorTopicYN="N">Rapamycin-Insensitive Companion of mTOR Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076223" MajorTopicYN="N">Regulatory-Associated Protein of mTOR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012265" MajorTopicYN="N">Ribonucleotides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AICAR</Keyword><Keyword MajorTopicYN="N">AMPK</Keyword><Keyword MajorTopicYN="N">Nrf2</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27611085</ArticleId><ArticleId IdType="doi">10.1080/15384101.2016.1231259</ArticleId><ArticleId IdType="pmc">PMC5134712</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">27681698</PMID><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2415</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>BMC ophthalmology</Title><ISOAbbreviation>BMC Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Association between polymorphisms of OGG1, EPHA2 and age-related cataract risk: a meta-analysis.</ArticleTitle><Pagination><MedlinePgn>168</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Evidences have identified the correlation of 8-oxoguanine DNA glycosylase-1 (OGG1) and eph-receptor tyrosine kinase-type A2 (EPHA2) polymorphisms in age-related cataract (ARC) risk. However, the results were not consistent. The objective of this study was to examine the role of these two gene polymorphisms in ARC susceptibility.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Eligible case-control studies published between January 2000 and 2015 were searched and retrieved in the electronic databases. The odds ratio with 95 % confidence interval (CI) was employed to calculate the strength of the relationship.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We totally screened out six articles, including 5971 cataract patients and 4189 matched controls. Three variants were contained (OGG1 rs1052133; EPHA2 rs7543472 and rs11260867). For OGG1 rs1052133, we detected a significant correlation between OGG1 polymorphism and ARC risk under the heterogenous model (CG vs. CC: OR = 1.34, 95 % CI = 1.06-1.70, P = 0.01) and dominant model (GG+CG vs. CC: OR = 1.45, 95 % CI = 1.16-1.81, P = 0.001), especially in patients with cortical cataract of subgroup analysis by phenotypes (P &lt; 0.05). For EPHA2 rs7543472 and rs11260867, we did not find a positive association between these two mutations and ARC susceptibility in total cases. Subgroup analysis by phenotypes of cataract showed that only in cortical cataract, genotypes of rs7543472 under the allele model, homogenous model and recessive model; genotypes of rs11260867 under the heterogenous model and dominant model were associated with ARC risk.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">OGG1 rs1052133 (CG and CG+GG genotypes) might be risk factor for ARC, particularly in cortical cataract risk. EPHA2 rs7543472 (T allele and TT genotype) and rs11260867 (CG and GG+CG genotypes) might be associated with cortical cataract.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongxu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ophtalmology, Hangzhou First People's Hospital, Hangzhou Hospital Affiliated to Nanjing Medical University, Huansha Road No. 261, Hangzhou, 310006, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Jianguang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ophtalmology, Hangzhou First People's Hospital, Hangzhou Hospital Affiliated to Nanjing Medical University, Huansha Road No. 261, Hangzhou, 310006, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bian</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Hangzhou First People's Hospital, Hangzhou Hospital Affiliated to Nanjing Medical University, Hangzhou, 310006, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Central Laboratory, Hangzhou First People's Hospital, Hangzhou Hospital Affiliated to Nanjing Medical University, Hangzhou, 310006, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>You</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Hangzhou First People's Hospital, Hangzhou Hospital Affiliated to Nanjing Medical University, Hangzhou, 310006, Zhejiang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yongping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Ophtalmology, Hangzhou First People's Hospital, Hangzhou Hospital Affiliated to Nanjing Medical University, Huansha Road No. 261, Hangzhou, 310006, Zhejiang, People's Republic of China. huypkf@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Ophthalmol</MedlineTA><NlmUniqueID>100967802</NlmUniqueID><ISSNLinking>1471-2415</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):708-26</RefSource><PMID Version="1">23901781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2012 May;96(5):614-8</RefSource><PMID Version="1">22133988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2014 May 21;20:661-9</RefSource><PMID Version="1">24868140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(8):e42120</RefSource><PMID Version="1">22916121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Jul 11;289(28):19694-703</RefSource><PMID Version="1">24825902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Ophthalmol. 2010 May;88(3):358-66</RefSource><PMID Version="1">19222399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2012 Jul;27(4):501-10</RefSource><PMID Version="1">22451681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pharmacol Toxicol. 2015;55:465-87</RefSource><PMID Version="1">25292427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2010 Mar 24;16:511-7</RefSource><PMID Version="1">20361013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Age (Dordr). 2013 Dec;35(6):2435-44</RefSource><PMID Version="1">23334603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2009 Jul;5(7):e1000584</RefSource><PMID Version="1">19649315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Chem Biol. 2015 Oct 16;10(10):2334-43</RefSource><PMID Version="1">26218629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(5):e36564</RefSource><PMID Version="1">22570727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2009 Nov 24;15:2448-63</RefSource><PMID Version="1">19956408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2015;40(8):815-21</RefSource><PMID Version="1">25310012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res Mol Brain Res. 1995 Apr;29(2):325-35</RefSource><PMID Version="1">7609620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2012 May;119(5):900-6</RefSource><PMID Version="1">22306120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2009 May;30(5):E603-11</RefSource><PMID Version="1">19306328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2008;14:2042-55</RefSource><PMID Version="1">19005574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2013 Oct;63:401-9</RefSource><PMID Version="1">23726996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2015 Jun;135:102-8</RefSource><PMID Version="1">25660075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2016 Jan 1;76(1):30-4</RefSource><PMID Version="1">26586787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(3):e33001</RefSource><PMID Version="1">22412971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2015 Aug 15;75(16):3327-39</RefSource><PMID Version="1">26130649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2015 Apr;40(4):378-85</RefSource><PMID Version="1">24911554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2013 Mar 15;126(Pt 6):1488-97</RefSource><PMID Version="1">23378024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Public Health. 1996;17:159-77</RefSource><PMID Version="1">8724222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci China Life Sci. 2012 May;55(5):434-43</RefSource><PMID Version="1">22645087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2013 Dec 13;54(14):ORSF5-ORSF13</RefSource><PMID Version="1">24335069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rev Prat. 2013 Jan;63(1):43-7</RefSource><PMID Version="1">23457826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2013 Feb 01;54(2):1201-7</RefSource><PMID Version="1">23322570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2012 Dec;119(12):2463-70</RefSource><PMID Version="1">22921386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2011;17:1553-8</RefSource><PMID Version="1">21686326</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2013 Apr 26;54(4):3010-8</RefSource><PMID Version="1">23572101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Ther Targets. 2011 Jan;15(1):31-51</RefSource><PMID Version="1">21142802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmic Genet. 2016;37(1):14-8</RefSource><PMID Version="1">24673449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Dec;12(12):1094-104</RefSource><PMID Version="1">24075420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):173-8</RefSource><PMID Version="1">17896293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2015 Nov;122(11):2179-85</RefSource><PMID Version="1">26278859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Aug 16;8(8):e71003</RefSource><PMID Version="1">23976972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2013 Sep 05;54(9):5989-94</RefSource><PMID Version="1">23887802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Aug 10;21(5):700-4</RefSource><PMID Version="1">24527727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2015 Nov;122(11):2169-78</RefSource><PMID Version="1">26256834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Aug 27;8(8):e72518</RefSource><PMID Version="1">24014202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Markers. 2015;2015:690878</RefSource><PMID Version="1">26089588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2013 Aug;84(2):120-7</RefSource><PMID Version="1">23647473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Geriatrics. 2009 May;64(5):19-22, 25-6</RefSource><PMID Version="1">19435391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Ophthalmol. 2015;2015:401894</RefSource><PMID Version="1">26664742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oftalmologia. 2006;50(2):3-9</RefSource><PMID Version="1">16927750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Ophthalmol. 1993 Jun;111(6):831-6</RefSource><PMID Version="1">8512486</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age-related cataract</Keyword><Keyword MajorTopicYN="N">EPHA2</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Polymorphism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>06</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>09</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27681698</ArticleId><ArticleId IdType="pmc">PMC5041552</ArticleId><ArticleId IdType="doi">10.1186/s12886-016-0341-y</ArticleId><ArticleId IdType="pii">10.1186/s12886-016-0341-y</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27655688</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>46</Issue><PubDate><Year>2016</Year><Month>11</Month><Day>15</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repair.</ArticleTitle><Pagination><MedlinePgn>75197-75209</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.12113</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic (AP) sites are frequently generated in the genome by spontaneous depurination/depyrimidination or after removal of oxidized/modified bases by DNA glycosylases during the base excision repair (BER) pathway. Unrepaired AP sites are mutagenic and block DNA replication and transcription. The primary enzyme to repair AP sites in mammalian cells is AP endonuclease (APE1), which plays a key role in this repair pathway. Although overexpression of APE1 in diverse cancer types and its association with chemotherapeutic resistance are well documented, alteration of posttranslational modification of APE1 and modulation of its functions during tumorigenesis are largely unknown. Here, we show that both classical histone deacetylase HDAC1 and NAD+-dependent deacetylase SIRT1 regulate acetylation level of APE1 and acetylation of APE1 enhances its AP-endonuclease activity both in vitro and in cells. Modulation of APE1 acetylation level in cells alters AP site repair capacity of the cell extracts in vitro. Primary tumor tissues of diverse cancer types have higher level of acetylated APE1 (AcAPE1) compared to adjacent non-tumor tissue and exhibit enhanced AP site repair capacity. Importantly, in the absence of APE1 acetylation, cells accumulate AP sites in the genome and show increased sensitivity to DNA damaging agents. Together, our study demonstrates that elevation of acetylation level of APE1 in tumor could be a novel mechanism by which cells handle the elevated levels of DNA damages in response to genotoxic stress and maintain sustained proliferation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Shiladitya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030 , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantha</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Animal Sciences, School of Basic and Applied Sciences, Central University of Punjab, Bathinda 151001, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Heyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roychoudhury</LastName><ForeName>Shrabasti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Somsubhra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Biology Research &amp; Diagnostic Laboratory, Saroj Gupta Cancer Centre &amp; Research Institute, Kolkata 700063, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray</LastName><ForeName>Sutapa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hematology/Oncology Division, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhakat</LastName><ForeName>Kishor K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA148941</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0U46U6E8UK</RegistryNumber><NameOfSubstance UI="D009243">NAD</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="D056564">Sirtuin 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.98</RegistryNumber><NameOfSubstance UI="D056284">Histone Deacetylase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):14-35</RefSource><PMID Version="1">22122462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Aug 25;643(1-2):54-63</RefSource><PMID Version="1">18579163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Nov 13;273(46):30360-5</RefSource><PMID Version="1">9804799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009 Jun 01;4(6):e5740</RefSource><PMID Version="1">19484131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Apr 29;280(17):17187-95</RefSource><PMID Version="1">15749705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Mar 31;674(1-2):131-6</RefSource><PMID Version="1">18948225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1994;63:915-48</RefSource><PMID Version="1">7979257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1997 Nov;385(2):139-49</RefSource><PMID Version="1">9447235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):686-91</RefSource><PMID Version="1">10639140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Oct;39(18):8017-28</RefSource><PMID Version="1">21727086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2008 Feb 1;7(2):177-86</RefSource><PMID Version="1">17974506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2011 Jan 27;30(4):482-93</RefSource><PMID Version="1">20856196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):83-108</RefSource><PMID Version="1">11018583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2010 Feb;24(2):391-401</RefSource><PMID Version="1">20032196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Jun;1820(6):730-5</RefSource><PMID Version="1">21571039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</RefSource><PMID Version="1">17560642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2010 Sep 1;334(3):988-98</RefSource><PMID Version="1">20504914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jul 15;29(14):3116-22</RefSource><PMID Version="1">11452037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Dec 8;4(12):1442-9</RefSource><PMID Version="1">16199212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1990 Oct 5;265(28):17174-9</RefSource><PMID Version="1">2211619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1972 Sep 12;11(19):3618-23</RefSource><PMID Version="1">4559796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 2006 Sep;19(9):1215-20</RefSource><PMID Version="1">16978026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):4079-96</RefSource><PMID Version="1">22918947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Jul 1;33(1):15-28</RefSource><PMID Version="1">12086678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1997 Dec 15;57(24):5457-9</RefSource><PMID Version="1">9407949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Feb 18;286(7):4968-77</RefSource><PMID Version="1">21081487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Dec;28(23):7066-80</RefSource><PMID Version="1">18809583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jul 16;8(7):e68467</RefSource><PMID Version="1">23874636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2012 May;30(5):917-25</RefSource><PMID Version="1">22441348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Res. 2008 Jan;42(1):20-9</RefSource><PMID Version="1">18324520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5061-6</RefSource><PMID Version="1">9560228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Jun 02;32(10):3033-9</RefSource><PMID Version="1">15175427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 1998 Mar;19(3):525-7</RefSource><PMID Version="1">9525290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2010 Jun;12 (6):563-71</RefSource><PMID Version="1">20473298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2010 Dec 1;49(11):1603-16</RefSource><PMID Version="1">20840865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2006 Dec;20(14):2612-4</RefSource><PMID Version="1">17068113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1995 Jan 16;358(1):1-3</RefSource><PMID Version="1">7821417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2522-32</RefSource><PMID Version="1">17403694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2011 Sep;28(3):673-8</RefSource><PMID Version="1">20354813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1990 Sep-Nov;236(2-3):173-201</RefSource><PMID Version="1">1697933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Aug 7;51(31):6246-59</RefSource><PMID Version="1">22788932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2016 Apr 19;7(16):22590-604</RefSource><PMID Version="1">26981776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2007 Jan;5(1):61-70</RefSource><PMID Version="1">17259346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 2010 Jan;23(1):99-107</RefSource><PMID Version="1">20017514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Nov;7(11):3510-8</RefSource><PMID Version="1">11705870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):651-68</RefSource><PMID Version="1">18715143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3609-20</RefSource><PMID Version="1">20711647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Mar;26(5):1654-65</RefSource><PMID Version="1">16478987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2001 Jul;114(Pt 13):2363-73</RefSource><PMID Version="1">11559745</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 1986;20:201-30</RefSource><PMID Version="1">3545059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2014 May 29;33(22):2876-87</RefSource><PMID Version="1">23831574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2008 May;60(2):277-84</RefSource><PMID Version="1">18061304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Des Devel Ther. 2014 May 09;8:485-96</RefSource><PMID Version="1">24872679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2008 May 23;379(1):28-37</RefSource><PMID Version="1">18436236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Oncol. 2015 Jun;9(6):1071-80</RefSource><PMID Version="1">25681012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Jan 5;3(1):1-12</RefSource><PMID Version="1">14697754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2003 Sep 1;35(5):495-503</RefSource><PMID Version="1">12927599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 2003 Apr;15(2):164-71</RefSource><PMID Version="1">12648672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43</RefSource><PMID Version="1">15824325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Nov 13;273(46):30352-9</RefSource><PMID Version="1">9804798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2009 Jun;136(7):2258-69</RefSource><PMID Version="1">19505426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2012 Mar 22;31(12 ):1546-57</RefSource><PMID Version="1">21841822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Oct 15;11(20):7405-14</RefSource><PMID Version="1">16243814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1999 Jan 28;18(4):1033-40</RefSource><PMID Version="1">10023679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2014 Jan 08;14:11</RefSource><PMID Version="1">24400589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2009 Apr 2;28(13):1616-25</RefSource><PMID Version="1">19219073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):621-39</RefSource><PMID Version="1">23879289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2010 Oct;24(10):3674-80</RefSource><PMID Version="1">20511393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2009 Jun;7(6):897-906</RefSource><PMID Version="1">19470598</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000107" MajorTopicYN="N">Acetylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056284" MajorTopicYN="N">Histone Deacetylase 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009243" MajorTopicYN="N">NAD</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056564" MajorTopicYN="N">Sirtuin 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BER</Keyword><Keyword MajorTopicYN="N">DNA damage repair</Keyword><Keyword MajorTopicYN="N">acetylation</Keyword><Keyword MajorTopicYN="N">apurinic/apyrimidinic endonuclease 1 (APE1)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>09</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27655688</ArticleId><ArticleId IdType="pii">12113</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.12113</ArticleId><ArticleId IdType="pmc">PMC5342734</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27637330</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>291</Volume><Issue>45</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses.</ArticleTitle><Pagination><MedlinePgn>23672-23680</MedlinePgn></Pagination><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1) is a multifunctional protein possessing DNA repair, redox control, and transcriptional regulatory activities. Although Ape1/Ref-1 plays multiple roles in the immune system, its functions in helper T (Th) cell activation and differentiation are largely unknown. In this study, the function of Ape1/Ref-1 in Th cell activation was analyzed using an Ape1/Ref-1 redox-specific inhibitor, E3330. When splenocytes from OT-II mice, which are ovalbumin (OVA)-specific T-cell receptor transgenic mice, were activated with OVA in the presence of E3330, the induction of IFN-γ-producing OT-II T cells was significantly increased. In contrast, E3330 did not enhance IFN-γ production from plate-bound anti-CD3 antibody-stimulated CD4<sup>+</sup> T cells in the absence of antigen presenting cells (APCs). Furthermore, E3330-pretreated and OVA-pulsed APCs also enhanced the IFN-γ production from OT-II T cells. These results suggested that E3330 enhances Th1 responses by modifying APC function. E3330 did not alter the surface expression of MHC-II or the co-stimulatory molecules CD80 and CD86 on APCs. On the other hand, E3330 up-regulated the IL-12 p35 and p40 gene expression, and IL-12 surface retention, but decreased the IL-12 secretion from Toll-like receptor (TLR) ligand-stimulated APCs. These results were confirmed with Ape1/Ref-1 knockdown experiments. Taken together, our findings indicated that the suppression of Ape1/Ref-1 redox function leads to an increased cell surface retention of IL-12 and enhances Th1 responses. This is the first study to demonstrate that Ape1/Ref-1 modulates the IL-12 production and secretion from APCs and controls Th1 immune responses.</AbstractText><CopyrightInformation>© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akhter</LastName><ForeName>Nasrin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>From the Department of Immunology, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Department of Immunology, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nara</LastName><ForeName>Hidetoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Immunology, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araki</LastName><ForeName>Akemi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Immunology, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>the Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai 980-8075, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asao</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>WPI-Advanced Institute for Materials Research, Tohoku University, Sendai 980-8577, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asao</LastName><ForeName>Hironobu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Immunology, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, asao-h@med.id.yamagata-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016227">Benzoquinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011422">Propionates</NameOfSubstance></Chemical><Chemical><RegistryNumber>136164-66-4</RegistryNumber><NameOfSubstance UI="C075569">E 3330</NameOfSubstance></Chemical><Chemical><RegistryNumber>187348-17-0</RegistryNumber><NameOfSubstance UI="D018664">Interleukin-12</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1853-67</RefSource><PMID Version="1">18627350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Oct 5;276(40):37692-9</RefSource><PMID Version="1">11477091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Cell Biol. 1998 Feb;76(1):34-40</RefSource><PMID Version="1">9553774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 Apr 15;14(8):1387-401</RefSource><PMID Version="1">20874257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1991 Oct 25;19(20):5519-23</RefSource><PMID Version="1">1719477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Jan 14;275(2):867-74</RefSource><PMID Version="1">10625620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</RefSource><PMID Version="1">17560642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 2007 Oct;19(10):1191-9</RefSource><PMID Version="1">17698559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Jan 16;279(3):1777-86</RefSource><PMID Version="1">14594818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11450-4</RefSource><PMID Version="1">1722334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2000 Aug 21;192(4):507-16</RefSource><PMID Version="1">10952720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2004 Mar 12;22(9-10):1199-205</RefSource><PMID Version="1">15003648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2009 Nov 15;183(10):6839-48</RefSource><PMID Version="1">19846872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 1996;14:233-58</RefSource><PMID Version="1">8717514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Inflamm Res. 2013 Nov;62(11):951-9</RefSource><PMID Version="1">23979690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e41260</RefSource><PMID Version="1">22844448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 1996 Aug 23;225(3):1063-7</RefSource><PMID Version="1">8780734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 2000 May;267(9):2624-31</RefSource><PMID Version="1">10785383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2013 Apr;33(7):1468-73</RefSource><PMID Version="1">23382073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Oct 3;278(40):38829-39</RefSource><PMID Version="1">12832423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytokine. 2013 May;62(2):262-71</RefSource><PMID Version="1">23557800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1991 Jul 12;66(1):9-10</RefSource><PMID Version="1">2070420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2012 Apr 13;420(3):628-34</RefSource><PMID Version="1">22450323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2000 Aug;18(8):877-81</RefSource><PMID Version="1">10932159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gene Med. 2004 Jul;6(7):777-85</RefSource><PMID Version="1">15241785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1999 Dec 15;163(12 ):6403-12</RefSource><PMID Version="1">10586030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Mar 1;109(5):1917-22</RefSource><PMID Version="1">17053053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Immunol Rev. 2005 Jun;1(2):119-137</RefSource><PMID Version="1">21037949</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000938" MajorTopicYN="N">Antigen-Presenting Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016227" MajorTopicYN="N">Benzoquinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018664" MajorTopicYN="N">Interleukin-12</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011422" MajorTopicYN="N">Propionates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018417" MajorTopicYN="N">Th1 Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Ape1/Ref-1</Keyword><Keyword MajorTopicYN="Y">IL-12</Keyword><Keyword MajorTopicYN="Y">T helper cells</Keyword><Keyword MajorTopicYN="Y">antigen presenting cell</Keyword><Keyword MajorTopicYN="Y">cytokine</Keyword><Keyword MajorTopicYN="Y">dendritic cell</Keyword><Keyword MajorTopicYN="Y">differentiation</Keyword><Keyword MajorTopicYN="Y">redox regulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>06</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27637330</ArticleId><ArticleId IdType="pii">M116.742353</ArticleId><ArticleId IdType="doi">10.1074/jbc.M116.742353</ArticleId><ArticleId IdType="pmc">PMC5095420</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27539671</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1880-4233</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>Breast cancer (Tokyo, Japan)</Title><ISOAbbreviation>Breast Cancer</ISOAbbreviation></Journal><ArticleTitle>Genetic polymorphisms in APE1 Asp148Glu(rs3136820) as a modifier of the background levels of abasic sites in human leukocytes derived from breast cancer patients and controls.</ArticleTitle><Pagination><MedlinePgn>420-426</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12282-016-0719-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Apurinic/apyrimidinic (abasic/AP) sites are among the most common endogenous DNA lesions. AP sites, if not repaired, could result in genomic instability as well as chromosome aberrations. Information regarding the direct assay of the number of abasic sites in human leukocytes and its association with risk of breast cancer has not been reported.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we investigated the association between certain risk factors for breast cancer and the background levels of AP sites in leukocytes derived from 148 Taiwanese women with breast cancer and 140 cancer-free controls. The risk factors studied include age, body mass index (BMI), and polymorphisms of apurinic/apyrimidinic endonuclease (APE1) [APE1 Asp148Glu(rs3136820)].</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean levels of AP sites were estimated to be 23.3 and 50.3 per 10<sup>6</sup> nucleotides in controls and breast cancer patients, respectively (~twofold, p &lt; 0.001). In subjects with age &lt;50 or BMI &lt; 27 (kg/m<sup>2</sup>), the levels of AP sites in breast cancer patients were ~2-3-fold greater than those of controls (p &lt; 0.05). Additionally, results from the AP site 3'-cleavage assay indicated that the AP sites detected in both controls and patients were likely to be oxidant-mediated 5'-cleaved AP sites (~61-64 %). The number of AP sites in breast cancer patients was ~twofold greater in subjects with Asp/Glu + Glu/Glugenotypes than those with Asp/Asp genotype (p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We confirmed that cumulative body burden of AP sites is a significant predictor of the risk of developing breast cancer and that genetic predisposition and environment factors may modulate the induction of oxidative DNA lesions in breast cancer patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Wei-Chung</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Da-Chien General Hospital, Miaoli, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Che</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dar-Ren</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Wen-Fa</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Da-Chien General Hospital, Miaoli, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guan-Jie</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Environmental Engineering, National Chung Hsing University, Taichung, 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Suh-Woan</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>College of Oral Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chin-Chen</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Environmental Engineering, National Chung Hsing University, Taichung, 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Mao-Huei</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Environmental Engineering, National Chung Hsing University, Taichung, 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Chang-Sin</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Environmental Engineering, National Chung Hsing University, Taichung, 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cheng-You</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Environmental Engineering, National Chung Hsing University, Taichung, 402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chia-Hua</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, National Formosa University, Yunlin, 63208, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Po-Hsiung</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Environmental Engineering, National Chung Hsing University, Taichung, 402, Taiwan. pohsiunglin@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Breast Cancer</MedlineTA><NlmUniqueID>100888201</NlmUniqueID><ISSNLinking>1340-6868</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>V10TVZ52E4</RegistryNumber><NameOfSubstance UI="D011700">Putrescine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011700" MajorTopicYN="N">Putrescine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AP sites</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>08</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27539671</ArticleId><ArticleId IdType="doi">10.1007/s12282-016-0719-y</ArticleId><ArticleId IdType="pii">10.1007/s12282-016-0719-y</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27538622</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5883</ISSN><JournalIssue CitedMedium="Internet"><Volume>368</Volume><PubDate><Year>2016</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the neurological sciences</Title><ISOAbbreviation>J. Neurol. Sci.</ISOAbbreviation></Journal><ArticleTitle>The levels of 7,8-dihydrodeoxyguanosine (8-oxoG) and 8-oxoguanine DNA glycosylase 1 (OGG1) - A potential diagnostic biomarkers of Alzheimer's disease.</ArticleTitle><Pagination><MedlinePgn>155-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2016.07.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-510X(16)30421-X</ELocationID><Abstract><AbstractText>Evidence indicates that oxidative stress contributes to neuronal cell death in Alzheimer's disease (AD). Increased oxidative DNA damage l, as measured with 8-oxoguanine (8-oxoG), and reduced capacity of proteins responsible for removing of DNA damage, including 8-oxoguanine DNA glycosylase 1 (OGG1), were detected in brains of AD patients. In the present study we assessed peripheral blood biomarkers of oxidative DNA damage, i.e. 8- oxoG and OGG1, in AD diagnosis, by comparing their levels between the patients and the controls. Our study was performed on DNA and serum isolated from peripheral blood taken from 100 AD patients and 110 controls. For 8-oxoG ELISA was employed. The OGG1 level was determined using ELISA and Western blot technique. Levels of 8-oxoG were significantly higher in DNA of AD patients. Both ELISA and Western blot showed decreased levels of OGG1 in serum of AD patients. Our results show that oxidative DNA damage biomarkers detected in peripheral tissue could reflect the changes occurring in the brain of patients with AD. These results also suggest that peripheral blood samples may be useful to measure oxidative stress biomarkers in AD. </AbstractText><CopyrightInformation>Copyright © 2016 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sliwinska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Disease, Diabetology and Clinical Pharmacology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwiatkowski</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Lodz, Department of Molecular Genetics, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czarny</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Lodz, Department of Molecular Genetics, Lodz, Poland; Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toma</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Lodz, Department of Molecular Genetics, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wigner</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Lodz, Department of Molecular Genetics, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drzewoski</LastName><ForeName>Jozef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Disease, Diabetology and Clinical Pharmacology, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabianowska-Majewska</LastName><ForeName>Krystyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Chemistry, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szemraj</LastName><ForeName>Janusz</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Deakin University IMPACT Strategic Research Centre, Deakin University, School of Medicine, Barwon Health, Geelong, Australia; Department of Psychiatry, Chulalongkorn University, Bangkok, Thailand; Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galecki</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Adult Psychiatry, Medical University of Lodz, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sliwinski</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Lodz, Department of Molecular Genetics, Lodz, Poland. Electronic address: tomsliw@biol.uni.lodz.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neurol Sci</MedlineTA><NlmUniqueID>0375403</NlmUniqueID><ISSNLinking>0022-510X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C453560">7,8-dihydro-8-oxoguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001774" MajorTopicYN="N">Blood Chemical Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">7,8-dihydrodeoxyguanosine (8-oxoG)</Keyword><Keyword MajorTopicYN="N">8-oxoguanine DNA glycosylase 1 (OGG1)</Keyword><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">DNA base excision repair</Keyword><Keyword MajorTopicYN="N">Oxidative DNA damage</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27538622</ArticleId><ArticleId IdType="pii">S0022-510X(16)30421-X</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2016.07.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27513750</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9778</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>3</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology</Title><ISOAbbreviation>Cell. Physiol. Biochem.</ISOAbbreviation></Journal><ArticleTitle>Cadmium Exposure Enhances Bisphenol A-Induced Genotoxicity through 8-Oxoguanine-DNA Glycosylase-1 OGG1 Inhibition in NIH3T3 Fibroblast Cells.</ArticleTitle><Pagination><MedlinePgn>961-74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000447804</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Both cadmium (Cd) and bisphenol A (BPA) are commonly encountered in humans' daily activities, but their combined genotoxic effects remain unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the present study, we exposed a mouse embryonic fibroblast cell line (NIH3T3) to Cd for 24 h, followed by a 24 h BPA exposure to evaluate toxicity. The cytotoxicity was evaluated by viability with CCK-8 assay and lactate dehydrogenase (LDH) release. Reactive oxygen species (ROS) production was measured by 2',7'-dichlorofluorescein diacetate (DCFH-DA). And DNA damage was measured by 8-hydroxydeoxyguanosine (8-OHdG), phosphorylated H2AX (γH2AX) and the comet assay. The flow cytometry was used to detect cell cycle distribution, and apoptosis was determined by TUNEL assay and western blot against poly-ADP-ribose polymerase (PARP).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The results showed that Cd or BPA treatments alone (with the exception of BPA exposure at 50 μM) did not alter cell viability. However, pre-treatment with Cd aggravated the BPA-induced reduction in cell viability; increased BPA-induced LDH release, ROS production, DNA damage and G2 phase arrest; and elevated BPA-induced TUNEL-positive cells and the expression levels of cleaved PARP. Cd exposure concurrently decreased the expression of 8-oxoguanine-DNA glycosylase-1 (OGG1), whereas OGG1 over-expression abolished the enhancement of Cd on BPA-induced genotoxicity and cytotoxicity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings indicate that Cd exposure aggravates BPA-induced genotoxicity and cytotoxicity through OGG1 inhibition.</AbstractText><CopyrightInformation>© 2016 The Author(s) Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhi-Yu</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Occupational Health, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yong-Hui</ForeName><Initials>YH</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ling-Ling</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Min</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Min-Di</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chun-Hai</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zheng-Ping</ForeName><Initials>ZP</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhou</ForeName><Initials>Z</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Physiol Biochem</MedlineTA><NlmUniqueID>9113221</NlmUniqueID><ISSNLinking>1015-8987</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000395">Air Pollutants, Occupational</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001559">Benzhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004968">Estrogens, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C468783">H2AFX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010636">Phenols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.1.27</RegistryNumber><NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="D011065">Poly(ADP-ribose) Polymerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>J6K4F9V3BA</RegistryNumber><NameOfSubstance UI="D019256">Cadmium Chloride</NameOfSubstance></Chemical><Chemical><RegistryNumber>MLT3645I99</RegistryNumber><NameOfSubstance UI="C006780">bisphenol A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000395" MajorTopicYN="N">Air Pollutants, Occupational</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001559" MajorTopicYN="N">Benzhydryl Compounds</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019256" MajorTopicYN="N">Cadmium Chloride</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020552" MajorTopicYN="N">Comet Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004968" MajorTopicYN="N">Estrogens, Non-Steroidal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059565" MajorTopicYN="N">G2 Phase Cell Cycle Checkpoints</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007770" MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName><QualifierName UI="Q000557" MajorTopicYN="N">secretion</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041681" MajorTopicYN="N">NIH 3T3 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010636" MajorTopicYN="N">Phenols</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011065" MajorTopicYN="N">Poly(ADP-ribose) Polymerases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27513750</ArticleId><ArticleId IdType="pii">000447804</ArticleId><ArticleId IdType="doi">10.1159/000447804</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27463724</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>07</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Genetic Variations in the Promoter of the APE1 Gene Are Associated with DMF-Induced Abnormal Liver Function: A Case-Control Study in a Chinese Population.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph13080752</ELocationID><ELocationID EIdType="pii" ValidYN="Y">E752</ELocationID><Abstract><AbstractText>Acute or long-term exposure to N,N-dimethylformamide (DMF) can induce abnormal liver function. It is well known that DMF is mainly metabolized in the liver and thereby produces reactive oxygen species (ROS). The base excision repair (BER) pathway is regarded as a very important pathway involved in repairing ROS-induced DNA damage. Several studies have explored the associations between GSTM1, GSTT1, CYP2E1 polymorphisms and DMF-induced abnormal liver function; however, little is known about how common hOGG1, XRCC1 and APE1 polymorphisms and DMF induce abnormal liver function. The purpose of this study was to investigate whether the polymorphisms in the hOGG1 (rs159153 and rs2072668), XRCC1 (rs25487, rs25489, and rs1799782), APE1 (rs1130409 and 1760944) genes in the human BER pathway were associated with the susceptibility to DMF-induced abnormal liver function in a Chinese population. These polymorphisms were genotyped in 123 workers with DMF-induced abnormal liver function and 123 workers with normal liver function. We found that workers with the APE1 rs1760944 TG/GG genotypes had a reduced risk of abnormal liver function, which was more pronounced in the subgroups that were exposed to DMF for &lt;10 years, exposed to ≥10 mg/m³ DMF, never smoked and never drank. In summary, our study supported the hypothesis that the APE1 rs1760944 T &gt; G polymorphism may be associated with DMF-induced abnormal liver function in the Chinese Han population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Zhimin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Kunshan Municipal Center for Disease Prevention and Control, Kunshan 215301, China. 79972002tzm@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Huanxi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Kunshan Municipal Center for Disease Prevention and Control, Kunshan 215301, China. shenhuanxi@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing 211166, China. shenhuanxi@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Integrated Management &amp;amp; Emergency Preparedness and Response, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210009, China. Yangdan1997@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, No.172 Jiangsu Road, Nanjing 210009, China. zhangfeng0401@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, No.172 Jiangsu Road, Nanjing 210009, China. baiy@jscdc.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The First People's Hospital of Kunshan, Kunshan 215300, China. qianyingbingfeng@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kunshan Municipal Center for Disease Prevention and Control, Kunshan 215301, China. sjian@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hengdong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, No.172 Jiangsu Road, Nanjing 210009, China. hd-zhang@263.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Baoli</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing 211166, China. zhubl@jscdc.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, No.172 Jiangsu Road, Nanjing 210009, China. zhubl@jscdc.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8696NH0Y2X</RegistryNumber><NameOfSubstance UI="D004126">Dimethylformamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Oct;38(7):4565-73</RefSource><PMID Version="1">21499756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 1987 Mar;43(3):231-8</RefSource><PMID Version="1">3824392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomarkers. 2005 Nov-Dec;10 (6):464-74</RefSource><PMID Version="1">16308270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2014 Jun;391(1-2):127-36</RefSource><PMID Version="1">24557852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2007 Feb;25(2):80-3</RefSource><PMID Version="1">17456397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Feb 24;403(6772):859-66</RefSource><PMID Version="1">10706276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2009 Jun;27(6):333-7</RefSource><PMID Version="1">19927646</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 2001;68:129-38</RefSource><PMID Version="1">11554292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2003 Sep 18;2(9):955-69</RefSource><PMID Version="1">12967653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Arch Occup Environ Health. 1999 Jan;72(1):19-25</RefSource><PMID Version="1">10029226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2008 Jan;23(1):35-41</RefSource><PMID Version="1">17971348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Arch Occup Environ Health. 2001 Sep;74(7):519-22</RefSource><PMID Version="1">11697456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Arch Occup Environ Health. 1992;63(7):461-8</RefSource><PMID Version="1">1577525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2005 Mar;42(3):127-41</RefSource><PMID Version="1">15584022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 2003 Jul 15;189(1-2):21-39</RefSource><PMID Version="1">12821280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Sep;25(9):1689-94</RefSource><PMID Version="1">15073047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Toxicol. 2001 Feb;74(12):755-9</RefSource><PMID Version="1">11305777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 May;25(5):757-63</RefSource><PMID Version="1">14729591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Mar-Apr;658(3):215-33</RefSource><PMID Version="1">18037339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1991 Jan 31;349(6308):431-4</RefSource><PMID Version="1">1992344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2009 Nov;24(6):507-12</RefSource><PMID Version="1">19762350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Environ Health. 1991 May-Jun;46(3):161-6</RefSource><PMID Version="1">2039271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Occup Med Environ Health. 2015 ;28(2):395-8</RefSource><PMID Version="1">26182934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Occup Health. 2004 Nov;46(6):429-39</RefSource><PMID Version="1">15613765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 1988 May;108(5):680-6</RefSource><PMID Version="1">3358569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2007 Jul;28(7):1520-5</RefSource><PMID Version="1">17374727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2014 Apr;32(4):285-6</RefSource><PMID Version="1">24754947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 05;9(3):e89662</RefSource><PMID Version="1">24599382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2003 Apr;72(2):347-58</RefSource><PMID Version="1">12655034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2009 Oct;23(10):3459-69</RefSource><PMID Version="1">19541747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Saf Health Work. 2011 Jun;2(2):97-104</RefSource><PMID Version="1">22953193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 Jan 7;101(1):24-36</RefSource><PMID Version="1">19116388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Med. 2014 Jul 18;46:e106</RefSource><PMID Version="1">25033834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Mar;21(3):453-60</RefSource><PMID Version="1">10688865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):537-45</RefSource><PMID Version="1">16965996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 May 17;411(6835):366-74</RefSource><PMID Version="1">11357144</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004126" MajorTopicYN="N">Dimethylformamide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">APE1</Keyword><Keyword MajorTopicYN="Y">N,N-dimethylformamide</Keyword><Keyword MajorTopicYN="Y">XRCC1</Keyword><Keyword MajorTopicYN="Y">hOGG1</Keyword><Keyword MajorTopicYN="Y">polymorphism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>06</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27463724</ArticleId><ArticleId IdType="pii">ijerph13080752</ArticleId><ArticleId IdType="doi">10.3390/ijerph13080752</ArticleId><ArticleId IdType="pmc">PMC4997438</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27447800</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-9968</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><PubDate><Year>2016</Year><Month>12</Month></PubDate></JournalIssue><Title>Ultrasonics</Title><ISOAbbreviation>Ultrasonics</ISOAbbreviation></Journal><ArticleTitle>Suppression of human 8-oxoguanine DNA glycosylase (OGG1) augments ultrasound-induced apoptosis in cervical cancer cells.</ArticleTitle><Pagination><MedlinePgn>1-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ultras.2016.07.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0041-624X(16)30111-1</ELocationID><Abstract><AbstractText Label="PURPOSE">Human 8-oxoguanine DNA glycosylase (OGG1) is a major base excision repair enzyme, and it was reported to suppress the activation of intrinsic apoptotic signaling pathway in response to oxidative stress. In this study, our aim was to investigate the effects of OGG1 downregulation on ultrasound-induced apoptosis in cervical cancer cells.</AbstractText><AbstractText Label="METHODS">OGG1 expression was silenced by shRNA in the cervical cancer SW756 and CaSki cells. Cell viability was evaluated by MTT assay after OGG1 knockdown following ultrasound treatment. Ultrasound-induced apoptosis was measured by Annexin V-FITC/propidium iodide. Intracellular reactive oxygen species (ROS) production and Ca(2+) concentration were detected using a fluorescent probe, 2',7'-dichlorofluorescin diacetate (DCFH-DA) and a green fluorescent dye fluo-4AM, respectively. Western blotting was used to analyze the expression of Bcl-2, Bax, cleaved caspase-3, and nuclear factor-κB p65 (NF-κB p65).</AbstractText><AbstractText Label="RESULTS">The results indicated that OGG1 knockdown did not suppress cell proliferation, but significantly augmented ultrasound-induced inhibitory effects on the cell viability, and increased ultrasound-induced early apoptosis and late apoptosis and necrosis in the SW756 and CaSki cells when exposure to ultrasound (1MHz) at 1.5W/cm(2) for 30 and 60s. OGG1 knockdown significantly increased intracellular ROS production and Ca(2+) concentration after incubation of 6, 24, and 48h post-ultrasound treatment. The downregulation of Bcl-2 protein and the upregulation of Bax, cleaved caspase-3, and NF-κB p65 protein levels were observed in the shRNA-OGG1 cells and mock-shRNA cells, but no significant change of these protein levels was found between of them.</AbstractText><AbstractText Label="CONCLUSIONS">These results indicate that downregulation of OGG1 expression can augment ultrasound-induced apoptosis in cervical cancer cells, which suggests that OGG1 suppression might provide a new insight for ultrasound-induced therapeutic effects on cervical cancer treatment.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Yongli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Oncology, Han Jiang Group Co. Ltd-Han Jiang Hospital, DanJiangKou 442700, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Linjun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Guangmei</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jianyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Xiongfei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Hongxia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei Province, China. Electronic address: hongxiajing@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ultrasonics</MedlineTA><NlmUniqueID>0050452</NlmUniqueID><ISSNLinking>0041-624X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000814">Aniline Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017304">Annexin A5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492760">FITC-annexin A5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C409648">Fluo 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005452">Fluoresceins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019253">Proto-Oncogene Proteins c-bcl-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014966">Xanthenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051028">bcl-2-Associated X Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>2044-85-1</RegistryNumber><NameOfSubstance UI="C029569">diacetyldichlorofluorescein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505407">CASP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>I223NX31W9</RegistryNumber><NameOfSubstance UI="D016650">Fluorescein-5-isothiocyanate</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000814" MajorTopicYN="N">Aniline Compounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017304" MajorTopicYN="N">Annexin A5</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016650" MajorTopicYN="N">Fluorescein-5-isothiocyanate</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005452" MajorTopicYN="N">Fluoresceins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019253" MajorTopicYN="N">Proto-Oncogene Proteins c-bcl-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014464" MajorTopicYN="Y">Ultrasonic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014966" MajorTopicYN="N">Xanthenes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051028" MajorTopicYN="N">bcl-2-Associated X Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Apoptosis</Keyword><Keyword MajorTopicYN="Y">Cervical cancer cells</Keyword><Keyword MajorTopicYN="Y">OGG1</Keyword><Keyword MajorTopicYN="Y">Reactive oxygen species</Keyword><Keyword MajorTopicYN="Y">Ultrasound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27447800</ArticleId><ArticleId IdType="pii">S0041-624X(16)30111-1</ArticleId><ArticleId IdType="doi">10.1016/j.ultras.2016.07.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27393451</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1011-601X</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Pakistan journal of pharmaceutical sciences</Title><ISOAbbreviation>Pak J Pharm Sci</ISOAbbreviation></Journal><ArticleTitle>Polymorphisms in DNA repair genes XRCC1 and OGG1 lead to the progression of rheumatoid arthritis in Pakistani patients.</ArticleTitle><Pagination><MedlinePgn>1189-95</MedlinePgn></Pagination><Abstract><AbstractText>This study points at the elucidation of a possible association of Rheumatoid arthritis (RA) with Ser326Cys in OGG1 Arg194Trp and Arg399Gln polymorphisms of XRCC1 using a sample size of 100 patients and 100 controls from a Pakistani population. This association was determined using Random Fragment Length Polymorphism Analysis as well as the DAS scoring system. In RA, oxidative damage due to free radical production leads to destructive proliferative synovitis showing cellular transformations of synoviocytes into a tumorigenic state. XRCC1 and OGG1 genes, which are part of the DNA Break Excision Repair pathway, manifest various polymorphisms which may cause a variation in the response to inflammation by changing DNA repair potential. Our results showed a significant association between the DAS28 score values as well as the genotypic state of the RA patients. It was seen that the score was significantly higher in GG genotypes thereby corroborating the role of the polymorphism XRCC1 Arg399Gln. Using a Pearson's correlation test it was found to be &lt;0.000003. It has been shown by the results in this research that an increased risk of DNA damage exists when the polymorphic genotypes studied, exist in a RA patient. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qadir</LastName><ForeName>Mirza Muhammad Fahd</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Atta-ur-Rahman School of Applied Biosciences (ASAB). National University of Sciences and Technology (NUST). Sector H-12, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatti</LastName><ForeName>Attya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Atta-ur-Rahman School of Applied Biosciences (ASAB). National University of Sciences and Technology (NUST). Sector H-12, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khurshid</LastName><ForeName>Rabia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Atta-ur-Rahman School of Applied Biosciences (ASAB). National University of Sciences and Technology (NUST). Sector H-12, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Muhammad Usman</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Atta-ur-Rahman School of Applied Biosciences (ASAB). National University of Sciences and Technology (NUST). Sector H-12, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anjum</LastName><ForeName>Sidrah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Atta-ur-Rahman School of Applied Biosciences (ASAB). National University of Sciences and Technology (NUST). Sector H-12, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Atta-ur-Rahman School of Applied Biosciences (ASAB). National University of Sciences and Technology (NUST). Sector H-12, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Pakistan</Country><MedlineTA>Pak J Pharm Sci</MedlineTA><NlmUniqueID>9426356</NlmUniqueID><ISSNLinking>1011-601X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27393451</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27390603</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1837-9664</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>10</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Journal of Cancer</Title><ISOAbbreviation>J Cancer</ISOAbbreviation></Journal><ArticleTitle>Association between the OGG1 Ser326Cys Polymorphism and Cancer Risk: Evidence from 152 Case-Control Studies.</ArticleTitle><Pagination><MedlinePgn>1273-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/jca.15035</ELocationID><Abstract><AbstractText>Although it has been suggested that the 8-oxoguanine DNA glycosylase (OGG1) gene Ser326Cys polymorphism may be a risk factor for cancer, the conclusions from previous studies are inconsistent. Thus, we conducted an updated meta-analysis to estimate the effect of OGG1 variant genotypes on cancer susceptibility. We searched the PubMed for all eligible studies published in English for the period ending September 2014. We found the association between OGG1 Ser326Cys polymorphism and cancer susceptibility based on 152 case-control studies in different genetic model comparisons (dominant model: OR = 1.053, P = 0.018; recessive model: OR = 1.108, P &lt; 0.001; homozygote: OR = 1.135, P &lt; 0.001; additive model: OR = 1.059, P &lt; 0.001). However, the results from the subgroup analyses based on types of cancer, health population as controls or studies with relatively large sample size did not support the conclusion. Although the overall results of this meta-analysis showed a positive association between OGG1 variant genotypes and cancer susceptibility, the subgroup analyses by cancer type, sample size, and source of controls presented inconsistent results. Therefore, the current evidence from the meta-analysis did not support the hypothesis of OGG1 Ser326Cys polymorphism as a risk factor of cancer. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>1. Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>1. Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>1. Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>3. Intensive care unit, Suining Central Hospital, Deshengxi Road 127, Chuanshan District, Suining, Sichuan 629000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>2. Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>1. Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China;</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Cancer</MedlineTA><NlmUniqueID>101535920</NlmUniqueID><ISSNLinking>1837-9664</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>BMC Med Res Methodol. 2002 Aug 09;2:10</RefSource><PMID Version="1">12171604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Oct;30(10):4141-5</RefSource><PMID Version="1">21036733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2014 Jun;34(6):3217-24</RefSource><PMID Version="1">24922697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Dec 24;726(2):227-33</RefSource><PMID Version="1">21986195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Biochem Biophys. 2000 May 1;377(1):1-8</RefSource><PMID Version="1">10775435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2005 Jun 8;223(2):265-74</RefSource><PMID Version="1">15896461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2009 Jan;30(1):78-87</RefSource><PMID Version="1">19029194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2004 Jun 15;64(12):4378-84</RefSource><PMID Version="1">15205355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2011 Oct;137(10):1477-85</RefSource><PMID Version="1">21822670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:67-72</RefSource><PMID Version="1">21414327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2011 Sep;50(9):732-7</RefSource><PMID Version="1">21520294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2012 Jan;39(1):527-34</RefSource><PMID Version="1">21559836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2006 Aug;97(8):724-8</RefSource><PMID Version="1">16800823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2008 Jan;29(1):100-5</RefSource><PMID Version="1">17984110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Feb 3;684(1-2):43-8</RefSource><PMID Version="1">19962393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2011 Nov-Dec;29(6):641-6</RefSource><PMID Version="1">19914098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Cancer. 2013 Nov;23(9):1561-8</RefSource><PMID Version="1">24172093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Jun 15;68(12):4928-35</RefSource><PMID Version="1">18544627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2013;14(9):5145-51</RefSource><PMID Version="1">24175791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Surg. 2010;8(5):336-41</RefSource><PMID Version="1">20171303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Dec 15;648(1-2):65-72</RefSource><PMID Version="1">18977234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12 ):3384-8</RefSource><PMID Version="1">19959686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2012 Jul;103(7):1215-20</RefSource><PMID Version="1">22463382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Oct;30(10):4205-8</RefSource><PMID Version="1">21036742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2010 Aug;14(4):559-64</RefSource><PMID Version="1">20649433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:21-31</RefSource><PMID Version="1">21376741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2008 Jul 1;123(1):51-5</RefSource><PMID Version="1">18366059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2012 May;27(3):329-36</RefSource><PMID Version="1">22121210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1100-4</RefSource><PMID Version="1">14578150</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2008 Dec;37(6):1316-25</RefSource><PMID Version="1">18641418</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2007 Mar;28(3):665-71</RefSource><PMID Version="1">17040931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource><PMID Version="1">3802833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2004 Dec;95(12):977-83</RefSource><PMID Version="1">15596047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gastrointest Cancer. 2010 Jun;41(2):110-5</RefSource><PMID Version="1">20069464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2002 Jun 1;99(4):624-7</RefSource><PMID Version="1">11992556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2005 Mar;42(3):127-41</RefSource><PMID Version="1">15584022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arh Hig Rada Toksikol. 2008 Dec;59(4):241-50</RefSource><PMID Version="1">19064361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 May;27(5):997-1007</RefSource><PMID Version="1">16308313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2007 Jul 28;631(2):101-10</RefSource><PMID Version="1">17531525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 Jun;27(6):1245-50</RefSource><PMID Version="1">16364924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(1):59-62</RefSource><PMID Version="1">12779082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oral Oncol. 2007 Sep;43(8):791-5</RefSource><PMID Version="1">17207658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Aug 1;121(3):501-5</RefSource><PMID Version="1">17417784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2002 Dec;16(14):1895-902</RefSource><PMID Version="1">12468454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):409-12</RefSource><PMID Version="1">11927502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2007 Mar;28(3):657-64</RefSource><PMID Version="1">17028303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2008 Mar;22(3):551-8</RefSource><PMID Version="1">18059482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2009 Sep 15;170(6):695-702</RefSource><PMID Version="1">19671832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 2001;68:285-97</RefSource><PMID Version="1">11554304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Mar;17(3):760-71</RefSource><PMID Version="1">20183911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):736-9</RefSource><PMID Version="1">18349297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasma. 2008;55(4):330-7</RefSource><PMID Version="1">18505345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2008 Sep 30;27:49</RefSource><PMID Version="1">18823566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(1):e30013</RefSource><PMID Version="1">22253860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(11):e27545</RefSource><PMID Version="1">22114677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2010;11(1):165-8</RefSource><PMID Version="1">20593951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2005 Nov;27(5):1315-20</RefSource><PMID Version="1">16211227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):84-91</RefSource><PMID Version="1">17220334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 Dec 15;532(2):192-6</RefSource><PMID Version="1">24076439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thorac Oncol. 2011 Apr;6(4):813-7</RefSource><PMID Version="1">21623257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2014;15(3):1133-40</RefSource><PMID Version="1">24606430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2011 Apr;42(3):226-34</RefSource><PMID Version="1">21722819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2007 Apr;121(2):233-42</RefSource><PMID Version="1">17203305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2010 Dec 06;29:157</RefSource><PMID Version="1">21134244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Nov;38(8):5379-86</RefSource><PMID Version="1">21390502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Oct 15;27(20):4001-7</RefSource><PMID Version="1">10497264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3167-73</RefSource><PMID Version="1">21037106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2001 Sep 10;170(1):53-61</RefSource><PMID Version="1">11448535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2006 Nov-Dec;26(6C):4955-8</RefSource><PMID Version="1">17214369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2012 Dec;29(4):2949-54</RefSource><PMID Version="1">22271435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2003 May;9(5):956-60</RefSource><PMID Version="1">12717837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 May 1;519(2):231-7</RefSource><PMID Version="1">23454624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Jul 1;116(13):3160-9</RefSource><PMID Version="1">20564624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Sep;40(9):5261-73</RefSource><PMID Version="1">23673479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jun;115(3):623-7</RefSource><PMID Version="1">18553220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2012 Sep;32(9):3799-803</RefSource><PMID Version="1">22993322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Mar 1;639(1-2):45-54</RefSource><PMID Version="1">18155253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Clin Oncol. 2008 Mar;38(3):186-91</RefSource><PMID Version="1">18272472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Jul;23(7):1229-34</RefSource><PMID Version="1">12117782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2014 Apr 21;15(4):6703-16</RefSource><PMID Version="1">24756092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):403-4</RefSource><PMID Version="1">16492938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 May 12;664(1-2):13-9</RefSource><PMID Version="1">19428376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2011 Jun;102(6):1123-7</RefSource><PMID Version="1">21401806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2006 Jul 25;599(1-2):124-34</RefSource><PMID Version="1">16564556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2002 May;12(3):258-65</RefSource><PMID Version="1">12164330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2009 Jan 15;15(2):740-6</RefSource><PMID Version="1">19147782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2005 Nov 8;229(1):85-91</RefSource><PMID Version="1">15946795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2008 Dec;19(10):1077-83</RefSource><PMID Version="1">18478337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Feb;38(2):1163-70</RefSource><PMID Version="1">20602259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Gastroenterol. 2011 Jun 14;11:74</RefSource><PMID Version="1">21672255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Apr 20;97(8):567-76</RefSource><PMID Version="1">15840879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Cancer. 2011 Nov;21(8):1407-13</RefSource><PMID Version="1">21997177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2003 Dec;170(6 Pt 1):2471-4</RefSource><PMID Version="1">14634453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Nov-Dec;680(1-2):56-63</RefSource><PMID Version="1">19815090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2005 Jan;65(1):70-5</RefSource><PMID Version="1">15667866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Nov;25(11):2177-81</RefSource><PMID Version="1">15284179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 1997 Nov 1;127(9):820-6</RefSource><PMID Version="1">9382404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Genet Cytogenet. 2009 Dec;195(2):143-9</RefSource><PMID Version="1">19963114</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">meta-analysis.</Keyword><Keyword MajorTopicYN="N">polymorphism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27390603</ArticleId><ArticleId IdType="doi">10.7150/jca.15035</ArticleId><ArticleId IdType="pii">jcav07p1273</ArticleId><ArticleId IdType="pmc">PMC4934036</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27388124</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>07</Month><Day>08</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression.</ArticleTitle><Pagination><MedlinePgn>29389</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep29389</ELocationID><Abstract><AbstractText>APE1 is an essential DNA repair protein that also possesses the ability to regulate transcription. It has a unique cysteine residue C65, which maintains the reduce state of several transcriptional activators such as NF-κB. How APE1 is being recruited to execute the various biological functions remains unknown. Herein, we show that APE1 interacts with a novel partner PRDX1, a peroxidase that can also prevent oxidative damage to proteins by serving as a chaperone. PRDX1 knockdown did not interfere with APE1 expression level or its DNA repair activities. However, PRDX1 knockdown greatly facilitates APE1 detection within the nucleus by indirect immunofluorescence analysis, even though APE1 level was unchanged. The loss of APE1 interaction with PRDX1 promotes APE1 redox function to activate binding of the transcription factor NF-κB onto the promoter of a target gene, the proinflammatory chemokine IL-8 involved in cancer invasion and metastasis, resulting in its upregulation. Depletion of APE1 blocked the upregulation of IL-8 in the PRDX1 knockdown cells. Our findings suggest that the interaction of PRDX1 with APE1 represents a novel anti-inflammatory function of PRDX1, whereby the association safeguards APE1 from reducing transcription factors and activating superfluous gene expression, which otherwise could trigger cancer invasion and metastasis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nassour</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal, Department of Medicine, 5415 Boul. de l' Assomption, Montréal, Québec, H1T 2M4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal, Department of Medicine, 5415 Boul. de l' Assomption, Montréal, Québec, H1T 2M4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saad</LastName><ForeName>Amine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, 3755 Cote Ste-Catherine Road, Montréal, Québec, H3T 1E2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papaluca</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal, Department of Medicine, 5415 Boul. de l' Assomption, Montréal, Québec, H1T 2M4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brosseau</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal, Department of Medicine, 5415 Boul. de l' Assomption, Montréal, Québec, H1T 2M4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Affar</LastName><ForeName>El Bachir</ForeName><Initials>el B</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal, Department of Medicine, 5415 Boul. de l' Assomption, Montréal, Québec, H1T 2M4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alaoui-Jamali</LastName><ForeName>Moulay A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, 3755 Cote Ste-Catherine Road, Montréal, Québec, H3T 1E2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramotar</LastName><ForeName>Dindial</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal, Department of Medicine, 5415 Boul. de l' Assomption, Montréal, Québec, H1T 2M4, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOP-93573 </GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508606">IL8 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.15</RegistryNumber><NameOfSubstance UI="C515940">PRDX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.15</RegistryNumber><NameOfSubstance UI="D054464">Peroxiredoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2003;370:430-44</RefSource><PMID Version="1">14712665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2003 Oct;71(10):5523-30</RefSource><PMID Version="1">14500470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Leukoc Biol. 2002 Nov;72(5):847-55</RefSource><PMID Version="1">12429706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2013;15(4):210</RefSource><PMID Version="1">24041156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2002 Jul 15;365(Pt 2):547-53</RefSource><PMID Version="1">11966472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Jun 28;277(26):23573-81</RefSource><PMID Version="1">11950839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1994;63:915-48</RefSource><PMID Version="1">7979257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Elife. 2015 Jun 01;4:null</RefSource><PMID Version="1">26030852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2013 Apr 15;190(8):4349-59</RefSource><PMID Version="1">23509368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2001 Jul 1;357(Pt 1):241-7</RefSource><PMID Version="1">11415455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2003 Jan;28(1):32-40</RefSource><PMID Version="1">12517450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2005 Dec 1;24(54):8038-50</RefSource><PMID Version="1">16170382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):83-108</RefSource><PMID Version="1">11018583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurochem Int. 2009 Nov;55(6):362-8</RefSource><PMID Version="1">19375465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2015 Jan;11(1):64-70</RefSource><PMID Version="1">25402766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Apr 26;277(17):14564-74</RefSource><PMID Version="1">11834746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jul 15;29(14):3116-22</RefSource><PMID Version="1">11452037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Biochem Nutr. 2012 Mar;50(2):91-105</RefSource><PMID Version="1">22448089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2011 Oct;22(20):3887-901</RefSource><PMID Version="1">21865600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Jun 7;277(23 ):20336-42</RefSource><PMID Version="1">11916965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Jul 24;454(7203):428-35</RefSource><PMID Version="1">18650913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmaceuticals (Basel). 2013 Aug 06;6(8):929-59</RefSource><PMID Version="1">24276377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2009 May 20;28(10 ):1505-17</RefSource><PMID Version="1">19369943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Jul 17;98 (15):8774-9</RefSource><PMID Version="1">11438700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3071-80</RefSource><PMID Version="1">23898172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2010 Feb 12;392(3):363-8</RefSource><PMID Version="1">20074557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2003 Feb;4(2):145-53</RefSource><PMID Version="1">12524539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2006 Jan 9;580(1):351-5</RefSource><PMID Version="1">16376335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Oct 1;53(7):1522-30</RefSource><PMID Version="1">22902630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2003 Jul 31;424(6948):561-5</RefSource><PMID Version="1">12891360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 17;51(2):695-705</RefSource><PMID Version="1">22148505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1996 Dec 13;271(50):32253-9</RefSource><PMID Version="1">8943284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2013;3:2456</RefSource><PMID Version="1">23949117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Transl Res. 2016 Feb 15;8(2):842-59</RefSource><PMID Version="1">27158373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Jun 29;474(7353):609-15</RefSource><PMID Version="1">21720365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2002 Mar-Apr;383(3-4):347-64</RefSource><PMID Version="1">12033427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2004 Jun 25;117(7):859-72</RefSource><PMID Version="1">15210108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2009 Sep;7(9):1543-52</RefSource><PMID Version="1">19737972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2014 Jul 10;16(4):R79</RefSource><PMID Version="1">25011585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Nov 8;277(45):43175-84</RefSource><PMID Version="1">12196529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 Aug 1;15(3):781-94</RefSource><PMID Version="1">20919930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2013 Feb 06;14(2):3467-86</RefSource><PMID Version="1">23389043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Feb 10;287(7):4403-10</RefSource><PMID Version="1">22147704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Oct 15;18(20):5609-21</RefSource><PMID Version="1">10523305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Mar 15;29(6):1285-92</RefSource><PMID Version="1">11238994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 Nov 24;270(47):28006-9</RefSource><PMID Version="1">7499282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(7):1834-54</RefSource><PMID Version="1">19188445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Aug 15;8(8):e70909</RefSource><PMID Version="1">23967134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cells. 2013 Nov;36(5):439-45</RefSource><PMID Version="1">24213673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2009 Feb;9(4):1058-74</RefSource><PMID Version="1">19180539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Apoptosis. 2007 Jul;12(7):1243-55</RefSource><PMID Version="1">17333320</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Sep;11(9):3323-35</RefSource><PMID Version="1">1380454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Rev. 2012 Mar;246(1):311-26</RefSource><PMID Version="1">22435563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D808-15</RefSource><PMID Version="1">23203871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocr Relat Cancer. 2012 Apr 10;19(2):197-208</RefSource><PMID Version="1">22277193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2015 Jan 30;290(5):3057-68</RefSource><PMID Version="1">25492865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2012 Jul 1;735(1-2):39-45</RefSource><PMID Version="1">22583657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Jan 10;415(6868):183-7</RefSource><PMID Version="1">11805838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2001 Aug;3(4):671-83</RefSource><PMID Version="1">11554453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Nov 15;277(46):44548-56</RefSource><PMID Version="1">12213807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 2003 Nov 15;193(1-2):43-65</RefSource><PMID Version="1">14599767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2001 Feb;158(2):639-46</RefSource><PMID Version="1">11159200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2007 Jul 15;43(2):282-8</RefSource><PMID Version="1">17603937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2009 Apr 2;28(13):1616-25</RefSource><PMID Version="1">19219073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2012 Mar 15;16(6):506-23</RefSource><PMID Version="1">22114845</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3589-608</RefSource><PMID Version="1">20706766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Oct;123(3):725-31</RefSource><PMID Version="1">20020197</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054464" MajorTopicYN="N">Peroxiredoxins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>06</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27388124</ArticleId><ArticleId IdType="pii">srep29389</ArticleId><ArticleId IdType="doi">10.1038/srep29389</ArticleId><ArticleId IdType="pmc">PMC4937415</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27384322</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4571</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Circulation research</Title><ISOAbbreviation>Circ. Res.</ISOAbbreviation></Journal><ArticleTitle>Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.</ArticleTitle><Pagination><MedlinePgn>e76-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCRESAHA.116.308362</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Activation of NLRP3 (nucleotide-binding domain and leucine-rich repeat pyrin domain containing 3) inflammasome-mediating interleukin (IL)-1β secretion has emerged as an important component of inflammatory processes in atherosclerosis. Mitochondrial DNA (mtDNA) damage is detrimental in atherosclerosis, and mitochondria are central regulators of the nucleotide-binding domain and leucine-rich repeat pyrin domain containing 3 inflammasome. Human atherosclerotic plaques express increased mtDNA damage. The major DNA glycosylase, 8-oxoguanine glycosylase (OGG1), is responsible for removing the most abundant form of oxidative DNA damage.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To test the role of OGG1 in the development of atherosclerosis in mouse.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We observed that Ogg1 expression decreases over time in atherosclerotic lesion macrophages of low-density lipoprotein receptor (Ldlr) knockout mice fed a Western diet. Ogg1(-/-)Ldlr(-/-) mice fed a Western diet resulted in an increase in plaque size and lipid content. We found increased oxidized mtDNA, inflammasome activation, and apoptosis in atherosclerotic lesions and also higher serum IL-1β and IL-18 in Ogg1(-/-)Ldlr(-/-) mice than in Ldlr(-/-). Transplantation with Ogg1(-/-) bone marrow into Ldlr(-/-) mice led to larger atherosclerotic lesions and increased IL-1β production. However, transplantation of Ogg1(-/-)Nlrp3(-/-) bone marrow reversed the Ogg1(-/-) phenotype of increased plaque size. Ogg1(-/-) macrophages showed increased oxidized mtDNA and had greater amounts of cytosolic mtDNA and cytochrome c, increased apoptosis, and more IL-1β secretion. Finally, we found that proatherogenic miR-33 can directly inhibit human OGG1 expression and indirectly suppress both mouse and human OGG1 via AMP-activated protein kinase.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">OGG1 plays a protective role in atherogenesis by preventing excessive inflammasome activation. Our study provides insight into a new target for therapeutic intervention based on a link between oxidative mtDNA damage, OGG1, and atherosclerosis via NLRP3 inflammasome.</AbstractText><CopyrightInformation>© 2016 American Heart Association, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tumurkhuu</LastName><ForeName>Gantsetseg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimada</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagvadorj</LastName><ForeName>Jargalsaikhan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crother</LastName><ForeName>Timothy R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenxuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luthringer</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottlieb</LastName><ForeName>Roberta A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arditi</LastName><ForeName>Moshe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Biomedical Sciences, and Infectious and Immunologic Diseases Research Center (IIDRC) (G.T., K.S., J.D., T.R.C., W.Z., S.C.), Department of Pathology (D.L.), Cedars-Sinai Medical Center, Los Angeles, CA; Department of Medicine, Barbra Streisand Women's Heart Center, Heart Institute of Cedars-Sinai (R.A.G.), Cedars-Sinai Medical Center, Los Angeles, CA; and David Geffen School of Medicine, University of California, Los Angeles (M.A.). moshe.arditi@cshs.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL111483</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI105845</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL112730</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL132075</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL066436</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL130353</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Res</MedlineTA><NlmUniqueID>0047103</NlmUniqueID><ISSNLinking>0009-7330</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492716">Nlrp3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2255-64</RefSource><PMID Version="1">16141399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2011 Jul;121(7):2921-31</RefSource><PMID Version="1">21646721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2010 Jan;10(1):36-46</RefSource><PMID Version="1">19960040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e51697</RefSource><PMID Version="1">23284747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 May 1;32(9):804-12</RefSource><PMID Version="1">11978482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2015 Feb 09;16(2):3757-68</RefSource><PMID Version="1">25671815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Cardiol. 2012 Mar-Apr;28(2):222-9</RefSource><PMID Version="1">22265992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1997 Dec 15;419(2-3):276-80</RefSource><PMID Version="1">9428650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Mar 12;279(11):9857-66</RefSource><PMID Version="1">14688259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2014 Jan 31;114(3):421-33</RefSource><PMID Version="1">24297735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Jul 15;61(14):5378-81</RefSource><PMID Version="1">11454679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2234-9</RefSource><PMID Version="1">11842210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2014 Feb 1;306(3):C221-9</RefSource><PMID Version="1">24304833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Physiol Rev. 2006 Apr;86(2):515-81</RefSource><PMID Version="1">16601268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2008 Aug 1;79(3):360-76</RefSource><PMID Version="1">18487233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Lung Cell Mol Physiol. 2013 Feb 15;304(4):L287-97</RefSource><PMID Version="1">23241530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15093-8</RefSource><PMID Version="1">17846428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Pharmacol Sin. 2010 Sep;31(9):1075-84</RefSource><PMID Version="1">20711221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2014 Apr;176(1):66-77</RefSource><PMID Version="1">24345202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2012 Apr 4;15(4):545-53</RefSource><PMID Version="1">22445600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2015 Feb 27;116(5):816-26</RefSource><PMID Version="1">25524056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2004 Jul 1;64(13):4411-4</RefSource><PMID Version="1">15231648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cardiol. 2010 Feb;7(2):77-86</RefSource><PMID Version="1">20065951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Cell Physiol. 2008 Feb;294(2):C413-22</RefSource><PMID Version="1">18077603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2015 Jun;21(6):549-51</RefSource><PMID Version="1">26046571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:21-31</RefSource><PMID Version="1">21376741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2013 Aug;33(15):2891-902</RefSource><PMID Version="1">23716591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2014 May 23;114(11):1757-71</RefSource><PMID Version="1">24855200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Mar 16;5:9144</RefSource><PMID Version="1">25775051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 27;9(1):e87552</RefSource><PMID Version="1">24475307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2002 Aug 20;106(8):927-32</RefSource><PMID Version="1">12186795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Thromb Haemost. 2012 Apr;107(4):642-7</RefSource><PMID Version="1">22274626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Atheroscler Thromb. 2012;19(4):316-25</RefSource><PMID Version="1">22277767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Dec 11;273(50):33811-6</RefSource><PMID Version="1">9837971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 Nov 1;185(9):5619-27</RefSource><PMID Version="1">20935201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2011 May 1;50(9):1107-13</RefSource><PMID Version="1">20969951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2006 Aug;55(8):2180-91</RefSource><PMID Version="1">16873680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2011 Jan 15;183(2):226-33</RefSource><PMID Version="1">20732986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2012 Mar 23;36(3):401-14</RefSource><PMID Version="1">22342844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2011 Feb;17 (2):179-88</RefSource><PMID Version="1">21217695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jun 25;8(6):e67532</RefSource><PMID Version="1">23825667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2014 Jul 18;6(9):1133-41</RefSource><PMID Version="1">25038053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2010 Oct;46(15):2806-20</RefSource><PMID Version="1">20656472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2007 Nov-Dec;128(11-12):637-49</RefSource><PMID Version="1">18006041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2013 Oct;13(10):709-21</RefSource><PMID Version="1">23995626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2015 Jul 17;117(3):266-78</RefSource><PMID Version="1">26002865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Lipidol. 2011 Apr;22(2):86-92</RefSource><PMID Version="1">21178770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ageing Res Rev. 2012 Apr;11(2):230-41</RefSource><PMID Version="1">22186033</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Heart Assoc. 2012 Dec;1(6):e003376</RefSource><PMID Version="1">23316322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2014;20(1):108-24</RefSource><PMID Version="1">23944376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2005 Mar 15;38(6):737-45</RefSource><PMID Version="1">15721984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Inflamm Res. 2015 Jan 16;8:15-27</RefSource><PMID Version="1">25653548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Oct 19;478(7369):404-7</RefSource><PMID Version="1">22012398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2014 Oct 10;115(9):759-69</RefSource><PMID Version="1">25201910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2015 Jul 17;117(3):225-8</RefSource><PMID Version="1">26185207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2010 Feb 16;121(6):792-803</RefSource><PMID Version="1">20124121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Endocrinol Metab. 2010 Dec;21(12):699-706</RefSource><PMID Version="1">20880716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2015 Oct 26;125(12):4334-48</RefSource><PMID Version="1">26517695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1973-7</RefSource><PMID Version="1">23702658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Med. 2015 Mar 13;47:e150</RefSource><PMID Version="1">25766619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2011 May;12 (5):408-15</RefSource><PMID Version="1">21478880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2007 Mar 2;100(4):460-73</RefSource><PMID Version="1">17332437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Atheroscler Thromb. 2014;21(5):381-90</RefSource><PMID Version="1">24717761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Dec 19-26;420(6917):868-74</RefSource><PMID Version="1">12490960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2010 Oct;11(10 ):897-904</RefSource><PMID Version="1">20835230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Jun 15;287(25):20769-73</RefSource><PMID Version="1">22568941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):514-9</RefSource><PMID Version="1">9012815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2002 Jul 30;106(5):544-9</RefSource><PMID Version="1">12147534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1992 Sep;275(3-6):169-80</RefSource><PMID Version="1">1383759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Mol Med. 2015 Mar;21(3):193-201</RefSource><PMID Version="1">25500014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Oct 10;272(41):25409-12</RefSource><PMID Version="1">9325246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Apr 29;145(3):341-55</RefSource><PMID Version="1">21529710</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2000 Feb;45(3):736-46</RefSource><PMID Version="1">10728396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2010 Feb;1797(2):113-28</RefSource><PMID Version="1">19761752</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Apr 29;464(7293):1357-61</RefSource><PMID Version="1">20428172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2013 Aug 13;128(7):702-12</RefSource><PMID Version="1">23841983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):656-60</RefSource><PMID Version="1">12615675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Jun 27;493(1-2):23-30</RefSource><PMID Version="1">11516712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Metab. 2011 Apr 6;13(4):376-88</RefSource><PMID Version="1">21459323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Coron Artery Dis. 2015 Jun;26(4):322-7</RefSource><PMID Version="1">25768243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Heart Assoc. 2014 Dec;3(6):e001202</RefSource><PMID Version="1">25527624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Atheroscler Rep. 2013 May;15(5):322</RefSource><PMID Version="1">23512606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Lung Cell Mol Physiol. 2005 Mar;288(3):L530-5</RefSource><PMID Version="1">15563690</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Circ Res. 2016 Sep 2;119(6):698-700</RefSource><PMID Version="1">27587405</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050197" MajorTopicYN="N">Atherosclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066273" MajorTopicYN="N">Diet, Western</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">atherosclerosis</Keyword><Keyword MajorTopicYN="N">inflammasomes</Keyword><Keyword MajorTopicYN="N">macrophages</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27384322</ArticleId><ArticleId IdType="pii">CIRCRESAHA.116.308362</ArticleId><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.308362</ArticleId><ArticleId IdType="pmc">PMC5010464</ArticleId><ArticleId IdType="mid">NIHMS801600</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27366307</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2008-2398</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Iranian journal of cancer prevention</Title><ISOAbbreviation>Iran J Cancer Prev</ISOAbbreviation></Journal><ArticleTitle>XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature.</ArticleTitle><Pagination><MedlinePgn>e3467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.17795/ijcp-3467</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Known polymorphisms of DNA repair genes can be associated with the risk of many types of cancer. There is no consensus regarding association between XRCC1 and OGG1 with breast cancer (BC).</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study is to collect relevant published studies systematically.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Sixty-two publications were identified through searching PubMed, PubMed Central, ISI web of knowledge, and reference list of related articles.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">We performed a systematic review according MOOSE guideline criteria. All longitudinal cohort and case-control studies investigating association of any type and grade of breast cancer with XRCC1 and OGG1 gene and their polymorphisms were eligible for initial inclusion.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Two authors screened titles and abstracts and extracted all needed information from eligible studies. Four research methodological components causing bias for the association between gene polymorphisms and breast cancer risk, including source of controls sampling, population ethnicity, sample size of studies and menopausal status of cases and controls was used for assessment of quality of studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 14,793 breast cancer cases and 15,409 controls were included in assessment of XRCC1 Arg194Trp. Four studies showed significant association and one study showed protective effect of XRCC1 Arg194Trp and BC. A total of 7,716 cases and 7,370 controls were included for XRCC1 Arg280His. Only one study showed significant association of XRCC1 Arg280His and breast cancer (OR = 1.82 (1.06 - 3.15). A total of 27,167 cases and 31,998 controls were included to estimate association between XRCC1 Arg399Gln polymorphism and breast cancer. Seven studies showed significant association and one showed protective effect of XRCC1 Arg399Gln and BC. A total of 9,417 cases and 11,087 controls were included for OGG1 Ser326Cys. Among studies focused on OGG1 Ser326Cys, none showed significant association with breast cancer.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Systematic search of major databases identify many studies addressing the relationship between BC and susceptible alleles in the base excision repair genes and the fact that there are many variations in the magnitude of association depending on inheritance model and the population of the study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanjari Moghaddam</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazarzadeh</LastName><ForeName>Milad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, IR Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noroozi</LastName><ForeName>Rezvan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darvish</LastName><ForeName>Hossein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosavi Jarrahi</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran; Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, IR Iran; Faculty of Health Sciences, Simon Fraser University, BC., Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Iran J Cancer Prev</MedlineTA><NlmUniqueID>101500574</NlmUniqueID><ISSNLinking>2008-2398</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2005 Jan;89(1):15-21</RefSource><PMID Version="1">15666192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Apr;35(4):3495-502</RefSource><PMID Version="1">24402573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Med. 2004 Dec 31;36(6):572-5</RefSource><PMID Version="1">15665590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2000 Jun;36(10 ):1193-9</RefSource><PMID Version="1">10882856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jun 03;8(6):e64896</RefSource><PMID Version="1">23755158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1810-8</RefSource><PMID Version="1">16030121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Detect Prev. 2006;30(4):313-21</RefSource><PMID Version="1">16963196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):170-1</RefSource><PMID Version="1">12582029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Breast Cancer. 2013 Feb;13(1):61-8</RefSource><PMID Version="1">23103366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2013 Oct 30;13:510</RefSource><PMID Version="1">24171766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2014 Dec 14;35(47):3336-45</RefSource><PMID Version="1">25416325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2007 Feb;11(2):103-5</RefSource><PMID Version="1">17292821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2006 Oct;99(3):257-65</RefSource><PMID Version="1">16596326</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Protoc. 2012 Mar 01;2012(3):297-306</RefSource><PMID Version="1">22383645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Feb 3;684(1-2):43-8</RefSource><PMID Version="1">19962393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathol Oncol Res. 2009 Sep;15(3):389-97</RefSource><PMID Version="1">19051060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2006 Jan;95(1):73-80</RefSource><PMID Version="1">16319991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Mol Res. 2005 Dec 30;4(4):771-82</RefSource><PMID Version="1">16475125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Mol Biol. 2010 Oct;33(4):637-40</RefSource><PMID Version="1">21637570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2008 Apr;19(4):1033-8</RefSource><PMID Version="1">18357393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Aug 9;486(3):207-16</RefSource><PMID Version="1">11459633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Dec 15;648(1-2):65-72</RefSource><PMID Version="1">18977234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2008;59(4):201-4</RefSource><PMID Version="1">19391486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2006 Dec;54(3):267-83</RefSource><PMID Version="1">16982113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2013 Oct;22(5):707-12</RefSource><PMID Version="1">23369609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2011 Jan;125(2):479-87</RefSource><PMID Version="1">20549339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Med. 2016 Feb;16(1):21-8</RefSource><PMID Version="1">25537147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytogenet Genome Res. 2014;144(2):77-91</RefSource><PMID Version="1">25401968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2014 Nov 21;14:861</RefSource><PMID Version="1">25416100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):835-42</RefSource><PMID Version="1">20058067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Feb 1;134(3):654-63</RefSource><PMID Version="1">23852586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Sep 09;8(9):e73448</RefSource><PMID Version="1">24039945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Oct;111(3):549-53</RefSource><PMID Version="1">17987379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):217-22</RefSource><PMID Version="1">11303590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Afr J Reprod Health. 2003 Dec;7(3):17-28</RefSource><PMID Version="1">15055143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2007 Jun;103(2):209-17</RefSource><PMID Version="1">17063276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Feb;14 (2):336-42</RefSource><PMID Version="1">15734955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Sep;111(2):279-88</RefSource><PMID Version="1">17922186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 1993 Feb 20;53(4):538-49</RefSource><PMID Version="1">8436428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2013;14(6):3809-13</RefSource><PMID Version="1">23886187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1999 Sep 15;282(11):1054-60</RefSource><PMID Version="1">10493204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Dec;112(3):575-9</RefSource><PMID Version="1">18188695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(1):59-62</RefSource><PMID Version="1">12779082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathol Oncol Res. 2008 Jun;14(2):131-5</RefSource><PMID Version="1">18415712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1168-74</RefSource><PMID Version="1">14652276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2005;7(6):R987-97</RefSource><PMID Version="1">16280050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2000 Apr 19;283(15):2008-12</RefSource><PMID Version="1">10789670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Mar;17(3):760-71</RefSource><PMID Version="1">20183911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 Feb 16;371(9612):569-78</RefSource><PMID Version="1">18280327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2004 Apr;11(4):917-22</RefSource><PMID Version="1">15010895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2014 Nov;18(11):754-60</RefSource><PMID Version="1">25340946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 2007 Oct;127(10):2283-7</RefSource><PMID Version="1">17853910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Jan;119(1):201-11</RefSource><PMID Version="1">19360465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-8</RefSource><PMID Version="1">16492928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1462-7</RefSource><PMID Version="1">14693738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 Dec 15;532(2):192-6</RefSource><PMID Version="1">24076439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2014;15(3):1133-40</RefSource><PMID Version="1">24606430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genet. 2012 Aug;82(2):105-14</RefSource><PMID Version="1">22356477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2004 Nov;4(11):850-60</RefSource><PMID Version="1">15516958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Jun;18(6):3563-71</RefSource><PMID Version="1">9584196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Cell. 2008 Nov;21(4):95-104</RefSource><PMID Version="1">19067761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2008 May;65(10):1544-65</RefSource><PMID Version="1">18259689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Detect Prev. 2007;31(4):303-9</RefSource><PMID Version="1">17935911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Carcinog. 2010 Apr 16;9:4</RefSource><PMID Version="1">20442803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2005;7(6):R1168-73</RefSource><PMID Version="1">16457697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 18;9(3):e92083</RefSource><PMID Version="1">24642895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2009;60(2):76-80</RefSource><PMID Version="1">19886181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2012 Jul 15;503(1):118-22</RefSource><PMID Version="1">22579466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Res. 2008;17(3):127-35</RefSource><PMID Version="1">18669164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol Merkur Lekarski. 2007 Mar;22(129):200-3</RefSource><PMID Version="1">17682675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2000 Oct 16;159(1):79-86</RefSource><PMID Version="1">10974409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2010 Apr;136(4):631-6</RefSource><PMID Version="1">20140625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2003 Feb 20;190(2):183-90</RefSource><PMID Version="1">12565173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacogenetics. 2002 Jun;12(4):335-8</RefSource><PMID Version="1">12042672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):403-4</RefSource><PMID Version="1">16492938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2008 Nov;29(11):2132-8</RefSource><PMID Version="1">18701435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29</RefSource><PMID Version="1">24399786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Dec;25(12):2433-41</RefSource><PMID Version="1">15333465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2012 Feb;39(2):1895-901</RefSource><PMID Version="1">21643959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fam Cancer. 2015 Sep;14(3):349-54</RefSource><PMID Version="1">25690738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Epidemiol. 2009 Nov;33(7):637-45</RefSource><PMID Version="1">19235185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):583-91</RefSource><PMID Version="1">15066923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2011 Aug;32(8):1223-30</RefSource><PMID Version="1">21622940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Dec 1;63(23):8536-41</RefSource><PMID Version="1">14679022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):811-5</RefSource><PMID Version="1">16614128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2013;2013:747318</RefSource><PMID Version="1">23586058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1997 Apr 29;36(17 ):5207-11</RefSource><PMID Version="1">9136882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2010;61(4):206-12</RefSource><PMID Version="1">21290343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Mar 1;66(5):2860-8</RefSource><PMID Version="1">16510609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Genet. 2010;51(3):343-52</RefSource><PMID Version="1">20720310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Apr 20;97(8):567-76</RefSource><PMID Version="1">15840879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2002 May;31(1):33-6</RefSource><PMID Version="1">11984562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1200-4</RefSource><PMID Version="1">14652281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2006 Jan;15(1):247-52</RefSource><PMID Version="1">16328064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 2013 Jan;66(1):75-7</RefSource><PMID Version="1">23177896</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast Neoplasms</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Polymorphisms</Keyword><Keyword MajorTopicYN="N">XRCC1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>08</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27366307</ArticleId><ArticleId IdType="doi">10.17795/ijcp-3467</ArticleId><ArticleId IdType="pmc">PMC4922200</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27274063</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>113</Volume><Issue>25</Issue><PubDate><Year>2016</Year><Month>06</Month><Day>21</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.</ArticleTitle><Pagination><MedlinePgn>E3558-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1606226113</ELocationID><Abstract><AbstractText>A major hallmark of oxidative DNA damage after stroke is the induction of apurinic/apyrimidinic (AP) sites and strand breaks. To mitigate cell loss after oxidative DNA damage, ischemic cells rapidly engage the base excision-repair proteins, such as the AP site-repairing enzyme AP endonuclease-1 (APE1), also named redox effector factor-1 (Ref-1). Although forced overexpression of APE1 is known to protect against oxidative stress-induced neurodegeneration, there is no concrete evidence demonstrating a role for endogenous APE1 in the long-term recovery of gray and white matter following ischemic injury. To address this gap, we generated, to our knowledge, the first APE1 conditional knockout (cKO) mouse line under control of tamoxifen-dependent Cre recombinase. Using a well-established model of transient focal cerebral ischemia (tFCI), we show that induced deletion of APE1 dramatically enlarged infarct volume and impaired the recovery of sensorimotor and cognitive deficits. APE1 cKO markedly increased postischemic neuronal and oligodendrocyte degeneration, demonstrating that endogenous APE1 preserves both gray and white matter after tFCI. Because white matter repair is instrumental in behavioral recovery after stroke, we also examined the impact of APE1 cKO on demyelination and axonal conduction and discovered that APE1 cKO aggravated myelin loss and impaired neuronal communication following tFCI. Furthermore, APE1 cKO increased AP sites and activated the prodeath signaling proteins, PUMA and PARP1, after tFCI in topographically distinct manners. Our findings provide evidence that endogenous APE1 protects against ischemic infarction in both gray and white matter and facilitates the functional recovery of the central nervous system after mild stroke injury.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stetler</LastName><ForeName>R Anne</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China; Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yanqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China; Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leak</LastName><ForeName>Rehana K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA 15282;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Zhongfang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yejie</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-7502-9201</Identifier><AffiliationInfo><Affiliation>Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pu</LastName><ForeName>Hongjian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China; Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China; Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Sulaiman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA 15261; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Homanics</LastName><ForeName>Gregg E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh, Pittsburgh, PA 15261; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Guodong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China; Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Michael V L</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China; Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461 michael.bennett@einstein.yu.edu chenj2@upmc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China; Pittsburgh Institute of Brain Disorders &amp; Recovery, Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA 15261; michael.bennett@einstein.yu.edu chenj2@upmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R37 AA010422</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS095029</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS045287</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS089534</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS036736</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS045048</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AA010422</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18308-13</RefSource><PMID Version="1">17116882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8424-8</RefSource><PMID Version="1">8378314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2009 Jun 5;1274:1-10</RefSource><PMID Version="1">19374886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Biochem. 2009 Oct;42(15):1493-9</RefSource><PMID Version="1">19631633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cereb Blood Flow Metab. 2003 Nov;23(11):1324-39</RefSource><PMID Version="1">14600440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2853-8</RefSource><PMID Version="1">25691750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2002 Jun 3;21(11):2833-41</RefSource><PMID Version="1">12032096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Mar 2;4(3):367-79</RefSource><PMID Version="1">15661660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2001 Mar;7(3):683-94</RefSource><PMID Version="1">11463392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1974 Mar 10;249(5):1530-5</RefSource><PMID Version="1">4206354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Aug 14;273(33):21203-9</RefSource><PMID Version="1">9694877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 1996 Sep;27(9):1641-6; discussion 1647</RefSource><PMID Version="1">8784142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci Methods. 2002 Jun 30;117(2):207-14</RefSource><PMID Version="1">12100987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2000 Apr;74(4):1636-45</RefSource><PMID Version="1">10737622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cereb Blood Flow Metab. 2006 Feb;26(2):181-98</RefSource><PMID Version="1">16001017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1974 Mar 10;249(5):1536-40</RefSource><PMID Version="1">4361739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 1995 Mar 1;26(1):63-9</RefSource><PMID Version="1">7782087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotherapeutics. 2013 Jan;10 (1):124-42</RefSource><PMID Version="1">23132328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2008 Dec 3;28(49):13038-55</RefSource><PMID Version="1">19052195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 2013 Dec;44(12):3509-15</RefSource><PMID Version="1">24092548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 1997 Jul;69(1):232-45</RefSource><PMID Version="1">9202315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Aug 29;27(35):9278-93</RefSource><PMID Version="1">17728442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Nov 1;53(9):1782-90</RefSource><PMID Version="1">22841870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2002 Apr 15;244(2):305-18</RefSource><PMID Version="1">11944939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurocytol. 1996 Jan;25(1):1-7</RefSource><PMID Version="1">8852934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3204-9</RefSource><PMID Version="1">20133634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1999;93(4):1465-73</RefSource><PMID Version="1">10501471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 2009 Jun;40(6):2244-50</RefSource><PMID Version="1">19246690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1998 Oct 21;409(1):17-29</RefSource><PMID Version="1">9806499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2014 Apr;17 (4):506-12</RefSource><PMID Version="1">24609463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 May 15;14(10):1905-18</RefSource><PMID Version="1">20677909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1998 Jan 29;338(5):278-85</RefSource><PMID Version="1">9445407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cereb Blood Flow Metab. 2001 Apr;21(4):321-33</RefSource><PMID Version="1">11323518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 1999 Feb;30(2):441-8; discussion 449</RefSource><PMID Version="1">9933285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2015 Jan 10;22(2):135-48</RefSource><PMID Version="1">24180454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43</RefSource><PMID Version="1">15824325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 2009 Feb;40(2):530-6</RefSource><PMID Version="1">19109548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Neurosci. 2007 Oct 10;8:85</RefSource><PMID Version="1">17927825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2012 Sep 1;17(5):719-32</RefSource><PMID Version="1">22356734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 1998 Nov;29(11):2268-76</RefSource><PMID Version="1">9804633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CNS Neurol Disord Drug Targets. 2013 May 1;12(3):325-37</RefSource><PMID Version="1">23469858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95</RefSource><PMID Version="1">10959836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 2012 May;43(5):1390-7</RefSource><PMID Version="1">22461332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">base excision repair</Keyword><Keyword MajorTopicYN="Y">ischemia</Keyword><Keyword MajorTopicYN="Y">neurodegeneration</Keyword><Keyword MajorTopicYN="Y">oxidative DNA damage</Keyword><Keyword MajorTopicYN="Y">white matter injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27274063</ArticleId><ArticleId IdType="pii">1606226113</ArticleId><ArticleId IdType="doi">10.1073/pnas.1606226113</ArticleId><ArticleId IdType="pmc">PMC4922172</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27251462</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3913</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>09</Month></PubDate></JournalIssue><Title>Cellular signalling</Title><ISOAbbreviation>Cell. Signal.</ISOAbbreviation></Journal><ArticleTitle>OGG1 is essential in oxidative stress induced DNA demethylation.</ArticleTitle><Pagination><MedlinePgn>1163-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cellsig.2016.05.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0898-6568(16)30128-0</ELocationID><Abstract><AbstractText>DNA demethylation is an essential cellular activity to regulate gene expression; however, the mechanism that triggers DNA demethylation remains unknown. Furthermore, DNA demethylation was recently demonstrated to be induced by oxidative stress without a clear molecular mechanism. In this manuscript, we demonstrated that 8-oxoguanine DNA glycosylase-1 (OGG1) is the essential protein involved in oxidative stress-induced DNA demethylation. Oxidative stress induced the formation of 8-oxoguanine (8-oxoG). We found that OGG1, the 8-oxoG binding protein, promotes DNA demethylation by interacting and recruiting TET1 to the 8-oxoG lesion. Downregulation of OGG1 makes cells resistant to oxidative stress-induced DNA demethylation, while over-expression of OGG1 renders cells susceptible to DNA demethylation by oxidative stress. These data not only illustrate the importance of base excision repair (BER) in DNA demethylation but also reveal how the DNA demethylation signal is transferred to downstream DNA demethylation enzymes.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiaolong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Ziheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Changzhou No. 7 People's Hospital, Changzhou 213011, China; School of Pharmaceutical Engineering and Life Sciences, Changzhou University, Changzhou 213011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wentao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Lingfeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Feiyan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekhar</LastName><ForeName>Chandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, 1 WenYuan Road, Nanjing 210023, China. Electronic address: guozgang@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Signal</MedlineTA><NlmUniqueID>8904683</NlmUniqueID><ISSNLinking>0898-6568</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.-</RegistryNumber><NameOfSubstance UI="C462539">TET1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018899" MajorTopicYN="N">CpG Islands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073399" MajorTopicYN="Y">DNA Demethylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="N">Genome, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">8-OxoG</Keyword><Keyword MajorTopicYN="Y">DNA demethylation</Keyword><Keyword MajorTopicYN="Y">OGG1</Keyword><Keyword MajorTopicYN="Y">Oxidative stress</Keyword><Keyword MajorTopicYN="Y">TET1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27251462</ArticleId><ArticleId IdType="pii">S0898-6568(16)30128-0</ArticleId><ArticleId IdType="doi">10.1016/j.cellsig.2016.05.021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27240987</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">0973-7138</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of biosciences</Title><ISOAbbreviation>J. Biosci.</ISOAbbreviation></Journal><ArticleTitle>Accelerated processing of solitary and clustered abasic site DNA damage lesions by APE1 in the presence of aqueous extract of Ganoderma lucidum.</ArticleTitle><Pagination><MedlinePgn>265-75</MedlinePgn></Pagination><Abstract><AbstractText>The stimulatory effect of the aqueous extract of G. lucidum, a basidiomycetes class fungus in the APE1-enzyme-mediated processing of solitary and bistranded clustered abasic sites DNA damages is presented. Abasic sites are considered the most common type of DNA damage lesions. Our study shows enhanced activity of APE1 in the processing of abasic sites in the presence of the polysaccharides fraction of G. lucidum. Remarkable increase in the amount of single-strand breaks (SSBs) and double-strand breaks (DSBs) from solitary and bistranded clustered abasic sites respectively with APE1 in the presence of the extract was found. This trend is maintained when abasic sites in DNA oligomers are exposed to fibroblast cell extracts in the presence of the extract. While DNA conformational alteration is negligible, APE1 enzyme shows characteristic changes in the alpha helix and beta strand ratio after incubation with G. lucidum extract. The enhanced reactivity of APE1 at the molecular level in the presence of G. lucidium is attributed to this effect. This study potentially amplifies the scope of the use of G. lucidum, which was earlier shown to have only reactive oxygen species (ROS) scavenging properties with regards to DNA damage inhibition. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumari</LastName><ForeName>Bhavini</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Chemistry, IIT Patna, Patna, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DAS</LastName><ForeName>Prolay</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Kumari</LastName><ForeName>Rekha</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Biosci</MedlineTA><NlmUniqueID>8100809</NlmUniqueID><ISSNLinking>0250-5991</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062610">Fungal Polysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Hematol Oncol. 2009 Jun 10;2:25</RefSource><PMID Version="1">19515245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Res. 2006 Jul;30(7):841-8</RefSource><PMID Version="1">16423392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Nov 15;20(22):6530-9</RefSource><PMID Version="1">11707423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glycobiology. 2004 Apr;14(4):17R-30R</RefSource><PMID Version="1">14718374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 May 10;485(4):283-307</RefSource><PMID Version="1">11585362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2000 Jul 11;39(27):8026-31</RefSource><PMID Version="1">10891084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Oct 19;32(18):5609-20</RefSource><PMID Version="1">15494449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carbohydr Res. 2012 May 15;353:100-5</RefSource><PMID Version="1">22486826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phytochemistry. 2006 Sep;67(18):1985-2001</RefSource><PMID Version="1">16905165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Aug 14;273(33):21203-9</RefSource><PMID Version="1">9694877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Med. 1999 Sep;4(3):273-7</RefSource><PMID Version="1">10425278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Molecules. 2008 Aug 08;13(8):1599-616</RefSource><PMID Version="1">18794775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nutr Cancer. 2008;60(1):109-19</RefSource><PMID Version="1">18444142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2012 Mar;362(1-2):195-201</RefSource><PMID Version="1">22042551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phytomedicine. 2005 Apr;12(4):255-63</RefSource><PMID Version="1">15898702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Feb 24;33(4):1222-9</RefSource><PMID Version="1">15731342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2008 May 23;379(1):17-27</RefSource><PMID Version="1">18439621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2002 Nov 20;102(3):250-3</RefSource><PMID Version="1">12397644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 1989 May 15;179(1):209-15</RefSource><PMID Version="1">2757197</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):103-8</RefSource><PMID Version="1">10618378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Chin Med. 2011;39(1):15-27</RefSource><PMID Version="1">21213395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biofactors. 2004;21(1-4):109-12</RefSource><PMID Version="1">15630179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 May;36(8):2717-27</RefSource><PMID Version="1">18353858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2002 Aug;8(4):728-33</RefSource><PMID Version="1">12174387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Agric Food Chem. 2009 Nov 25;57(22):10565-72</RefSource><PMID Version="1">19863048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jan 12;33(1):260-71</RefSource><PMID Version="1">15647508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(9):e23679</RefSource><PMID Version="1">21935361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Food. 2005 Summer;8(2):159-68</RefSource><PMID Version="1">16117607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2014 May 22;15(5):9103-16</RefSource><PMID Version="1">24857920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2000 Jun 30;476(1-2):73-7</RefSource><PMID Version="1">10878254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biosci. 2011 Mar;36(1):105-16</RefSource><PMID Version="1">21451252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Apr 22;362(6422):709-15</RefSource><PMID Version="1">8469282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Food Chem. 2012 Dec 1;135(3):1097-103</RefSource><PMID Version="1">22953830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Jan 5;3(1):1-12</RefSource><PMID Version="1">14697754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Food Chem. 2014 Jul 15;155:50-6</RefSource><PMID Version="1">24594153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fitoterapia. 2014 Oct;98:254-9</RefSource><PMID Version="1">25111010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2007 Nov 09;8:411</RefSource><PMID Version="1">17996095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Rev Med Pharmacol Sci. 2012 Feb;16(2):166-75</RefSource><PMID Version="1">22428467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acupunct Meridian Stud. 2010 Mar;3(1):24-31</RefSource><PMID Version="1">20633512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>3 Biotech. 2012 Mar;2(1):1-15</RefSource><PMID Version="1">22582152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Jun 20;272(25):15650-5</RefSource><PMID Version="1">9188454</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D053903" MajorTopicYN="N">DNA Breaks, Double-Stranded</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053904" MajorTopicYN="N">DNA Breaks, Single-Stranded</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062610" MajorTopicYN="N">Fungal Polysaccharides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020940" MajorTopicYN="N">Reishi</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27240987</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27231670</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2233-7385</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Chonnam medical journal</Title><ISOAbbreviation>Chonnam Med J</ISOAbbreviation></Journal><ArticleTitle>Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.</ArticleTitle><Pagination><MedlinePgn>75-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4068/cmj.2016.52.2.75</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein that plays a central role in the cellular response to DNA damage and redox regulation against oxidative stress. APE1/Ref-1 functions in the DNA base excision repair pathway, the redox regulation of several transcription factors, and the control of intracellular redox status through the inhibition of reactive oxygen species (ROS) production. APE1/Ref-1 is predominantly localized in the nucleus; however, its subcellular localization is dynamically regulated and it may be found in the mitochondria or elsewhere in the cytoplasm. Studies have identified a nuclear localization signal and a mitochondrial target sequence in APE1/Ref-1, as well as the involvement of the nuclear export system, as determinants of APE1/Ref-1 subcellular distribution. Recently, it was shown that APE1/Ref-1 is secreted in response to hyperacetylation at specific lysine residues. Additionally, post-translational modifications such as phosphorylation, S-nitrosation, and ubiquitination appear to play a role in fine-tuning the activities and subcellular localization of APE1/Ref-1. In this review, we will introduce the multifunctional role of APE1/Ref-1 and its potential usefulness as a therapeutic target in cancer and cardiovascular disease. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, College of Medicine, Chungnam National University, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hee Kyoung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, College of Medicine, Chungnam National University, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeong Hwa</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, College of Medicine, Chungnam National University, Daejeon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Chonnam Med J</MedlineTA><NlmUniqueID>101564659</NlmUniqueID><ISSNLinking>2233-7393</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 1992 Dec;1(9):677-80</RefSource><PMID Version="1">1284593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2011 Feb;31(2):379-85</RefSource><PMID Version="1">21378315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Mar 7;485(2):143-52</RefSource><PMID Version="1">11182545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Aug 25;643(1-2):54-63</RefSource><PMID Version="1">18579163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hypertens. 2010 Feb;23(2):186-91</RefSource><PMID Version="1">20010699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(2):701-11</RefSource><PMID Version="1">21933813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vision Res. 2011 Jan;51(1):93-100</RefSource><PMID Version="1">20937296</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2004 Oct 29;95(9):902-10</RefSource><PMID Version="1">15472121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 14;435(4):621-6</RefSource><PMID Version="1">23685156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2006 Feb 1;69(2):520-6</RefSource><PMID Version="1">16325162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 11;6:23015</RefSource><PMID Version="1">26964514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2011 Jan 11;50(1):82-92</RefSource><PMID Version="1">21117647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res Mol Brain Res. 1997 Feb;44(1):167-70</RefSource><PMID Version="1">9030714</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2008 Mar 28;368(1):68-73</RefSource><PMID Version="1">18206643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2010 Sep 1;334(3):988-98</RefSource><PMID Version="1">20504914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jul 15;29(14):3116-22</RefSource><PMID Version="1">11452037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2011 Aug 1;91(3):502-9</RefSource><PMID Version="1">21467074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):571-4</RefSource><PMID Version="1">18715142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 7;435(3):403-7</RefSource><PMID Version="1">23665318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1997 Dec 15;57(24):5457-9</RefSource><PMID Version="1">9407949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2012 May;30(5):917-25</RefSource><PMID Version="1">22441348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 1998 Jun;10(3):392-9</RefSource><PMID Version="1">9640541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 17;51(2):695-705</RefSource><PMID Version="1">22148505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mitochondrion. 2014 Jul;17:42-9</RefSource><PMID Version="1">24861944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2013 Dec;20 Suppl 3:S336-47</RefSource><PMID Version="1">22688662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2012 Jul 6;111(2):212-9</RefSource><PMID Version="1">22652909</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2002 Jul;9(7):717-25</RefSource><PMID Version="1">12058277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2002 Jun;16(8):889-90</RefSource><PMID Version="1">12039869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Histopathology. 1998 Dec;33(6):561-9</RefSource><PMID Version="1">9870152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1995 Dec 15;55(24):6097-102</RefSource><PMID Version="1">8521399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jun 07;33(10 ):3303-12</RefSource><PMID Version="1">15942031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2522-32</RefSource><PMID Version="1">17403694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2015 Oct;106(10):1394-401</RefSource><PMID Version="1">26250694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2003 Feb;21(2):327-35</RefSource><PMID Version="1">12569263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Biochem. 1993 Jan;25(1):53-9</RefSource><PMID Version="1">7679358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 May 14;285(20):14871-81</RefSource><PMID Version="1">20231292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cells. 2013 Nov;36(5):439-45</RefSource><PMID Version="1">24213673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2009 Apr;219(1):209-18</RefSource><PMID Version="1">19097035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Aug 02;33(14):4379-94</RefSource><PMID Version="1">16077024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2008 May;60(2):277-84</RefSource><PMID Version="1">18061304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2004 Jun;18(9):986-8</RefSource><PMID Version="1">15084519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Aug 8;272(32):19633-6</RefSource><PMID Version="1">9289489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1994 Nov 25;22(23):4884-9</RefSource><PMID Version="1">7800476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2014 Feb;105(2):186-94</RefSource><PMID Version="1">24329908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2012 May;103(5):882-8</RefSource><PMID Version="1">22329793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e58001</RefSource><PMID Version="1">23472128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stroke. 1999 Feb;30(2):441-8; discussion 449</RefSource><PMID Version="1">9933285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 Mar;36(5):1555-66</RefSource><PMID Version="1">18208837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1999 Jan 28;18(4):1033-40</RefSource><PMID Version="1">10023679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Sep 15;6(27):23383-98</RefSource><PMID Version="1">26125438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2009 Apr 2;28(13):1616-25</RefSource><PMID Version="1">19219073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Markers. 2016;2016:7276502</RefSource><PMID Version="1">27057081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Korean Circ J. 2015 Sep;45(5):364-71</RefSource><PMID Version="1">26413103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2015 Oct;47(4):823-33</RefSource><PMID Version="1">25672588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Jun 23;43(11):5451-64</RefSource><PMID Version="1">25956655</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">DNA-(apurinic or apyrimidinic site) lyase</Keyword><Keyword MajorTopicYN="N">Oxidation-reduction</Keyword><Keyword MajorTopicYN="N">Protein processing, post-translational</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>03</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27231670</ArticleId><ArticleId IdType="doi">10.4068/cmj.2016.52.2.75</ArticleId><ArticleId IdType="pmc">PMC4880582</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27230458</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2093-4777</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>Suppl 1</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>International neurourology journal</Title><ISOAbbreviation>Int Neurourol J</ISOAbbreviation></Journal><ArticleTitle>Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer.</ArticleTitle><Pagination><MedlinePgn>S30-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5213/inj.1632600.300</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein involved in DNA repair and redox modulation. Recently, serum and urinary APE1/Ref-1 levels were reported to be increased in patients with bladder cancer. Genetic variations of APE/Ref-1 are associated with the risk of cancer. However, the effect of APE1/Ref-1 variants on its secretory activity is yet unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">APE1/Ref-1 variants were evaluated by DNA sequencing analysis of reverse transcription polymerase chain reaction products in coding DNA sequences (CDS) of APE1/Ref-1 in bladder tissue samples from patients with bladder cancer (n=10). Secretory activity of APE1/Ref-1 variants was evaluated with immunoblot and enzyme-linked immunosorbent assay of the culture medium supernatants.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four different substitution mutants (D148E, I64V/D148E, W67R/D148E, and E86G/D148E) of APE1/Ref-1 were identified in bladder cancer specimens. However, deletion mutants of APE1/Ref-1 CDS were not found. The secretory activity of the APE1/Ref-1 variants (D148E, I64V/D148E, and E86G/D148E) was increased compared to that of wild type APE1/Ref-1. Furthermore, the secretory activity in basal or hyperacetylated conditions was much higher than that in APE1/Ref-1 D148E-transfected HEK293 cells.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Taken together, our data suggest that the increased secretory activity of D148E might contribute to increased serum levels of APE1/Ref-1 in patients with bladder cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yu Ran</ForeName><Initials>YR</Initials><Identifier Source="ORCID">0000-0002-1902-8818</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Science, Chungnam National University, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jae Sung</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0003-4324-8148</Identifier><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Ju Hyun</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5996-5876</Identifier><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3358-7923</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hee Kyoung</ForeName><Initials>HK</Initials><Identifier Source="ORCID">0000-0002-2860-6448</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeong Hwa</ForeName><Initials>BH</Initials><Identifier Source="ORCID">0000-0002-3347-2739</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Science, Chungnam National University, Daejeon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Int Neurourol J</MedlineTA><NlmUniqueID>101534513</NlmUniqueID><ISSNLinking>2093-4777</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 1992 Dec;1(9):677-80</RefSource><PMID Version="1">1284593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Markers. 2015;2015:869512</RefSource><PMID Version="1">26257461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Mar 11;6:23015</RefSource><PMID Version="1">26964514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2010 Jun;29(6):303-11</RefSource><PMID Version="1">20218899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):571-4</RefSource><PMID Version="1">18715142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 7;435(3):403-7</RefSource><PMID Version="1">23665318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2004 Feb;14(1):5-10</RefSource><PMID Version="1">15108798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jun 07;33(10 ):3303-12</RefSource><PMID Version="1">15942031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):84-91</RefSource><PMID Version="1">17220334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2522-32</RefSource><PMID Version="1">17403694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12754-7</RefSource><PMID Version="1">9398071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cells. 2013 Nov;36(5):439-45</RefSource><PMID Version="1">24213673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jun 03;8(6):e65415</RefSource><PMID Version="1">23755229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oxid Med Cell Longev. 2014;2014:730301</RefSource><PMID Version="1">25243052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2012;22(6):537-42</RefSource><PMID Version="1">23038158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 12;8(12):e83527</RefSource><PMID Version="1">24349526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Sep 15;6(27):23383-98</RefSource><PMID Version="1">26125438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Markers. 2016;2016:7276502</RefSource><PMID Version="1">27057081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Korean Circ J. 2015 Sep;45(5):364-71</RefSource><PMID Version="1">26413103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2011 Mar;43(1):1-11</RefSource><PMID Version="1">21509157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2015 Oct;47(4):823-33</RefSource><PMID Version="1">25672588</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (APE1/Ref-1)</Keyword><Keyword MajorTopicYN="N">Bladder Cancer</Keyword><Keyword MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</Keyword><Keyword MajorTopicYN="N">Point Mutation</Keyword><Keyword MajorTopicYN="N">Secretion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>04</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27230458</ArticleId><ArticleId IdType="doi">10.5213/inj.1632600.300</ArticleId><ArticleId IdType="pii">inj-1632600-300</ArticleId><ArticleId IdType="pmc">PMC4895906</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27074577</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>19</Issue><PubDate><Year>2016</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of Epithelial-Mesenchymal Transition.</ArticleTitle><Pagination><MedlinePgn>28523-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.8660</ELocationID><Abstract><AbstractText>The DNA base excision repair gene APE1 involves in DNA damage repair pathway and overexpression in a variety of human cancers. Analyses of patients with non-small cell lung cancer (NSCLC) suggested that multiple factors associated with prognosis of NSCLC patients. Further investigation showed that APE1 expression was able to predict the progression-free survival and overall survival in patients with NSCLC and correlated with lymph node metastasis. Intriguingly, as a stratification of APE1-141 SNPs in APE1 positive expression, we also found APE1-141 GT/GG was identified as a marker for prediction of poor survival in NSCLC patients. In the in vitro experiments, the results showed that when APE1 expression was inhibited by siRNA or AT101 (an APE1 inhibitor), the migration and invasion of NSCLC cells were suppressed. Furthermore, Epithelial-Mesenchymal Transition (EMT) markers was tested to provide evidence that APE1 promoted NSCLC EMT through interaction with SirT1. Using NSCLC xenograft models, we confirmed that AT101 shrank tumor volumes and inhibited lymph node metastasis. In conclusion, APE1 could be a potential target for patients with NSCLC metastasis and AT101 is a potent inhibitor in further treatment of NSCLC patients. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chongbiao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Senior Ward, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiangqian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Cervical Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Jingtao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Department of Otorhinolaryngology and Maxillofacial Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute, National Clinical Research Center of Cancer, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xin</LastName><ForeName>Xiaojie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Thyroid and Cervical Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>KAV15B369O</RegistryNumber><NameOfSubstance UI="D006072">Gossypol</NameOfSubstance></Chemical><Chemical><RegistryNumber>S7RL72610R</RegistryNumber><NameOfSubstance UI="C028178">gossypol acetic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Health Technol Assess. 2013 Jul;17(31):1-278</RefSource><PMID Version="1">23886301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2013;14(9):5145-51</RefSource><PMID Version="1">24175791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2009 Apr;9(4):265-73</RefSource><PMID Version="1">19262571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 May 10;485(4):283-307</RefSource><PMID Version="1">11585362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Dec 1;135(11):2687-96</RefSource><PMID Version="1">24729390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):4079-96</RefSource><PMID Version="1">22918947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2007 Dec;98(12):1993-2001</RefSource><PMID Version="1">17892509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Pulm Med. 2005 Jul;11(4):287-91</RefSource><PMID Version="1">15928493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907</RefSource><PMID Version="1">20647400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Des Devel Ther. 2015 Jun 08;9:2887-910</RefSource><PMID Version="1">26089640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Sep 26;278(39):37768-76</RefSource><PMID Version="1">12842873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96</RefSource><PMID Version="1">18287387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Sep;35(9):8559-64</RefSource><PMID Version="1">24863948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2013 Oct;33(10):4631-7</RefSource><PMID Version="1">24123041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2014 Feb;25(4):532-47</RefSource><PMID Version="1">24356447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transl Oncol. 2014 Apr;7(2):284-91</RefSource><PMID Version="1">24685547</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000972" MajorTopicYN="N">Antineoplastic Agents, Phytogenic</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006072" MajorTopicYN="N">Gossypol</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Epithelial-Mesenchymal Transition (EMT)</Keyword><Keyword MajorTopicYN="N">lymph node metastasis</Keyword><Keyword MajorTopicYN="N">non-small cell lung cancer (NSCLC)</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27074577</ArticleId><ArticleId IdType="pmc">PMC5053743</ArticleId><ArticleId IdType="pii">8660</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.8660</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27057081</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-8630</ISSN><JournalIssue CitedMedium="Internet"><Volume>2016</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Disease markers</Title><ISOAbbreviation>Dis. Markers</ISOAbbreviation></Journal><ArticleTitle>Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.</ArticleTitle><Pagination><MedlinePgn>7276502</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2016/7276502</ELocationID><Abstract><AbstractText>Bladder cancer (BCa) is one of the most common urothelial cancers with still noticeable incidence rate. Early detection of BCa is highly correlated with successful therapeutic outcomes. We previously showed that apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) was expressed at an increased level in the serum of BCa patients when compared to the level in healthy controls. In this study, we investigated whether urinary APE1/Ref-1 was also elevated in patients with BCa. In this case-control study, voided urine was collected from 277 subjects including 169 BCa patients and 108 non-BCa controls. Urinary APE1/Ref-1 level was assessed by enzyme-linked immunosorbent assay (ELISA). APE1/Ref-1 levels were significantly elevated in BCa patients relative to levels in non-BCa controls and were correlated with tumor grade and stage. Urinary APE1/Ref-1 levels were also higher in patients with recurrence history of BCa. The receiver operating characteristics (ROC) curve of APE1/Ref-1 showed an area under the curve of 0.83, indicating the reliability and validity of this biomarker. The optimal combination of sensitivity and specificity was determined to be 82% and 80% at a cut-off value of 0.376 ng/100 μL for detection of APE1/Ref-1 in urine. In conclusion, urinary APE1/Ref-1 levels measured from noninvasively obtained body fluids would be clinically applicable for diagnosis of BCa. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Ju Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yu Ran</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hee Kyoung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Ki Hak</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Yong Gil</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Seok Jong</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Physiology, College of Medicine, Seonam University, Namwon 55724, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jae Sung</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeong Hwa</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Markers</MedlineTA><NlmUniqueID>8604127</NlmUniqueID><ISSNLinking>0278-0240</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2004 Jul-Aug;24(4):2127-34</RefSource><PMID Version="1">15330152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2014 Feb 4;110(3):679-85</RefSource><PMID Version="1">24292452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41</RefSource><PMID Version="1">22700443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2011 Jun;10(6):M110.005330</RefSource><PMID Version="1">21474795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Diagn Ther. 2013 Apr;17(2):71-84</RefSource><PMID Version="1">23479428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300</RefSource><PMID Version="1">20610543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2007 Aug 14;177(4):361-8</RefSource><PMID Version="1">17698825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 7;435(3):403-7</RefSource><PMID Version="1">23665318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2004 Nov;4(11):3485-97</RefSource><PMID Version="1">15529407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Nov 15;162(10):925-42</RefSource><PMID Version="1">16221808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2010 Nov;49(8):1283-7</RefSource><PMID Version="1">20843171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2002 Feb;167(2 Pt 1):555-8</RefSource><PMID Version="1">11792917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Nov;7(11):3510-8</RefSource><PMID Version="1">11705870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2002 Mar;167(3):1318-9; discussion 1319-20</RefSource><PMID Version="1">11832722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biom J. 2005 Aug;47(4):458-72</RefSource><PMID Version="1">16161804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2008 May;60(2):277-84</RefSource><PMID Version="1">18061304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can Urol Assoc J. 2008 Jun;2(3):212-21</RefSource><PMID Version="1">18682775</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e58001</RefSource><PMID Version="1">23472128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Urol. 2012;12:12</RefSource><PMID Version="1">22559832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncotarget. 2015 Sep 15;6(27):23383-98</RefSource><PMID Version="1">26125438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2000 Sep;164(3 Pt 1):680-4</RefSource><PMID Version="1">10954628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2011 Mar;43(1):1-11</RefSource><PMID Version="1">21509157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2015 Oct;47(4):823-33</RefSource><PMID Version="1">25672588</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="N">Early Detection of Cancer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27057081</ArticleId><ArticleId IdType="doi">10.1155/2016/7276502</ArticleId><ArticleId IdType="pmc">PMC4745317</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27050370</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>18</Issue><PubDate><Year>2016</Year><Month>May</Month><Day>03</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>APE1 polymorphic variants cause persistent genomic stress and affect cancer cell proliferation.</ArticleTitle><Pagination><MedlinePgn>26293-306</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.8477</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1 (APE1) is the main mammalian AP-endonuclease responsible for the repair of endogenous DNA damage through the base excision repair (BER) pathway. Molecular epidemiological studies have identified several genetic variants associated with human diseases, but a well-defined functional connection between mutations in APE1 and disease development is lacking. In order to understand the biological consequences of APE1 genetic mutations, we examined the molecular and cellular consequences of the selective expression of four non-synonymous APE1 variants (L104R, R237C, D148E and D283G) in human cells. We found that D283G, L104R and R237C variants have reduced endonuclease activity and impaired ability to associate with XRCC1 and DNA polymerase β, which are enzymes acting downstream of APE1 in the BER pathway. Complementation experiments performed in cells, where endogenous APE1 had been silenced by shRNA, showed that the expression of these variants resulted in increased phosphorylation of histone H2Ax and augmented levels of poly(ADP-ribosyl)ated (PAR) proteins. Persistent activation of DNA damage response markers was accompanied by growth defects likely due to combined apoptotic and autophagic processes. These phenotypes were observed in the absence of exogenous stressors, suggesting that chronic replication stress elicited by the BER defect may lead to a chronic activation of the DNA damage response. Hence, our data reinforce the concept that non-synonymous APE1 variants present in the human population may act as cancer susceptibility alleles. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lirussi</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology and DNA Repair, Department of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1474 Nordbyhagen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniali</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology and DNA Repair, Department of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ambrosio</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Proteomics and Mass Spectrometry Laboratory, ISPAAM, National Research Council, 80147 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scaloni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Proteomics and Mass Spectrometry Laboratory, ISPAAM, National Research Council, 80147 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsen</LastName><ForeName>Hilde</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, 1474 Nordbyhagen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tell</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology and DNA Repair, Department of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2014 Jul;71(13):2451-65</RefSource><PMID Version="1">24496644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W239-42</RefSource><PMID Version="1">16845001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22090-5</RefSource><PMID Version="1">21127267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Jun 3;711(1-2):100-12</RefSource><PMID Version="1">21167187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2015 Jan 30;427(2):298-311</RefSource><PMID Version="1">25498387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2007 Sep 15;120(Pt 18):3219-27</RefSource><PMID Version="1">17878236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Med. 1999;28:17-23</RefSource><PMID Version="1">21374023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jun 11;8(6):e65922</RefSource><PMID Version="1">23776569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):4079-96</RefSource><PMID Version="1">22918947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pathol. 2015;10:425-48</RefSource><PMID Version="1">25621662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Oncol. 2015 Jan;9(1):204-17</RefSource><PMID Version="1">25205036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2013;4:2674</RefSource><PMID Version="1">24154628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2015 Sep;779:96-104</RefSource><PMID Version="1">26164266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2013 Jan 24;49(2):339-45</RefSource><PMID Version="1">23246433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e46688</RefSource><PMID Version="1">23056405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2014 May;25(10 ):1641-52</RefSource><PMID Version="1">24648491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2010 May;35(5):247-52</RefSource><PMID Version="1">20172733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Aug 14;512(7513):198-202</RefSource><PMID Version="1">25079315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2010 Apr;7(4):248-9</RefSource><PMID Version="1">20354512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Jan;432(3-4):53-9</RefSource><PMID Version="1">11465542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Gerontol. 2010 Oct;45(10):772-8</RefSource><PMID Version="1">20117203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2000 Jun 7;92(11):874-97</RefSource><PMID Version="1">10841823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Apr 22;286(16):14564-74</RefSource><PMID Version="1">21357694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 Mar-Apr;743-744:44-52</RefSource><PMID Version="1">23219605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Jun 3;711(1-2):193-201</RefSource><PMID Version="1">21216256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2013 Apr;33(7):1468-73</RefSource><PMID Version="1">23382073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 04;9(9):e106485</RefSource><PMID Version="1">25188410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Biomed Sci. 2011 Sep;7(3):158-71</RefSource><PMID Version="1">23675233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 04;9(3):e90837</RefSource><PMID Version="1">24595156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(7):1834-54</RefSource><PMID Version="1">19188445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 3;471(7336):74-9</RefSource><PMID Version="1">21368826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cells. 2012 Oct 15;1(4):774-98</RefSource><PMID Version="1">24710530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2009 Feb;9(4):1058-74</RefSource><PMID Version="1">19180539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Jun 7;447(7145):730-4</RefSource><PMID Version="1">17554310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2014 May 29;33(22):2876-87</RefSource><PMID Version="1">23831574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2012 Jul 15;84(2):137-46</RefSource><PMID Version="1">22469522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2015 Aug 21;290(34):21067-75</RefSource><PMID Version="1">26134573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Dec;38(22):8239-56</RefSource><PMID Version="1">20699270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Apr 22;362(6422):709-15</RefSource><PMID Version="1">8469282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2009;4(7):1073-81</RefSource><PMID Version="1">19561590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2005 Jul;1(2):84-91</RefSource><PMID Version="1">16874052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jun;37(11):3723-38</RefSource><PMID Version="1">19372272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 2001;68:41-54</RefSource><PMID Version="1">11554312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2010 Oct 22;40(2):216-27</RefSource><PMID Version="1">20965417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Nov 13;273(46):30352-9</RefSource><PMID Version="1">9804798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2013 Dec;34(6):1153-67</RefSource><PMID Version="1">23416893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):621-39</RefSource><PMID Version="1">23879289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3589-608</RefSource><PMID Version="1">20706766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2012;809:519-33</RefSource><PMID Version="1">22113298</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1/Ref-1</Keyword><Keyword MajorTopicYN="N">genetic variants</Keyword><Keyword MajorTopicYN="N">genotoxic damage</Keyword><Keyword MajorTopicYN="N">replication stress</Keyword></KeywordList><CoiStatement>Authors declare they have no conflicts of interest pending.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>03</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27050370</ArticleId><ArticleId IdType="pmc">PMC5041981</ArticleId><ArticleId IdType="pii">8477</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.8477</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27042118</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6930</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>OncoTargets and therapy</Title><ISOAbbreviation>Onco Targets Ther</ISOAbbreviation></Journal><ArticleTitle>Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case-control studies.</ArticleTitle><Pagination><MedlinePgn>1499-510</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/OTT.S101456</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several observational studies suggested that APE1 Asp148Glu was significantly associated with urinary cancers; however, the results of published studies are inconsistent.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The PubMed and EMBASE were searched for case-control studies regarding the association between Asp148Glu and the risk of urinary cancers with a time limit of September 12, 2015. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association between Asp148Glu and the risk of developing prostate cancer, kidney cancer, bladder cancer, as well as all urinary cancers combined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 18 case-control studies were included in the analysis. Our meta-analysis revealed that the inheritance of at least one APE1 148Glu among Asian men was associated with a 1.26-fold increase in the risk of developing urinary cancers. Meanwhile, APE1 Asp148Glu was significantly associated with the risk of prostate cancer. However, there were no significant relationships between the APE1 SNP (single nucleotide polymorphism) and all urinary cancers combined and bladder cancer and kidney cancer among the men of Caucasian/Asian/African descent or all racial/ethnic groups combined. When stratified by the quality score, no significant association was found in high-quality studies (score ≥7), but a significant increased risk of urinary cancers was observed in lower quality studies (score &lt;7) (dominant model: OR=1.27, 95% CI=1.11-1.45).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our meta-analysis suggests that APE1 Asp148Glu was not associated with the risk of urinary cancers but might increase the risk of urinary cancers among Asians. Stratification by cancer type identified a significant association of Asp148Glu with prostate cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Jie-Hui</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, The First Clinical Medical College, Southern Medical University, Guangzhou, People's Republic of China; Institute of Genetic Engineering, School of Basic Medical Sciences, Southern Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urinary Surgery, Southern Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hai-Lang</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Institute of Genetic Engineering, School of Basic Medical Sciences, Southern Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jue-Yu</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Institute of Genetic Engineering, School of Basic Medical Sciences, Southern Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Genetic Engineering, School of Basic Medical Sciences, Southern Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Onco Targets Ther</MedlineTA><NlmUniqueID>101514322</NlmUniqueID><ISSNLinking>1178-6930</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochimie. 2003 Nov;85(11):1053-71</RefSource><PMID Version="1">14726013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2012;135:64-71</RefSource><PMID Version="1">22382185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2011 Jul;32(7):945-54</RefSource><PMID Version="1">21459759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2005 Jul;26(7):1263-71</RefSource><PMID Version="1">15746160</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):83-108</RefSource><PMID Version="1">11018583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2010 Jun;29(6):303-11</RefSource><PMID Version="1">20218899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 1999;33(1):3-20</RefSource><PMID Version="1">10037319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2006 Jan;175(1):108-12; discussion 112</RefSource><PMID Version="1">16406883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2011 Nov;50(11):863-70</RefSource><PMID Version="1">21538578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Med. 2002 Mar-Apr;4(2):45-61</RefSource><PMID Version="1">11882781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource><PMID Version="1">3802833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Oct;35(10):10111-9</RefSource><PMID Version="1">25023401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Mar;38(3):1585-91</RefSource><PMID Version="1">20852942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1990 Mar 9;263(10 ):1385-9</RefSource><PMID Version="1">2406472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 May;27(5):997-1007</RefSource><PMID Version="1">16308313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prostate. 2010 Feb 1;70(2):113-9</RefSource><PMID Version="1">19760636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2004 Feb;14(1):5-10</RefSource><PMID Version="1">15108798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Med. 2010 Jul 29;2(7):45</RefSource><PMID Version="1">20667146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 Jun 15;118(12):3170-3</RefSource><PMID Version="1">16425270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Hered. 2008;65(2):105-18</RefSource><PMID Version="1">17898541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2003 Sep 6;327(7414):557-60</RefSource><PMID Version="1">12958120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Jun;22(6):917-22</RefSource><PMID Version="1">11375899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2009 May;30(5):763-8</RefSource><PMID Version="1">19237606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 May;27(5):1030-7</RefSource><PMID Version="1">16311243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):84-91</RefSource><PMID Version="1">17220334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2007 Apr;121(2):233-42</RefSource><PMID Version="1">17203305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 1995 Aug;17(8):713-9</RefSource><PMID Version="1">7661852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2004 Jun;83(6):970-9</RefSource><PMID Version="1">15177551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2009 Mar;73(3):675-80</RefSource><PMID Version="1">19041121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</RefSource><PMID Version="1">25559415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Aug 1;162(3):201-11</RefSource><PMID Version="1">15987731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1959 Apr;22(4):719-48</RefSource><PMID Version="1">13655060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2010 Feb 4;9(2):191-200</RefSource><PMID Version="1">20061190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2006 Mar;78(3):464-79</RefSource><PMID Version="1">16465622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2012 Jul;33(7):1259-69</RefSource><PMID Version="1">22523086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1997 Sep 13;315(7109):629-34</RefSource><PMID Version="1">9310563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2014 Feb;140(2):179-88</RefSource><PMID Version="1">24077840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</RefSource><PMID Version="1">21296855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2004 Mar 15;64(6):2251-7</RefSource><PMID Version="1">15026370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lab. 2013;59(1-2):163-8</RefSource><PMID Version="1">23505922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Genet Genomics. 2015 Feb;290(1):281-8</RefSource><PMID Version="1">25234162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2009;471:361-85</RefSource><PMID Version="1">19109789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1992 Sep 11;20(17):4417-21</RefSource><PMID Version="1">1383925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2009 Apr;29(4):1389-93</RefSource><PMID Version="1">19414392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Biol (Noisy-le-grand). 2015 Aug 05;61(4):21-4</RefSource><PMID Version="1">26255264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2012 Apr;133(4):127-32</RefSource><PMID Version="1">22019847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Genet Dev. 2010 Jun;20(3):201-9</RefSource><PMID Version="1">20418093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 2003 Nov;111(15):1843-50</RefSource><PMID Version="1">14630517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Jan;40(1):171-6</RefSource><PMID Version="1">23143180</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">polymorphism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27042118</ArticleId><ArticleId IdType="doi">10.2147/OTT.S101456</ArticleId><ArticleId IdType="pii">ott-9-1499</ArticleId><ArticleId IdType="pmc">PMC4801150</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27026921</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2193-1801</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>SpringerPlus</Title><ISOAbbreviation>Springerplus</ISOAbbreviation></Journal><ArticleTitle>Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers: a meta-analysis.</ArticleTitle><Pagination><MedlinePgn>227</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-016-1858-5</ELocationID><Abstract><AbstractText>Cancers of the upper aero-digestive and gastrointestinal tract are one of the major causes of mortality around the world. DNA repair genes play a vital role in preventing carcinogenesis by maintaining genomic integrity. Polymorphisms in the nucleotide sequence of DNA repair genes are often reported to be associated with an increased risk for different cancers. The OGG1 gene encodes the enzyme 8-oxoguanine DNA glycosylase which removes oxidatively damaged bases of DNA. Several studies report that the OGG1 Ser326Cys polymorphism increases the risk for cancers of the upper aero-digestive and gastrointestinal tract. However, other studies provide evidence that such an association does not exist. A meta-analysis to assess the role of OGG1 Ser326Cys polymorphism in the cancers of the upper aero-digestive and gastrointestinal tract was therefore undertaken in order to resolve this ambiguity. Seventeen studies were recruited for this meta-analysis after screening 58 articles with a total of 5533 cases and 6834 controls for which the odds ratio with 95 % confidence interval was calculated. Begg's funnel test and Egger's test were performed for calculating publication bias. Our study reveals an association between OGG1 Ser326Cys polymorphism and cancer susceptibility of the upper aero-digestive and gastrointestinal tract (CG + GG vs CC; odds ratio, OR 1.22; 95 % CI 1.05-1.41; GG vs CG + CC; OR 1.36; 95 % CI 1.09-1.70; GG vs CC; OR 1.46; 95 % CI 1.12-1.92). Subgroup analysis based on cancer types and ethnicity also revealed the association of OGG1 Ser326Cys polymorphism to the risk for upper aero-digestive and gastrointestinal tract cancers among both the Asian and the Caucasian populations. No risk was however observed for smoking habits and OGG1 Ser326Cys polymorphism. In conclusion, OGG1 Ser326Cys polymorphism may be associated with the increased risk for aero-digestive tract and gastro-intestinal cancers in both Asian and Caucasian populations. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Sambuddha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011 India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Sayantan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011 India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhowmik</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011 India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Sankar Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011 India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Yashmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011 India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Springerplus</MedlineTA><NlmUniqueID>101597967</NlmUniqueID><ISSNLinking>2193-1801</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2013 Oct;17(10):780-5</RefSource><PMID Version="1">23909557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Dec 24;726(2):227-33</RefSource><PMID Version="1">21986195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2011 Sep;50(9):732-7</RefSource><PMID Version="1">21520294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2015 Feb;32(2):472</RefSource><PMID Version="1">25588927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2010 Aug;132:129-49</RefSource><PMID Version="1">20716813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 May-Jun;745-746:6-15</RefSource><PMID Version="1">23618615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Oct 8;361(15):1475-85</RefSource><PMID Version="1">19812404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2015 Sep;36(10):7569-79</RefSource><PMID Version="1">25916209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2004 Nov 18;432(7015):294-7</RefSource><PMID Version="1">15549090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Res. 2006 Aug;40(8):885-91</RefSource><PMID Version="1">17015267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2013;14(9):5145-51</RefSource><PMID Version="1">24175791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterol Hepatol Bed Bench. 2015 Winter;8(1):19-27</RefSource><PMID Version="1">25584172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12 ):3384-8</RefSource><PMID Version="1">19959686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2014 Jul;35(7):1523-7</RefSource><PMID Version="1">24658182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1998 Feb 7;316(7129):469; author reply 470-1</RefSource><PMID Version="1">9492685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biometrika. 1950 Dec;37(3-4):256-66</RefSource><PMID Version="1">14801052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2015 ;16(14 ):5767-72</RefSource><PMID Version="1">26320449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource><PMID Version="1">3802833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gastrointest Cancer. 2010 Jun;41(2):110-5</RefSource><PMID Version="1">20069464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Jun;16(6):1695-703</RefSource><PMID Version="1">19266243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oral Oncol. 2007 Sep;43(8):791-5</RefSource><PMID Version="1">17207658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Apr-Jun;704(1-3):152-9</RefSource><PMID Version="1">20060490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Feb 1;638(1-2):146-53</RefSource><PMID Version="1">17991492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2012 Apr;31(4):541-6</RefSource><PMID Version="1">21899442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Colorectal Dis. 2011 Dec;26(12):1525-30</RefSource><PMID Version="1">21695387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Mar;35(3):2397-402</RefSource><PMID Version="1">24186001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Feb;38(2):1251-61</RefSource><PMID Version="1">20571908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Nov;25(6):569-75</RefSource><PMID Version="1">20817763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jan;35(1):513-7</RefSource><PMID Version="1">23975367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3642-9</RefSource><PMID Version="1">19351836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Nov;38(8):5379-86</RefSource><PMID Version="1">21390502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1959 Apr;22(4):719-48</RefSource><PMID Version="1">13655060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Jul 1;116(13):3160-9</RefSource><PMID Version="1">20564624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Jul;23(7):1229-34</RefSource><PMID Version="1">12117782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1997 Sep 13;315(7109):629-34</RefSource><PMID Version="1">9310563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2009 Jan 15;15(2):740-6</RefSource><PMID Version="1">19147782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2011;12(12):3427-31</RefSource><PMID Version="1">22471492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gastrointestinal</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Upper aero-digestive tract</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27026921</ArticleId><ArticleId IdType="doi">10.1186/s40064-016-1858-5</ArticleId><ArticleId IdType="pii">1858</ArticleId><ArticleId IdType="pmc">PMC4771670</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27022219</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2219-2840</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>12</Issue><PubDate><Year>2016</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>World journal of gastroenterology</Title><ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation></Journal><ArticleTitle>Association between polymorphisms of APE1 and OGG1 and risk of colorectal cancer in Taiwan.</ArticleTitle><Pagination><MedlinePgn>3372-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v22.i12.3372</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the effects of OGG1 (Ser326Cys, 11657A/G, and Arg154His) and APE1 (Asp148Glu, and T-656G) polymorphisms on colorectal cancer (CRC) risk.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled 727 cases newly diagnosed with colorectal adenocarcinoma and 736 age- and sex-matched healthy controls from a medical center in Taiwan. Genomic DNA isolated from the buffy coat was used for genotyping through polymerase chain reaction. Unconditional logistic regressions were used for calculating ORs and 95%CIs to determine the association between the genetic polymorphisms and CRC risk. Haplotype frequencies were estimated using PHASE software. Moreover, stratification analyses on the basis of sex, age at diagnosis, and tumor subsite and stage were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The CRC risk was higher in patients with the OGG1 326Ser/Cys + Cys/Cys genotype (OR = 1.38, 95%CI: 1.03-1.85, P = 0.030), particularly high in patients with stage III + IV cancer (OR = 1.48, 95%CI: 1.03-2.13) compared with patients with the Ser/Ser genotype. In addition, OGG1 11657G allele carriers had a 41% reduced CRC risk among stage 0-II patients (OR = 0.59, 95%CI: 0.35-0.98). The CRC risk was significantly higher among females with the APE1 Glu allele (OR = 1.41, 95%CI: 1.02-1.96). The APE1 148Glu/-656G haplotype was also associated with a significant CRC risk in females (OR = 1.36, 95%CI: 1.03-1.78).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">OGG1 and APE1 polymorphisms are associated with stage- and sex-specific risk of CRC in the Taiwanese population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Ching-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Ching-Yu Lai, Chih-Ching Yeh, School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Ling-Ling</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Ching-Yu Lai, Chih-Ching Yeh, School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Reiping</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ching-Yu Lai, Chih-Ching Yeh, School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santella</LastName><ForeName>Regina M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Ching-Yu Lai, Chih-Ching Yeh, School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang-Chieh</LastName><ForeName>Chung Rong</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Ching-Yu Lai, Chih-Ching Yeh, School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Chih-Ching</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Ching-Yu Lai, Chih-Ching Yeh, School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES009089</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Gastroenterol</MedlineTA><NlmUniqueID>100883448</NlmUniqueID><ISSNLinking>1007-9327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2009 Apr 1;124(7):1565-71</RefSource><PMID Version="1">19115208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2009 Nov;24(6):507-12</RefSource><PMID Version="1">19762350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Sep;25(5):463-71</RefSource><PMID Version="1">20534734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2011 Apr 1;17(7):1701-12</RefSource><PMID Version="1">21355073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Colorectal Dis. 2011 Dec;26(12):1525-30</RefSource><PMID Version="1">21695387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011;11:521</RefSource><PMID Version="1">22176746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2012 Sep;138(9):1443-8</RefSource><PMID Version="1">22526153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2012 Oct;51 Suppl 1:E94-103</RefSource><PMID Version="1">22213390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2012 Oct;31(10):981-1005</RefSource><PMID Version="1">23023028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2013 Jun;30(2):505</RefSource><PMID Version="1">23430444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2014 Jul 14;20(26):8700-8</RefSource><PMID Version="1">25024628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Biochem Cell Biol. 2000 Feb;32(2):157-70</RefSource><PMID Version="1">10687951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2000 Apr;6(4):1394-400</RefSource><PMID Version="1">10778969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Jun;22(6):917-22</RefSource><PMID Version="1">11375899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2002 Apr 15;62(8):2253-7</RefSource><PMID Version="1">11956079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2003 May;9(5):956-60</RefSource><PMID Version="1">12717837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Formos Med Assoc. 2003 May;102(5):305-12</RefSource><PMID Version="1">12874668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2004 Jun;83(6):970-9</RefSource><PMID Version="1">15177551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>IARC Sci Publ. 1980;(32):5-338</RefSource><PMID Version="1">7216345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Med (Berl). 1996 Jun;74(6):297-312</RefSource><PMID Version="1">8862511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7166-9</RefSource><PMID Version="1">9207062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Cancer Res. 1998 Aug;89(8):825-8</RefSource><PMID Version="1">9765618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 1999 May;9(5):492-8</RefSource><PMID Version="1">10330129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2005 Jan 28;5:12</RefSource><PMID Version="1">15679883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2005 Mar 14;11(10):1473-80</RefSource><PMID Version="1">15770723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006;34(5):1620-32</RefSource><PMID Version="1">16549874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8</RefSource><PMID Version="1">16609022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):811-5</RefSource><PMID Version="1">16614128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Radiat Res. 2006;47 Suppl B:B13-7</RefSource><PMID Version="1">17019047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Sci. 2007 Mar;14(2):183-93</RefSource><PMID Version="1">17191090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):258-75</RefSource><PMID Version="1">17628657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2007 Sep;17(5):156-60</RefSource><PMID Version="1">17827862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2363-72</RefSource><PMID Version="1">18006925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Feb 1;638(1-2):146-53</RefSource><PMID Version="1">17991492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2008;27:49</RefSource><PMID Version="1">18823566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2009 Oct;23(10):3459-69</RefSource><PMID Version="1">19541747</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N">Taiwan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Polymorphisms</Keyword><Keyword MajorTopicYN="N">Taiwan</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>06</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27022219</ArticleId><ArticleId IdType="doi">10.3748/wjg.v22.i12.3372</ArticleId><ArticleId IdType="pmc">PMC4806195</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27015555</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>18</Issue><PubDate><Year>2016</Year><Month>May</Month><Day>03</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers.</ArticleTitle><Pagination><MedlinePgn>25815-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.8272</ELocationID><Abstract><AbstractText>We have recently shown that rs2304277 variant in the OGG1 glycosidase gene of the Base Excision Repair pathway can increase ovarian cancer risk in BRCA1 mutation carriers. In the present study, we aimed to explore the role of this genetic variant on different genome instability hallmarks to explain its association with cancer risk.We have evaluated the effect of this polymorphism on OGG1 transcriptional regulation and its contribution to telomere shortening and DNA damage accumulation. For that, we have used a series of 89 BRCA1 and BRCA2 mutation carriers, 74 BRCAX cases, 60 non-carrier controls and 23 lymphoblastoid cell lines (LCL) derived from BRCA1 mutation carriers and non-carriers.We have identified that this SNP is associated to a significant OGG1 transcriptional down regulation independently of the BRCA mutational status and that the variant may exert a synergistic effect together with BRCA1 or BRCA2 mutations on DNA damage and telomere shortening.These results suggest that this variant, could be associated to a higher cancer risk in BRCA1 mutation carriers, due to an OGG1 transcriptional down regulation and its effect on genome instability. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benitez-Buelga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaclová</LastName><ForeName>Tereza</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urioste</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Familial Cancer Clinical Unit, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spanish Network on Rare Diseases (CIBERER), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inglada-Perez</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spanish Network on Rare Diseases (CIBERER), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soberón</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Telomere and Telomerase Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasco</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Telomere and Telomerase Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osorio</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spanish Network on Rare Diseases (CIBERER), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benitez</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spanish Network on Rare Diseases (CIBERER), Madrid 28029, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DA006227</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101782</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101810</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101819</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA033684</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH090936</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH090951</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101820</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101825</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH090948</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH090941</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101822</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN261200800001C</GrantID><Acronym>RC</Acronym><Agency>CCR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH090937</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>232854</GrantID><Agency>European Research Council</Agency><Country>International</Country></Grant><Grant><GrantID>HHSN268201000029C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN261200800001E</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH101814</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019313">BRCA1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492913">BRCA1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024682">BRCA2 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C551750">BRCA2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2013 Dec 15;22(24):5056-64</RefSource><PMID Version="1">23900074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5300-5</RefSource><PMID Version="1">17369361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2014 Apr 03;10(4):e1004256</RefSource><PMID Version="1">24698998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2010 May 13;6(5):e1000951</RefSource><PMID Version="1">20485567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Cell Cardiol. 2015 Jan;78:9-22</RefSource><PMID Version="1">25446179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):835-42</RefSource><PMID Version="1">20058067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2010 Jan 20;29(2):398-409</RefSource><PMID Version="1">19942858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 Aug 15;755(2):115-9</RefSource><PMID Version="1">23830927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2007 Dec;81(6):1186-200</RefSource><PMID Version="1">17999359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2014 Jun;35(6):1426-33</RefSource><PMID Version="1">24632493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2016 Jan 1;76(1):30-4</RefSource><PMID Version="1">26586787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dig Dis Sci. 2012 Sep;57(9):2451-7</RefSource><PMID Version="1">22565339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2015 Apr 30;43(8):4039-54</RefSource><PMID Version="1">25813041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2012 Dec;33(12):1665-75</RefSource><PMID Version="1">22753153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(11):e27545</RefSource><PMID Version="1">22114677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Oct 29;9(10):e110963</RefSource><PMID Version="1">25354277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2006 Jul;38(7):813-8</RefSource><PMID Version="1">16751773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2003 Jan 23;421(6921):436-40</RefSource><PMID Version="1">12540918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Chim Slov. 2010 Mar;57(1):182-8</RefSource><PMID Version="1">24061671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Feb 1;61(3):912-5</RefSource><PMID Version="1">11221881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):27-47</RefSource><PMID Version="1">18166975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 Jul-Sep;753(1):24-40</RefSource><PMID Version="1">23416207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2012 May 15;12:177</RefSource><PMID Version="1">22587342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2014 Dec;35(12):2643-52</RefSource><PMID Version="1">25355293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2001 Mar;27(3):247-54</RefSource><PMID Version="1">11242102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Mar 1;63(5):902-5</RefSource><PMID Version="1">12615700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2015 Jan;149(2):385-94</RefSource><PMID Version="1">25528024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2015 Jul;152(2):271-82</RefSource><PMID Version="1">26071757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Apr 12;104(8):1356-61</RefSource><PMID Version="1">21427728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Apr 14;434(7035):917-21</RefSource><PMID Version="1">15829967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2008 May 1;14(9):2861-9</RefSource><PMID Version="1">18451254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2000 Jan 1;28(1):64-74</RefSource><PMID Version="1">10656292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Feb;38(2):1163-70</RefSource><PMID Version="1">20602259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2008 Aug;9(8):619-31</RefSource><PMID Version="1">18626472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2003 May;72(5):1117-30</RefSource><PMID Version="1">12677558</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D019313" MajorTopicYN="N">BRCA1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024682" MajorTopicYN="N">BRCA2 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BRCA1 and BRCA2</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">OGG1 polymorfism</Keyword><Keyword MajorTopicYN="N">cancer risk modifier</Keyword><Keyword MajorTopicYN="N">telomere shortening</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>03</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27015555</ArticleId><ArticleId IdType="pmc">PMC5041946</ArticleId><ArticleId IdType="pii">8272</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.8272</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26981776</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>16</Issue><PubDate><Year>2016</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Regulation of limited N-terminal proteolysis of APE1 in tumor via acetylation and its role in cell proliferation.</ArticleTitle><Pagination><MedlinePgn>22590-604</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.8026</ELocationID><Abstract><AbstractText>Mammalian apurinic/apyrimidinic (AP) endonuclease 1 (APE1), a ubiquitous and multifunctional protein, plays an essential role in the repair of both endogenous and drug-induced DNA damages in the genome. Unlike its E.coli counterpart Xth, mammalian APE1 has a unique N-terminal domain and possesses both DNA damage repair and transcriptional regulatory functions. Although the overexpression of APE1 in diverse cancer types and the association of APE1 expression with chemotherapy resistance and poor prognosis are well documented, the cellular and molecular mechanisms that alter APE1 functions during tumorigenesis are largely unknown. Here, we show the presence of full-length APE1 and N-terminal truncated isoforms of APE1 in tumor tissue samples of various cancer types. However, primary tumor tissue has higher levels of acetylated APE1 (AcAPE1) as well as full-length APE1 compared to adjacent non-tumor tissue. We found that APE1 is proteolytically cleaved by an unknown serine protease at its N-terminus following residue lysine (Lys) Lys6 and/or Lys7 and after Lys27 and Lys31 or Lys32. Acetylation of these Lys residues in APE1 prevents this proteolysis. The N-terminal domain of APE1 and its acetylation are required for modulation of the expression of hundreds of genes. Importantly, we found that AcAPE1 is essential for sustained cell proliferation. Together, our study demonstrates that increased acetylation levels of APE1 in tumor cells inhibit the limited N-terminal proteolysis of APE1 and thereby maintain the functions of APE1 to promote tumor cells' sustained proliferation and survival. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhakat</LastName><ForeName>Kishor K</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE-68198, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE-68198, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Shiladitya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Current Affiliation: Department of Radiation Oncology, Houston Methodist Research Institute, Houston, TX-77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeniyi</LastName><ForeName>Victor F</ForeName><Initials>VF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roychoudhury</LastName><ForeName>Shrabasti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE-68198, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Somsubhra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE-68198, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Current Affiliation: Molecular Biology Research and Diagnostic Laboratory, Saroj Gupta Cancer Centre and Research Institute (SGCC &amp; RI), Kolkata-63, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellot</LastName><ForeName>Larry J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE-68198, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantha</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Center for Animal Sciences, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, Punjab 151001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Mala</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Program, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Suimin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luxon</LastName><ForeName>Bruce A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Program, University of Texas Medical Branch, Galveston, TX-77555, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA148941</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Aug 25;643(1-2):54-63</RefSource><PMID Version="1">18579163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Sep 5;10(9):942-52</RefSource><PMID Version="1">21741887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2011 Jan 27;30(4):482-93</RefSource><PMID Version="1">20856196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 Apr 15;14(8):1387-401</RefSource><PMID Version="1">20874257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Subcell Biochem. 2013;61:37-55</RefSource><PMID Version="1">23150245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Dec 8;4(12):1442-9</RefSource><PMID Version="1">16199212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2011 Oct;22(20):3887-901</RefSource><PMID Version="1">21865600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1994 Nov 11;269(45):27855-62</RefSource><PMID Version="1">7961715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):4079-96</RefSource><PMID Version="1">22918947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Jul 1;33(1):15-28</RefSource><PMID Version="1">12086678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Dec;28(23):7066-80</RefSource><PMID Version="1">18809583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2015 Sep;779:96-104</RefSource><PMID Version="1">26164266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jul 16;8(7):e68467</RefSource><PMID Version="1">23874636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2012 May;30(5):917-25</RefSource><PMID Version="1">22441348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2003 Feb;4(2):145-53</RefSource><PMID Version="1">12524539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Res. 2008 Jan;42(1):20-9</RefSource><PMID Version="1">18324520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5061-6</RefSource><PMID Version="1">9560228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 1998 Mar;19(3):525-7</RefSource><PMID Version="1">9525290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2004;5(10):R80</RefSource><PMID Version="1">15461798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 17;51(2):695-705</RefSource><PMID Version="1">22148505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2009 Sep;23(9):1346-59</RefSource><PMID Version="1">19460860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3523-8</RefSource><PMID Version="1">11904416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jun 07;33(10 ):3303-12</RefSource><PMID Version="1">15942031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Sep 26;278(39):37768-76</RefSource><PMID Version="1">12842873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):651-68</RefSource><PMID Version="1">18715143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(7):1834-54</RefSource><PMID Version="1">19188445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3621-31</RefSource><PMID Version="1">20809131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2013 Jul 10;425(13):2359-71</RefSource><PMID Version="1">23542007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Dec;38(22):8239-56</RefSource><PMID Version="1">20699270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2008 May 23;379(1):28-37</RefSource><PMID Version="1">18436236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 1999 Nov;189(3):351-7</RefSource><PMID Version="1">10547596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Aug 15;73(16):4965-77</RefSource><PMID Version="1">23913938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43</RefSource><PMID Version="1">15824325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2009 Jun;136(7):2258-69</RefSource><PMID Version="1">19505426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2009 Apr 2;28(13):1616-25</RefSource><PMID Version="1">19219073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3589-608</RefSource><PMID Version="1">20706766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):27-36</RefSource><PMID Version="1">11316543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000107" MajorTopicYN="N">Acetylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">acetylation</Keyword><Keyword MajorTopicYN="N">base excision repair</Keyword><Keyword MajorTopicYN="N">proliferation</Keyword><Keyword MajorTopicYN="N">proteolysis</Keyword></KeywordList><CoiStatement>The authors disclose no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>02</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26981776</ArticleId><ArticleId IdType="pii">8026</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.8026</ArticleId><ArticleId IdType="pmc">PMC5008384</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26980281</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>06</Month><Day>20</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation></Journal><ArticleTitle>Oxidized dNTPs and the OGG1 and MUTYH DNA glycosylases combine to induce CAG/CTG repeat instability.</ArticleTitle><Pagination><MedlinePgn>5190-203</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkw170</ELocationID><Abstract><AbstractText>DNA trinucleotide repeat (TNR) expansion underlies several neurodegenerative disorders including Huntington's disease (HD). Accumulation of oxidized DNA bases and their inefficient processing by base excision repair (BER) are among the factors suggested to contribute to TNR expansion. In this study, we have examined whether oxidation of the purine dNTPs in the dNTP pool provides a source of DNA damage that promotes TNR expansion. We demonstrate that during BER of 8-oxoguanine (8-oxodG) in TNR sequences, DNA polymerase β (POL β) can incorporate 8-oxodGMP with the formation of 8-oxodG:C and 8-oxodG:A mispairs. Their processing by the OGG1 and MUTYH DNA glycosylases generates closely spaced incisions on opposite DNA strands that are permissive for TNR expansion. Evidence in HD model R6/2 mice indicates that these DNA glycosylases are present in brain areas affected by neurodegeneration. Consistent with prevailing oxidative stress, the same brain areas contained increased DNA 8-oxodG levels and expression of the p53-inducible ribonucleotide reductase. Our in vitro and in vivo data support a model where an oxidized dNTPs pool together with aberrant BER processing contribute to TNR expansion in non-replicating cells.</AbstractText><CopyrightInformation>© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cilli</LastName><ForeName>Piera</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Roma, Italy Department of Science, University Roma Tre, 00154 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ventura</LastName><ForeName>Ilenia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minoprio</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meccia</LastName><ForeName>Ettore</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martire</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Drug Safety and Evaluation, Istituto Superiore di Sanità, 00161 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bignami</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Roma, Italy Margherita.bignami@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzei</LastName><ForeName>Filomena</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Environment and Primary Prevention, Istituto Superiore di Sanità, 00161 Roma, Italy filomena.mazzei@iss.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z01 ES050158</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01 ES050159</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D019951">DNA Polymerase beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C061738">mutY adenine glycosylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13302-7</RefSource><PMID Version="1">22847445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2010 Jul;17(7):889-90</RefSource><PMID Version="1">20526335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2015 Oct 23;290(43):26259-69</RefSource><PMID Version="1">26338705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 1995;262:98-107</RefSource><PMID Version="1">8594388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2000 Feb 8;39(5):1029-33</RefSource><PMID Version="1">10653647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2015 Apr 17;11(4):e1005181</RefSource><PMID Version="1">25886163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2009 Jan;33(1):37-47</RefSource><PMID Version="1">18930147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1996 Nov 1;87(3):493-506</RefSource><PMID Version="1">8898202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 Apr;36(7):2174-81</RefSource><PMID Version="1">18276636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Jan 9;273(2):898-902</RefSource><PMID Version="1">9422747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Oct 19;443(7113):787-95</RefSource><PMID Version="1">17051205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2013 Jan;49:148-58</RefSource><PMID Version="1">22974734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2002 Jan 15;11(2):191-8</RefSource><PMID Version="1">11809728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2012 Apr;37(4):162-72</RefSource><PMID Version="1">22285516</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2003 Sep 15;12(18):2301-9</RefSource><PMID Version="1">12915485</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr;41(7):4093-103</RefSource><PMID Version="1">23460202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2009 Dec;5(12):e1000749</RefSource><PMID Version="1">19997493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2012 Dec;122(12 ):4344-61</RefSource><PMID Version="1">23143307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Neurobiol. 1999 Dec;59(5):427-68</RefSource><PMID Version="1">10515664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2006 Aug 15;41(4):620-6</RefSource><PMID Version="1">16863995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 May 24;447(7143):447-52</RefSource><PMID Version="1">17450122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 1999 Jan;8(1):115-22</RefSource><PMID Version="1">9887339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2010 Nov;11(11):786-99</RefSource><PMID Version="1">20953213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 1999 Sep 3;272(1):53-6</RefSource><PMID Version="1">10507541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1999 Dec;23(4):471-3</RefSource><PMID Version="1">10581038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2003 Feb 1;12 (3):273-81</RefSource><PMID Version="1">12554681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12277-82</RefSource><PMID Version="1">23840062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Oct 9;284(41):28352-66</RefSource><PMID Version="1">19674974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 May 8;51(18):3919-32</RefSource><PMID Version="1">22497302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2006 Jul;20(9):1300-14</RefSource><PMID Version="1">16816105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2008 Nov;4(11):e1000266</RefSource><PMID Version="1">19023407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Jun 2;275(22):16420-7</RefSource><PMID Version="1">10748145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2012 Oct;181(4):1378-86</RefSource><PMID Version="1">22841817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2007 Apr 13;367(5):1258-69</RefSource><PMID Version="1">17321545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2010 Feb;31(2):159-66</RefSource><PMID Version="1">19953527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 Mar-Apr;743-744:33-43</RefSource><PMID Version="1">23507534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2010 Dec 09;6(12 ):e1001242</RefSource><PMID Version="1">21170307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2007 Jun 5;46(22):6639-46</RefSource><PMID Version="1">17497830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Nov 28;703(1):18-23</RefSource><PMID Version="1">20696268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 1993 Aug;4(4):387-92</RefSource><PMID Version="1">8401587</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1994 Apr 19;33(15):4695-701</RefSource><PMID Version="1">8161527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 May 1;273(18):11069-74</RefSource><PMID Version="1">9556591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2006 Feb 8;26(6):1688-98</RefSource><PMID Version="1">16467516</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1993 Nov 5;268(31):23524-30</RefSource><PMID Version="1">8226881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2003 Mar;4(3):269-73</RefSource><PMID Version="1">12634844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jan 29;517(7536):635-9</RefSource><PMID Version="1">25409153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2008 Jul 1;7(7):1121-34</RefSource><PMID Version="1">18472310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2001 Dec;79(6):1246-9</RefSource><PMID Version="1">11752065</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 1999 Dec;4(6):1079-85</RefSource><PMID Version="1">10635332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2000 Aug 8;39(31):9508-13</RefSource><PMID Version="1">10924147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2012 Nov 15;21(22):4939-47</RefSource><PMID Version="1">22914735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Sep 20;33(16):5094-105</RefSource><PMID Version="1">16174844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Mar 2;404(6773):42-9</RefSource><PMID Version="1">10716435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2005 Aug;12(8):663-70</RefSource><PMID Version="1">16025128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1999 Mar 23;38(12):3610-4</RefSource><PMID Version="1">10090747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2006 Apr;13(4):551-63</RefSource><PMID Version="1">16273081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2015 Aug 06;11(8):e1005267</RefSource><PMID Version="1">26247199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Mar 24;281(12 ):7834-41</RefSource><PMID Version="1">16436374</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019951" MajorTopicYN="N">DNA Polymerase beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042822" MajorTopicYN="Y">Genomic Instability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018911" MajorTopicYN="Y">Trinucleotide Repeats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26980281</ArticleId><ArticleId IdType="pii">gkw170</ArticleId><ArticleId IdType="doi">10.1093/nar/gkw170</ArticleId><ArticleId IdType="pmc">PMC4914090</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26980051</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8392</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><PubDate><Year>2016</Year><Month>06</Month></PubDate></JournalIssue><Title>Human pathology</Title><ISOAbbreviation>Hum. Pathol.</ISOAbbreviation></Journal><ArticleTitle>Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.</ArticleTitle><Pagination><MedlinePgn>145-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.humpath.2016.01.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0046-8177(16)00038-1</ELocationID><Abstract><AbstractText>The effects of oxidative stress in adenocarcinomas of gastric cardia (AGCs) have not been fully elucidated. With a strict definition of AGC, we examined the immunohistochemical expressions of inducible nitric oxide synthase; 8-hydroxy-deoxyguanosine; and the base excision repair enzymes such as MUTYH, MTH1, and OGG1, and TP53 mutational status. Sixty-three cases of AGC were characterized by younger patient age (P = .0227) and more frequent venous invasion (P = .0106) compared with the adenocarcinomas of pylorus (APs). 8-hydroxy-deoxyguanosine was accumulated (P = .0011), whereas MUTYH (P = .0325) and OGG1 (P = .0007) were decreased, in the AGCs compared with the adjacent mucosa, but these differences were not detected in the APs. Among the AGCs, lower expressions of MUTYH (P = .0013) and MTH1 (P = .0059) were each significantly associated with diffuse-type histology. A lower expression of OGG1 was correlated with higher T-stage (P = .0011), lymphatic invasion (P = .004), and lymph node metastasis (P = .0094). In addition, the presence of TP53 mutation was associated with diffuse-type histology (P = .0153) and a lower level of MUTYH (P = .0221). The AGCs also showed a relatively high rate of a transversion-type mutation of TP53 (50%), whereas all TP53 mutations in the APs were transition type. Age 62years or older (P = .0073), diffuse-type histology (P = .0020), and TP53 mutation (P = .0066) were each associated with worse survival in the AGC patients. Our results indicate that oxidative stress accumulation and a downregulation of base excision repair enzymes may play an important role in the pathogenesis of AGC, in particular diffuse-type AGCs. Diffuse-type AGC might involve molecular pathways different from those of other subsets of gastric cancer.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kohno</LastName><ForeName>Yukiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anatomic Pathology, Graduate of School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Hidetaka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anatomic Pathology, Graduate of School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirahashi</LastName><ForeName>Minako</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anatomic Pathology, Graduate of School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumagae</LastName><ForeName>Yoshiteru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anatomic Pathology, Graduate of School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Masafumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery and Oncology, Graduate of School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oki</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery and Science, Graduate of School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oda</LastName><ForeName>Yoshinao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anatomic Pathology, Graduate of School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. Electronic address: oda@surgpath.med.kyushu-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Pathol</MedlineTA><NlmUniqueID>9421547</NlmUniqueID><ISSNLinking>0046-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495901">TP53 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance></Chemical><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="C496319">NOS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.2</RegistryNumber><NameOfSubstance UI="D010744">Phosphoric Monoester Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C061738">mutY adenine glycosylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.55</RegistryNumber><NameOfSubstance UI="C078207">8-oxodGTPase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.5.1.-</RegistryNumber><NameOfSubstance UI="D045643">DNA Repair Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="Y">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002299" MajorTopicYN="N">Cardia</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045643" MajorTopicYN="N">DNA Repair Enzymes</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010744" MajorTopicYN="N">Phosphoric Monoester Hydrolases</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Adenocarcinoma</Keyword><Keyword MajorTopicYN="Y">Base excision repair enzymes</Keyword><Keyword MajorTopicYN="Y">Cardia</Keyword><Keyword MajorTopicYN="Y">Oxidative stress</Keyword><Keyword MajorTopicYN="Y">Stomach</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>01</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26980051</ArticleId><ArticleId IdType="pii">S0046-8177(16)00038-1</ArticleId><ArticleId IdType="doi">10.1016/j.humpath.2016.01.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26964514</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2017</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Secreted APE1/Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor.</ArticleTitle><Pagination><MedlinePgn>23015</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep23015</ELocationID><Abstract><AbstractText>Apurinic apyrimidinic endonuclease 1/Redox factor-1 (APE1/Ref-1) is a multifunctional protein with redox activity and is proved to be secreted from stimulated cells. The aim of this study was to evaluate the functions of extracellular APE1/Ref-1 with respect to leading anti-inflammatory signaling in TNF-α-stimulated endothelial cells in response to acetylation. Treatment of TNF-α-stimulated endothelial cells with an inhibitor of deacetylase that causes intracellular acetylation, considerably suppressed vascular cell adhesion molecule-1 (VCAM-1). During TSA-mediated acetylation in culture, a time-dependent increase in secreted APE1/Ref-1 was confirmed. The acetyl moiety of acetylated-APE1/Ref-1 was rapidly removed based on the removal kinetics. Additionally, recombinant human (rh) APE1/Ref-1 with reducing activity induced a conformational change in rh TNF-α receptor 1 (TNFR1) by thiol-disulfide exchange. Following treatment with the neutralizing anti-APE1/Ref-1 antibody, inflammatory signals via the binding of TNF-α to TNFR1 were remarkably recovered, leading to up-regulation of reactive oxygen species generation and VCAM-1, in accordance with the activation of p66(shc) and p38 MAPK. These results strongly indicate that anti-inflammatory effects in TNF-α-stimulated endothelial cells by acetylation are tightly linked to secreted APE1/Ref-1, which inhibits TNF-α binding to TNFR1 by reductive conformational change, with suggestion as an endogenous inhibitor of vascular inflammation. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Myoung Soo</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yu Ran</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hee Kyoung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Gun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Cuk-Seong</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Soo Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Do</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeong Hwa</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Infectious Signaling Network Research Center and Research Institute for Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301-747, Republic of KOREA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056572">Histone Deacetylase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047888">Receptors, Tumor Necrosis Factor, Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012097">Repressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019010">Vascular Cell Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C468769">p66alpha protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048051">p38 Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2012 May 7;586(9):1349-55</RefSource><PMID Version="1">22616995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2404-9</RefSource><PMID Version="1">16141407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1853-67</RefSource><PMID Version="1">18627350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(8):e72156</RefSource><PMID Version="1">23977237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2000 Sep;14(12):1705-14</RefSource><PMID Version="1">10973919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 14;435(4):621-6</RefSource><PMID Version="1">23685156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2011 Jun;10(6):M110.005330</RefSource><PMID Version="1">21474795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2014 Sep 1;193(5):2427-37</RefSource><PMID Version="1">25063869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood Cancer J. 2013 Dec 13;3:e169</RefSource><PMID Version="1">24335889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Endocrinol. 2000 Jun;24(3):383-90</RefSource><PMID Version="1">10828831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2001 Apr;7(4):437-43</RefSource><PMID Version="1">11283670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2011 Feb;11(2):98-107</RefSource><PMID Version="1">21233852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Mar 31;281(13):8559-64</RefSource><PMID Version="1">16452475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 7;435(3):403-7</RefSource><PMID Version="1">23665318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Jun 15;68(12):4833-42</RefSource><PMID Version="1">18559531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2003 Nov 28;93(11):1029-33</RefSource><PMID Version="1">14645133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Dec 17;285(51):39888-97</RefSource><PMID Version="1">20937823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2003 Sep;2(9):736-46</RefSource><PMID Version="1">12951580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Apr;7(4):971-6</RefSource><PMID Version="1">11309348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2002 Jul;9(7):717-25</RefSource><PMID Version="1">12058277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Aug 21;51(33):6545-55</RefSource><PMID Version="1">22799488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2011 Nov;11(11):762-74</RefSource><PMID Version="1">21984070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2005 Dec 19;363:15-23</RefSource><PMID Version="1">16289629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2001 Sep 14;89(6):477-9</RefSource><PMID Version="1">11557733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Apr 12;288(15):10914-22</RefSource><PMID Version="1">23463508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2014 Jan 31;588(3):401-7</RefSource><PMID Version="1">24374337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2652-9</RefSource><PMID Version="1">17008592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 1997 Sep;109(3):458-63</RefSource><PMID Version="1">9328122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Dec 19-26;420(6917):868-74</RefSource><PMID Version="1">12490960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Jun;23(12):4257-66</RefSource><PMID Version="1">12773568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e58001</RefSource><PMID Version="1">23472128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Drug Targets. 2015;16(4):393-408</RefSource><PMID Version="1">25706111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(14):4379-94</RefSource><PMID Version="1">16077024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2010 Mar;22(3):404-14</RefSource><PMID Version="1">19879354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Rev. 2012 Mar;246(1):379-400</RefSource><PMID Version="1">22435567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2015 Oct;47(4):823-33</RefSource><PMID Version="1">25672588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2007 Jul 11;26(13):3086-97</RefSource><PMID Version="1">17557078</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000107" MajorTopicYN="N">Acetylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056572" MajorTopicYN="N">Histone Deacetylase Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047888" MajorTopicYN="N">Receptors, Tumor Necrosis Factor, Type I</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012097" MajorTopicYN="N">Repressor Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019010" MajorTopicYN="N">Vascular Cell Adhesion Molecule-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>08</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26964514</ArticleId><ArticleId IdType="pii">srep23015</ArticleId><ArticleId IdType="doi">10.1038/srep23015</ArticleId><ArticleId IdType="pmc">PMC4786854</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26934647</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>13</Issue><PubDate><Year>2016</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.</ArticleTitle><Pagination><MedlinePgn>16688-702</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.7696</ELocationID><Abstract><AbstractText>Chronic Gastroesophageal Reflux Disease (GERD) is the main risk factor for the development of Barrett's esophagus (BE) and its progression to esophageal adenocarcinoma (EAC). Accordingly, EAC cells are subjected to high levels of oxidative stress and subsequent DNA damage. In this study, we investigated the expression and role of Apurinic/apyrimidinic endonuclease 1 (APE1) protein in promoting cancer cell survival by counteracting the lethal effects of acidic bile salts (ABS)-induced DNA damage. Immunohistochemistry analysis of human tissue samples demonstrated overexpression of APE1 in more than half of EACs (70 of 130), as compared to normal esophagus and non-dysplastic BE samples (P &lt; 0.01). To mimic in vivo conditions, we treated in vitro cell models with a cocktail of ABS. The knockdown of endogenous APE1 in EAC FLO-1 cells significantly increased oxidative DNA damage (P &lt; 0.01) and DNA single- and double-strand breaks (P &lt; 0.01), whereas overexpression of APE1 in EAC OE33 cells reversed these effects. Annexin V/PI staining indicated that the APE1 expression in OE33 cells protects against ABS-induced apoptosis. In contrast, knockdown of endogenous APE1 in FLO-1 cells increased apoptosis under the same conditions. Mechanistic investigations indicated that the pro-survival function of APE1 was associated with the regulation of stress response c-Jun N-terminal protein kinase (JNK) and p38 kinases. Pharmacological inhibition of APE1 base excision repair (BER) function decreased cell survival and enhanced activation of JNK and p38 kinases by ABS. Our findings suggest that constitutive overexpression of APE1 in EAC may be an adaptive pro-survival mechanism that protects against the genotoxic lethal effects of bile reflux episodes. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Dunfa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaika</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Revetta</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Washington</LastName><ForeName>M Kay</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belkhiri</LastName><ForeName>Abbes</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Rifai</LastName><ForeName>Wael</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 CA095103</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA206564</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK058404</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA068485</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX002115</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA206563</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001647">Bile Acids and Salts</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C562730">Adenocarcinoma Of Esophagus</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Dec;23(12):3155-62</RefSource><PMID Version="1">22847812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 2005 Dec;140(12):1204-9; discussion 1209</RefSource><PMID Version="1">16365243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2009 May 15;8(10):1630-2</RefSource><PMID Version="1">19372763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2005 Dec 1;92(3):151-9</RefSource><PMID Version="1">16299786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2006 Apr;273(8):1620-9</RefSource><PMID Version="1">16623699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Sep 15;69(18):7285-93</RefSource><PMID Version="1">19723658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):83-108</RefSource><PMID Version="1">11018583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 2009 Jan;58(1):5-15</RefSource><PMID Version="1">18664505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Aug;23(8):1281-8</RefSource><PMID Version="1">12151345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Jan 1;73(1):331-40</RefSource><PMID Version="1">23117882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 May;23(9):3052-66</RefSource><PMID Version="1">12697808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Dec;1823(12):2201-9</RefSource><PMID Version="1">22917577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 2007 Jun;56(6):763-71</RefSource><PMID Version="1">17145738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300</RefSource><PMID Version="1">20610543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2004 Jul;19(4):319-24</RefSource><PMID Version="1">15215332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 May;23(5):687-96</RefSource><PMID Version="1">12016139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Feb 18;286(7):4968-77</RefSource><PMID Version="1">21081487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Lett. 2013 Apr 26;218(3):235-45</RefSource><PMID Version="1">23416140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2005 Nov 7;11(41):6466-71</RefSource><PMID Version="1">16425417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2012 Mar;11(3):763-74</RefSource><PMID Version="1">22302096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Mar 1;410(6824):37-40</RefSource><PMID Version="1">11242034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surgery. 1997 Nov;122(5):874-81</RefSource><PMID Version="1">9369886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G278-86</RefSource><PMID Version="1">21636532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatogastroenterology. 2007 Apr-May;54(75):761-5</RefSource><PMID Version="1">17591057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2014 May 16;33:42</RefSource><PMID Version="1">24887205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2014 Jul 10;5:e1318</RefSource><PMID Version="1">25010984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Scand J Gastroenterol Suppl. 2006;(243):11-7</RefSource><PMID Version="1">16782617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2011 May 19;2:e160</RefSource><PMID Version="1">21593792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2003 Aug;39(2):153-61</RefSource><PMID Version="1">12873810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2006 Dec;20(14):2612-4</RefSource><PMID Version="1">17068113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2008 Jul;7(7):2012-21</RefSource><PMID Version="1">18645011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 May 23;278(21):19245-56</RefSource><PMID Version="1">12637505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(8):2243-53</RefSource><PMID Version="1">19223463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2006 Sep 8;5(9-10):1021-9</RefSource><PMID Version="1">16807135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surgery. 2010 Aug;148(2):354-63</RefSource><PMID Version="1">20580047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1993 Apr;80(4):467-70</RefSource><PMID Version="1">8495313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Aug 19;33(15):4711-24</RefSource><PMID Version="1">16113242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Aug;21(8):1491-500</RefSource><PMID Version="1">10910949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2003 Jan;24(1):25-9</RefSource><PMID Version="1">12538345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Des Devel Ther. 2014 May 09;8:485-96</RefSource><PMID Version="1">24872679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2009 Jul 21;15(27):3329-40</RefSource><PMID Version="1">19610133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Oct 13;103(2):239-52</RefSource><PMID Version="1">11057897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2003 Apr 1;101(7):2454-60</RefSource><PMID Version="1">12446453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 1991;10(3-4):225-42</RefSource><PMID Version="1">1650738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 1999 May;44(5):598-602</RefSource><PMID Version="1">10205192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastrointest Cancer Res. 2012 Mar;5(2):49-57</RefSource><PMID Version="1">22690258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2008 Sep;23(5):399-405</RefSource><PMID Version="1">18515815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Mar 7;283(10 ):6572-83</RefSource><PMID Version="1">18162465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2010 Oct;24(10):3674-80</RefSource><PMID Version="1">20511393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Dec 1;69(23):9083-9</RefSource><PMID Version="1">19920191</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001471" MajorTopicYN="N">Barrett Esophagus</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001647" MajorTopicYN="N">Bile Acids and Salts</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005764" MajorTopicYN="N">Gastroesophageal Reflux</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">JNK</Keyword><Keyword MajorTopicYN="N">acidic bile salts</Keyword><Keyword MajorTopicYN="N">base excision repair</Keyword><Keyword MajorTopicYN="N">p38</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26934647</ArticleId><ArticleId IdType="pii">7696</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.7696</ArticleId><ArticleId IdType="pmc">PMC4941344</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26884880</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1936-2625</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>12</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>International journal of clinical and experimental pathology</Title><ISOAbbreviation>Int J Clin Exp Pathol</ISOAbbreviation></Journal><ArticleTitle>Senile cataract and genetic polymorphisms of APE1, XRCC1 and OGG1.</ArticleTitle><Pagination><MedlinePgn>16036-45</MedlinePgn></Pagination><Abstract><AbstractText>Polymorphisms of DNA repair enzymes which may influence their repair efficiency lead to diseases, for example, senile cataract. In this study, we aimed to analyze the association of single nucleotide polymorphisms in AP endonuclease-1 (APE1), 8-oxoguanine glycosylase-1 (OGG1) and X-ray repair cross-complementing-1 (XRCC1) genes with the risk of age-related cataract in a Chinese population. Genotyping was carried out by the polymerase chain reaction and DNA sequencing on 402 cataract patients and 813 controls in this study. Differences in the frequencies were estimated by the chi-square test, and risk was estimated using unconditional logistic regression after adjusting for age and gender. Our results demonstrated there was a significant difference between the case and control groups in the APE1-141 G/G genotype (P=0.002). This difference still existed after adjusting for age and gender (P*=0.003). The APE1-141 T/T genotype and T allele frequencies were significantly higher in cataract patients, while the G/G genotype and G allele frequencies in patients were significantly lower than in controls (P &lt; 0.05). The APE1-141 G/G genotype (OR, 0.49; 95% CI, 0.31-0.77) seems to have a protective role against cataract, and the T allele seems to have a deleterious role in the development of cataract. In OGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms, there were no significant differences in frequencies of the variant homozygous in patients compared with controls. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan 430030, China; Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Qiaohong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan 430030, China; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan 430030, China; Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan 430030, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Clin Exp Pathol</MedlineTA><NlmUniqueID>101480565</NlmUniqueID><ISSNLinking>1936-2625</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 Apr 30;753(1):12-22</RefSource><PMID Version="1">23499241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmic Res. 2014;51(3):124-8</RefSource><PMID Version="1">24457594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2007 Sep;85(3):328-34</RefSource><PMID Version="1">17637462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):157-63</RefSource><PMID Version="1">14637252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011;11:104</RefSource><PMID Version="1">21429202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1995 Jul;130(1):169-81</RefSource><PMID Version="1">7790371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2013 Oct;54(10):6789-97</RefSource><PMID Version="1">24022010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4661-70</RefSource><PMID Version="1">16303963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nippon Ganka Gakkai Zasshi. 1995 Dec;99(12):1303-41</RefSource><PMID Version="1">8571853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Ophthalmol. 2010 Dec;88(8):891-5</RefSource><PMID Version="1">19706013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Photochem Photobiol. 2014 Jul-Aug;90(4):853-9</RefSource><PMID Version="1">24483628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Dec 1;135(11):2687-96</RefSource><PMID Version="1">24729390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2011;17:127-33</RefSource><PMID Version="1">21245954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 Aug 15;755(2):115-9</RefSource><PMID Version="1">23830927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2003 Jan;124(1):27-32</RefSource><PMID Version="1">12618003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Physiol. 2013 Dec 16;4:366</RefSource><PMID Version="1">24379787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2010;16:698-704</RefSource><PMID Version="1">20431719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2012 Oct;53(11):7276-85</RefSource><PMID Version="1">23010639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2001 Aug;3(4):597-609</RefSource><PMID Version="1">11554447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 2009 Jan 8;255(1-2):1-5</RefSource><PMID Version="1">18852014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2012 Aug 15;505(1):121-7</RefSource><PMID Version="1">22652274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer. 2014 Mar 13;5(3):253-9</RefSource><PMID Version="1">24665350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Feb 16;291(5507):1284-9</RefSource><PMID Version="1">11181991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):408-14</RefSource><PMID Version="1">24939308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 Feb 12-18;365(9459):599-609</RefSource><PMID Version="1">15708105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):391-404</RefSource><PMID Version="1">8230310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 2011 Jul;36(7):632-6</RefSource><PMID Version="1">21599457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Biosci (Elite Ed). 2012;4:141-55</RefSource><PMID Version="1">22201860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Ophthalmol. 2013 Nov;91(7):652-6</RefSource><PMID Version="1">22994213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2012 Oct;31(10):981-1005</RefSource><PMID Version="1">23023028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4732-7</RefSource><PMID Version="1">20375340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2009 Oct;23(10):3459-69</RefSource><PMID Version="1">19541747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Aug;1822(8):1308-15</RefSource><PMID Version="1">22587838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Top Dev Biol. 2014;108:217-46</RefSource><PMID Version="1">24512711</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lab. 2013;59(1-2):163-8</RefSource><PMID Version="1">23505922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2012 Dec 31;327(1-2):26-47</RefSource><PMID Version="1">22293091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2014 Jun;18:52-62</RefSource><PMID Version="1">24794400</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002386" MajorTopicYN="N">Cataract</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065840" MajorTopicYN="N">Protective Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1 gene</Keyword><Keyword MajorTopicYN="N">Genetic polymorphisms</Keyword><Keyword MajorTopicYN="N">OGG1 gene</Keyword><Keyword MajorTopicYN="N">XRCC1 gene</Keyword><Keyword MajorTopicYN="N">senile cataract</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26884880</ArticleId><ArticleId IdType="pmc">PMC4730093</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26811994</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2016</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-135X</ISSN><JournalIssue CitedMedium="Internet"><Volume>784-785</Volume><PubDate><MedlineDate>2016 Feb-Mar</MedlineDate></PubDate></JournalIssue><Title>Mutation research</Title><ISOAbbreviation>Mutat. Res.</ISOAbbreviation></Journal><ArticleTitle>XPC deficiency is related to APE1 and OGG1 expression and function.</ArticleTitle><Pagination><MedlinePgn>25-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrfmmm.2016.01.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0027-5107(16)30003-3</ELocationID><Abstract><AbstractText>Oxidative DNA damage is considered to be a major cause of neurodegeneration and internal tumors observed in syndromes that result from nucleotide excision repair (NER) deficiencies, such as Xeroderma Pigmentosum (XP) and Cockayne Syndrome (CS). Recent evidence has shown that NER aids in removing oxidized DNA damage and may interact with base excision repair (BER) enzymes. Here, we investigated APE1 and OGG1 expression, localization and activity after oxidative stress in XPC-deficient cells. The endogenous APE1 and OGG1 mRNA levels were lower in XPC-deficient fibroblasts. However, XPC-deficient cells did not show hypersensitivity to oxidative stress compared with NER-proficient cells. To confirm the impact of an XPC deficiency in regulating APE1 and OGG1 expression and activity, we established an XPC-complemented cell line. Although the XPC complementation was only partial and transient, the transfected cells exhibited greater OGG1 expression and activity compared with XPC-deficient cells. However, the APE1 expression and activity did not significantly change. Furthermore, we observed a physical interaction between the XPC and APE1 proteins. Together, the results indicate that the responses of XPC-deficient cells under oxidative stress may not only be associated with NER deficiency per se but may also include new XPC functions in regulating BER proteins. </AbstractText><CopyrightInformation>Copyright © 2016 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Melo</LastName><ForeName>Julliane Tamara Araújo</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza Timoteo</LastName><ForeName>Ana Rafaela</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lajus</LastName><ForeName>Tirzah Braz Petta</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandão</LastName><ForeName>Juliana Alves</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza-Pinto</LastName><ForeName>Nadja Cristhina</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Laboratório de Genética Mitocondrial, Departamento de Química, Instituto de Química, Universidade de São Paulo-USP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menck</LastName><ForeName>Carlos Frederico Martins</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Laboratório de Reparo de DNA, Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo-USP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campalans</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CEA, Institut de Radiobiologie Cellulaire et Moléculaire, 18 Route du Panorama, F-92265 Fontenay aux Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radicella</LastName><ForeName>J Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>CEA, Institut de Radiobiologie Cellulaire et Moléculaire, 18 Route du Panorama, F-92265 Fontenay aux Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vessoni</LastName><ForeName>Alexandre Teixeira</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Laboratório de Reparo de DNA, Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo-USP, São Paulo, Brazil; Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muotri</LastName><ForeName>Alysson Renato</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics/Rady Children's Hospital San Diego, Department of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnez-Lima</LastName><ForeName>Lucymara Fassarella</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil. Electronic address: lfagnez@ufrnet.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016877">Oxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>156533-34-5</RegistryNumber><NameOfSubstance UI="C086984">XPC protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047468" MajorTopicYN="N">Immunoprecipitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016877" MajorTopicYN="N">Oxidants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014983" MajorTopicYN="N">Xeroderma Pigmentosum</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">XPC</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26811994</ArticleId><ArticleId IdType="pii">S0027-5107(16)30003-3</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2016.01.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26790616</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2017</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6893</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology</Title><ISOAbbreviation>J Obstet Gynaecol</ISOAbbreviation></Journal><ArticleTitle>The association of -656T &gt; G and 1349T &gt; G polymorphisms of ApE1 gene and the risk of female infertility.</ArticleTitle><Pagination><MedlinePgn>544-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/01443615.2015.1127903</ELocationID><Abstract><AbstractText>Despite enormous progress in the understanding of human reproductive physiology, the underlying cause of male infertility remains undefined in about 50.0% of cases, which are referred to as idiopathic infertility. Human apurinic/apyrimidinic endonuclease 1 (ApE1) is a multifunctional protein that has an important role in the base excision repair pathway. The present study aimed to evaluate whether two functional ApE1 polymorphisms (-656T &gt; G and 1349T &gt; G) are associated with the susceptibility of female infertility. Blood samples were collected from 100 patients diagnosed with female infertility and 100 control subjects and genotyped by tetra-primer amplification refractory mutation system PCR (T-ARMS-PCR). The results indicated that individuals with the variant TG genotypes had a significantly increased risk of female infertility (p = 0.035, OR = 1.98, 95% CI = 1.04-3.74). Whereas, a significant association between 1349T &gt; G polymorphism and female infertility risk was not observed (p = 0.1). Larger studies with more patients and controls are required to confirm the results. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mashayekhi</LastName><ForeName>Farhad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>a Department of Biology, Faculty of Sciences , University of Guilan , Rasht , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousefi</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Department of Biology, Faculty of Sciences , University of Guilan , Rasht , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salehi</LastName><ForeName>Zivar</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>a Department of Biology, Faculty of Sciences , University of Guilan , Rasht , Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pournourali</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a Department of Biology, Faculty of Sciences , University of Guilan , Rasht , Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Obstet Gynaecol</MedlineTA><NlmUniqueID>8309140</NlmUniqueID><ISSNLinking>0144-3615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007247" MajorTopicYN="N">Infertility, Female</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ApE1</Keyword><Keyword MajorTopicYN="N">BER</Keyword><Keyword MajorTopicYN="N">female infertility</Keyword><Keyword MajorTopicYN="N">gene polymorphism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26790616</ArticleId><ArticleId IdType="doi">10.3109/01443615.2015.1127903</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26711335</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month><Day>29</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>Synergistic Actions of Ogg1 and Mutyh DNA Glycosylases Modulate Anxiety-like Behavior in Mice.</ArticleTitle><Pagination><MedlinePgn>2671-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2015.12.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(15)01413-8</ELocationID><Abstract><AbstractText>Ogg1 and Mutyh DNA glycosylases cooperate to prevent mutations caused by 8-oxoG, a major premutagenic DNA lesion associated with cognitive decline. We have examined behavior and cognitive function in mice deficient of these glycosylases. Ogg1(-/-)Mutyh(-/-) mice were more active and less anxious, with impaired learning ability. In contrast, Mutyh(-/-) mice showed moderately improved memory. We observed no apparent change in genomic 8-oxoG levels, suggesting that Ogg1 and Mutyh play minor roles in global repair in adult brain. Notably, transcriptome analysis of hippocampus revealed that differentially expressed genes in the mutants belong to pathways known to be involved in anxiety and cognition. Esr1 targets were upregulated, suggesting a role of Ogg1 and Mutyh in repression of Esr1 signaling. Thus, beyond their involvement in DNA repair, Ogg1 and Mutyh regulate hippocampal gene expression related to cognition and behavior, suggesting a role for the glycosylases in regulating adaptive behavior. </AbstractText><CopyrightInformation>Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bjørge</LastName><ForeName>Monica D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hildrestrand</LastName><ForeName>Gunn A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheffler</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suganthan</LastName><ForeName>Rajikala</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolseth</LastName><ForeName>Veslemøy</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuśnierczyk</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Proteomics and Metabolomics Core Facility PROMEC, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Alexander D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vågbø</LastName><ForeName>Cathrine B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Proteomics and Metabolomics Core Facility PROMEC, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vetlesen</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eide</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slupphaug</LastName><ForeName>Geir</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Proteomics and Metabolomics Core Facility PROMEC, Norwegian University of Science and Technology, 7491 Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakabeppu</LastName><ForeName>Yusaku</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, and Research Center for Nucleotide Pool, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bredy</LastName><ForeName>Timothy W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klungland</LastName><ForeName>Arne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjørås</LastName><ForeName>Magnar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway. Electronic address: magnar.bjoras@rr-research.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C061738">mutY adenine glycosylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>09</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26711335</ArticleId><ArticleId IdType="pii">S2211-1247(15)01413-8</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2015.12.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26692147</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0038</ISSN><JournalIssue CitedMedium="Internet"><Volume>578</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Gene</Title><ISOAbbreviation>Gene</ISOAbbreviation></Journal><ArticleTitle>Association of XRCC1 and OGG1 DNA repair gene polymorphisms with rheumatoid arthritis in Egyptian patients.</ArticleTitle><Pagination><MedlinePgn>112-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gene.2015.12.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0378-1119(15)01493-6</ELocationID><Abstract><AbstractText>Rheumatoid arthritis (RA) is a chronic autoimmune disease and can lead to deformities and severe disabilities, due to irreversible damage of tendons, joints, and bones. Previous studies indicated that the DNA repair system was involved in the pathology of RA. In this study, we investigated the association of two XRCC1 (X-ray repair cross-complementing group 1) (rs25487 and rs25489) gene polymorphisms and two OGG1 (8-oxoguanine glycosylase 1) gene polymorphisms (rs159153 and rs3219008) with the susceptibility to RA in 320 Egyptians individuals (160 RA patients and 160 controls). Genotyping was performed using restriction fragment length polymorphism polymerase chain reaction. We found an association between variant XRCC1 (rs25487 and rs25489) genotype polymorphisms, OGG1 (rs3219008) genotype polymorphism, and RA disease susceptibility. Moreover, the presence of the Gln/Gln, Arg/His, and His/His genotypes of XRCC1 was significantly more likely to have bone erosion and extra-articular features in RA patients. Further, patient's carrying the OGG1 A/G and G/G genotypes more likely to have bone erosion. However, the AA genotype and A allele were significantly more likely to have extra-articular features. Also, there were no significant associations between C/T OGG1 gene polymorphism and RA susceptibility, bone erosion, and extra-articular features occurrence in RA patients. We concluded that the XRCC1-Arg/Gln, XRCC1-Arg/His, and OGG1 A/G polymorphism have a role in the development of rheumatoid arthritis disease. Also, these variant are associated with the severity of RA.</AbstractText><CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Randa H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Electronic address: randahussiny@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Shal</LastName><ForeName>Amal S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Shahawy</LastName><ForeName>Eman E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Rheumatology and rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel Galil</LastName><ForeName>Sahar M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Rheumatology and rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Gene</MedlineTA><NlmUniqueID>7706761</NlmUniqueID><ISSNLinking>0378-1119</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N">Egypt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">European Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Polymorphism</Keyword><Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">XRCC1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26692147</ArticleId><ArticleId IdType="pii">S0378-1119(15)01493-6</ArticleId><ArticleId IdType="doi">10.1016/j.gene.2015.12.021</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26639148</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2015</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Inhibition of Ape1 Redox Activity Promotes Odonto/osteogenic Differentiation of Dental Papilla Cells.</ArticleTitle><Pagination><MedlinePgn>17483</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep17483</ELocationID><Abstract><AbstractText>Dentinogenesis is the formation of dentin, a substance that forms the majority of teeth, and this process is performed by odontoblasts. Dental papilla cells (DPCs), as the progenitor cells of odontoblasts, undergo the odontogenic differentiation regulated by multiple cytokines and paracrine signal molecules. Ape1 is a perfect paradigm of the function complexity of a biological macromolecule with two major functional regions for DNA repair and redox regulation, respectively. To date, it remains unclear whether Ape1 can regulate the dentinogenesis in DPCs. In the present study, we firstly examed the spatio-temporal expression of Ape1 during tooth germ developmental process, and found the Ape1 expression was initially high and then gradually reduced along with the tooth development. Secondly, the osteo/odontogenic differentiation capacity of DPCs was up-regulated when treated with either Ape1-shRNA or E3330 (a specific inhibitor of the Ape1 redox function), respectively. Moreover, we found that the canonical Wnt signaling pathway was activated in this process, and E3330 reinforced-osteo/odontogenic differentiation capacity was suppressed by Dickkopf1 (DKK1), a potent antagonist of canonical Wnt signaling pathway. Taken together, we for the first time showed that inhibition of Ape1 redox regulation could promote the osteo/odontogenic differentiation capacity of DPCs via canonical Wnt signaling pathway. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthodontics, West China School of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Wenhua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthodontics, West China School of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xianrui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthodontics, West China School of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthodontics, West China School of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Mei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Weidong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, West China School of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guoqing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Ding</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthodontics, West China School of Stomatology, Sichuan University, Chengdu 610041, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016227">Benzoquinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011422">Propionates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>136164-66-4</RegistryNumber><NameOfSubstance UI="C075569">E 3330</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C470319">Apex1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Dent Res. 1958 Sep-Oct;37(5):767-79</RefSource><PMID Version="1">13587798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatr Dent. 2013 Sep-Oct;35(5):E179-84</RefSource><PMID Version="1">24290548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Endod. 2010 May;36(5):781-9</RefSource><PMID Version="1">20416419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Cell Dev Biol. 2014 Jan-Feb;25-26:61-70</RefSource><PMID Version="1">24355560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Biol Int. 2015 Jan;39(1):94-103</RefSource><PMID Version="1">25077982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 2013 Mar 8;305:120-9</RefSource><PMID Version="1">23370007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dent Res. 2009 Jan;88(1):51-5</RefSource><PMID Version="1">19131317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1997 Mar 1;11(5):558-70</RefSource><PMID Version="1">9119221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2013 Jan;54:26-39</RefSource><PMID Version="1">23085514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Histol Cytol. 2008 Sep;71(2):131-46</RefSource><PMID Version="1">18974605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</RefSource><PMID Version="1">17560642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 Aug;36(13):4327-36</RefSource><PMID Version="1">18586825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Endod. 2014 Nov;40(11):1771-7</RefSource><PMID Version="1">25258338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Diagn Res. 2015 Jan;9(1):ZE07-10</RefSource><PMID Version="1">25738099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neural Regen Res. 2013 May 5;8(13):1190-200</RefSource><PMID Version="1">25206413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone. 2014 Jun;63:158-65</RefSource><PMID Version="1">24657304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2000 Apr;127(8):1671-9</RefSource><PMID Version="1">10725243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bone Miner Res. 2001 Apr;16(4):731-41</RefSource><PMID Version="1">11316001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dent Res. 2009 Oct;88(10):904-9</RefSource><PMID Version="1">19783797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2009 Jun;27(6):1455-62</RefSource><PMID Version="1">19492297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Oral Biol. 2012 Sep;57(9):1165-75</RefSource><PMID Version="1">22534175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Oct 3;289(40):27937-51</RefSource><PMID Version="1">25124032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Res. 2008 Jan;42(1):20-9</RefSource><PMID Version="1">18324520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5061-6</RefSource><PMID Version="1">9560228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasma. 2013;60(4):384-94</RefSource><PMID Version="1">23581410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2009 Nov 15;183(10):6839-48</RefSource><PMID Version="1">19846872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(2):e89232</RefSource><PMID Version="1">24586617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Jun 6;272(23):14497-500</RefSource><PMID Version="1">9169404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2012 Oct;139(19):3487-97</RefSource><PMID Version="1">22949612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Dyn. 2015 Apr;244(4):577-90</RefSource><PMID Version="1">25645398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Comput Biol. 2015 Mar;11(3):e1004106</RefSource><PMID Version="1">25793621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Dev Biol. 1995 Feb;39(1):51-68</RefSource><PMID Version="1">7626422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oral Maxillofac Surg. 2009 Mar;67(3):507-14</RefSource><PMID Version="1">19231773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dent Res. 2015 Apr;94(4):608-14</RefSource><PMID Version="1">25694469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Differentiation. 2008 May;76(5):495-505</RefSource><PMID Version="1">18093227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2015 Nov;230(11):2588-95</RefSource><PMID Version="1">26037045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Aug 7;512(7512):36-7</RefSource><PMID Version="1">25079312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):589-600</RefSource><PMID Version="1">18717627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells. 2015 Mar;33(3):627-38</RefSource><PMID Version="1">25447379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2009 Apr;219(1):209-18</RefSource><PMID Version="1">19097035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(9):e106485</RefSource><PMID Version="1">25188410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):27-47</RefSource><PMID Version="1">18166975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Sep;11(9):3323-35</RefSource><PMID Version="1">1380454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Dev. 2014 Jun 15;23(12):1405-16</RefSource><PMID Version="1">24517722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Neurobiol. 2013 Feb;47(1):313-24</RefSource><PMID Version="1">23054678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2013;4:e537</RefSource><PMID Version="1">23492768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2009 Oct 1;334(1):174-85</RefSource><PMID Version="1">19631205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Endod. 2015 Jul;41(7):1091-9</RefSource><PMID Version="1">25882137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(6):e67504</RefSource><PMID Version="1">23840726</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2015 Aug;47(2):610-20</RefSource><PMID Version="1">26081414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Physiol Biochem. 2015;35(3):1008-22</RefSource><PMID Version="1">25661467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2012 Sep 7;11(3):291-301</RefSource><PMID Version="1">22958928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2015 Aug;1850(8):1518-26</RefSource><PMID Version="1">25766871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Mar 1;109(5):1917-22</RefSource><PMID Version="1">17053053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Apr 1;6(4):461-9</RefSource><PMID Version="1">17166779</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016227" MajorTopicYN="N">Benzoquinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="Y">Cell Differentiation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003771" MajorTopicYN="N">Dental Papilla</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009805" MajorTopicYN="Y">Odontogenesis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010012" MajorTopicYN="Y">Osteogenesis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011422" MajorTopicYN="N">Propionates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014070" MajorTopicYN="N">Tooth</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26639148</ArticleId><ArticleId IdType="pii">srep17483</ArticleId><ArticleId IdType="doi">10.1038/srep17483</ArticleId><ArticleId IdType="pmc">PMC4671010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26636502</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2284-0729</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>22</Issue><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European review for medical and pharmacological sciences</Title><ISOAbbreviation>Eur Rev Med Pharmacol Sci</ISOAbbreviation></Journal><ArticleTitle>The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology.</ArticleTitle><Pagination><MedlinePgn>4207-9</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9830</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berretta</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, National Cancer Institute, Aviano (PN) Italy. mberretta@cro.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanzione</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Di Francia</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Tirelli</LastName><ForeName>U</ForeName><Initials>U</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Eur Rev Med Pharmacol Sci</MedlineTA><NlmUniqueID>9717360</NlmUniqueID><ISSNLinking>1128-3602</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060890">B7-H1 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):3063-71</RefSource><PMID Version="1">26367730</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D060890" MajorTopicYN="N">B7-H1 Antigen</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26636502</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26624999</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.</ArticleTitle><Pagination><MedlinePgn>e0143289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0143289</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Human Hepatocellular Carcinoma (HCC) is the fifth most frequent neoplasm worldwide and the most serious complication of long-standing chronic liver diseases (CLD). Its development is associated with chronic inflammation and sustained oxidative stress. Deregulation of apurinic apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1), a master regulator of cellular response to oxidative stress, has been associated with poor prognosis in several cancers including HCC.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">In the present study we investigated the APE1/Ref-1 mRNA levels in cirrhotic and HCC tissues obtained during HCC resection. The possible protective role of APE1/Ref-1 against oxidative stress and apoptosis was evaluated in vitro in immortalized human hepatocytes (IHH) over-expressing APE1/Ref-1.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">APE1/Ref-1 was up-regulated in HCC, regulation occurring at the transcriptional level. APE1/Ref-1 mRNA content increased with the progression of liver disease with the transcriptional up-regulation present in cirrhosis significantly increased in HCC. The up-regulation was higher in the less differentiated cancers. In vitro, over-expression of APE1/Ref-1 in normal hepatocytes conferred cell protection against oxidative stress and it was associated with BAX inhibition and escape from apoptosis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">APE1/Ref-1 is up-regulated in HCC and this over-expression correlates with cancer aggressiveness. The up-regulation occurs at the transcriptional level and it is present in the earliest phases of hepatocarcinogenesis. The APE-1/Ref-1 over-expression is associated with hepatocyte survival and inhibits BAX activation and apoptosis. These data suggest a possible role of APE1/Ref-1 over-expression both in hepatocyte survival and HCC development calling attention to this molecule as a promising marker for HCC diagnosis and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Maso</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>FIF- Fondazione Italiana Fegato Area Science Park Basovizza. Trieste, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mediavilla</LastName><ForeName>María Gabriela</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>FIF- Fondazione Italiana Fegato Area Science Park Basovizza. Trieste, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vascotto</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze Mediche e Biologiche, Università di Udine. Udine, Itala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lupo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Chirurgia Generale 2 Centro Trapianto Fegato Universitá Torino. Torino, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baccarani</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze Mediche e Biologiche, Università di Udine. Udine, Itala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avellini</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dipartimento Scienze Mediche e Biologiche, Università di Udine. Udine, Itala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tell</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>FIF- Fondazione Italiana Fegato Area Science Park Basovizza. Trieste, Italia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento Scienze Mediche e Biologiche, Università di Udine. Udine, Itala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiribelli</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>FIF- Fondazione Italiana Fegato Area Science Park Basovizza. Trieste, Italia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento Scienze Mediche, Università di Trieste. Trieste, Italia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crocè</LastName><ForeName>Lory Saveria</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>FIF- Fondazione Italiana Fegato Area Science Park Basovizza. Trieste, Italia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento Scienze Mediche, Università di Trieste. Trieste, Italia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051028">bcl-2-Associated X Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2007 Nov;28(11):2382-90</RefSource><PMID Version="1">17566060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1954 May;7(3):462-503</RefSource><PMID Version="1">13160935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 1999 Mar;20(3):415-9</RefSource><PMID Version="1">10190555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2005 Dec;4(12):1923-35</RefSource><PMID Version="1">16373707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2004 Apr;126(4):1134-46</RefSource><PMID Version="1">15057752</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2005 Dec;43(6):1031-7</RefSource><PMID Version="1">16169114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(10):3303-12</RefSource><PMID Version="1">15942031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Hepatol. 2004 Jul-Sep;3(3):86-92</RefSource><PMID Version="1">15505592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2002 Aug;31(4):339-46</RefSource><PMID Version="1">12149612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Liver Dis. 2005;25(2):143-54</RefSource><PMID Version="1">15918143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gastroenterol Hepatol. 2000 Jul;15(7):718-24</RefSource><PMID Version="1">10937675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Chemother Pharmacol. 2012 Jun;69(6):1545-55</RefSource><PMID Version="1">22481618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2008 Sep 1;45(5):592-601</RefSource><PMID Version="1">18515104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):4079-96</RefSource><PMID Version="1">22918947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2001 Nov;35(5):613-8</RefSource><PMID Version="1">11690707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2006 May-Jun;8(5-6):1047-58</RefSource><PMID Version="1">16771694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Biochem Nutr. 2013 Mar;52(2):112-9</RefSource><PMID Version="1">23525727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Hepatol. 2013 Apr 27;5(4):206-13</RefSource><PMID Version="1">23671725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1998 Apr;77(7):1169-73</RefSource><PMID Version="1">9569057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2007 Apr 2;26(15):2166-76</RefSource><PMID Version="1">17401425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Biotechnol Biochem. 2008 Dec;72(12):3206-10</RefSource><PMID Version="1">19060414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5061-6</RefSource><PMID Version="1">9560228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Cell Sci. 2000;22(4):313-8</RefSource><PMID Version="1">11549944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2005 Oct;42(4):809-18</RefSource><PMID Version="1">16175600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2008;432:101-16</RefSource><PMID Version="1">18370013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2006 Sep;6(9):674-87</RefSource><PMID Version="1">16929323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2010 Jul 29;29(30):4330-40</RefSource><PMID Version="1">20498636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2006 Apr;4(4):221-33</RefSource><PMID Version="1">16603636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2013 Jul 1;:null</RefSource><PMID Version="1">23863623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2013 Feb;58(2):365-74</RefSource><PMID Version="1">23023012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2005 Jun 3;121(5):671-4</RefSource><PMID Version="1">15935754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 May 1;29(9):e45</RefSource><PMID Version="1">11328886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2522-32</RefSource><PMID Version="1">17403694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2007 Apr;132(4):1465-75</RefSource><PMID Version="1">17433324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 1973 Aug;60(8):646-9</RefSource><PMID Version="1">4541913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2003 Jun 12;22(24):3813-20</RefSource><PMID Version="1">12802289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transplant Proc. 2010 May;42(4):1204-8</RefSource><PMID Version="1">20534262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e55313</RefSource><PMID Version="1">23418439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2007 Jan-Feb;13(1-2):89-96</RefSource><PMID Version="1">17515960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Liver Int. 2007 Mar;27(2):155-62</RefSource><PMID Version="1">17311609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Probes. 2004 Feb;18(1):45-50</RefSource><PMID Version="1">15036369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 2003 Apr 1;315(1):90-4</RefSource><PMID Version="1">12672416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(7):1834-54</RefSource><PMID Version="1">19188445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2009 Feb;9(4):1058-74</RefSource><PMID Version="1">19180539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2009 Jun 1;46(11):1488-99</RefSource><PMID Version="1">19268524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Detect Prev. 2004;28(6):385-91</RefSource><PMID Version="1">15582261</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Mar 1;28(5):1099-105</RefSource><PMID Version="1">10666449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(8):e70909</RefSource><PMID Version="1">23967134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 1998 Sep;28(3):751-5</RefSource><PMID Version="1">9731568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2002 Jan-Feb;9(1):11-7</RefSource><PMID Version="1">11748448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2000;32(1 Suppl):39-47</RefSource><PMID Version="1">10728793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):39-62</RefSource><PMID Version="1">15757804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2009 Jun;136(7):2258-69</RefSource><PMID Version="1">19505426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Apr;7(4):824-30</RefSource><PMID Version="1">11309329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Apr 1;6(4):461-9</RefSource><PMID Version="1">17166779</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Liver Dis. 2005 May;9(2):191-211, v</RefSource><PMID Version="1">15831268</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="Y">Transcription, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051028" MajorTopicYN="N">bcl-2-Associated X Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>08</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26624999</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0143289</ArticleId><ArticleId IdType="pii">PONE-D-15-33947</ArticleId><ArticleId IdType="pmc">PMC4666459</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26608791</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-1466</ISSN><JournalIssue CitedMedium="Internet"><Volume>310</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>04</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of physiology. Renal physiology</Title><ISOAbbreviation>Am. J. Physiol. Renal Physiol.</ISOAbbreviation></Journal><ArticleTitle>Unilateral ureteral obstruction induces DNA repair by APE1.</ArticleTitle><Pagination><MedlinePgn>F763-F776</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1152/ajprenal.00613.2014</ELocationID><Abstract><AbstractText>Ureteral obstruction is associated with oxidative stress and the development of fibrosis of the kidney parenchyma. Apurinic/apyrimidinic endonuclease (APE1) is an essential DNA repair enzyme for repair of oxidative DNA lesions and regulates several transcription factors. The aim of the present study was to investigate whether APE1 is regulated by acute (24 h) and chronic (7 days) unilateral ureteral obstruction (UUO). APE1 was expressed in essentially all kidney cells with the strongest expression in proximal tubuli. After 24 h of UUO, APE1 mRNA was induced in the cortex, inner stripe of the outer medulla (ISOM), and inner medulla (IM). In contrast, the APE1 protein level was not regulated in the IM and ISOM and only slightly increased in the cortex. APE1 DNA repair activity was not significantly changed. A different pattern of regulation was observed after 7 days of UUO, with an increase of the APE1 mRNA level in the cortex but not in the ISOM and IM. The APE1 protein level in the cortex, ISOM, and IM increased significantly. Importantly, we observed a significant increase in APE1 DNA repair activity in the cortex and IM. To confirm our model, we investigated heme oxygenase-1, collagen type I, fibronectin I, and α-smooth muscle actin levels. In vitro, we found the transcriptional regulatory activity of APE1 to be involved in the upregulation of the profibrotic factor connective tissue growth factor. In summary, APE1 is regulated at different levels after acute and chronic UUO. Thus, our results suggest that DNA repair activity is regulated in response to progressive (7 days) obstruction and that APE1 potentially could play a role in the development of fibrosis in kidney disease.</AbstractText><CopyrightInformation>Copyright © 2016 the American Physiological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aamann</LastName><ForeName>Maria D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nørregaard</LastName><ForeName>Rikke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kristensen</LastName><ForeName>Marie Louise Vindvad</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevnsner</LastName><ForeName>Tinna</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Danish Center for Molecular Gerontology and Danish Aging Research Center, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frøkiær</LastName><ForeName>Jørgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark; JF@clin.au.dk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Physiology and Molecular Imaging, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Physiol Renal Physiol</MedlineTA><NlmUniqueID>100901990</NlmUniqueID><ISSNLinking>1522-1466</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024042">Collagen Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005353">Fibronectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.14.18</RegistryNumber><NameOfSubstance UI="D051547">Heme Oxygenase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024042" MajorTopicYN="N">Collagen Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005353" MajorTopicYN="N">Fibronectins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051547" MajorTopicYN="N">Heme Oxygenase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014517" MajorTopicYN="N">Ureteral Obstruction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">DNA repair</Keyword><Keyword MajorTopicYN="Y">apurinic/apyrimidinic endonuclease I</Keyword><Keyword MajorTopicYN="Y">fibrosis</Keyword><Keyword MajorTopicYN="Y">kidney</Keyword><Keyword MajorTopicYN="Y">obstructive nephropathy</Keyword><Keyword MajorTopicYN="Y">unilateral ureteral obstruction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26608791</ArticleId><ArticleId IdType="pii">ajprenal.00613.2014</ArticleId><ArticleId IdType="doi">10.1152/ajprenal.00613.2014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26586787</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>01</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7445</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Cancer research</Title><ISOAbbreviation>Cancer Res.</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial DNA Repair through OGG1 Activity Attenuates Breast Cancer Progression and Metastasis.</ArticleTitle><Pagination><MedlinePgn>30-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1158/0008-5472.CAN-15-0692</ELocationID><Abstract><AbstractText>Production of mitochondrial reactive oxygen species and integrity of mitochondrial DNA (mtDNA) are crucial in breast cancer progression and metastasis. Therefore, we evaluated the role of mtDNA damage in breast cancer by genetically modulating the DNA repair enzyme 8-oxoguanine DNA glycosylase (OGG1) in the PyMT transgenic mouse model of mammary tumorigenesis. We generated mice lacking OGG1 (KO), mice overexpressing human OGG1 subunit 1α in mitochondria (Tg), and mice simultaneously lacking OGG1 and overexpressing human OGG1 subunit 1α in mitochondria (KO/Tg). We found that Tg and KO/Tg mice developed significantly smaller tumors than KO and wild-type (WT) mice after 16 weeks. Histologic analysis revealed a roughly 2-fold decrease in the incidence of lung metastases in Tg mice (33.3%) compared to WT mice (62.5%). Furthermore, lungs from Tg mice exhibited nearly a 15-fold decrease in the average number of metastatic foci compared with WT mice (P ≤ 0.05). Primary tumors isolated from Tg mice also demonstrated reduced total and mitochondrial oxidative stress, diminished mtDNA damage, and increased mitochondrial function. Targeting hOGG1 to the mitochondria protected cells from mtDNA damage, resulting in downregulation of HIF1α and attenuated phosphorylation of Akt. Collectively, we demonstrate proof of concept that mtDNA damage results in breast cancer progression and metastasis in vivo. Moreover, our findings offer new therapeutic strategies for modulating the levels of mtDNA repair enzymes to delay or stall metastatic progression.</AbstractText><CopyrightInformation>©2015 American Association for Cancer Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuzefovych</LastName><ForeName>Larysa V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Andrea G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, University of South Alabama, Mobile, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuler</LastName><ForeName>Michele A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Comparative Medicine, College of Medicine, University of South Alabama, Mobile, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eide</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, University of Oslo and Centre of Molecular Biology and Neuroscience, University of Oslo and Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Glenn L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rachek</LastName><ForeName>Lyudmila I</ForeName><Initials>LI</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama. lrachek@southalabama.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA149646</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01CA149646</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Res</MedlineTA><NlmUniqueID>2984705R</NlmUniqueID><ISSNLinking>0008-5472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Osteoarthritis Cartilage. 2010 Mar;18(3):424-32</RefSource><PMID Version="1">19822235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011;11:191</RefSource><PMID Version="1">21605372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2011 Jun 29;31(26):9746-51</RefSource><PMID Version="1">21715639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 2012 Jan;153(1):92-100</RefSource><PMID Version="1">22128025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2012 Jan 17;106(2):344-7</RefSource><PMID Version="1">22108520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(1):e54059</RefSource><PMID Version="1">23342074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 2013 Aug;154(8):2640-9</RefSource><PMID Version="1">23748360</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2000 Feb 21;19(8):968-88</RefSource><PMID Version="1">10713680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Nov 22;277(47):44932-7</RefSource><PMID Version="1">12244119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Mar 1;63(5):902-5</RefSource><PMID Version="1">12615700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(18):5596-608</RefSource><PMID Version="1">15494448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1992 Mar;12(3):954-61</RefSource><PMID Version="1">1312220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Metastasis Rev. 2006 Dec;25(4):695-705</RefSource><PMID Version="1">17160708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Transgenic Res. 2007 Apr;16(2):193-201</RefSource><PMID Version="1">17206489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 May 15;67(10):4687-94</RefSource><PMID Version="1">17510395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13300-5</RefSource><PMID Version="1">10557315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 May 2;320(5876):661-4</RefSource><PMID Version="1">18388260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2007 Aug;28(8):1629-37</RefSource><PMID Version="1">17389610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2008 Jul 18;266(1):53-9</RefSource><PMID Version="1">18362051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Mar 15;69(6):2375-83</RefSource><PMID Version="1">19276362</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26586787</ArticleId><ArticleId IdType="pii">0008-5472.CAN-15-0692</ArticleId><ArticleId IdType="doi">10.1158/0008-5472.CAN-15-0692</ArticleId><ArticleId IdType="pmc">PMC4703513</ArticleId><ArticleId IdType="mid">NIHMS734184</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26548492</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2015</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1742-2051</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Molecular bioSystems</Title><ISOAbbreviation>Mol Biosyst</ISOAbbreviation></Journal><ArticleTitle>New oligonucleotide derivatives as unreactive substrate analogues and potential inhibitors of human apurinic/apyrimidinic endonuclease APE1.</ArticleTitle><Pagination><MedlinePgn>67-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/c5mb00692a</ELocationID><Abstract><AbstractText>Human apurinic/apyrimidinic endonuclease APE1 is one of the key enzymes of the base excision DNA repair system. The main biological function of APE1 is the hydrolysis of the phosphodiester bond on the 5'-side of an apurinic/apyrimidinic site (AP-site) to give the 5'-phosphate and 3'-hydroxyl group. It has long been known that AP-sites have mutagenic and cytotoxic effects and their accumulation in DNA is a potential hazard to the cell lifecycle. The structural and biochemical studies of APE1 are complicated by its high catalytic activity towards the AP-site and its cyclic or acyclic analogues. This work has focussed on the design, synthesis and analysis of oligonucleotide derivatives as potentially unreactive APE1 substrates. We have shown that the replacement of oxygen atoms in the phosphate group on the 5'-side from the AP-site analogue tetrahydrofuran (F) considerably decreases the rate of enzymatic hydrolysis of modified oligonucleotides. We have calculated that a N3'-P5' phosphoramidate linkage is hydrolysed about 30 times slower than the native phosphodiester bond while phosphorothioate or primary phosphoramidate linkages are cleaved more than three orders of magnitude slower. The value of IC50 of the oligonucleotide duplex containing a primary phosphoramidate linkage is 2.5 × 10(-7) M, which is in accordance with the APE1 association constant of DNA duplexes containing AP-sites. Thus, it is demonstrated that oligonucleotide duplexes with chemical modifications could be used as unreactive substrates and potential competitive inhibitors of APE1. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuznetsov</LastName><ForeName>Nikita A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru and Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kupryushkin</LastName><ForeName>Maxim S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abramova</LastName><ForeName>Tatyana V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuznetsova</LastName><ForeName>Alexandra A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miroshnikova</LastName><ForeName>Anastasia D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stetsenko</LastName><ForeName>Dmitry A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru and Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pyshnyi</LastName><ForeName>Dmitrii V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru and Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedorova</LastName><ForeName>Olga S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. fedorova@niboch.nsc.ru and Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Biosyst</MedlineTA><NlmUniqueID>101251620</NlmUniqueID><ISSNLinking>1742-2051</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009841">Oligonucleotides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010710">Phosphates</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002384" MajorTopicYN="N">Catalysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006868" MajorTopicYN="N">Hydrolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009841" MajorTopicYN="N">Oligonucleotides</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010710" MajorTopicYN="N">Phosphates</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26548492</ArticleId><ArticleId IdType="doi">10.1039/c5mb00692a</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26520369</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3592</ISSN><JournalIssue CitedMedium="Internet"><Volume>793</Volume><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Mutation research. Genetic toxicology and environmental mutagenesis</Title><ISOAbbreviation>Mutat Res Genet Toxicol Environ Mutagen</ISOAbbreviation></Journal><ArticleTitle>APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.</ArticleTitle><Pagination><MedlinePgn>19-29</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrgentox.2015.06.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1383-5718(15)00141-2</ELocationID><Abstract><AbstractText>Temozolomide (TMZ) is widely used for patients with glioblastoma (GBM); however, tumor cells frequently exhibit drug-resistance. Base excision repair (BER) has been identified as a possible mediator of TMZ resistance, and an attractive approach to sensitizing cells to chemotherapy. Human apurinic/apyrimidinic endonuclease/redox factor-1 (APE1) is an essential enzyme with a role in the BER pathway by repairing abasic sites, and it also acts as a reduction factor, maintaining transcription factors in an active reduced state. Thus, we aimed to investigate whether the down-regulation of APE1 expression by siRNA can interfere with the resistance of GBM to TMZ, being evaluated by several cellular and molecular parameters. We demonstrated that APE1 knockdown associated with TMZ treatment efficiently reduced cell proliferation and clonogenic survival of resistant cells (T98G), which appears to be a consequence of increased DNA damage, S-phase arrest, and H2AX phosphorylation, resulting in apoptosis induction. On the contrary, for those assays, the sensitization effects of APE1 silencing plus TMZ treatment did not occur in the TMZ-sensitive cell line (U87MG). Interestingly, TMZ-treatment and APE1 knockdown significantly reduced cell invasion in both cell lines, but TMZ alone did not reduce the invasion capacity of U87MG cells, as observed for T98G. We also found that VEGF expression was down-regulated by TMZ treatment in T98G cells, regardless of APE1 knockdown, but U87MG showed a different response, since APE1 silencing counteracted VEGF induction promoted by TMZ, suggesting that the APE1-redox function may play an indirect role, depending on the cell line. The present results support the contribution of BER in the GBM resistance to TMZ, with a greater effect in TMZ-resistant, compared with TMZ-sensitive cells, emphasizing that APE1 can be a promising target for modifying TMZ tolerance. Furthermore, genetic characteristics of tumor cells should be considered as critical information to select an appropriate therapeutic strategy. </AbstractText><CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Montaldi</LastName><ForeName>Ana P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Brazil; Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto - University of São Paulo (USP), Ribeirão Preto, S.P., Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godoy</LastName><ForeName>Paulo R D V</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Brazil; Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto - University of São Paulo (USP), Ribeirão Preto, S.P., Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakamoto-Hojo</LastName><ForeName>Elza T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Brazil; Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto - University of São Paulo (USP), Ribeirão Preto, S.P., Brazil. Electronic address: etshojo@usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res Genet Toxicol Environ Mutagen</MedlineTA><NlmUniqueID>101632149</NlmUniqueID><ISSNLinking>1383-5718</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018906">Antineoplastic Agents, Alkylating</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>7GR28W0FJI</RegistryNumber><NameOfSubstance UI="D003606">Dacarbazine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>YF1K15M17Y</RegistryNumber><NameOfSubstance UI="C047246">temozolomide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018906" MajorTopicYN="N">Antineoplastic Agents, Alkylating</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003606" MajorTopicYN="N">Dacarbazine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="Y">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019008" MajorTopicYN="Y">Drug Resistance, Neoplasm</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005909" MajorTopicYN="N">Glioblastoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1 gene</Keyword><Keyword MajorTopicYN="N">Base excision repair</Keyword><Keyword MajorTopicYN="N">Glioblastoma</Keyword><Keyword MajorTopicYN="N">Temozolomide</Keyword><Keyword MajorTopicYN="N">siRNA methodology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26520369</ArticleId><ArticleId IdType="pii">S1383-5718(15)00141-2</ArticleId><ArticleId IdType="doi">10.1016/j.mrgentox.2015.06.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26507517</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1246</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>International archives of occupational and environmental health</Title><ISOAbbreviation>Int Arch Occup Environ Health</ISOAbbreviation></Journal><ArticleTitle>Genetic variation in APE1 gene promoter is associated with noise-induced hearing loss in a Chinese population.</ArticleTitle><Pagination><MedlinePgn>621-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00420-015-1100-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether the apurinic/apyrimidinic endonuclease 1 (APE1) 1349 T&gt;G and -656 T&gt;G polymorphisms were associated with the risk of noise-induced hearing loss (NIHL) in a Chinese population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The two APE1 polymorphisms were analyzed among 613 NIHL workers and 613 normal hearing workers using the minor groove binder TaqMan probe assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that the APE1 -656 TT genotype was associated with a increased risk of NIHL [adjusted odds ratio (OR) 1.46, 95% confidence interval (CI) 1.05-2.06]. This increased risk was more pronounced in the stratification analysis. Furthermore, we found that subjects with two risk genotypes (hOGG1 Cys/Cys, APE1 -656 TT) had a significantly increased risk of NIHL (adjusted OR 1.91, 95% CI 1.27-2.88).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study identified that the APE1 -656 T&gt;G polymorphism may contribute to the susceptibility of NIHL.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Huanxi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Kunshan Municipal Center for Disease Prevention and Control, Kunshan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dou</LastName><ForeName>Jianrui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yangzhou Center for Disease Prevention and Control, Yangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing, 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing, 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The First People's Hospital of Kunshan, Kunshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing, 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kunshan Municipal Center for Disease Prevention and Control, Kunshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hengdong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing, 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing, 210009, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kunshan Municipal Center for Disease Prevention and Control, Kunshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Zhimin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Kunshan Municipal Center for Disease Prevention and Control, Kunshan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Baoli</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China. zhubl@jscdc.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Prevention and Control, 172 Jiangsu Road, Nanjing, 210009, China. zhubl@jscdc.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int Arch Occup Environ Health</MedlineTA><NlmUniqueID>7512134</NlmUniqueID><ISSNLinking>0340-0131</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Biochimie. 2003 Nov;85(11):1053-71</RefSource><PMID Version="1">14726013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2006 Aug;27(8):786-95</RefSource><PMID Version="1">16823764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hear Res. 2002 Nov;173(1-2):164-71</RefSource><PMID Version="1">12372644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Otolaryngol Head Neck Surg. 2014 Oct;22(5):388-93</RefSource><PMID Version="1">25188429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2014 Apr 12;383(9925):1325-32</RefSource><PMID Version="1">24183105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ear Hear. 2009 Apr;30(2):151-9</RefSource><PMID Version="1">19194285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assoc Res Otolaryngol. 2000 Nov;1(3):243-54</RefSource><PMID Version="1">11545230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 2001;68:129-38</RefSource><PMID Version="1">11554292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Occup Health. 2013;55(2):56-65</RefSource><PMID Version="1">23327886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Audiol Neurootol. 1999 Sep-Oct;4(5):237-46</RefSource><PMID Version="1">10436316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Sch Health. 2007 May;77(5):225-31</RefSource><PMID Version="1">17430434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Apr 1;6(4):544-59</RefSource><PMID Version="1">17112792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Audiol. 2000 Feb;34(1):47-55</RefSource><PMID Version="1">10759077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Obstet Gynecol. 2013 Oct;209(4):360.e1-7</RefSource><PMID Version="1">23871947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ear Hear. 2011 Feb;32(1):46-52</RefSource><PMID Version="1">20802338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hear Res. 2002 Feb;164(1-2):231-9</RefSource><PMID Version="1">11950541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Hum Genet. 2009 Jul;73(Pt 4):411-21</RefSource><PMID Version="1">19523148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacogenet Genomics. 2005 Aug;15(8):557-64</RefSource><PMID Version="1">16006999</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Sep;25(9):1689-94</RefSource><PMID Version="1">15073047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2004 Nov;50(11):2012-8</RefSource><PMID Version="1">15345661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Epidemiol. 2010 Jun;20(6):452-9</RefSource><PMID Version="1">20470972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2009 Nov;24(6):507-12</RefSource><PMID Version="1">19762350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assoc Res Otolaryngol. 2004 Mar;5(1):66-79</RefSource><PMID Version="1">14648237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Hum Genet. 2009 Mar;73(2):215-24</RefSource><PMID Version="1">19183343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Mar 05;9(3):e89662</RefSource><PMID Version="1">24599382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Public Health. 2001 May;115(3):192-6</RefSource><PMID Version="1">11429714</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2000 Jun 30;476(1-2):73-7</RefSource><PMID Version="1">10878254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ear Hear. 2006 Feb;27(1):1-19</RefSource><PMID Version="1">16446561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stress Chaperones. 2006 Autumn;11(3):233-9</RefSource><PMID Version="1">17009596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Occup Environ Med. 2012 Sep;54(9):1157-62</RefSource><PMID Version="1">22885711</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2013 Jan;136(Pt 1):194-208</RefSource><PMID Version="1">23365097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Audiol. 2011 Mar;50 Suppl 1:S3-10</RefSource><PMID Version="1">21288065</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2009 Oct;23(10):3459-69</RefSource><PMID Version="1">19541747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011 Dec 18;11:521</RefSource><PMID Version="1">22176746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 Jan 7;101(1):24-36</RefSource><PMID Version="1">19116388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Occup Environ Med. 2004 Jan;46(1):30-8</RefSource><PMID Version="1">14724476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Med. 2014 Jul 18;46:e106</RefSource><PMID Version="1">25033834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2007 Aug 1;16(15):1872-83</RefSource><PMID Version="1">17567781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hear Res. 1998 Mar;117(1-2):31-8</RefSource><PMID Version="1">9557976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 May 17;411(6835):366-74</RefSource><PMID Version="1">11357144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Hum Genet. 2009 Mar;17(3):329-35</RefSource><PMID Version="1">18813331</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006317" MajorTopicYN="N">Hearing Loss, Noise-Induced</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009623" MajorTopicYN="N">Noise, Occupational</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009784" MajorTopicYN="N">Occupational Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Noise-induced hearing loss susceptibility</Keyword><Keyword MajorTopicYN="N">Polymorphisms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26507517</ArticleId><ArticleId IdType="doi">10.1007/s00420-015-1100-8</ArticleId><ArticleId IdType="pii">10.1007/s00420-015-1100-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26458045</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1545-9985</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>11</Issue><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Nature structural &amp; molecular biology</Title><ISOAbbreviation>Nat. Struct. Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>Capturing snapshots of APE1 processing DNA damage.</ArticleTitle><Pagination><MedlinePgn>924-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nsmb.3105</ELocationID><Abstract><AbstractText>DNA apurinic-apyrimidinic (AP) sites are prevalent noncoding threats to genomic stability and are processed by AP endonuclease 1 (APE1). APE1 incises the AP-site phosphodiester backbone, generating a DNA-repair intermediate that is potentially cytotoxic. The molecular events of the incision reaction remain elusive, owing in part to limited structural information. We report multiple high-resolution human APE1-DNA structures that divulge new features of the APE1 reaction, including the metal-binding site, the nucleophile and the arginine clamps that mediate product release. We also report APE1-DNA structures with a T-G mismatch 5' to the AP site, representing a clustered lesion occurring in methylated CpG dinucleotides. These structures reveal that APE1 molds the T-G mismatch into a unique Watson-Crick-like geometry that distorts the active site, thus reducing incision. These snapshots provide mechanistic clarity for APE1 while affording a rational framework to manipulate biological responses to DNA damage. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Freudenthal</LastName><ForeName>Bret D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Research Triangle Park, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beard</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Research Triangle Park, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuneo</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Neutron Sciences Directorate, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyrkheeva</LastName><ForeName>Nadezhda S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Research Triangle Park, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Research Triangle Park, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>5DFF</AccessionNumber><AccessionNumber>5DFH</AccessionNumber><AccessionNumber>5DFI</AccessionNumber><AccessionNumber>5DFJ</AccessionNumber><AccessionNumber>5DG0</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>Z01 ES050158</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01 ES050161</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA ES050158-18</GrantID><Acronym>NULL</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Struct Mol Biol</MedlineTA><NlmUniqueID>101186374</NlmUniqueID><ISSNLinking>1545-9985</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2014 Sep;21:43-54</RefSource><PMID Version="1">25038572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):3-13</RefSource><PMID Version="1">22122461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2008 Jul 23;130(29):9332-41</RefSource><PMID Version="1">18576638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1999 Jul 9;290(2):447-57</RefSource><PMID Version="1">10390343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2015 Jan 30;427(2):298-311</RefSource><PMID Version="1">25498387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jul 12;487(7406):196-201</RefSource><PMID Version="1">22785315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2013 Dec;69(Pt 12):2555-62</RefSource><PMID Version="1">24311596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1997 Nov 3;16(21):6548-58</RefSource><PMID Version="1">9351835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Jul 15;61(14):5552-7</RefSource><PMID Version="1">11454706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Biol. 2000 Mar;7(3):176-8</RefSource><PMID Version="1">10700268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16852-7</RefSource><PMID Version="1">23035246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Oct 19;282(42):30577-85</RefSource><PMID Version="1">17724035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Jan 10;272(2):1302-7</RefSource><PMID Version="1">8995436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2015 Jan;56(1):1-21</RefSource><PMID Version="1">25111769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Nov 2;3(11):1447-55</RefSource><PMID Version="1">15380100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 2006 Jul 5;224(1-2):44-55</RefSource><PMID Version="1">16730871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioinformation. 2011;7(4):184-98</RefSource><PMID Version="1">22102776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2004 Jan 27;43(3):684-9</RefSource><PMID Version="1">14730972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(1):73-81</RefSource><PMID Version="1">14704345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1970 Mar 7;225(5236):948-9</RefSource><PMID Version="1">4391887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1991 Nov 11;19(21):5907-14</RefSource><PMID Version="1">1719484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11995-9</RefSource><PMID Version="1">7505451</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 1995 Jun;18(6):1033-77</RefSource><PMID Version="1">7628729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2013 Oct 29;52(43):7669-77</RefSource><PMID Version="1">24079850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2012 Dec;19(12):1363-71</RefSource><PMID Version="1">23104055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(6):e65922</RefSource><PMID Version="1">23776569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Mar 19;519(7543):315-20</RefSource><PMID Version="1">25762137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2013 Jul 3;154(1):157-68</RefSource><PMID Version="1">23827680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2004 May;19(3):169-85</RefSource><PMID Version="1">15123782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 Jul 7;270(27):16002-7</RefSource><PMID Version="1">7608159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2009 Jan 13;48(1):19-26</RefSource><PMID Version="1">19123919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 Sep 15;270(37):21441-4</RefSource><PMID Version="1">7665552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17644-8</RefSource><PMID Version="1">22006298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2007 Jan;5(1):61-70</RefSource><PMID Version="1">17259346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21</RefSource><PMID Version="1">20124702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 2012 Feb 15;421(2):433-8</RefSource><PMID Version="1">22230282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 2005 Aug;18(8):1187-92</RefSource><PMID Version="1">16097791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 1986;20:201-30</RefSource><PMID Version="1">3545059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 May 4;282(18):13532-41</RefSource><PMID Version="1">17355977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Jan;1834(1):247-71</RefSource><PMID Version="1">23076011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1998 Apr 15;17(8):2426-35</RefSource><PMID Version="1">9545253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2014 Oct 21;53(41):6520-9</RefSource><PMID Version="1">25251148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2011 Mar 18;407(1):149-70</RefSource><PMID Version="1">21262234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2001 Apr 6;307(4):1023-34</RefSource><PMID Version="1">11286553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Rev. 2006 Feb;106(2):361-82</RefSource><PMID Version="1">16464010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Mar 22;288(12):8445-55</RefSource><PMID Version="1">23355472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2000 May 5;298(3):447-59</RefSource><PMID Version="1">10772862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2015 Jan;22(1):65-72</RefSource><PMID Version="1">25486305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Med. 2014;46:e106</RefSource><PMID Version="1">25033834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1994 Mar 25;22(6):972-6</RefSource><PMID Version="1">8152929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 May 16;289(20):13996-4008</RefSource><PMID Version="1">24695738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jul;37(12):3946-58</RefSource><PMID Version="1">19401441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1990 May 20;213(2):303-14</RefSource><PMID Version="1">2342108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr 1;41(6):3483-90</RefSource><PMID Version="1">23408852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Oct 26;287(44):36702-10</RefSource><PMID Version="1">22989888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1862-7</RefSource><PMID Version="1">21233421</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteins. 2007 Jul 1;68(1):313-23</RefSource><PMID Version="1">17427952</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>09</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26458045</ArticleId><ArticleId IdType="pii">nsmb.3105</ArticleId><ArticleId IdType="doi">10.1038/nsmb.3105</ArticleId><ArticleId IdType="pmc">PMC4654669</ArticleId><ArticleId IdType="mid">NIHMS721537</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26439176</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-7856</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><PubDate><Year>2015</Year><Month>Nov</Month></PubDate></JournalIssue><Title>DNA repair</Title><ISOAbbreviation>DNA Repair (Amst.)</ISOAbbreviation></Journal><ArticleTitle>Efficient cleavage of single and clustered AP site lesions within mono-nucleosome templates by CHO-K1 nuclear extract contrasts with retardation of incision by purified APE1.</ArticleTitle><Pagination><MedlinePgn>27-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dnarep.2015.08.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-7864(15)30011-2</ELocationID><Abstract><AbstractText>Clustered DNA damage is a unique characteristic of radiation-induced DNA damage and the formation of these sites poses a serious challenge to the cell's repair machinery. Within a cell DNA is compacted, with nucleosomes being the first order of higher level structure. However, few data are reported on the efficiency of clustered-lesion processing within nucleosomal DNA templates. Here, we show retardation of cleavage of a single AP site by purified APE1 when contained in nucleosomal DNA, compared to cleavage of an AP site in non-nucleosomal DNA. This retardation seen in nucleosomal DNA was alleviated by incubation with CHO-K1 nuclear extract. When clustered DNA damage sites containing bistranded AP sites were present in nucleosomal DNA, efficient cleavage of the AP sites was observed after treatment with nuclear extract. The resultant DSB formation led to DNA dissociating from the histone core and nucleosomal dispersion. Clustered damaged sites containing bistranded AP site/8-oxoG residues showed no retardation of cleavage of the AP site but retardation of 8-oxoG excision, compared to isolated lesions, thus DSB formation was not seen. An increased understanding of processing of clustered DNA damage in a nucleosomal environment may lead to new strategies to enhance the cytotoxic effects of radiotherapeutics. </AbstractText><CopyrightInformation>Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eccles</LastName><ForeName>Laura J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>CRUK-MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menoni</LastName><ForeName>Hervé</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Université de Lyon, Laboratoire de Biologie Moléculaire de la Cellule, CNRS-UMR 5239, Ecole Normale Supérieure de Lyon, 69007, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelov</LastName><ForeName>Dimitar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Université de Lyon, Laboratoire de Biologie Moléculaire de la Cellule, CNRS-UMR 5239, Ecole Normale Supérieure de Lyon, 69007, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomax</LastName><ForeName>Martine E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>CRUK-MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CRUK-MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK. Electronic address: peter.oneill@oncology.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_12001</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>DNA Repair (Amst)</MedlineTA><NlmUniqueID>101139138</NlmUniqueID><ISSNLinking>1568-7856</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002457">Cell Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009707">Nucleosomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>5614-64-2</RegistryNumber><NameOfSubstance UI="C024829">8-hydroxyguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1999 Jul 16;290(3):667-84</RefSource><PMID Version="1">10395822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2015 Aug;32:113-9</RefSource><PMID Version="1">25957487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Oct 2;669(1-2):162-8</RefSource><PMID Version="1">19540248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1997 Sep 18;389(6648):251-60</RefSource><PMID Version="1">9305837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Jul 18;289(29):19881-93</RefSource><PMID Version="1">24891506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Biol. 1994 Jan;65(1):7-17</RefSource><PMID Version="1">7905912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2004 Aug 31;43(34):11017-26</RefSource><PMID Version="1">15323560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2013 Jul;180(1):100-9</RefSource><PMID Version="1">23682596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2004 Aug 15;37(4):488-99</RefSource><PMID Version="1">15256220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1999 Jul 20;38(29):9485-94</RefSource><PMID Version="1">10413526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Dec 24;462(7276):1016-21</RefSource><PMID Version="1">20033039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2007 Dec;27(24):8442-53</RefSource><PMID Version="1">17923696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Nov 27;284(48):33056-61</RefSource><PMID Version="1">19808662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 May 10;288(19):13863-75</RefSource><PMID Version="1">23543741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2010 Feb 4;9(2):134-43</RefSource><PMID Version="1">20005182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2002 Dec 16;21(24):6865-73</RefSource><PMID Version="1">12486007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2000 Oct 16;19(20):5492-501</RefSource><PMID Version="1">11032816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Genet. 2012 Sep 03;3:169</RefSource><PMID Version="1">22969794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Subcell Biochem. 2007;41:29-43</RefSource><PMID Version="1">17484122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Apr 21;275(16):11865-73</RefSource><PMID Version="1">10766813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Jun 3;711(1-2):134-41</RefSource><PMID Version="1">21130102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Jun 3;711(1-2):123-33</RefSource><PMID Version="1">21185841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2014 Aug;766-767:19-24</RefSource><PMID Version="1">25083139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2001;148:275-90</RefSource><PMID Version="1">11357591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(4):1602-9</RefSource><PMID Version="1">15004247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1877-82</RefSource><PMID Version="1">15671175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biosyst. 2008 Jan;4(1):30-5</RefSource><PMID Version="1">18075671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7426-30</RefSource><PMID Version="1">11404468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Aug 4;275(31):23729-35</RefSource><PMID Version="1">10821833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Biol. 2009 Jan;85(1):9-25</RefSource><PMID Version="1">19205982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2002 Jun;157(6):611-6</RefSource><PMID Version="1">12005538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2002 Aug 1;30(15):3464-72</RefSource><PMID Version="1">12140332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2007 Jul;168(1):87-97</RefSource><PMID Version="1">17723001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):103-8</RefSource><PMID Version="1">10618378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 May;36(8):2717-27</RefSource><PMID Version="1">18353858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2010 Mar;173(3):272-82</RefSource><PMID Version="1">20199212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2001 Oct 2;40(39):11811-8</RefSource><PMID Version="1">11570881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2008 May;65(10):1544-65</RefSource><PMID Version="1">18259689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biophys J. 1980 Oct;32(1):261-70</RefSource><PMID Version="1">6264987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 1999 May;20(5):905-9</RefSource><PMID Version="1">10334210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Mar 4;3(3):289-99</RefSource><PMID Version="1">15177044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Apr;37(6):1767-77</RefSource><PMID Version="1">19174565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Jan 22;285(4):2876-85</RefSource><PMID Version="1">19933279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1990 Oct;87(19):7405-9</RefSource><PMID Version="1">2170977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1998 Feb 13;276(1):19-42</RefSource><PMID Version="1">9514715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2001 Nov;8(5):1085-92</RefSource><PMID Version="1">11741543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2002 Oct;22(20):7147-57</RefSource><PMID Version="1">12242292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2002 Nov 1;21(21):5943-52</RefSource><PMID Version="1">12411511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Dec;12(12):1037-42</RefSource><PMID Version="1">24183900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4646-51</RefSource><PMID Version="1">20176960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7465-70</RefSource><PMID Version="1">12799467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):119-30</RefSource><PMID Version="1">20123074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):27-47</RefSource><PMID Version="1">18166975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6599-604</RefSource><PMID Version="1">11381129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(2):692-700</RefSource><PMID Version="1">21930508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Feb 3;4(2):203-9</RefSource><PMID Version="1">15590328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2003 Sep 1;35(5):495-503</RefSource><PMID Version="1">12927599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2007 Sep;27(17):5949-56</RefSource><PMID Version="1">17591702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2002 Jan 15;41(2):634-42</RefSource><PMID Version="1">11781104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22475-80</RefSource><PMID Version="1">21149689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2002 Nov;22(21):7484-90</RefSource><PMID Version="1">12370295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2006 Jun;7(6):437-47</RefSource><PMID Version="1">16723979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2008 Nov 18;47(46):11909-19</RefSource><PMID Version="1">18950195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Mar;38(4):1123-34</RefSource><PMID Version="1">19965771</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Jun 20;272(25):15650-5</RefSource><PMID Version="1">9188454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2011 Nov;31(22):4623-32</RefSource><PMID Version="1">21930793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2001 Apr 27;308(2):341-52</RefSource><PMID Version="1">11327771</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002457" MajorTopicYN="N">Cell Extracts</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053837" MajorTopicYN="Y">DNA Cleavage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009707" MajorTopicYN="N">Nucleosomes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013698" MajorTopicYN="N">Templates, Genetic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">8-oxoG</Keyword><Keyword MajorTopicYN="N">AP site</Keyword><Keyword MajorTopicYN="N">BER</Keyword><Keyword MajorTopicYN="N">Clustered DNA damage</Keyword><Keyword MajorTopicYN="N">Nucleosome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>08</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>08</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26439176</ArticleId><ArticleId IdType="pii">S1568-7864(15)30011-2</ArticleId><ArticleId IdType="doi">10.1016/j.dnarep.2015.08.003</ArticleId><ArticleId IdType="pmc">PMC4655832</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26400813</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-2000</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Molecular diagnosis &amp; therapy</Title><ISOAbbreviation>Mol Diagn Ther</ISOAbbreviation></Journal><ArticleTitle>DNA Base-Excision Repair Genes OGG1 and NTH1 in Brazilian Lung Cancer Patients.</ArticleTitle><Pagination><MedlinePgn>389-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40291-015-0164-1</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Lung cancer is the leading global cause of cancer-related mortality and is associated with poor prognosis. To improve survival rates of lung cancer patients, better understanding of tumorigenic mechanisms is necessary, which may lead to development of new therapeutic strategies. The hOGG1 and NTH1 genes act in the DNA BER repair pathway and their involvement in lung cancer pathogenesis has been analyzed in several populations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed targeted regions of the hOGG1 and NTH1 genes in 96 Brazilian patients with non-small-cell lung cancer (NSCLC) and 89 cancer-free, ethnically matched controls.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The NTH1 c.98G&gt;T polymorphism rs2302172 (p = 0.02 and p = 0.02 for allele and genotype frequency between cases and controls, respectively) and the 140-17C&gt; T variant (rs2233518) (p = 0.02 and p = 0.02 for allele and genotype frequency between cases and controls, respectively) were detected in four lung cancer cases (4 %) while the NTH1 Q131K (C391A) polymorphism was found in seven lung cancer cases (7 %) (p = 0.001 and p = 0.008, for allele and genotype frequency between cases and controls, respectively). None of these sequence variants were detected in controls. The Ser326Cys (C1245G, rs1052133) polymorphism in the OGG1 gene was detected in 42 % of analyzed NSCLC patients and in 34 % of the controls (p = 0.11 and p = 0.25 for allele and genotype frequency between cases and controls, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study provides preliminary evidence that polymorphisms in OGG1 do not contribute to development of NSCLC in Brazilian patients and that NTH1 polymorphisms may be associated with NSCLC pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Couto</LastName><ForeName>Patricia G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universidade Federal de Minas Gerais, Av. Alfredo Balena 190, Room 114, Belo Horizonte, 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastos-Rodrigues</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universidade Federal de Juiz de Fora, Campus Governador Valadares, Governador Valadares, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carneiro</LastName><ForeName>Juliana G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Faculty of Medical Science, Centro de Ensino Superior e Desenvolvimento, Campina Grande, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guieiro</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universidade Federal de Minas Gerais, Av. Alfredo Balena 190, Room 114, Belo Horizonte, 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bicalho</LastName><ForeName>Maria Aparecida</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leidenz</LastName><ForeName>Franciele B</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universidade Federal de Minas Gerais, Av. Alfredo Balena 190, Room 114, Belo Horizonte, 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bicalho</LastName><ForeName>Ana J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universidade Federal de Minas Gerais, Av. Alfredo Balena 190, Room 114, Belo Horizonte, 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Eitan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Marco</LastName><ForeName>Luiz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Universidade Federal de Minas Gerais, Av. Alfredo Balena 190, Room 114, Belo Horizonte, 30130-100, Brazil. Ldemarco@ufmg.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Mol Diagn Ther</MedlineTA><NlmUniqueID>101264260</NlmUniqueID><ISSNLinking>1177-1062</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.25.1</RegistryNumber><NameOfSubstance UI="D043224">Deoxyribonuclease (Pyrimidine Dimer)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.25.1</RegistryNumber><NameOfSubstance UI="C468347">NTHL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2012;2:548</RefSource><PMID Version="1">22855704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2009 Jan;30(1):78-87</RefSource><PMID Version="1">19029194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Genet. 2004 Dec;42(11-12):453-60</RefSource><PMID Version="1">15587988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2015 Feb;32(2):472</RefSource><PMID Version="1">25588927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2006 Aug;97(8):724-8</RefSource><PMID Version="1">16800823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2011;12(4):1067-72</RefSource><PMID Version="1">21790253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2009 Mar;66(6):981-93</RefSource><PMID Version="1">19153658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2014 Dec;55(9):689-703</RefSource><PMID Version="1">25044514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2012 Dec 15;131(12):2724-32</RefSource><PMID Version="1">22945513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 09;8(12):e81667</RefSource><PMID Version="1">24349107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2003 Sep 3;95(17):1312-9</RefSource><PMID Version="1">12953085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:21-31</RefSource><PMID Version="1">21376741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1739-45</RefSource><PMID Version="1">18628426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2005 Mar 10;219(2):191-5</RefSource><PMID Version="1">15723719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Dec 1;135(11):2687-96</RefSource><PMID Version="1">24729390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2014 Jul;19:14-26</RefSource><PMID Version="1">24780558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2011 Aug;73(2):138-46</RefSource><PMID Version="1">21195504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2007 Jul 28;631(2):101-10</RefSource><PMID Version="1">17531525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):409-12</RefSource><PMID Version="1">11927502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Sep;25(9):1689-94</RefSource><PMID Version="1">15073047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2013 Mar 10;31(8):992-1001</RefSource><PMID Version="1">23401443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Jan 1;73(1):256-64</RefSource><PMID Version="1">23108145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 Dec 15;532(2):192-6</RefSource><PMID Version="1">24076439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1991 Oct 11;19(19):5444</RefSource><PMID Version="1">1681511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Cell Mol Biol. 2010 Nov;43(5):576-84</RefSource><PMID Version="1">20008282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource><PMID Version="1">25651787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Prev Res (Phila). 2014 Apr;7(4):398-406</RefSource><PMID Version="1">24356339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3642-9</RefSource><PMID Version="1">19351836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 Mar;27(3):560-7</RefSource><PMID Version="1">16195237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14314-9</RefSource><PMID Version="1">23940330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2012 Dec 31;327(1-2):73-89</RefSource><PMID Version="1">22252118</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2012 Dec;12(12):801-17</RefSource><PMID Version="1">23175119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2012 Dec;39(12):11249-62</RefSource><PMID Version="1">23065211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2012 Nov 21;104(22):1765-9</RefSource><PMID Version="1">23104324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Prev Res (Phila). 2014 Jan;7(1):1-8</RefSource><PMID Version="1">24403288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(4):e35970</RefSource><PMID Version="1">22540013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2012 May;33(5):1059-64</RefSource><PMID Version="1">22382497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nucleic Acids. 2010 Oct 14;2010:701760</RefSource><PMID Version="1">20981350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2014 Nov 1;74(21):6071-81</RefSource><PMID Version="1">25189529</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043224" MajorTopicYN="N">Deoxyribonuclease (Pyrimidine Dimer)</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26400813</ArticleId><ArticleId IdType="doi">10.1007/s40291-015-0164-1</ArticleId><ArticleId IdType="pii">10.1007/s40291-015-0164-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26379967</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1940-5901</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>7</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>International journal of clinical and experimental medicine</Title><ISOAbbreviation>Int J Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>Association between polymorphisms in APE1 and XRCC1 and the risk of gastric cancer in Korean population.</ArticleTitle><Pagination><MedlinePgn>11484-9</MedlinePgn></Pagination><Abstract><AbstractText>The DNA repair system plays a pivotal role in maintaining genomic integrity and protection against mutations that could lead to cancer development. The aim of this study was to explore the association between common polymorphisms of DNA repair genes, APE1 (rs1760944 and rs1130409) and XRCC1 (rs1799782, rs25487, and rs25489), and gastric cancer (GC) risk in the Korean population. We conducted a case-control study of 368 GC patients and 398 controls by using TaqMan genotyping assay. None of the polymorphisms was associated with the risk of GC. Further analysis showed a lack of association between APE1 and XRCC1 polymorphisms or haplotypes and the risk of GC and GC subgroups. The heterozygous CT genotype of XRCC1 rs25487 was related to 1.94 times increased risk of lymph node metastasis (LNM) in diffuse type GC compared to the XRCC1 rs25487 CC genotype (adjusted OR = 1.94, 95% CI = 1.06-3.53, P = 0.031) after adjusting for gender and age, whereas the remaining polymorphisms showed no association with GC or GC subgroups. This result suggests that genetic variation of XRCC1 rs25487 could be a risk factor for LNM in diffuse type of GC in the Korean population. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Eun-Heui</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Clinical Trials Center, Chungnam National University Hospital Daejeon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>JaeWoo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Trials Center, Chungnam National University Hospital Daejeon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang-Il</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Chungnam National University Hospital Daejeon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Jang Hee</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Clinical Trials Center, Chungnam National University Hospital Daejeon, South Korea ; Department of Pharmacology, College of Medicine, Chungnam National University Daejeon, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Clin Exp Med</MedlineTA><NlmUniqueID>101471010</NlmUniqueID><ISSNLinking>1940-5901</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2002 Dec 10;187(1-2):53-60</RefSource><PMID Version="1">12359351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 1996;20 Suppl 1:S8-22</RefSource><PMID Version="1">8694148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2011 Feb 15;173(4):363-75</RefSource><PMID Version="1">21216841</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2000 Nov 15;88(4):601-6</RefSource><PMID Version="1">11058877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(12):e28971</RefSource><PMID Version="1">22205985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2006 Jun 15;118(12):3030-44</RefSource><PMID Version="1">16404738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 1999;33(1):3-20</RefSource><PMID Version="1">10037319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2014 Apr;46(2):124-30</RefSource><PMID Version="1">24851103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Pathol Microbiol Scand. 1965;64:31-49</RefSource><PMID Version="1">14320675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arh Hig Rada Toksikol. 2011 Sep;62(3):207-14</RefSource><PMID Version="1">21971103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol. 2011 Apr;35(2):170-4</RefSource><PMID Version="1">20863780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2004 Oct;5(10):764-72</RefSource><PMID Version="1">15510167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2009 Aug 1;125(3):666-73</RefSource><PMID Version="1">19382179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):258-75</RefSource><PMID Version="1">17628657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Mol Res. 2012 Nov 12;11(4):3852-60</RefSource><PMID Version="1">23212324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2012;13(5):2139-44</RefSource><PMID Version="1">22901183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Nov;25(6):569-75</RefSource><PMID Version="1">20817763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Nov 15;162(10):925-42</RefSource><PMID Version="1">16221808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer. 2014 Mar 13;5(3):253-9</RefSource><PMID Version="1">24665350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2011 Jul;102(7):1293-7</RefSource><PMID Version="1">21615620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2012;13(11):5637-42</RefSource><PMID Version="1">23317230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Feb 16;291(5507):1284-9</RefSource><PMID Version="1">11181991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2004 Dec 28;216(2):157-64</RefSource><PMID Version="1">15533591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Esophagus. 2009;22(5):396-401</RefSource><PMID Version="1">19673050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2005 Nov 14;11(42):6593-600</RefSource><PMID Version="1">16425350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2012 Oct;31(10):981-1005</RefSource><PMID Version="1">23023028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2006 Aug;131(2):420-7</RefSource><PMID Version="1">16890595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Apr;462(2-3):129-35</RefSource><PMID Version="1">10767624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2000 Sep 20;92(18):1536-7</RefSource><PMID Version="1">10995815</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">Gastric cancer</Keyword><Keyword MajorTopicYN="N">XRCC1</Keyword><Keyword MajorTopicYN="N">diffuse type</Keyword><Keyword MajorTopicYN="N">lymph node metastasis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>07</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26379967</ArticleId><ArticleId IdType="pmc">PMC4565350</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26377038</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2015</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-548X</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>88</Issue><PubDate><Year>2015</Year><Month>Nov</Month><Day>14</Day></PubDate></JournalIssue><Title>Chemical communications (Cambridge, England)</Title><ISOAbbreviation>Chem. Commun. (Camb.)</ISOAbbreviation></Journal><ArticleTitle>Efficient inhibition of human AP endonuclease 1 (APE1) via substrate masking by abasic site-binding macrocyclic ligands.</ArticleTitle><Pagination><MedlinePgn>15948-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/c5cc06084b</ELocationID><Abstract><AbstractText>Bis-naphthalene macrocycles, which bind with high affinity and selectivity to abasic sites in DNA, efficiently inhibit their cleavage by APE1 (IC50 = 55-60 nM in the kinetic assay with a model THF substrate). These results demonstrate that substrate masking by non-covalent abasic-site ligands is an efficient strategy for inhibition of APE1. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kotera</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CNRS UMR9187/INSERM U1196 "Chemistry, Modelling and Imaging for Biology", Centre de Recherche, Institut Curie, 91405 Orsay, France. anton.granzhan@curie.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poyer</LastName><ForeName>Florent</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Granzhan</LastName><ForeName>Anton</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Teulade-Fichou</LastName><ForeName>Marie-Paule</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chem Commun (Camb)</MedlineTA><NlmUniqueID>9610838</NlmUniqueID><ISSNLinking>1359-7345</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C503406">7-nitro-1H-indole-2-carboxylic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007364">Intercalating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047028">Macrocyclic Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009281">Naphthalenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>4431-00-9</RegistryNumber><NameOfSubstance UI="D001312">Aurintricarboxylic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>91080-16-9</RegistryNumber><NameOfSubstance UI="C427203">calf thymus DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EN464416SI</RegistryNumber><NameOfSubstance UI="D004996">Ethidium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001312" MajorTopicYN="N">Aurintricarboxylic Acid</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004996" MajorTopicYN="N">Ethidium</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007364" MajorTopicYN="N">Intercalating Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="Y">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047028" MajorTopicYN="N">Macrocyclic Compounds</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009281" MajorTopicYN="N">Naphthalenes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26377038</ArticleId><ArticleId IdType="doi">10.1039/c5cc06084b</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26367730</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2284-0729</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>16</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European review for medical and pharmacological sciences</Title><ISOAbbreviation>Eur Rev Med Pharmacol Sci</ISOAbbreviation></Journal><ArticleTitle>The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology.</ArticleTitle><Pagination><MedlinePgn>3063-71</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9367</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the expression of programmed death-ligand1 (PD-L1) in hepatocellular carcinoma and its relationship with clinicopathological characteristics and, prognosis of hepatocellular carcinoma and APE1, P53 protein expression levels.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A total of 128 patients with hepatocellular carcinoma were enrolled in this study. The expression of PD-L1, APE1 and P53 were detected by immunohistochemistry.Use immunohistochemical ABC staining method to detect the expression levels of PD-L1, APE1 and P53 protein in the hepatocellular carcinoma of 128 cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Positive The positive expression rates levels of PD-L1, APE1, and P53 protein in hepatocellular carcinoma tissues are were 82.03%, 92.19%, and 60.94%. PD-L1 positive expression were significantly associated with clinical stage, The PD-L1 protein has a high expression in patients with I ~ II stage liver cancerHBV infection positive and nonportal vein thrombosis (p=0.041; p=0.030; p=0.014). It is inversely correlated with P53 and PD-L1 expression (correlation coefficient -0.227, p=0.010), and positively correlated with APE1 expression (correlation coefficient 0.189, p=0.032). The expression of PD-L1 is associated with the survival time of patients with hepatocellular carcinoma, and the median survival time of patients with high expression of PD-L1 is ten months. The median survival time of patients with low expression is five months (p=0.001). The relationship between the expression of APE1 and P53 protein and overall survival time of patients with hepatocellular carcinoma has not been found.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The PD-L1 and APE1 expression in hepatocellular carcinoma are related to the level of the expression of P53 protein. The expression state of PD-L1 may be a prognostic factor in hepatocellular carcinoma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kan</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cancer Center of Research Institute of field surgery of the Third Military Medical University Daping Hospital, Chongqing, China. dongwang64@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>W</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Eur Rev Med Pharmacol Sci</MedlineTA><NlmUniqueID>9717360</NlmUniqueID><ISSNLinking>1128-3602</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060890">B7-H1 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C423236">CD274 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495901">TP53 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Rev Med Pharmacol Sci. 2015 Nov;19(22):4207-9</RefSource><PMID Version="1">26636502</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060890" MajorTopicYN="N">B7-H1 Antigen</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26367730</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26364627</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2015</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Synthetic Routes to N-9 Alkylated 8-Oxoguanines; Weak Inhibitors of the Human DNA Glycosylase OGG1.</ArticleTitle><Pagination><MedlinePgn>15944-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules200915944</ELocationID><Abstract><AbstractText>The human 8-oxoguanine DNA glycosylase OGG1 is involved in base excision repair (BER), one of several DNA repair mechanisms that may counteract the effects of chemo- and radiation therapy for the treatment of cancer. We envisage that potent inhibitors of OGG1 may be found among the 9-alkyl-8-oxoguanines. Thus we explored synthetic routes to 8-oxoguanines and examined these as OGG1 inhibitors. The best reaction sequence started from 6-chloroguanine and involved N-9 alkylation, C-8 bromination, and finally simultaneous hydrolysis of both halides. Bromination before N-alkylation should only be considered when the N-substituent is not compatible with bromination conditions. The 8-oxoguanines were found to be weak inhibitors of OGG1. 6-Chloro-8-oxopurines, byproducts in the hydrolysis of 2,6-halopurines, turned out to be slightly better inhibitors than the corresponding 8-oxoguanines. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mahajan</LastName><ForeName>Tushar R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Oslo, P. O. Box 1033, Blindern, N-0315 Oslo, Norway. t.r.mahajan@kjemi.uio.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ytre-Arne</LastName><ForeName>Mari Eknes</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital, P. O. Box 4950, Nydalen, N-0424 Oslo, Norway. pernille.strom-andersen@medisin.uio.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Institute of Clinical Medicine, University of Oslo, P. O. Box 4950, Nydalen, N-0424 Oslo, Norway. pernille.strom-andersen@medisin.uio.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strøm-Andersen</LastName><ForeName>Pernille</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Institute of Clinical Medicine, University of Oslo, P. O. Box 4950, Nydalen, N-0424 Oslo, Norway. pernille.strom-andersen@medisin.uio.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalhus</LastName><ForeName>Bjørn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital, P. O. Box 4950, Nydalen, N-0424 Oslo, Norway. pernille.strom-andersen@medisin.uio.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Institute of Clinical Medicine, University of Oslo, P. O. Box 4950, Nydalen, N-0424 Oslo, Norway. pernille.strom-andersen@medisin.uio.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gundersen</LastName><ForeName>Lise-Lotte</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Chemistry, University of Oslo, P. O. Box 1033, Blindern, N-0315 Oslo, Norway. l.l.gundersen@kjemi.uio.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>5614-64-2</RegistryNumber><NameOfSubstance UI="C024829">8-hydroxyguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000478" MajorTopicYN="N">Alkylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA</Keyword><Keyword MajorTopicYN="N">alkylation</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">enzyme inhibitors</Keyword><Keyword MajorTopicYN="N">guanine</Keyword><Keyword MajorTopicYN="N">halogenation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>07</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>08</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26364627</ArticleId><ArticleId IdType="pii">molecules200915944</ArticleId><ArticleId IdType="doi">10.3390/molecules200915944</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26359670</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2015</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>38</Issue><PubDate><Year>2015</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Biochemistry</Title><ISOAbbreviation>Biochemistry</ISOAbbreviation></Journal><ArticleTitle>Extreme Expression of DNA Repair Protein Apurinic/Apyrimidinic Endonuclease 1 (APE1) in Human Breast Cancer As Measured by Liquid Chromatography and Isotope Dilution Tandem Mass Spectrometry.</ArticleTitle><Pagination><MedlinePgn>5787-90</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.biochem.5b00928</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1 (APE1) is a DNA repair protein and plays other important roles. Increased levels of APE1 in cancer have been reported. However, available methods for measuring APE1 levels are indirect and not quantitative. We previously developed an approach using liquid chromatography and tandem mass spectrometry with isotope dilution to accurately measure APE1 levels. Here, we applied this methodology to measure APE1 levels in normal and cancerous human breast tissues. Extreme expression of APE1 in malignant tumors was observed, suggesting that breast cancer cells may require APE1 for survival. Accurate measurement of APE1 may be essential for the development of novel treatment strategies and APE1 inhibitors as anticancer drugs. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coskun</LastName><ForeName>Erdem</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Biomolecular Measurement Division, National Institute of Standards and Technology , Gaithersburg, Maryland 20899, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Toxicology, Faculty of Pharmacy, Gazi University , Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaruga</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomolecular Measurement Division, National Institute of Standards and Technology , Gaithersburg, Maryland 20899, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Prasad T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Biomolecular Measurement Division, National Institute of Standards and Technology , Gaithersburg, Maryland 20899, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dizdaroglu</LastName><ForeName>Miral</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomolecular Measurement Division, National Institute of Standards and Technology , Gaithersburg, Maryland 20899, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochemistry</MedlineTA><NlmUniqueID>0370623</NlmUniqueID><ISSNLinking>0006-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26359670</ArticleId><ArticleId IdType="doi">10.1021/acs.biochem.5b00928</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26314200</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1165-158X</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Cellular and molecular biology (Noisy-le-Grand, France)</Title><ISOAbbreviation>Cell. Mol. Biol. (Noisy-le-grand)</ISOAbbreviation></Journal><ArticleTitle>The association of ApE1 -656T&gt;G and 1349T&gt;G polymorphisms with breast cancer susceptibility in northern Iran.</ArticleTitle><Pagination><MedlinePgn>70-4</MedlinePgn></Pagination><Abstract><AbstractText>Breast cancer is the most common cancer and one of the main causes of cancer-related death in the world and has become a major public health concern. Many genes have been shown to be involved in the progress of the breast cancer. Human apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional protein that has an important role in the base excision repair (BER) pathway. The aim of this study was to evaluate the association between ApE1 -656T&gt;G and 1349T&gt;G polymorphisms and the susceptibility to breast cancer in northern Iran population. Samples were obtained from 150 patients diagnosed with breast cancer and 150 control subjects and genotyped by tetra - primer amplification refractory mutation system PCR (T-ARMS-PCR). We observed a significant difference in genotype distributions of -656T&gt;G polymorphism between patients and controls (P= 0.03). Findings indicated that individuals with the variant TG genotypes had a significant decreased risk of breast cancer (OR= 0.55, 95% CI= 0.33 - 0.91, P= 0.019). However, the significant association between 1349T&gt;G polymorphism and breast cancer risk was not observed (P = 0.89). Larger studies are needed to confirm our results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mashayekhi</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Guilan Department of Biology, Faculty of Sciences Rasht Iran mashayekhi&amp;commat;guilan.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousefi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Guilan Department of Biology, Faculty of Sciences Rasht Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salehi</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of Guilan Department of Biology, Faculty of Sciences Rasht Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saedi</LastName><ForeName>H S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Guilan University of Medical Sciences Department of Radiotherapy, Faculty of Medicine Rasht Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pournourali</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Guilan Department of Biology, Faculty of Sciences Rasht Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Cell Mol Biol (Noisy-le-grand)</MedlineTA><NlmUniqueID>9216789</NlmUniqueID><ISSNLinking>0145-5680</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>06</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>08</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26314200</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26309678</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1940-5901</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>6</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>International journal of clinical and experimental medicine</Title><ISOAbbreviation>Int J Clin Exp Med</ISOAbbreviation></Journal><ArticleTitle>Effect of APE1 and XRCC1 gene polymorphism on susceptibility to hepatocellular carcinoma and sensitivity to cisplatin.</ArticleTitle><Pagination><MedlinePgn>9931-6</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The relationship between APE1 and XRCC1 gene polymorphism and the susceptibility to hepatocellular carcinoma (HCC) was discussed, and the effect of APE1 and XRCC1 gene polymorphism on the sensitivity of HCC to cisplatin was investigated.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">From January 2010 to August 2014, 118 HCC patients were admitted to our hospital. 120 patients treated for non-tumor diseases during this period were recruited as controls. PCR-RFLP analyses were performed to determine the association between APE1 Asp148Glu and XRCC1 Arg194Trp polymorphism, risk of HCC, and sensitivity to cisplatin.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The risk of HCC in patients with Glu/Glu genotype of APE1 gene was increased by 4.510 times (95% CI: 1.235~16.472, P&lt;0.05). Compared with Asp/Asp, the risk of cisplatin resistance in patients with Glu/Glu genotype was increased by 10.500 times (95% CI: 1.800~61.241). Compared Arg/Arg genotype, the risk of cisplatin resistance in patients with Arp/Trp genotype of XRCC1 gene was increased by 6.701 times (95% CI: 1.464~30.732, P&lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">APE1 Asp148Glu polymorphism is associated with the susceptibility to HCC. APE1 Asp148Glu and XRCC1 Arg194Trp polymorphism plays a part in the cisplatin resistance of HCC cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhihong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Digestive, Yantaishan Hospital Yantai 264000, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Oncology, Xiangyang Central Hospital Xiangyang 441021, Hubei Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Clin Exp Med</MedlineTA><NlmUniqueID>101471010</NlmUniqueID><ISSNLinking>1940-5901</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Iran J Med Sci. 2015 Jan;40(1):2-12</RefSource><PMID Version="1">25649829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Mar;35(3):2529-35</RefSource><PMID Version="1">24254302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2014 Jan;14(11):6613-8</RefSource><PMID Version="1">24377576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 1996 Apr;2(4):695-706</RefSource><PMID Version="1">9816220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2009 Jan 18;273(2):201-9</RefSource><PMID Version="1">18824293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2012 Nov 6;107(10):1672-7</RefSource><PMID Version="1">23059748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2009 Dec;66(3):298-304</RefSource><PMID Version="1">19324449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Clin Oncol. 2014 Dec 10;5(5):874-82</RefSource><PMID Version="1">25493225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Med. 2015 Jan 15;8(1):145-54</RefSource><PMID Version="1">25784983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biomark. 2014;14(6):449-56</RefSource><PMID Version="1">25335737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2014 Dec 04;5:e1551</RefSource><PMID Version="1">25476899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepat Mon. 2013 May 08;13(5):e7612</RefSource><PMID Version="1">23922558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Vaccin Immunother. 2014;10(10):2983-91</RefSource><PMID Version="1">25483678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):157-63</RefSource><PMID Version="1">25865688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Mol Res. 2014 Mar 06;13(1):1438-46</RefSource><PMID Version="1">24634242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2015;2015:509215</RefSource><PMID Version="1">25710005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2014 May;31(5):2328-34</RefSource><PMID Version="1">24676454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Clin Oncol. 2013 May;1(3):403-410</RefSource><PMID Version="1">24649183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2012 Oct;31(10):981-1005</RefSource><PMID Version="1">23023028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med J Aust. 1994 Oct 3;161(7):433-5</RefSource><PMID Version="1">7935098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2012 Jul 13;423(4):826-31</RefSource><PMID Version="1">22713463</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gene polymorphism</Keyword><Keyword MajorTopicYN="N">cisplatin resistance</Keyword><Keyword MajorTopicYN="N">hepatocellular carcinoma</Keyword><Keyword MajorTopicYN="N">sensitivity to cisplatin</Keyword><Keyword MajorTopicYN="N">susceptibility</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26309678</ArticleId><ArticleId IdType="pmc">PMC4538105</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26297428</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0945</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Experimental and molecular pathology</Title><ISOAbbreviation>Exp. Mol. Pathol.</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial OGG1 protects against PM2.5-induced oxidative DNA damage in BEAS-2B cells.</ArticleTitle><Pagination><MedlinePgn>365-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.yexmp.2015.08.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0014-4800(15)00167-7</ELocationID><Abstract><AbstractText>The enzyme 8-oxoguanine glycosylase 1 (OGG1) has been shown to be involved in the repair of oxidative DNA damage. However, the effect of OGG1 on oxidative DNA damage caused by particulate matter 2.5 (PM2.5) is unknown. Herein, we demonstrated that OGG1 could inhibit the generation of ROS and alleviate mitochondrial dysfunction and increased the expression of IL-1β caused by PM2.5. The dichlorodihydrofluorescein diacetate (DCFH-DA) staining and 5,5',6,6'-tetrachloro-1,1',3,3'-. tetraethylbenzi-midazolylcarbocyanine iodide (JC-1) staining using flow cytometry showed that PM2.5 induces the generation of ROS and leads to a reduction in mitochondrial membrane potential (MMP) in BEAS-2B cells. Overexpression of OGG1 inhibited the generation of ROS and the decline in MMP. Knockdown of OGG1 by RNA interference (RNAi) increased the generation of ROS and reduced the MMP. Real-time quantitative PCR (RT-qPCR) for the mitochondrial DNA copy number (mtDNAcn) and flow cytometry for apoptosis revealed that OGG1 inhibits the apoptosis and decreases mtDNAcn induced by PM2.5. Additionally, the results of the comet assay showed that OGG1 had a significant repair effect on DNA strand breaks caused by PM2.5. Overexpression of OGG1 also significantly suppressed the expression of IL-1β caused by PM2.5. Together, these data suggest that PM2.5 leads to mitochondrial dysfunction and the up-regulation of IL-1β could be reversed by overexpression of OGG1. The mitochondrial dysfunction caused by PM2.5 could be relieved by OGG1. Thus, the base excision repair enzyme OGG1 may alleviate mitochondrial dysfunction caused by PM2.5 involved in the expression of IL-1β. </AbstractText><CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lawei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yahong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ziying</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Huijuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Haili</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Teng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China; Department of Respiratory Medicine, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wenya</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China; Department of Respiratory Medicine, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Weimin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Immunology and Tumor Research Instituted, The First Affiliated Hospital, Health Science Center of Xi'an Jiaotong University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China; Department of Respiratory Medicine, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China. Electronic address: gangliu11@gdmc.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Exp Mol Pathol</MedlineTA><NlmUniqueID>0370711</NlmUniqueID><ISSNLinking>0014-4800</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000393">Air Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052638">Particulate Matter</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000393" MajorTopicYN="N">Air Pollutants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001980" MajorTopicYN="N">Bronchi</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052638" MajorTopicYN="N">Particulate Matter</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MMP</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">PM2.5</Keyword><Keyword MajorTopicYN="N">ROS</Keyword><Keyword MajorTopicYN="N">mtDNAcn</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>08</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26297428</ArticleId><ArticleId IdType="pii">S0014-4800(15)00167-7</ArticleId><ArticleId IdType="doi">10.1016/j.yexmp.2015.08.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26292623</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1643-3750</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><PubDate><Year>2015</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Medical science monitor : international medical journal of experimental and clinical research</Title><ISOAbbreviation>Med. Sci. Monit.</ISOAbbreviation></Journal><ArticleTitle>Association of APE1 Gene Asp148Glu Variant with Digestive Cancer: A Meta-Analysis.</ArticleTitle><Pagination><MedlinePgn>2456-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/MSM.893954</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Apurinic/apyrimidinic endonuclease-1 (APE1) is a rate-limiting enzyme in DNA base excision repair and has been implicated in carcinogenesis. In this study, we summarize available data to examine the susceptibility of APE1 gene Asp148Glu variant to digestive cancer via a meta-analysis.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Study selection and data abstraction were conducted independently by 2 authors. Random-effects model was utilized to pool effect estimates. Heterogeneity and publication bias were addressed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen articles involving 4916 digestive cancer patients and 7748 controls were qualified for this meta-analysis. Overall association showed an indicative association between Asp148Glu variant and digestive cancer under allelic (odds ratio or OR=1.11; 95% confidence interval or CI: 0.99-1.25; P=0.074) and dominant (OR=1.18; 95% CI: 1.00-1.40; P=0.056) models, with strong evidence of heterogeneity. Deviation from Hardy-Weinberg equilibrium was an obvious source of heterogeneity. In subgroup analyses by cancer sites, this variant was significantly associated with the increased risk for hepatocellular cancer under allelic (OR=1.50; 95% CI: 1.25-1.80; P&lt;0.001) and homozygous genotypic (OR=1.55; 95% CI: 1.02-2.29; P=0.028) models. There were low probabilities of publication bias for the above comparisons.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of this meta-analysis collectively suggest that APE1 gene Asp148Glu variant is not a risk-conferring factor for digestive cancer. Further large and well-designed studies are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gastric and Intestine, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mi</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medicine and Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Xiaodan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medicine and Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Anatomy, Binzhou Medical University, Yantai, Shandong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuping</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Pharmacology, Binzhou Medical University, Yantai, Shandong, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Geng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medicine and Pharmacy Research Center, Binzhou Medical University, Yantai, Shandong, China (mainland).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Sci Monit</MedlineTA><NlmUniqueID>9609063</NlmUniqueID><ISSNLinking>1234-1010</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>3KX376GY7L</RegistryNumber><NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Feb 1;67(3):1395-404</RefSource><PMID Version="1">17283177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2012 Aug;31(8):1384-91</RefSource><PMID Version="1">22691054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Oncol. 2012;2012:370481</RefSource><PMID Version="1">22997517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2008 Jan;29(1):100-5</RefSource><PMID Version="1">17984110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(12):e28971</RefSource><PMID Version="1">22205985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2015 Feb 15;75(4):624-7</RefSource><PMID Version="1">25634214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2010 Jun;29(6):303-11</RefSource><PMID Version="1">20218899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 2004 Sep;20(9):439-44</RefSource><PMID Version="1">15313553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jul 15;29(14):3116-22</RefSource><PMID Version="1">11452037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Med Res Methodol. 2011;11:41</RefSource><PMID Version="1">21473747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2011 Sep;10(9):1698-708</RefSource><PMID Version="1">21700832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2012;13(2):1951-2011</RefSource><PMID Version="1">22408433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2011 Oct;40(5):1329-41</RefSource><PMID Version="1">21729879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Detect Prev. 2006;30(3):284-91</RefSource><PMID Version="1">16844323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Sci Monit. 2011 Jun;17(6):CR329-33</RefSource><PMID Version="1">21629187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Feb 1;638(1-2):146-53</RefSource><PMID Version="1">17991492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(6):e37970</RefSource><PMID Version="1">22701590</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2003 Sep 6;327(7414):557-60</RefSource><PMID Version="1">12958120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Sep 19;501(7467):338-45</RefSource><PMID Version="1">24048066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e40131</RefSource><PMID Version="1">22792228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Nov;25(6):569-75</RefSource><PMID Version="1">20817763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2013 Jul 1;:null</RefSource><PMID Version="1">23863623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(8):2264-77</RefSource><PMID Version="1">19188437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2012;22(6):477-83</RefSource><PMID Version="1">22850545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3167-73</RefSource><PMID Version="1">21037106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2013 Jun;30(2):505</RefSource><PMID Version="1">23430444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2012;13 Suppl:59-64</RefSource><PMID Version="1">23480773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8</RefSource><PMID Version="1">16609022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2002 Aug 15;156(4):300-10</RefSource><PMID Version="1">12181099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2008;27:49</RefSource><PMID Version="1">18823566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2012;22(6):537-42</RefSource><PMID Version="1">23038158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2008 Dec;19(10):1077-83</RefSource><PMID Version="1">18478337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Genet. 2010;51(3):343-52</RefSource><PMID Version="1">20720310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2010 May;56(5):723-8</RefSource><PMID Version="1">20224045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2012 Oct;53(10):1934-44</RefSource><PMID Version="1">22475179</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004067" MajorTopicYN="N">Digestive System Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018740" MajorTopicYN="N">Genetic Heterogeneity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26292623</ArticleId><ArticleId IdType="pii">893954</ArticleId><ArticleId IdType="doi">10.12659/MSM.893954</ArticleId><ArticleId IdType="pmc">PMC4548740</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26275420</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-3804</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Mutagenesis</Title><ISOAbbreviation>Mutagenesis</ISOAbbreviation></Journal><ArticleTitle>Influence of Ogg1 repair on the genetic stability of ccc2 mutant of Saccharomyces cerevisiae chemically challenged with 4-nitroquinoline-1-oxide (4-NQO).</ArticleTitle><Pagination><MedlinePgn>107-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/mutage/gev062</ELocationID><Abstract><AbstractText>In Saccharomyces cerevisiae, disruption of genes by deletion allowed elucidation of the molecular mechanisms of a series of human diseases, such as in Wilson disease (WD). WD is a disorder of copper metabolism, due to inherited mutations in human copper-transporting ATPase (ATP7B). An orthologous gene is present in S. cerevisiae, CCC2 gene. Copper is required as a cofactor for a number of enzymes. In excess, however, it is toxic, potentially carcinogenic, leading to many pathological conditions via oxidatively generated DNA damage. Deficiency in ATP7B (human) or Ccc2 (yeast) causes accumulation of intracellular copper, favouring the generation of reactive oxygen species. Thus, it becomes important to study the relative importance of proteins involved in the repair of these lesions, such as Ogg1. Herein, we addressed the influence Ogg1 repair in a ccc2 deficient strain of S. cerevisiae. We constructed ccc2-disrupted strains from S. cerevisiae (ogg1ccc2 and ccc2), which were analysed in terms of viability and spontaneous mutator phenotype. We also investigated the impact of 4-nitroquinoline-1-oxide (4-NQO) on nuclear DNA damage and on the stability of mitochondrial DNA. The results indicated a synergistic effect on spontaneous mutagenesis upon OGG1 and CCC2 double inactivation, placing 8-oxoguanine as a strong lesion-candidate at the origin of spontaneous mutations. The ccc2 mutant was more sensitive to cell killing and to mutagenesis upon 4-NQO challenge than the other studied strains. However, Ogg1 repair of exogenous-induced DNA damage revealed to be toxic and mutagenic to ccc2 deficient cells, which can be due to a detrimental action of Ogg1 on DNA lesions induced in ccc2 cells. Altogether, our results point to a critical and ambivalent role of BER mediated by Ogg1 in the maintenance of genomic stability in eukaryotes deficient in CCC2 gene.</AbstractText><CopyrightInformation>© The Author 2015. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Claudia R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Laboratório de Radio e Fotobiologia, Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, UERJ, Rio de Janeiro CEP 20551-030, Brasil, Laboratório de Radiobiologia Molecular; Instituto de Biofísica Carlos Chagas Filho, UFRJ, Rio de Janeiro CEP 21.941-902, Brasil and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Gabriella S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Laboratório de Radio e Fotobiologia, Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, UERJ, Rio de Janeiro CEP 20551-030, Brasil, Laboratório de Radiobiologia Molecular; Instituto de Biofísica Carlos Chagas Filho, UFRJ, Rio de Janeiro CEP 21.941-902, Brasil and Laboratório de Microbiologia e Avaliação Genotóxica, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, UFRJ, Rio de Janeiro CEP 21.941-902, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldeira-de-Araújo</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratório de Radio e Fotobiologia, Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, UERJ, Rio de Janeiro CEP 20551-030, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leitão</LastName><ForeName>Alvaro C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Laboratório de Radiobiologia Molecular; Instituto de Biofísica Carlos Chagas Filho, UFRJ, Rio de Janeiro CEP 21.941-902, Brasil and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Pádula</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratório de Radiobiologia Molecular; Instituto de Biofísica Carlos Chagas Filho, UFRJ, Rio de Janeiro CEP 21.941-902, Brasil and Laboratório de Microbiologia e Avaliação Genotóxica, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, UFRJ, Rio de Janeiro CEP 21.941-902, Brasil marcelo@pharma.ufrj.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mutagenesis</MedlineTA><NlmUniqueID>8707812</NlmUniqueID><ISSNLinking>0267-8357</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D027682">Cation Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004271">DNA, Fungal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>56-57-5</RegistryNumber><NameOfSubstance UI="D015112">4-Nitroquinoline-1-oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>5614-64-2</RegistryNumber><NameOfSubstance UI="C024829">8-hydroxyguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C505160">Ogg1 protein, S cerevisiae</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.3.4</RegistryNumber><NameOfSubstance UI="C092974">CCC2 protein, S cerevisiae</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015112" MajorTopicYN="N">4-Nitroquinoline-1-oxide</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027682" MajorTopicYN="N">Cation Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004271" MajorTopicYN="N">DNA, Fungal</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029701" MajorTopicYN="N">Saccharomyces cerevisiae Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26275420</ArticleId><ArticleId IdType="pii">gev062</ArticleId><ArticleId IdType="doi">10.1093/mutage/gev062</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26257461</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-8630</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Disease markers</Title><ISOAbbreviation>Dis. Markers</ISOAbbreviation></Journal><ArticleTitle>Association of DNA Repair Gene APE1 Asp148Glu Polymorphism with Breast Cancer Risk.</ArticleTitle><Pagination><MedlinePgn>869512</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2015/869512</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to investigate the role of APE1 Asp148Glu polymorphism in breast cancer progression in Saudi population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We examined the genetic variations (rs1130409) in the DNA base excision repair gene APE1 at codon 148 (Asp148Glu) and its association with breast cancer risk using genotypic assays and in silico structural as well as functional predictions. In silico structural analysis was performed with Asp148Glu allele and compared with the predicted native protein structure. The wild and mutant 3D structures of APE1 were compared and analyzed using solvent accessibility models for protein stability confirmation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Genotypic analysis of APE1 (rs1130409) showed statistically significant association of Asp148Glu with elevated susceptibility to breast cancer. The in silico analysis results indicated that the nsSNP Asp148Glu may cause changes in the protein structure and is associated with breast cancer risk.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Taken together, this is the first report that established that Asp148Glu variant has structural and functional effect on the APE1 and may play an important role in breast cancer progression in Saudi population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AlMutairi</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pathan</LastName><ForeName>Akbar Ali Khan</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia ; Integrated Gulf Biosystems, Riyadh 11391, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shalaby</LastName><ForeName>Manal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia ; Genetic Engineering and Biotechnology Research Institute (GEBRI), City for Scientific Research and Technology Applications, Alexandria 21934, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alabdulkarim</LastName><ForeName>Huda A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>The Comprehensive Cancer Center, King Fahad Medical City, Riyadh 11525, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamri</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Naeem</LastName><ForeName>Abdulrahman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Women's Imaging, King Fahad Medical City, Riyadh 11525, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elrobh</LastName><ForeName>Moammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaik</LastName><ForeName>Jilani P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Wajahatullah</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Basic Sciences, College of Science and Health Professions, King Saud Bin Abdul Aziz University for Health Sciences, Riyadh 11426, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Zahid</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parine</LastName><ForeName>Narasimha Reddy</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Markers</MedlineTA><NlmUniqueID>8604127</NlmUniqueID><ISSNLinking>0278-0240</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2011;12:151</RefSource><PMID Version="1">21569468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2011 Apr;42(3):226-34</RefSource><PMID Version="1">21722819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2011 Dec 6;50(48):10540-9</RefSource><PMID Version="1">22032234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2012 Apr;133(4):127-32</RefSource><PMID Version="1">22019847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Jan;40(1):171-6</RefSource><PMID Version="1">23143180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e59555</RefSource><PMID Version="1">23516639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr 1;41(6):3483-90</RefSource><PMID Version="1">23408852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Res. 2013;46(2):161-7</RefSource><PMID Version="1">23959014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(12):e85541</RefSource><PMID Version="1">24392019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 May;35(5):4727-34</RefSource><PMID Version="1">24414702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Med. 2014;46:e106</RefSource><PMID Version="1">25033834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2014;2014:290325</RefSource><PMID Version="1">25136576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Biochem Mol Biol. 2008 Jul-Aug;43(4):239-76</RefSource><PMID Version="1">18756381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2000 Apr;182(8):2104-12</RefSource><PMID Version="1">10735851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Feb 16;291(5507):1284-9</RefSource><PMID Version="1">11181991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Jan;432(3-4):53-9</RefSource><PMID Version="1">11465542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Jul 1;33(1):15-28</RefSource><PMID Version="1">12086678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuromolecular Med. 2002;2(1):47-60</RefSource><PMID Version="1">12230304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2002 Dec 16;21(58):8905-25</RefSource><PMID Version="1">12483508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 May 15;526(1-2):93-125</RefSource><PMID Version="1">12714187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1990 Sep-Nov;236(2-3):173-201</RefSource><PMID Version="1">1697933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Sep;11(9):3323-35</RefSource><PMID Version="1">1380454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1994;63:915-48</RefSource><PMID Version="1">7979257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 1995 Aug;17(8):713-9</RefSource><PMID Version="1">7661852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 1995 Aug;32(8):623-6</RefSource><PMID Version="1">7473654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteins. 1995 Nov;23(3):318-26</RefSource><PMID Version="1">8710825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 1998 Nov 9;252(1):178-83</RefSource><PMID Version="1">9813166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Anal. 1999 Feb;14(5-6):143-9</RefSource><PMID Version="1">10084106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Apr 1;18(7):1905-14</RefSource><PMID Version="1">10202154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Oct 15;18(20):5609-21</RefSource><PMID Version="1">10523305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2006 Jan;175(1):108-12; discussion 112</RefSource><PMID Version="1">16406883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W239-42</RefSource><PMID Version="1">16845001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2006 Nov;100(1):121-6</RefSource><PMID Version="1">16685588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2007 Jun;103(2):161-6</RefSource><PMID Version="1">17131038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2007 Jan-Feb;13(1-2):89-96</RefSource><PMID Version="1">17515960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007 Jul;35(Web Server issue):W407-10</RefSource><PMID Version="1">17517781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Sep;111(2):279-88</RefSource><PMID Version="1">17922186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Chem. 2009 Jul 30;30(10):1545-614</RefSource><PMID Version="1">19444816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2010 Feb 16;102(4):704-9</RefSource><PMID Version="1">20087352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2010 Apr;5(4):725-38</RefSource><PMID Version="1">20360767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2010;11:548</RefSource><PMID Version="1">21059217</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>04</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26257461</ArticleId><ArticleId IdType="doi">10.1155/2015/869512</ArticleId><ArticleId IdType="pmc">PMC4519542</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26255264</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1165-158X</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Cellular and molecular biology (Noisy-le-Grand, France)</Title><ISOAbbreviation>Cell. Mol. Biol. (Noisy-le-grand)</ISOAbbreviation></Journal><ArticleTitle>The association between 1349T&gt;G polymorphism of ApE1 gene and the risk of prostate cancer in northern Iran.</ArticleTitle><Pagination><MedlinePgn>21-4</MedlinePgn></Pagination><Abstract><AbstractText>Prostate cancer (PCa) is the most common malignancy in men and the fourth most common cause of death based on cancer all over the world. Many genes has been shown to be involved in the progress of the prostate cancer. Human apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional protein that has an important role in the base excision repair (BER) pathway. The aim of this study was to evaluate the association of ApE1 1349T&gt;G polymorphism and the susceptibility to prostate cancer in northern Iran population. Samples were collected from 100 patients diagnosed with prostate cancer patients and 100 controls subjects and genotyped by PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length Polymorphism). We observed a significant difference in genotype distributions of ApE1 1349T&gt;G polymorphism between patients and controls (P= 0.039). Our findings revealed individuals with the variant TG and GG had a significant increased risk of prostate cancer (GG: OR= 2.50, 95%CI= 1.063-5.874, P= 0.035. TG: OR= 2.40, 95%CI= 1.16-4.95, P= 0.017). Also, more analyses were showed that G allele were associated with increased risk of prostate cancer (OR= 1.493, 95%CI= 1.007-2.21, P= 0.045). The data from this study indicates that the ApE1 1349T&gt;G polymorphism is associated with increased risk of prostate cancer. Although more studies should be considered with larger number of patients and control subjects to confirm our results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pournourali</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Sciences, University of Guilan Department of Biology Rasht Iran mostafapournourali&amp;commat;yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarang</LastName><ForeName>A R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Agriculture Biotechnology Research Institute of Iran (ABRII) Department of Genomics and Animal, Branches of north region of Iran Rasht Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousefi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Sciences, University of Guilan Department of Biology Rasht Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Cell Mol Biol (Noisy-le-grand)</MedlineTA><NlmUniqueID>9216789</NlmUniqueID><ISSNLinking>0145-5680</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012150" MajorTopicYN="N">Polymorphism, Restriction Fragment Length</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>07</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26255264</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26238022</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1791-2431</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Oncology reports</Title><ISOAbbreviation>Oncol. Rep.</ISOAbbreviation></Journal><ArticleTitle>Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder.</ArticleTitle><Pagination><MedlinePgn>1667-74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/or.2015.4151</ELocationID><Abstract><AbstractText>Molecular evidence indicates that alterations in genes involved in the maintenance of genome stability may be related to susceptibility to bladder carcinoma. Our goal was to evaluate the prognostic role of base excision repair (BER) genes in a cohort of patients diagnosed with primary urothelial carcinoma of the bladder (UCB). The levels of all APE1, XRCC1 and POLB transcripts were detected by quantitative real-time PCR (qPCR) technique in tumor samples from 52 patients undergoing transurethral resection (TUR) for primary UCB at the Department of Urology, Brazilian National Cancer Institute, Rio de Janeiro. Increased levels of APE1, XRCC1 and POLB transcripts were significantly associated with high-grade tumors when compared to these levels in low-grade tumors (p&lt;0.01) and could be attributed to different mechanisms of transcriptional regulation as a response to tumorigenesis and oxidative stress. By analyzing the collected data in the present study, regardless of pathological grade or stage, univariate analysis revealed that the reduced levels of APE1 transcripts were significantly associated with cancer-specific mortality (p=0.032). Furthermore, the variant genotype (TG/GG) of the APE1 T1349G polymorphism was observed in 75% of a subset of patients who concomitantly experienced reduced levels of the APE1 transcript and death and/or recurrence events. Taken together, our data reinforce the idea that human DNA repair mechanisms must be finely regulated in order to avoid instability leading to tumorigenesis and poor clinical outcomes in UCB patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chantre-Justino</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Carlos Chagas Filho Institute of Biophysics, Rio de Janeiro Federal University, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Gilda</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Research Coordination, National Institute of Cancer (INCA), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Britto</LastName><ForeName>Constança</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Molecular Biology and Endemic Diseases Laboratory, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Angélica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular Biology and Endemic Diseases Laboratory, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherrer</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Brazilian Society of Clinical Oncology, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Aline dos Santos</ForeName><Initials>Ados S</Initials><AffiliationInfo><Affiliation>DNA Sequencing Platform, PDTIS/FIOCRUZ, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quirino</LastName><ForeName>Raul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Urology, National Institute of Cancer, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ornellas</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, National Institute of Cancer, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leitão</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Carlos Chagas Filho Institute of Biophysics, Rio de Janeiro Federal University, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lage</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Carlos Chagas Filho Institute of Biophysics, Rio de Janeiro Federal University, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Oncol Rep</MedlineTA><NlmUniqueID>9422756</NlmUniqueID><ISSNLinking>1021-335X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D019951">DNA Polymerase beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2009 Apr;55(4):611-22</RefSource><PMID Version="1">19246619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2009 May;30(5):763-8</RefSource><PMID Version="1">19237606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2009 Apr;29(4):1389-93</RefSource><PMID Version="1">19414392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2009 Aug;182(2):741-8</RefSource><PMID Version="1">19539325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2009 Nov;35(5):1069-79</RefSource><PMID Version="1">19787261</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2009 Nov;24(6):507-12</RefSource><PMID Version="1">19762350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2010 Jul;184(1):336-43</RefSource><PMID Version="1">20488473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2010 Jul-Aug;28(4):401-8</RefSource><PMID Version="1">20610278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(12):e28971</RefSource><PMID Version="1">22205985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2012 Mar 15;105(4):425-30</RefSource><PMID Version="1">22311819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2012 May;138(5):739-43</RefSource><PMID Version="1">22258852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Jan;40(1):171-6</RefSource><PMID Version="1">23143180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2013 Feb;63(2):234-41</RefSource><PMID Version="1">22877502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2013 Jan;63(1):11-30</RefSource><PMID Version="1">23335087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Biol Med (Maywood). 2013 Jan;238(1):66-76</RefSource><PMID Version="1">23479765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2013 Aug;31(6):802-11</RefSource><PMID Version="1">21924649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Urol. 2013;13:56</RefSource><PMID Version="1">24156254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2003 Aug 29;331(5):1017-23</RefSource><PMID Version="1">12927538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 2003 Nov 15;193(1-2):3-34</RefSource><PMID Version="1">14599765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 2003 Nov;111(15):1843-50</RefSource><PMID Version="1">14630517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Mar 15;22(6):1014-24</RefSource><PMID Version="1">14981102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2004 Aug;3(8):998-1001</RefSource><PMID Version="1">15280658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1996 Dec 2;15(23):6662-70</RefSource><PMID Version="1">8978692</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1999 Feb 5;274(6):3642-50</RefSource><PMID Version="1">9920913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 May 2;4(5):583-93</RefSource><PMID Version="1">15811630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2005;4(1):18</RefSource><PMID Version="1">15882455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Jul 12;4(7):826-35</RefSource><PMID Version="1">15927541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2005 Sep 4;577(1-2):275-83</RefSource><PMID Version="1">15922366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Sep 1;11(17):6205-11</RefSource><PMID Version="1">16144922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2006 Feb;5(3):250-9</RefSource><PMID Version="1">16418580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 Mar;27(3):361-73</RefSource><PMID Version="1">16352616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2007 Feb 15;6(4):471-7</RefSource><PMID Version="1">17329970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2007 Apr;121(2):233-42</RefSource><PMID Version="1">17203305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Mar 15;68(6):1777-85</RefSource><PMID Version="1">18339858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2000 Feb;6(2):602-9</RefSource><PMID Version="1">10690545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3110-5</RefSource><PMID Version="1">24520177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Biochem Cell Biol. 2000 Sep;32(9):925-9</RefSource><PMID Version="1">11084372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Mar 1;61(5):2220-5</RefSource><PMID Version="1">11280790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Apr;7(4):824-30</RefSource><PMID Version="1">11309329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 May 17;411(6835):366-74</RefSource><PMID Version="1">11357144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Nov;7(11):3510-8</RefSource><PMID Version="1">11705870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Dec 3;20(23):6919-26</RefSource><PMID Version="1">11726527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2002 Jun 15;62(12):3511-4</RefSource><PMID Version="1">12067997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2003 Jan;33(1):90-6</RefSource><PMID Version="1">12469123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2008 Apr;99(4):646-52</RefSource><PMID Version="1">18377416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2008 May 23;379(1):17-27</RefSource><PMID Version="1">18439621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2008 May;65(10):1544-65</RefSource><PMID Version="1">18259689</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019951" MajorTopicYN="N">DNA Polymerase beta</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26238022</ArticleId><ArticleId IdType="doi">10.3892/or.2015.4151</ArticleId><ArticleId IdType="pmc">PMC4564093</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26218629</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8937</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>ACS chemical biology</Title><ISOAbbreviation>ACS Chem. Biol.</ISOAbbreviation></Journal><ArticleTitle>Small Molecule Inhibitors of 8-Oxoguanine DNA Glycosylase-1 (OGG1).</ArticleTitle><Pagination><MedlinePgn>2334-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschembio.5b00452</ELocationID><Abstract><AbstractText>The DNA base excision repair (BER) pathway, which utilizes DNA glycosylases to initiate repair of specific DNA lesions, is the major pathway for the repair of DNA damage induced by oxidation, alkylation, and deamination. Early results from clinical trials suggest that inhibiting certain enzymes in the BER pathway can be a useful anticancer strategy when combined with certain DNA-damaging agents or tumor-specific genetic deficiencies. Despite this general validation of BER enzymes as drug targets, there are many enzymes that function in the BER pathway that have few, if any, specific inhibitors. There is a growing body of evidence that suggests inhibition of 8-oxoguanine DNA glycosylase-1 (OGG1) could be useful as a monotherapy or in combination therapy to treat certain types of cancer. To identify inhibitors of OGG1, a fluorescence-based screen was developed to analyze OGG1 activity in a high-throughput manner. From a primary screen of ∼50,000 molecules, 13 inhibitors were identified, 12 of which were hydrazides or acyl hydrazones. Five inhibitors with an IC50 value of less than 1 μM were chosen for further experimentation and verified using two additional biochemical assays. None of the five OGG1 inhibitors reduced DNA binding of OGG1 to a 7,8-dihydro-8-oxoguanine (8-oxo-Gua)-containing substrate, but all five inhibited Schiff base formation during OGG1-mediated catalysis. All of these inhibitors displayed a &gt;100-fold selectivity for OGG1 relative to several other DNA glycosylases involved in repair of oxidatively damaged bases. These inhibitors represent the most potent and selective OGG1 inhibitors identified to date.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Donley</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Oregon Institute of Occupational Health Sciences, Oregon Health &amp; Science University , Portland, Oregon 97239, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaruga</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomolecular Measurement Division, National Institute of Standards and Technology , Gaithersburg, Maryland 20899, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coskun</LastName><ForeName>Erdem</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Biomolecular Measurement Division, National Institute of Standards and Technology , Gaithersburg, Maryland 20899, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dizdaroglu</LastName><ForeName>Miral</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomolecular Measurement Division, National Institute of Standards and Technology , Gaithersburg, Maryland 20899, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCullough</LastName><ForeName>Amanda K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Oregon Institute of Occupational Health Sciences, Oregon Health &amp; Science University , Portland, Oregon 97239, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>R Stephen</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Oregon Institute of Occupational Health Sciences, Oregon Health &amp; Science University , Portland, Oregon 97239, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 CA160032</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 ES007060</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Biol</MedlineTA><NlmUniqueID>101282906</NlmUniqueID><ISSNLinking>1554-8929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006834">Hydrazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance></Chemical><Chemical><RegistryNumber>27RFH0GB4R</RegistryNumber><NameOfSubstance UI="C029424">hydrazine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Apr 1;6(4):470-80</RefSource><PMID Version="1">17116430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Structure. 2011 Jan 12;19(1):117-27</RefSource><PMID Version="1">21220122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res Rev Mutat Res. 2015 Jan-Mar;763:212-45</RefSource><PMID Version="1">25795122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Proteome Res. 2013 Feb 1;12(2):1049-61</RefSource><PMID Version="1">23268652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2010 Dec 15;9(24):4876-83</RefSource><PMID Version="1">21131780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2009 Jul;8(7):2015-26</RefSource><PMID Version="1">19567822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 2014 Dec 15;27(12):2113-8</RefSource><PMID Version="1">25405892</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chim Acta. 2006 Mar;365(1-2):30-49</RefSource><PMID Version="1">16214123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Oct;12(10):856-63</RefSource><PMID Version="1">23890570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2009 Sep;1(6-7):315-22</RefSource><PMID Version="1">20049735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</RefSource><PMID Version="1">17560642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Allergy Clin Immunol. 2015 Feb;15(1):89-97</RefSource><PMID Version="1">25486379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 09;8(12):e81667</RefSource><PMID Version="1">24349107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006 Mar 20;34(5):1620-32</RefSource><PMID Version="1">16549874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014;42(16):10748-61</RefSource><PMID Version="1">25143530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Jan 1;12(1):18-26</RefSource><PMID Version="1">23127499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Apr 10;508(7495):222-7</RefSource><PMID Version="1">24695225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochimie. 2002 Jan;84(1):27-47</RefSource><PMID Version="1">11900875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Dec 19;9(12 ):e115558</RefSource><PMID Version="1">25526641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2015 Apr;81:107-18</RefSource><PMID Version="1">25614460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Apr 10;508(7495):215-21</RefSource><PMID Version="1">24695224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2004 Dec 21;43(50):15909-14</RefSource><PMID Version="1">15595846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Dec 30;286(52):44679-90</RefSource><PMID Version="1">22057269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Dec 9;280(49):40544-51</RefSource><PMID Version="1">16221681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1994 Mar 14;341(1):59-64</RefSource><PMID Version="1">8137923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2014 Nov 1;193(9):4643-53</RefSource><PMID Version="1">25267977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2012 Nov 15;131(10):2433-44</RefSource><PMID Version="1">22377908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Jul 24;376(9737):235-44</RefSource><PMID Version="1">20609467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2013 Aug;61:384-94</RefSource><PMID Version="1">23612479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2009 Dec;7(12 ):1973-83</RefSource><PMID Version="1">19996303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2002 Jun 4;41(22):7054-64</RefSource><PMID Version="1">12033939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3589-96</RefSource><PMID Version="1">19351835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2014 Aug;73:430-8</RefSource><PMID Version="1">24681335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2014 Mar 1;192(5):2384-94</RefSource><PMID Version="1">24489103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3523-8</RefSource><PMID Version="1">11904416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Jan 15;52(2):392-401</RefSource><PMID Version="1">22100973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Sci Pollut Res Int. 2014 Feb;21(3):1599-613</RefSource><PMID Version="1">24170504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2006 Apr 20;25(17):2425-32</RefSource><PMID Version="1">16369492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 May 25;282(21):15790-8</RefSource><PMID Version="1">17389588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Oct 15;27(20):4001-7</RefSource><PMID Version="1">10497264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2008 Dec 15;45(12):1601-9</RefSource><PMID Version="1">18926902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Feb 1;32(3):212-20</RefSource><PMID Version="1">11827746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Nov 28;703(1):18-23</RefSource><PMID Version="1">20696268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2012 Dec;12(12):801-17</RefSource><PMID Version="1">23175119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Jan;1834(1):247-71</RefSource><PMID Version="1">23076011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2014 Apr;105(4):370-88</RefSource><PMID Version="1">24484288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):27-47</RefSource><PMID Version="1">18166975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Pharmacol. 2013 Aug;169(8):1745-65</RefSource><PMID Version="1">23682925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Biol. 2014 Mar 11;12(3):e1001807</RefSource><PMID Version="1">24618719</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2010 Mar 16;17 (3):235-48</RefSource><PMID Version="1">20227038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1992 Jan 14;31(1):106-10</RefSource><PMID Version="1">1731864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1980 Sep 2;19(18):4299-303</RefSource><PMID Version="1">6158332</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006834" MajorTopicYN="N">Hydrazines</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26218629</ArticleId><ArticleId IdType="doi">10.1021/acschembio.5b00452</ArticleId><ArticleId IdType="pmc">PMC4894821</ArticleId><ArticleId IdType="mid">NIHMS790632</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26210637</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-135X</ISSN><JournalIssue CitedMedium="Internet"><Volume>779</Volume><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Mutation research</Title><ISOAbbreviation>Mutat. Res.</ISOAbbreviation></Journal><ArticleTitle>Reduced cellular DNA repair capacity after environmentally relevant arsenic exposure. Influence of Ogg1 deficiency.</ArticleTitle><Pagination><MedlinePgn>144-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrfmmm.2015.07.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0027-5107(15)30023-3</ELocationID><Abstract><AbstractText>Inorganic arsenic (i-As) is a genotoxic and carcinogenic environmental contaminant known to affect millions of people worldwide. Our previous work demonstrated that chronic sub-toxic i-As concentrations were able to induce biologically significant levels of genotoxic and oxidative DNA damage that were strongly influenced by the Ogg1 genotype. In order to study the nature of the observed levels of damage and the observed differences between MEF Ogg1(+/+) and Ogg1(-/-) genetic backgrounds, the genotoxic and oxidative DNA repair kinetics of 18-weeks exposed MEF cells were evaluated by the comet assay. Results indicate that MEF Ogg1(+/+) and Ogg1(-/-) cells chronically exposed to i-As repair the DNA damage induced by arsenite, potassium bromide and UVC radiation less efficiently than control cells, being that observation clearly more pronounced in MEF Ogg1(-/-) cells. Consequently, exposed cells accumulate a higher percentage of unrepaired DNA damage at the end of the repair period. As an attempt to eliminate i-As associated toxicity, chronically exposed MEF Ogg1(-/-) cells overexpress the arsenic metabolizing enzyme As3mt. This adaptive response confers cells a significant resistance to i-As-induced cell death, but at expenses of accumulating high levels of DNA damage due to their repair impairment. Overall, the work presented here evidences that i-As chronic exposure disrupts the normal cellular repair function, and that oxidative DNA damage-and Ogg1 deficiency-exacerbates this phenomenon. The observed cell death resistance under a chronic scenario of genotoxic and oxidative stress may in turn contribute to the carcinogenic effects of i-As. </AbstractText><CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bach</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peremartí</LastName><ForeName>Jana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annangi</LastName><ForeName>Balasubramnayam</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcos</LastName><ForeName>Ricard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain; CIBER Epidemiología y Salud Pública, ISCIII, Madrid, Spain. Electronic address: ricard.marcos@uab.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernández</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain; CIBER Epidemiología y Salud Pública, ISCIII, Madrid, Spain. Electronic address: alba.hernandez@uab.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="D008780">Methyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.137</RegistryNumber><NameOfSubstance UI="C532135">AS3MT protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>N712M78A8G</RegistryNumber><NameOfSubstance UI="D001151">Arsenic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001151" MajorTopicYN="N">Arsenic</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008780" MajorTopicYN="N">Methyltransferases</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014466" MajorTopicYN="N">Ultraviolet Rays</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arsenic</Keyword><Keyword MajorTopicYN="N">As3mt</Keyword><Keyword MajorTopicYN="N">Chronic exposure</Keyword><Keyword MajorTopicYN="N">DNA repair kinetics</Keyword><Keyword MajorTopicYN="N">Ogg1</Keyword><Keyword MajorTopicYN="N">Oxidative DNA damage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>07</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26210637</ArticleId><ArticleId IdType="pii">S0027-5107(15)30023-3</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2015.07.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26208681</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>Structure of yeast Ape1 and its role in autophagic vesicle formation.</ArticleTitle><Pagination><MedlinePgn>1580-93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2015.1067363</ELocationID><Abstract><AbstractText>In Saccharomyces cerevisiae, a constitutive biosynthetic transport pathway, termed the cytoplasm-to-vacuole targeting (Cvt) pathway, sequesters precursor aminopeptidase I (prApe1) dodecamers in the form of a large complex into a Cvt vesicle using autophagic machinery, targeting it into the vacuole (the yeast lysosome) where it is proteolytically processed into its mature form, Ape1, by removal of an amino-terminal 45-amino acid propeptide. prApe1 is thought to serve as a scaffolding cargo critical for the assembly of the Cvt vesicle by presenting the propeptide to mediate higher-ordered complex formation and autophagic receptor recognition. Here we report the X-ray crystal structure of Ape1 at 2.5 Å resolution and reveal its dodecameric architecture consisting of dimeric and trimeric units, which associate to form a large tetrahedron. The propeptide of prApe1 exhibits concentration-dependent oligomerization and forms a stable tetramer. Structure-based mutagenesis demonstrates that disruption of the inter-subunit interface prevents dodecameric assembly and vacuolar targeting in vivo despite the presence of the propeptide. Furthermore, by examining the vacuolar import of propeptide-fused exogenous protein assemblies with different quaternary structures, we found that 3-dimensional spatial distribution of propeptides presented by a scaffolding cargo is essential for the assembly of the Cvt vesicle for vacuolar delivery. This study describes a molecular framework for understanding the mechanism of Cvt or autophagosomal biogenesis in selective macroautophagy. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Ming-Yuan</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>a Institute of Biological Chemistry; Academia Sinica ; Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute of Biochemical Sciences; College of Life Science; National Taiwan University ; Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Wen-Hsin</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>a Institute of Biological Chemistry; Academia Sinica ; Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Meng-Ru</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>a Institute of Biological Chemistry; Academia Sinica ; Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Shih-Chieh</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>a Institute of Biological Chemistry; Academia Sinica ; Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute of Biochemical Sciences; College of Life Science; National Taiwan University ; Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yuan-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>c Institute of Cellular and Organismic Biology; Academia Sinica ; Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guang-Chao</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>a Institute of Biological Chemistry; Academia Sinica ; Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute of Biochemical Sciences; College of Life Science; National Taiwan University ; Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chung-I</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>a Institute of Biological Chemistry; Academia Sinica ; Taipei , Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute of Biochemical Sciences; College of Life Science; National Taiwan University ; Taipei , Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029701">Saccharomyces cerevisiae Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.11.-</RegistryNumber><NameOfSubstance UI="D000626">Aminopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.11.22</RegistryNumber><NameOfSubstance UI="C019689">APE1 protein, S cerevisiae</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 May 1;70(9):3431-4</RefSource><PMID Version="1">20424122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2011 Apr;7(4):386-400</RefSource><PMID Version="1">21183797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2001 Jun;7(6):1131-41</RefSource><PMID Version="1">11430817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Soc Rev. 2010 Sep;39(9):3541-75</RefSource><PMID Version="1">20676430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674</RefSource><PMID Version="1">19461840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 2002 Aug;14(4):468-75</RefSource><PMID Version="1">12383798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Mar 23;287(13):10121-33</RefSource><PMID Version="1">22123825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2007 Mar-Apr;3(2):106-16</RefSource><PMID Version="1">17204848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Jan 19;276(3):2083-7</RefSource><PMID Version="1">11085977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Z Naturforsch C. 1977 Nov-Dec;32(11-12):938-43</RefSource><PMID Version="1">146356</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):1002-11</RefSource><PMID Version="1">16929101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2013 Aug;69(Pt 8):1395-402</RefSource><PMID Version="1">23897463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2014 Jun;16(6):495-501</RefSource><PMID Version="1">24875736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2005 Apr;16(4):1593-605</RefSource><PMID Version="1">15659643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 May 25;336(6084):1030-3</RefSource><PMID Version="1">22628654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1997 Jul 14;138(1):37-44</RefSource><PMID Version="1">9214379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Feb 27;33(4):505-16</RefSource><PMID Version="1">19250911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>IEEE Trans Vis Comput Graph. 2006 Sep-Oct;12(5):1237-44</RefSource><PMID Version="1">17080857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2007 May;61(5):476-83</RefSource><PMID Version="1">17469125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2014 May;16(5):425-33</RefSource><PMID Version="1">24705553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Chem. 2004 Oct;25(13):1605-12</RefSource><PMID Version="1">15264254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(7):e67843</RefSource><PMID Version="1">23861819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Nov 1;20(21):5971-81</RefSource><PMID Version="1">11689437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 2013 Jan;25(1):1-10</RefSource><PMID Version="1">23042773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Z Naturforsch C. 1977 Nov-Dec;32(11-12):929-37</RefSource><PMID Version="1">146355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 2003 Sep 1;320(1):104-24</RefSource><PMID Version="1">12895474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1996 Mar;132(6):999-1010</RefSource><PMID Version="1">8601598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Struct Biol. 2007 Jan;157(1):38-46</RefSource><PMID Version="1">16859925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biophys J. 2000 Mar;78(3):1606-19</RefSource><PMID Version="1">10692345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1997 Dec 29;139(7):1687-95</RefSource><PMID Version="1">9412464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67</RefSource><PMID Version="1">21460454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 Jul 1;466(7302):68-76</RefSource><PMID Version="1">20562859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3</RefSource><PMID Version="1">15299374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32</RefSource><PMID Version="1">15572765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Struct Biol. 2012;12:14</RefSource><PMID Version="1">22720794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1992 Oct;119(2):287-99</RefSource><PMID Version="1">1400574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2010 Sep;12(9):814-22</RefSource><PMID Version="1">20811353</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Jan 1;67(Pt 1):17-22</RefSource><PMID Version="1">21206015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1997 May 5;137(3):609-18</RefSource><PMID Version="1">9151668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2008;9:40</RefSource><PMID Version="1">18215316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2002 Dec;3(6):815-24</RefSource><PMID Version="1">12479807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2012 Sep 28;422(4):495-507</RefSource><PMID Version="1">22709581</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000626" MajorTopicYN="N">Aminopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022162" MajorTopicYN="N">Cytoplasmic Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029701" MajorTopicYN="N">Saccharomyces cerevisiae Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013347" MajorTopicYN="N">Subcellular Fractions</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014617" MajorTopicYN="N">Vacuoles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ape1</Keyword><Keyword MajorTopicYN="N">Atg19</Keyword><Keyword MajorTopicYN="N">Cvt</Keyword><Keyword MajorTopicYN="N">X-ray crystallography</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26208681</ArticleId><ArticleId IdType="doi">10.1080/15548627.2015.1067363</ArticleId><ArticleId IdType="pmc">PMC4590589</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26187872</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Free radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic. Biol. Med.</ISOAbbreviation></Journal><ArticleTitle>Whole transcriptome analysis reveals a role for OGG1-initiated DNA repair signaling in airway remodeling.</ArticleTitle><Pagination><MedlinePgn>20-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2015.07.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0891-5849(15)00328-7</ELocationID><Abstract><AbstractText>Reactive oxygen species (ROS) generated by environmental exposures, and endogenously as by-products of respiration, oxidatively modify biomolecules including DNA. Accumulation of ROS-induced DNA damage has been implicated in various diseases that involve inflammatory processes, and efficient DNA repair is considered critical in preventing such diseases. One of the most abundant DNA base lesions is 7,8-dihydro-8-oxoguanine (8-oxoG), which is repaired by the 8-oxoguanine DNA glycosylase 1 (OGG1)-initiated base-excision repair (OGG1-BER) pathway. Recent studies have shown that the OGG1-BER by-product 8-oxoG base forms a complex with cytosolic OGG1, activating small GTPases and downstream cell signaling in cultured cells and lungs. This implies that persistent OGG1-BER could result in signaling leading to histological changes in airways. To test this, we mimicked OGG1-BER by repeatedly challenging airways with its repair product 8-oxoG base. Gene expression was analyzed by RNA sequencing (RNA-Seq) and qRT-PCR, and datasets were evaluated by gene ontology and statistical tools. RNA-Seq analysis identified 3252 differentially expressed transcripts (2435 up- and 817 downregulated, ≥ 3-fold change). Among the upregulated transcripts, 2080 mRNAs were identified whose encoded protein products were involved in modulation of the actin family cytoskeleton, extracellular matrix, cell adhesion, cadherin, and cell junctions, affecting biological processes such as tissue development, cell-to-cell adhesion, cell communication, and the immune system. These data are supported by histological observations showing epithelial alterations, subepithelial fibrosis, and collagen deposits in the lungs. These data imply that continuous challenge by the environment and consequent OGG1-BER-driven signaling trigger gene expression consistent with airway remodeling.</AbstractText><CopyrightInformation>Copyright © 2015. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aguilera-Aguirre</LastName><ForeName>Leopoldo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosoki</LastName><ForeName>Koa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacsi</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radák</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sur</LastName><ForeName>Sanjiv</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Molecular Medicine, and, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegde</LastName><ForeName>Muralidhar L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Molecular Medicine, and, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saavedra-Molina</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasier</LastName><ForeName>Allan R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Molecular Medicine, and, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba</LastName><ForeName>Xueqing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boldogh</LastName><ForeName>Istvan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Molecular Medicine, and, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address: sboldogh@utmb.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI062885</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>N01HV00245</GrantID><Acronym>HV</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES018948</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS088645</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 ES007254</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 ES006676</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 ES007254-22</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI062885</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>5614-64-2</RegistryNumber><NameOfSubstance UI="C024829">8-hydroxyguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 May 31;447(7144):606-8</RefSource><PMID Version="1">17507928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hypertension. 2010 Apr;55(4):939-45</RefSource><PMID Version="1">20177000</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource><PMID Version="1">16199517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):44-8</RefSource><PMID Version="1">24322009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e51697</RefSource><PMID Version="1">23284747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Oct;12(10):856-63</RefSource><PMID Version="1">23890570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Dev Biol. 2011;27:265-90</RefSource><PMID Version="1">21568710</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2011;763:195-206</RefSource><PMID Version="1">21874453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2009;563:123-40</RefSource><PMID Version="1">19597783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2003 Jul;17(10):1195-214</RefSource><PMID Version="1">12832285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Feb 15;52(4):749-56</RefSource><PMID Version="1">22198182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):109-26</RefSource><PMID Version="1">14637249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2011 Jun 15;354(2):191-207</RefSource><PMID Version="1">21420400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2006 Jun 15;294(2):271-9</RefSource><PMID Version="1">16643883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Cell Dev Biol. 2004;20:61-86</RefSource><PMID Version="1">15473835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2005 Aug;115(8):2169-79</RefSource><PMID Version="1">16075057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Jan 1;12(1):18-26</RefSource><PMID Version="1">23127499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2015 Apr;81:107-18</RefSource><PMID Version="1">25614460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Jun;28(11):3623-38</RefSource><PMID Version="1">18362169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Allergy Clin Immunol. 2015 Feb;15(1):21-6</RefSource><PMID Version="1">25546326</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Med. 2006 Sep;18(3):523-8</RefSource><PMID Version="1">16865240</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2014 Nov 1;193(9):4643-53</RefSource><PMID Version="1">25267977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brief Bioinform. 2013 Nov;14(6):671-83</RefSource><PMID Version="1">22988256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Nov 2;3(11):1457-68</RefSource><PMID Version="1">15380101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2013 Aug;61:384-94</RefSource><PMID Version="1">23612479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2014 Sep 23;15(9):16975-97</RefSource><PMID Version="1">25250913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2014 Aug;73:430-8</RefSource><PMID Version="1">24681335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2014 Feb;14(2):121-34</RefSource><PMID Version="1">24442140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2014 Mar 1;192(5):2384-94</RefSource><PMID Version="1">24489103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2014 Mar;1839(3):169-77</RefSource><PMID Version="1">24345612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World Allergy Organ J. 2014 Jun 02;7(1):13</RefSource><PMID Version="1">24982697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2010 Mar 1;123(Pt 5):637-42</RefSource><PMID Version="1">20164302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2009 Oct 15;183(8):5379-87</RefSource><PMID Version="1">19786549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2010 Feb;1803(2):191-200</RefSource><PMID Version="1">19171166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2000 May;161(5):1720-45</RefSource><PMID Version="1">10806180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2006 Dec 1;20(23):3199-214</RefSource><PMID Version="1">17158740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):5-13</RefSource><PMID Version="1">10708948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2010 Aug 15;49(4):587-96</RefSource><PMID Version="1">20483371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Cell Biol. 2011 Jun;3(3):159-66</RefSource><PMID Version="1">21502305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2006 May-Jun;8(5-6):985-92</RefSource><PMID Version="1">16771688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Dec;12(12):1094-104</RefSource><PMID Version="1">24075420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2013 Apr;27(4):1631-43</RefSource><PMID Version="1">23254341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cells. 1997 Jun 30;7(3):305-12</RefSource><PMID Version="1">9264015</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2012 Nov;11(11):2362-72</RefSource><PMID Version="1">22933707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Jun 15;287(25):20769-73</RefSource><PMID Version="1">22568941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2011 May;121(1):177-90</RefSource><PMID Version="1">21297082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2013 Aug;8(8):1551-66</RefSource><PMID Version="1">23868073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):5-23</RefSource><PMID Version="1">14637244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2012 Mar 13;3:735</RefSource><PMID Version="1">22415826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Allergy Asthma Immunol. 2009 Mar;102(3):238-46</RefSource><PMID Version="1">19354071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2006 May 22;580(12):2811-20</RefSource><PMID Version="1">16678165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Allergy. 2009 Jul;39(7):1018-26</RefSource><PMID Version="1">19364333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 2007 Jul;30(1):134-55</RefSource><PMID Version="1">17601971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2014 Jun;15(6):411-21</RefSource><PMID Version="1">24854789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2007 Jul;19(7):1419-33</RefSource><PMID Version="1">17317104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Nov 13;284(46):31658-63</RefSource><PMID Version="1">19758983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Aug 1;73(15):4909-22</RefSource><PMID Version="1">23761328</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D056151" MajorTopicYN="N">Airway Remodeling</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063990" MajorTopicYN="N">Gene Ontology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">8-Oxoguanine</Keyword><Keyword MajorTopicYN="N">Airway remodeling</Keyword><Keyword MajorTopicYN="N">OGG1-BER</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>07</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26187872</ArticleId><ArticleId IdType="pii">S0891-5849(15)00328-7</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.07.007</ArticleId><ArticleId IdType="pmc">PMC4924473</ArticleId><ArticleId IdType="mid">NIHMS782672</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26164266</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-135X</ISSN><JournalIssue CitedMedium="Internet"><Volume>779</Volume><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Mutation research</Title><ISOAbbreviation>Mutat. Res.</ISOAbbreviation></Journal><ArticleTitle>APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER.</ArticleTitle><Pagination><MedlinePgn>96-104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrfmmm.2015.06.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0027-5107(15)30016-6</ELocationID><Abstract><AbstractText>Peripheral neuropathy is one of the major side effects of treatment with the anticancer drug, cisplatin. One proposed mechanism for this neurotoxicity is the formation of platinum adducts in sensory neurons that could contribute to DNA damage. Although this damage is largely repaired by nuclear excision repair (NER), our previous findings suggest that augmenting the base excision repair pathway (BER) by overexpressing the repair protein APE1 protects sensory neurons from cisplatin-induced neurotoxicity. The question remains whether APE1 contributes to the ability of the NER pathway to repair platinum-damage in neuronal cells. To examine this, we manipulated APE1 expression in sensory neuronal cultures and measured Pt-removal after exposure to cisplatin. When neuronal cultures were treated with increasing concentrations of cisplatin for two or three hours, there was a concentration-dependent increase in Pt-damage that peaked at four hours and returned to near baseline levels after 24h. In cultures where APE1 expression was reduced by ∼ 80% using siRNA directed at APE1, there was a significant inhibition of Pt-removal over eight hours which was reversed by overexpressing APE1 using a lentiviral construct for human wtAPE1. Overexpressing a mutant APE1 (C65 APE1), which only has DNA repair activity, but not its other significant redox-signaling function, mimicked the effects of wtAPE1. Overexpressing DNA repair activity mutant APE1 (226 + 177APE1), with only redox activity was ineffective suggesting it is the DNA repair function of APE1 and not its redox-signaling, that restores the Pt-damage removal. Together, these data provide the first evidence that a critical BER enzyme, APE1, helps regulate the NER pathway in the repair of cisplatin damage in sensory neurons.</AbstractText><CopyrightInformation>Copyright © 2015 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyun-Suk</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Chunlu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Eric L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yanlin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Indianapolis, IN 46202, USA; Department of Pharmacology and Toxicology, Indianapolis, IN 46202, USA; Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasko</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Suk-Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Indianapolis, IN 46202, USA. Electronic address: slee@iu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA151367</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA121168S1</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA151367</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Chemother Pharmacol. 1989;25(1):62-4</RefSource><PMID Version="1">2556219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metallomics. 2009;1(4):280-91</RefSource><PMID Version="1">20046924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1990 Oct 15;66(8):1697-702</RefSource><PMID Version="1">2119878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1992 Jan 1;69(1):203-7</RefSource><PMID Version="1">1309303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1992 May;10(5):795-803</RefSource><PMID Version="1">1569451</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 1995 May 26;191(3):189-92</RefSource><PMID Version="1">7644143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1995 Dec 15;55(24):6097-102</RefSource><PMID Version="1">8521399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 1996 Mar;138(1):93-104</RefSource><PMID Version="1">8593900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1996 Apr 2;362(3):237-48</RefSource><PMID Version="1">8637502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1996;65:135-67</RefSource><PMID Version="1">8811177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1998 Jun 15;101(12):2842-50</RefSource><PMID Version="1">9637718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2005 Mar;18(2):305-13</RefSource><PMID Version="1">15686959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1999 Jan;17(1):409-22</RefSource><PMID Version="1">10458260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Feb 17;281(7):3889-98</RefSource><PMID Version="1">16356936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Sep 5;10(9):942-52</RefSource><PMID Version="1">21741887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):3-13</RefSource><PMID Version="1">22122461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 1999 Dec;20(6):883-7</RefSource><PMID Version="1">10693969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2000 May 30;39(21):6433-9</RefSource><PMID Version="1">10828957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2001 Apr;21(7):2281-91</RefSource><PMID Version="1">11259578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Feb 28;278(9):7476-85</RefSource><PMID Version="1">12486030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2003 Jun 10;42(22):6747-53</RefSource><PMID Version="1">12779329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Mar 2;4(3):367-79</RefSource><PMID Version="1">15661660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2011 Jan 11;50(1):82-92</RefSource><PMID Version="1">21117647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Nov 1;53(9):1782-90</RefSource><PMID Version="1">22841870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Redox Biol. 2014;2:485-94</RefSource><PMID Version="1">24624338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rev Med Suisse. 2014 Apr 30;10(428):954, 956-7</RefSource><PMID Version="1">24834616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mitochondrion. 2014 May;16:38-49</RefSource><PMID Version="1">24220222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(9):e106485</RefSource><PMID Version="1">25188410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 2003 Jul;182(1):12-20</RefSource><PMID Version="1">12821373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Med. 2004;99:189-202</RefSource><PMID Version="1">15131338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Respir Res. 2004;5:16</RefSource><PMID Version="1">15450125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1984 Oct 1;54(7):1269-75</RefSource><PMID Version="1">6088023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1985 May 15;55(10):2303-l6</RefSource><PMID Version="1">3886121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1988 Jun 1;61(11):2192-5</RefSource><PMID Version="1">2835140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 2006 Dec;27(6):992-1002</RefSource><PMID Version="1">16797073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2007 Jan 3;614(1-2):24-36</RefSource><PMID Version="1">16879837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2007 Feb 1;6(3):318-29</RefSource><PMID Version="1">17297309</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(6):1812-21</RefSource><PMID Version="1">17329374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Aug 29;27(35):9451-7</RefSource><PMID Version="1">17728458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Peripher Nerv Syst. 2008 Mar;13(1):27-46</RefSource><PMID Version="1">18346229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Aug 1;68(15):6425-34</RefSource><PMID Version="1">18676868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Aug 25;643(1-2):54-63</RefSource><PMID Version="1">18579163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Res. 2008 Sep 16;1230:91-8</RefSource><PMID Version="1">18657527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2009 Jan;8(1):10-6</RefSource><PMID Version="1">19139108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2009 Mar;45(4):656-65</RefSource><PMID Version="1">19091544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pain. 2009;5:9</RefSource><PMID Version="1">19245717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(8):2264-77</RefSource><PMID Version="1">19188437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2009 Nov 2;8(11):1273-82</RefSource><PMID Version="1">19726241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2010 Jun 1;12(11):1247-69</RefSource><PMID Version="1">19764832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2010 Sep 1;334(3):988-98</RefSource><PMID Version="1">20504914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurol. 2010 Dec;6(12):657-66</RefSource><PMID Version="1">21060341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1990 Sep 15;66(6):1117-23</RefSource><PMID Version="1">2169332</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010523" MajorTopicYN="N">Peripheral Nervous System Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011984" MajorTopicYN="N">Sensory Receptor Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Base excision repair</Keyword><Keyword MajorTopicYN="N">Cisplatin damage</Keyword><Keyword MajorTopicYN="N">Nucleotide excision repair</Keyword><Keyword MajorTopicYN="N">Replication protein A</Keyword><Keyword MajorTopicYN="N">Sensory neuronal cultures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26164266</ArticleId><ArticleId IdType="pii">S0027-5107(15)30016-6</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2015.06.010</ArticleId><ArticleId IdType="pmc">PMC4554977</ArticleId><ArticleId IdType="mid">NIHMS709203</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26161242</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1942-0994</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Oxidative medicine and cellular longevity</Title><ISOAbbreviation>Oxid Med Cell Longev</ISOAbbreviation></Journal><ArticleTitle>OGG1 Involvement in High Glucose-Mediated Enhancement of Bupivacaine-Induced Oxidative DNA Damage in SH-SY5Y Cells.</ArticleTitle><Pagination><MedlinePgn>683197</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2015/683197</ELocationID><Abstract><AbstractText>Hyperglycemia can inhibit expression of the 8-oxoG-DNA glycosylase (OGG1) which is one of the key repair enzymes for DNA oxidative damage. The effect of hyperglycemia on OGG1 expression in response to local anesthetics-induced DNA damage is unknown. This study was designed to determine whether high glucose inhibits OGG1 expression and aggravates bupivacaine-induced DNA damage via reactive oxygen species (ROS). SH-SY5Y cells were cultured with or without 50 mM glucose for 8 days before they were treated with 1.5 mM bupivacaine for 24 h. OGG1 expression was measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. ROS was estimated using the redox-sensitive fluorescent dye DCFH-DA. DNA damage was investigated with immunostaining for 8-oxodG and comet assays. OGG1 expression was inhibited in cells exposed to high glucose with concomitant increase in ROS production and more severe DNA damage as compared to control culture conditions, and these changes were further exacerbated by bupivacaine. Treatment with the antioxidant N-acetyl-L-cysteine (NAC) prevented high glucose and bupivacaine mediated increase in ROS production and restored functional expression of OGG1, which lead to attenuated high glucose-mediated exacerbation of bupivacaine neurotoxicity. Our findings indicate that subjects with diabetes may experience more detrimental effects following bupivacaine use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhong-Jie</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, No. 253 Middle Gongye Street, Guangzhou, Guangdong 510282, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, No. 253 Middle Gongye Street, Guangzhou, Guangdong 510282, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qing-Guo</ForeName><Initials>QG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, No. 253 Middle Gongye Street, Guangzhou, Guangdong 510282, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, No. 253 Middle Gongye Street, Guangzhou, Guangdong 510282, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lu-Ying</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, No. 253 Middle Gongye Street, Guangzhou, Guangdong 510282, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, No. 253 Middle Gongye Street, Guangzhou, Guangdong 510282, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shi-Yuan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, No. 253 Middle Gongye Street, Guangzhou, Guangdong 510282, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oxid Med Cell Longev</MedlineTA><NlmUniqueID>101479826</NlmUniqueID><ISSNLinking>1942-0994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>WYQ7N0BPYC</RegistryNumber><NameOfSubstance UI="D000111">Acetylcysteine</NameOfSubstance></Chemical><Chemical><RegistryNumber>Y8335394RO</RegistryNumber><NameOfSubstance UI="D002045">Bupivacaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):5-23</RefSource><PMID Version="1">14637244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S241-5</RefSource><PMID Version="1">12874439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2005 Jun;54(6):1615-25</RefSource><PMID Version="1">15919781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dent Res. 2005 Sep;84(9):852-7</RefSource><PMID Version="1">16109997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2006 Mar 1;40(5):754-62</RefSource><PMID Version="1">16520228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):257-73</RefSource><PMID Version="1">16506271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anesth Analg. 2006 Nov;103(5):1294-9</RefSource><PMID Version="1">17056972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2006 Nov 8;5(11):1337-45</RefSource><PMID Version="1">16861056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2007 Nov-Dec;128(11-12):637-49</RefSource><PMID Version="1">18006041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Feb 1;638(1-2):110-21</RefSource><PMID Version="1">17961607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2008;3(6):1101-8</RefSource><PMID Version="1">18546601</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2008 Oct;57(10):2626-36</RefSource><PMID Version="1">18599524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes. 2009 Jun;58(6):1356-64</RefSource><PMID Version="1">19252136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacology. 2011;87(3-4):121-9</RefSource><PMID Version="1">21304223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):1856-61</RefSource><PMID Version="1">22308447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cells. 2013 Jun;35(6):489-97</RefSource><PMID Version="1">23677377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oxid Med Cell Longev. 2013;2013:159864</RefSource><PMID Version="1">24228138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(11):e79739</RefSource><PMID Version="1">24260294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ageing Res Rev. 2013 Sep;12(4):918-30</RefSource><PMID Version="1">24080227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):708-26</RefSource><PMID Version="1">23901781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2014 Jul;19:143-51</RefSource><PMID Version="1">24767258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2014 May-Jun;763-764:53-63</RefSource><PMID Version="1">24732344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reprod Sci. 2015 Jan;22(1):102-12</RefSource><PMID Version="1">24828139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2014 Jul;15(7):906-10</RefSource><PMID Version="1">24755532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metabolism. 2000 Aug;49(8):1030-5</RefSource><PMID Version="1">10954022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Jul 15;61(14):5378-81</RefSource><PMID Version="1">11454679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Jun 1;32(11):1102-15</RefSource><PMID Version="1">12031895</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2004 Sep;567(1):1-61</RefSource><PMID Version="1">15341901</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000111" MajorTopicYN="N">Acetylcysteine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002045" MajorTopicYN="N">Bupivacaine</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020552" MajorTopicYN="N">Comet Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>09</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26161242</ArticleId><ArticleId IdType="doi">10.1155/2015/683197</ArticleId><ArticleId IdType="pmc">PMC4486758</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26134573</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>290</Volume><Issue>34</Issue><PubDate><Year>2015</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Reduced Nuclease Activity of Apurinic/Apyrimidinic Endonuclease (APE1) Variants on Nucleosomes: IDENTIFICATION OF ACCESS RESIDUES.</ArticleTitle><Pagination><MedlinePgn>21067-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M115.665547</ELocationID><Abstract><AbstractText>Non-coding apurinic/apyrimidinic (AP) sites are generated at high frequency in genomic DNA via spontaneous hydrolytic, damage-induced or enzyme-mediated base release. AP endonuclease 1 (APE1) is the predominant mammalian enzyme responsible for initiating removal of mutagenic and cytotoxic abasic lesions as part of the base excision repair (BER) pathway. We have examined here the ability of wild-type (WT) and a collection of variant/mutant APE1 proteins to cleave at an AP site within a nucleosome core particle. Our studies indicate that, in comparison to the WT protein and other variant/mutant enzymes, the incision activity of the tumor-associated variant R237C and the rare population variant G241R are uniquely hypersensitive to nucleosome complexes in the vicinity of the AP site. This defect appears to stem from an abnormal interaction of R237C and G241R with abasic DNA substrates, but is not simply due to a DNA binding defect, as the site-specific APE1 mutant Y128A, which displays markedly reduced AP-DNA complex stability, did not exhibit a similar hypersensitivity to nucleosome structures. Notably, this incision defect of R237C and G241R was observed on a pre-assembled DNA glycosylase·AP-DNA complex as well. Our results suggest that the BER enzyme, APE1, has acquired distinct surface residues that permit efficient processing of AP sites within the context of protein-DNA complexes independent of classic chromatin remodeling mechanisms. </AbstractText><CopyrightInformation>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hinz</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>From the School of Molecular Biosciences, Washington State University, Pullman, Washington 99164-7520 and jmhinz@wsu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the School of Molecular Biosciences, Washington State University, Pullman, Washington 99164-7520 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNeill</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>the Laboratory of Molecular Gerontology, National Institute on Aging, IRP, National Institutes of Health, Baltimore, Maryland 21224.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>the Laboratory of Molecular Gerontology, National Institute on Aging, IRP, National Institutes of Health, Baltimore, Maryland 21224.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>3LZ0</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>R01 ES002614</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES004106</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES004106</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES002614</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 ES020955</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 ES002614</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES020955</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009707">Nucleosomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 1997 Sep 18;389(6648):251-60</RefSource><PMID Version="1">9305837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2007 Aug 17;371(3):649-68</RefSource><PMID Version="1">17586522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Apr 1;6(4):454-60</RefSource><PMID Version="1">17123872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2007 Dec;27(24):8442-53</RefSource><PMID Version="1">17923696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2015 Jan 30;427(2):298-311</RefSource><PMID Version="1">25498387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2013 Feb;228(2):258-66</RefSource><PMID Version="1">22718094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 May 10;288(19):13863-75</RefSource><PMID Version="1">23543741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Jul 15;61(14):5552-7</RefSource><PMID Version="1">11454706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Biol. 2000 Mar;7(3):176-8</RefSource><PMID Version="1">10700268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2012 Mar;69(5):727-40</RefSource><PMID Version="1">21952828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2014 Aug;766-767:19-24</RefSource><PMID Version="1">25083139</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2008 Nov 4;47(44):11434-45</RefSource><PMID Version="1">18839966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Mar 1;685(1-2):11-20</RefSource><PMID Version="1">19909758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1998 Jun 1;26(11):2771-8</RefSource><PMID Version="1">9592167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1998 Sep 1;17(17):5214-26</RefSource><PMID Version="1">9724657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(6):e65922</RefSource><PMID Version="1">23776569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(3):e90837</RefSource><PMID Version="1">24595156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Jan 22;285(4):2876-85</RefSource><PMID Version="1">19933279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1998 Feb 13;276(1):19-42</RefSource><PMID Version="1">9514715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 1986;20:201-30</RefSource><PMID Version="1">3545059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2002 Nov 1;21(21):5943-52</RefSource><PMID Version="1">12411511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4646-51</RefSource><PMID Version="1">20176960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2013 Jan;1834(1):247-71</RefSource><PMID Version="1">23076011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7465-70</RefSource><PMID Version="1">12799467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Apr 22;362(6422):709-15</RefSource><PMID Version="1">8469282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2010 Sep 14;49(36):7879-91</RefSource><PMID Version="1">20701268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1995 Aug;15(8):4375-84</RefSource><PMID Version="1">7623832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1998 Jan 13;37(2):580-9</RefSource><PMID Version="1">9425080</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2014 Dec;35(12):2643-52</RefSource><PMID Version="1">25355293</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2000 May 5;298(3):447-59</RefSource><PMID Version="1">10772862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(2):692-700</RefSource><PMID Version="1">21930508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1980 Aug 25;8(16):3517-34</RefSource><PMID Version="1">7433098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43</RefSource><PMID Version="1">15824325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1999 Dec 14;38(50):16553-60</RefSource><PMID Version="1">10600117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2010 Oct 15;403(1):1-10</RefSource><PMID Version="1">20800598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Aug 30;460(3-4):183-99</RefSource><PMID Version="1">10946228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2011 Nov;31(22):4623-32</RefSource><PMID Version="1">21930793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1993 Dec 11;21(24):5561-9</RefSource><PMID Version="1">8284199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1993 Dec;7(12A):2471-82</RefSource><PMID Version="1">8253391</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009707" MajorTopicYN="N">Nucleosomes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AP endonuclease 1</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">base excision repair (BER)</Keyword><Keyword MajorTopicYN="N">genetic polymorphism</Keyword><Keyword MajorTopicYN="N">nucleosome</Keyword><Keyword MajorTopicYN="N">protein-DNA interaction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26134573</ArticleId><ArticleId IdType="pii">M115.665547</ArticleId><ArticleId IdType="doi">10.1074/jbc.M115.665547</ArticleId><ArticleId IdType="pmc">PMC4543664</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26125438</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>27</Issue><PubDate><Year>2015</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation.</ArticleTitle><Pagination><MedlinePgn>23383-98</MedlinePgn></Pagination><Abstract><AbstractText>The present study evaluated the mechanism of apoptosis caused by post-translational modification, hyperacetylation in triple-negative breast cancer (TNBC) cells. We previously showed that trichostatin A (TSA) induced secretion of acetylated apurinic apyrimidinic endonuclease 1/redox factor-1 (Ac-APE1/Ref-1). This is the first report showing that Ac-APE1/Ref-1 initiates apoptosis in TNBC cells by binding to the receptor for advanced glycation end products (RAGE). The functional significance of secreted Ac-APE1/Ref-1 was studied by induction of intracellular hyperacetylation through co-treatment with acetylsalicylic acid and TSA in MDA-MB-231 cells. In response to hyperacetylation, secretion of Ac-APE1/Ref-1 in vesicles was observed, resulting in significantly decreased cell viability and induction of apoptosis with increased expression of RAGE. The hyperacetylation-induced apoptosis was similar in two other TNBC cell lines: BT-459 and MDA-MB-468. Therefore, hyperacetylation may be a therapeutic target for treatment of TNBCs. This study introduces a novel paradigm whereby post-translational modification induces apoptotic cell death in breast cancer cells resistant to standard chemotherapeutic agents through secretion of auto- or paracrine molecules such as Ac-APE1/Ref-1. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yu Ran</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301747, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ki Mo</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Cancer Research Team, Korean Medicine Based Herbal Drug Research Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine, (KIOM), Daejeon, 305811, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeong Hwa</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301747, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Institute of Medical Sciences, Department of Physiology, School of Medicine, Chungnam National University, Daejeon, 301747, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000951">Antigens, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006877">Hydroxamic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067759">Receptor for Advanced Glycation End Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>3X2S926L3Z</RegistryNumber><NameOfSubstance UI="C012589">trichostatin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048051">p38 Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Oct 15;22(20):5551-60</RefSource><PMID Version="1">14532127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2014;20(7):1161-9</RefSource><PMID Version="1">24552186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2013;4:e519</RefSource><PMID Version="1">23449455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2006 Dec;3(12):995-1000</RefSource><PMID Version="1">17072308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2006;75:93-109</RefSource><PMID Version="1">16756486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2007 Jul 31;581(19):3689-94</RefSource><PMID Version="1">17499247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2011 Jun;31(6):2017-22</RefSource><PMID Version="1">21737617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2009 Jul;10(7):783-9</RefSource><PMID Version="1">19483673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 14;435(4):621-6</RefSource><PMID Version="1">23685156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Inflam. 2013;2013:403460</RefSource><PMID Version="1">24102034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2008 Dec 15;14(24):8010-8</RefSource><PMID Version="1">19088017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2004 Jun;34(6):1503-12</RefSource><PMID Version="1">15162419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2006 Apr;97(1):151-61</RefSource><PMID Version="1">16515552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e41945</RefSource><PMID Version="1">22860037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med Rep. 2009 Jul-Aug;2(4):533-7</RefSource><PMID Version="1">21475861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2011 Dec 1;257(2):165-73</RefSource><PMID Version="1">21933677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 7;435(3):403-7</RefSource><PMID Version="1">23665318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2013 Dec 15;273(3):659-71</RefSource><PMID Version="1">24161344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Nov;36 Suppl 3:S80-6</RefSource><PMID Version="1">21129616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Anticancer Ther. 2010 Jun;10(6):935-54</RefSource><PMID Version="1">20553216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Mar 15;186(6):3517-26</RefSource><PMID Version="1">21300822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Dec 1;24(34):5381-7</RefSource><PMID Version="1">17135639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1998 Nov 26;339(22):1609-18</RefSource><PMID Version="1">9828250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2000 Apr 1;151(7):703-14</RefSource><PMID Version="1">10752798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2001 May 4;84(9):1188-92</RefSource><PMID Version="1">11336469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Rep. 2002 Oct;3(10):995-1001</RefSource><PMID Version="1">12231511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Oncol. 2010 Dec;33(6):637-45</RefSource><PMID Version="1">20023571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2001 Dec;1(2):85-94</RefSource><PMID Version="1">12467226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Mar;42(5):3089-103</RefSource><PMID Version="1">24335147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 2003 May;270(10):2109-19</RefSource><PMID Version="1">12752430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Dec 29;353(26):2747-57</RefSource><PMID Version="1">16382061</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):768-72</RefSource><PMID Version="1">15824141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Oct;3(10):1215-20</RefSource><PMID Version="1">15486188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Ther. 2008 Aug;30(8):1426-47</RefSource><PMID Version="1">18803986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2007 Jun;103(2):149-60</RefSource><PMID Version="1">17039263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2001 May;15(7):1273-5</RefSource><PMID Version="1">11344111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Sep;22(9):1393-7</RefSource><PMID Version="1">11532860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Med. 2007 Dec;7(8):777-89</RefSource><PMID Version="1">18331236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Dis. 2005-2006;24:3-15</RefSource><PMID Version="1">16917136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2003 Jun 12;348(24):2431-42</RefSource><PMID Version="1">12802030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(3):e91610</RefSource><PMID Version="1">24626188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Cell Biol. 2012 Jan;90(1):85-94</RefSource><PMID Version="1">22124371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotox Res. 2011 Aug;20(2):159-69</RefSource><PMID Version="1">21116767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Clin Oncol. 1988 Jan;24(1):29-43</RefSource><PMID Version="1">3276531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34</RefSource><PMID Version="1">17671126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2006;8(4):R39</RefSource><PMID Version="1">16846528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1995 Sep 30;346(8979):883-7</RefSource><PMID Version="1">7564675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Exp Biol. 2003 Nov;41(11):1273-8</RefSource><PMID Version="1">15332496</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000107" MajorTopicYN="N">Acetylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000951" MajorTopicYN="N">Antigens, Neoplasm</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="Y">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006877" MajorTopicYN="N">Hydroxamic Acids</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046529" MajorTopicYN="N">Microscopy, Electron, Transmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067759" MajorTopicYN="N">Receptor for Advanced Glycation End Products</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064726" MajorTopicYN="N">Triple Negative Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1/Ref-1</Keyword><Keyword MajorTopicYN="N">RAGE</Keyword><Keyword MajorTopicYN="N">acetylation</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">triple-negative breast cancer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26125438</ArticleId><ArticleId IdType="pii">4345</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.4345</ArticleId><ArticleId IdType="pmc">PMC4695125</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26119662</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1880-5779</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>1</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Genes &amp; genetic systems</Title><ISOAbbreviation>Genes Genet. Syst.</ISOAbbreviation></Journal><ArticleTitle>Drosophila Ogg1 is required to suppress 8-oxo-guanine accumulation following oxidative stress.</ArticleTitle><Pagination><MedlinePgn>11-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1266/ggs.90.11</ELocationID><Abstract><AbstractText>Reactive oxygen species (ROS) generated during energy production processes are a major cause of oxidative DNA damage. A DNA glycosylase encoded by the Ogg1 gene removes oxidized guanine bases and is widely conserved. However, the biological role of the gene in individual organisms has not yet been characterized in Drosophila, which is a suitable model to study the influence of oxidative damage on senescence. Here, we performed a genetic analysis to confirm that Ogg1 plays an essential role in the removal of 8-oxo-guanines from nuclei. We first confirmed by quantitative real-time PCR that Ogg1 mRNA expression was reduced by 30-55% in Ogg1 mutants and in flies expressing inducible Ogg1 dsRNA compared to control flies. We then showed that additional accumulation of 8-oxo-guanines occurred in the nuclei of epithelial midgut cells after paraquat feeding in flies with downregulated Ogg1 expression. We confirmed that a transposon possessing the UAS sequence was integrated in the 5'-UTR of the Ogg1 alleles and that it is oriented in the same transcriptional direction as the gene. Using the Gal4/UAS system, which enables us to induce ectopic expression in Drosophila, we induced overexpression of Ogg1 by 40-fold. We observed a lower amount of 8-oxo-guanine in the midgut epithelial cells of adults overexpressing Ogg1. These genetic data strongly suggest that the Drosophila Ogg1 ortholog CG1795 plays an essential role in the suppression of 8-oxo-guanines, consistent with its role in other organisms. Although adult flies with reduced Ogg1 expression failed to show elevated sensitivity to paraquat, those with Ogg1 overexpression showed resistance to oxidative stress by paraquat feeding and had a significantly longer lifespan in normal feeding conditions. These observations are consistent with the hypothesis that oxidative DNA damage by ROS accumulation is a major contributor to senescence. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yasukawa</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Insect Biomedical Research Center, Kyoto Institute of Technology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakahara</LastName><ForeName>Yasuyuki</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Hirai</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Yoshihiro H</ForeName><Initials>YH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Genes Genet Syst</MedlineTA><NlmUniqueID>9607822</NlmUniqueID><ISSNLinking>1341-7568</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004251">DNA Transposable Elements</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C557617">GAL4 protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C516999">Ogg1 protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>PLG39H7695</RegistryNumber><NameOfSubstance UI="D010269">Paraquat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004251" MajorTopicYN="N">DNA Transposable Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010269" MajorTopicYN="N">Paraquat</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26119662</ArticleId><ArticleId IdType="doi">10.1266/ggs.90.11</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26089640</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1177-8881</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Drug design, development and therapy</Title><ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation></Journal><ArticleTitle>Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.</ArticleTitle><Pagination><MedlinePgn>2887-910</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S82724</ELocationID><Abstract><AbstractText>AT-101 is a BH3 mimetic and pan-Bcl-2 inhibitor that has shown potent anticancer activity in non-small-cell lung cancer (NSCLC) in murine models, but failed to show clinical efficacy when used in combination with docetaxel in NSCLC patients. Our recent study has demonstrated that AT-101 enhanced the antitumor effect of cisplatin (CDDP) in a murine model of NSCLC via inhibition of the interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway. This study explored the underlying mechanisms for the enhanced anticancer activity of CDDP by AT-101. Our results show that, when compared with monotherapy, AT-101 significantly enhanced the inhibitory effects of CDDP on proliferation and migration of A549 cells and on tube formation and migration in human umbilical vein endothelial cells. AT-101 promoted the proapoptotic activity of CDDP in A549 cells. AT-101 also enhanced the inhibitory effect of CDDP on DNA repair and redox activities of apurinic/apyrimidinic endonuclease 1 (APE1) in A549 cells. In tumor tissues from nude mice treated with AT-101 plus CDDP or monotherapy, the combination therapy resulted in greater inhibition of angiogenesis and tumor cell proliferation than the monotherapy. These results suggest that AT-101 can enhance the antitumor activity of CDDP in NSCLC via inhibition of APE1 DNA repair and redox activities and by angiogenesis and induction of apoptosis, but other mechanisms cannot be excluded. We are now conducting a Phase II trial to examine the clinical efficacy and safety profile of combined use of AT-101 plus CDDP in advanced NSCLC patients. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China ; Department of Oncology, The Affiliated Hospital, North Sichuan Medical College, Sichuan, People's Republic of China ; Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Jinlu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncology, The 97 Hospital of PLA, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guangjie</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cancer Diagnosis and Treatment Center, Military District General Hospital of Chengdu Military Region, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China ; Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Guoshou</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chongyi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shiheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yuxing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shu-Feng</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Des Devel Ther</MedlineTA><NlmUniqueID>101475745</NlmUniqueID><ISSNLinking>1177-8881</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>KAV15B369O</RegistryNumber><NameOfSubstance UI="D006072">Gossypol</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>S7RL72610R</RegistryNumber><NameOfSubstance UI="C028178">gossypol acetic acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2001 Apr;66(3):239-48</RefSource><PMID Version="1">11510695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):14-35</RefSource><PMID Version="1">22122462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2003 Sep 25;46(20):4259-64</RefSource><PMID Version="1">13678404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2015 Mar 14;385(9972):977-1010</RefSource><PMID Version="1">25467588</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2013 Oct;54(10):2263-8</RefSource><PMID Version="1">23398207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2007 Aug;7(8):573-84</RefSource><PMID Version="1">17625587</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):157-63</RefSource><PMID Version="1">14637252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2010 Feb 16;102(4):704-9</RefSource><PMID Version="1">20087352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Androl. 1998 Feb;21(1):8-12</RefSource><PMID Version="1">9639146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Jul;23(7):1803-8</RefSource><PMID Version="1">22112969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Oncol. 2014 Apr;41(2):235-51</RefSource><PMID Version="1">24787295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2014 Aug;1846(1):161-79</RefSource><PMID Version="1">24836679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2009 May 1;15(9):3172-6</RefSource><PMID Version="1">19366825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2008 Jun 18;264(2):192-200</RefSource><PMID Version="1">18314260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2012 Feb 1;72(3):716-25</RefSource><PMID Version="1">22158856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Des Devel Ther. 2014;8:2517-29</RefSource><PMID Version="1">25548514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Aug 24;130(4):691-703</RefSource><PMID Version="1">17719546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Angiogenesis. 2014 Jul;17(3):471-94</RefSource><PMID Version="1">24482243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2008 Sep 25;359(13):1367-80</RefSource><PMID Version="1">18815398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2014 May;40(4):548-57</RefSource><PMID Version="1">24360358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Life Sci. 2014 Apr 25;102(1):41-8</RefSource><PMID Version="1">24625733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunopharmacol Immunotoxicol. 2013 Oct;35(5):615-21</RefSource><PMID Version="1">23981004</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(5):e96733</RefSource><PMID Version="1">24824755</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Cancer Biol. 2003 Apr;13(2):159-67</RefSource><PMID Version="1">12654259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Mar 1;61(5):2183-8</RefSource><PMID Version="1">11280784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2013 Aug 24;382(9893):709-19</RefSource><PMID Version="1">23972814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2008 Sep 1;45(5):592-601</RefSource><PMID Version="1">18515104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;9(6):e99528</RefSource><PMID Version="1">24914806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2007 Dec;98(12):1993-2001</RefSource><PMID Version="1">17892509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thorac Oncol. 2010 Oct;5(10):1637-43</RefSource><PMID Version="1">20808253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1999 Feb;154(2):375-84</RefSource><PMID Version="1">10027396</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancers (Basel). 2014 Sep 05;6(3):1769-92</RefSource><PMID Version="1">25198391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2014 Jan;34(1):493-501</RefSource><PMID Version="1">24403507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2005 Jan;4(1):13-21</RefSource><PMID Version="1">15657349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thorac Oncol. 2011 Oct;6(10):1757-60</RefSource><PMID Version="1">21918390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2009 Dec;66(3):298-304</RefSource><PMID Version="1">19324449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2010 Jul;8(7):1002-16</RefSource><PMID Version="1">20587533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Clin Oncol. 2014 Jul;11(7):413-31</RefSource><PMID Version="1">24913374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Pharmacol. 2014 Oct 5;740:364-78</RefSource><PMID Version="1">25058905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Jun 15;65(12):5063-9</RefSource><PMID Version="1">15958549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2005 Mar;5(3):231-7</RefSource><PMID Version="1">15738985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Oct 15;121(8):1670-9</RefSource><PMID Version="1">17597109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2014;5:e1257</RefSource><PMID Version="1">24874729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17844-9</RefSource><PMID Version="1">24127576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest New Drugs. 2014 Apr;32(2):295-302</RefSource><PMID Version="1">23860642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2006 Oct;20(12):2147-9</RefSource><PMID Version="1">16935937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2011 Nov 12;378(9804):1727-40</RefSource><PMID Version="1">21565398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Jan 22;140(2):268-79</RefSource><PMID Version="1">20141840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Lett. 2014 Apr;7(4):1078-1082</RefSource><PMID Version="1">24944672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2005 Jul;4(7):1096-104</RefSource><PMID Version="1">16020667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2013 Oct;13(10):714-26</RefSource><PMID Version="1">24060863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2005 Jan;4(1):23-31</RefSource><PMID Version="1">15657350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chin J Cancer. 2014 Aug;33(8):402-5</RefSource><PMID Version="1">25011459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Des Devel Ther. 2014;8:485-96</RefSource><PMID Version="1">24872679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autophagy. 2010 Nov;6(8):1201-3</RefSource><PMID Version="1">20930561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource><PMID Version="1">25651787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2013 Sep;12(9):1691-700</RefSource><PMID Version="1">23974697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e50786</RefSource><PMID Version="1">23226540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Redox Biol. 2014;2:485-94</RefSource><PMID Version="1">24624338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2012 Mar 16;148(6):1145-59</RefSource><PMID Version="1">22424226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e55313</RefSource><PMID Version="1">23418439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2013 Nov;31(9):582-99</RefSource><PMID Version="1">24164298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2014 Dec 9;111(12):2275-86</RefSource><PMID Version="1">25375271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</RefSource><PMID Version="1">25559415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2014 Nov 10;26(5):605-22</RefSource><PMID Version="1">25517747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2010 Feb;9(2):461-70</RefSource><PMID Version="1">20124455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2003 Jul 1;66(1):93-103</RefSource><PMID Version="1">12818369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2011 Nov 12;378(9804):1741-55</RefSource><PMID Version="1">21565397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Contraception. 1988 Mar;37(3):269-77</RefSource><PMID Version="1">2836127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Res. 2008 Nov-Dec;58(5-6):323-31</RefSource><PMID Version="1">18840529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2014 May 21;311(19):1975-6</RefSource><PMID Version="1">24846033</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 Jul-Sep;753(1):24-40</RefSource><PMID Version="1">23416207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharm Biol. 2014 Jan;52(1):124-8</RefSource><PMID Version="1">24073600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasma. 2014;61(2):186-92</RefSource><PMID Version="1">24299314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2014 Feb;105(2):186-94</RefSource><PMID Version="1">24329908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2014 Jul;55(7):4461-9</RefSource><PMID Version="1">24970265</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2015 Jan 30;290(5):3057-68</RefSource><PMID Version="1">25492865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Med. 2014;46:e106</RefSource><PMID Version="1">25033834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Dec 12;135(6):1004-6</RefSource><PMID Version="1">19070569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Nov 11;147(4):742-58</RefSource><PMID Version="1">22078876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2008 Dec;27 Suppl 1:S2-19</RefSource><PMID Version="1">19641503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Sep 16;146(6):873-87</RefSource><PMID Version="1">21925313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2011 May;10(5):795-805</RefSource><PMID Version="1">21372225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2009 Feb 15;15(4):1126-32</RefSource><PMID Version="1">19228717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thorac Oncol. 2011 Apr;6(4):781-5</RefSource><PMID Version="1">21289522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2014 Jan;4(1):31-41</RefSource><PMID Version="1">24356098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Metastasis. 2012 Feb;29(2):165-78</RefSource><PMID Version="1">22167622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47462</RefSource><PMID Version="1">23094050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2002 Jan 25;108(2):153-64</RefSource><PMID Version="1">11832206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Jul 15;53(2):237-48</RefSource><PMID Version="1">22580151</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006072" MajorTopicYN="N">Gossypol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061307" MajorTopicYN="N">Human Umbilical Vein Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009389" MajorTopicYN="N">Neovascularization, Pathologic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AT-101</Keyword><Keyword MajorTopicYN="N">angiogenesis</Keyword><Keyword MajorTopicYN="N">apurinic/apyrimidinic endonuclease 1</Keyword><Keyword MajorTopicYN="N">cisplatin</Keyword><Keyword MajorTopicYN="N">non-small-cell lung cancer</Keyword><Keyword MajorTopicYN="N">tumor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26089640</ArticleId><ArticleId IdType="doi">10.2147/DDDT.S82724</ArticleId><ArticleId IdType="pii">dddt-9-2887</ArticleId><ArticleId IdType="pmc">PMC4467754</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26089588</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-8630</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Disease markers</Title><ISOAbbreviation>Dis. Markers</ISOAbbreviation></Journal><ArticleTitle>OGG1 Mutations and Risk of Female Breast Cancer: Meta-Analysis and Experimental Data.</ArticleTitle><Pagination><MedlinePgn>690878</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2015/690878</ELocationID><Abstract><AbstractText>In first part of this study association between OGG1 polymorphisms and breast cancer susceptibility was explored by meta-analysis. Second part of the study involved 925 subjects, used for mutational analysis of OGG1 gene using PCR-SSCP and sequencing. Fifteen mutations were observed, which included five intronic mutations, four splice site mutations, two 3'UTR mutations, three missense mutations, and a nonsense mutation. Significantly (p &lt; 0.001) increased (~29 fold) breast cancer risk was associated with a splice site variant g.9800972T&gt;G and 3'UTR variant g.9798848G&gt;A. Among intronic mutations, highest (~15 fold) increase in breast cancer risk was associated with g.9793680G&gt;A (p &lt; 0.009). Similarly ~14-fold increased risk was associated with Val159Gly (p &lt; 0.01), ~17-fold with Gly221Arg (p &lt; 0.005), and ~18-fold with Ser326Cys (p &lt; 0.004) in breast cancer patients compared with controls, whereas analysis of nonsense mutation showed that ~13-fold (p &lt; 0.01) increased breast cancer risk was associated with Trp375STOP in patients compared to controls. In conclusion, a significant association was observed between OGG1 germ line mutations and breast cancer risk. These findings provide evidence that OGG1 may prove to be a good candidate of better diagnosis, treatment, and prevention of breast cancer. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Kashif</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cancer Genetics Laboratory, Department of Biosciences, COMSATS Institute of Information Technology, Park Road, Chak Shahzad, Islamabad 44000, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahjabeen</LastName><ForeName>Ishrat</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cancer Genetics Laboratory, Department of Biosciences, COMSATS Institute of Information Technology, Park Road, Chak Shahzad, Islamabad 44000, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabir</LastName><ForeName>Maimoona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Genetics Laboratory, Department of Biosciences, COMSATS Institute of Information Technology, Park Road, Chak Shahzad, Islamabad 44000, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehmood</LastName><ForeName>Humera</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Nuclear Medicine Oncology &amp; Radiotherapy Institute (NORI), Islamabad 44000, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kayani</LastName><ForeName>Mahmood Akhtar</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cancer Genetics Laboratory, Department of Biosciences, COMSATS Institute of Information Technology, Park Road, Chak Shahzad, Islamabad 44000, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Markers</MedlineTA><NlmUniqueID>8604127</NlmUniqueID><ISSNLinking>0278-0240</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2012 Dec;29(4):2949-54</RefSource><PMID Version="1">22271435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2013 Jan 1;132(1):55-62</RefSource><PMID Version="1">22684821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Markers. 2013;34(2):71-80</RefSource><PMID Version="1">23324580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 May 1;519(2):231-7</RefSource><PMID Version="1">23454624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 May-Jun;745-746:6-15</RefSource><PMID Version="1">23618615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(8):e71157</RefSource><PMID Version="1">23951099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Sep;40(9):5261-73</RefSource><PMID Version="1">23673479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2013 Oct;34(5):2843-8</RefSource><PMID Version="1">23700156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:67-72</RefSource><PMID Version="1">21414327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2011 May;30(5):317-21</RefSource><PMID Version="1">21166493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2011 Jun;127(3):795-803</RefSource><PMID Version="1">21153698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2011 Jun;102(6):1123-7</RefSource><PMID Version="1">21401806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2011 Apr;42(3):226-34</RefSource><PMID Version="1">21722819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2011 Jun;133:605-12</RefSource><PMID Version="1">21727658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2011 Sep;50(9):732-7</RefSource><PMID Version="1">21520294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2011;12(4):1067-72</RefSource><PMID Version="1">21790253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2011;62(2):89-94</RefSource><PMID Version="1">21866464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2001 May 20;95(3):140-3</RefSource><PMID Version="1">11307145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2003 Feb 18;42(6):1564-72</RefSource><PMID Version="1">12578369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Jul 15;63(14):4287-92</RefSource><PMID Version="1">12874039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Sep;25(9):1689-94</RefSource><PMID Version="1">15073047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(18):5596-608</RefSource><PMID Version="1">15494448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1996 Jul 26;86(2):321-9</RefSource><PMID Version="1">8706136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2004 Dec;95(12):977-83</RefSource><PMID Version="1">15596047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-8</RefSource><PMID Version="1">16492928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Aug 1;121(3):501-5</RefSource><PMID Version="1">17417784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2007 Jul 28;631(2):101-10</RefSource><PMID Version="1">17531525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2007 Sep;17(5):156-60</RefSource><PMID Version="1">17827862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Clin Oncol. 2008 Mar;38(3):186-91</RefSource><PMID Version="1">18272472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Apr;25(2):211-3</RefSource><PMID Version="1">18393249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2008 Jan;7(1):23-7</RefSource><PMID Version="1">17932460</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasma. 2008;55(4):330-7</RefSource><PMID Version="1">18505345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Sep;111(2):279-88</RefSource><PMID Version="1">17922186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arh Hig Rada Toksikol. 2008 Dec;59(4):241-50</RefSource><PMID Version="1">19064361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 Jan 7;101(1):24-36</RefSource><PMID Version="1">19116388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2009 Jan;30(1):78-87</RefSource><PMID Version="1">19029194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2008;59(4):201-4</RefSource><PMID Version="1">19391486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Jun;16(6):1695-703</RefSource><PMID Version="1">19266243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2009 Apr;29(4):1389-93</RefSource><PMID Version="1">19414392</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tohoku J Exp Med. 2009 Jul;218(3):185-91</RefSource><PMID Version="1">19561388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tohoku J Exp Med. 2009 Dec;219(4):269-75</RefSource><PMID Version="1">19966524</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Mar;17(3):760-71</RefSource><PMID Version="1">20183911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Nov-Dec;680(1-2):56-63</RefSource><PMID Version="1">19815090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2010 Apr;7(4):248-9</RefSource><PMID Version="1">20354512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2010 Apr;75(4):779-85</RefSource><PMID Version="1">19914697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Coll Physicians Surg Pak. 2010 Mar;20(3):181-5</RefSource><PMID Version="1">20392381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gastrointest Cancer. 2010 Jun;41(2):110-5</RefSource><PMID Version="1">20069464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 Dec 15;532(2):192-6</RefSource><PMID Version="1">24076439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2013;14(9):5145-51</RefSource><PMID Version="1">24175791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2014;15(3):1133-40</RefSource><PMID Version="1">24606430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Mar;35(3):2397-402</RefSource><PMID Version="1">24186001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomarkers. 2014 Sep;19(6):509-16</RefSource><PMID Version="1">25089939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Feb;38(2):1251-61</RefSource><PMID Version="1">20571908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Jul 1;116(13):3160-9</RefSource><PMID Version="1">20564624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2010;16:991-6</RefSource><PMID Version="1">20577654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2010;11(1):165-8</RefSource><PMID Version="1">20593951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2010 Aug;7(8):575-6</RefSource><PMID Version="1">20676075</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2010 Aug;14(4):559-64</RefSource><PMID Version="1">20649433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2010 Sep 21;16(35):4476-82</RefSource><PMID Version="1">20845517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Oct;30(10):4141-5</RefSource><PMID Version="1">21036733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Jan;38(1):445-51</RefSource><PMID Version="1">20364408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Nov;38(8):5379-86</RefSource><PMID Version="1">21390502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Dec 24;726(2):227-33</RefSource><PMID Version="1">21986195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2011 Nov-Dec;29(6):641-6</RefSource><PMID Version="1">19914098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2012 Jan;39(1):527-34</RefSource><PMID Version="1">21559836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2011 Nov;31(11):3939-44</RefSource><PMID Version="1">22110223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Feb;23(2):401-5</RefSource><PMID Version="1">21515665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2011;12(10):2779-83</RefSource><PMID Version="1">22320992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2012;135:64-71</RefSource><PMID Version="1">22382185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol. 2012 Apr;36(2):183-9</RefSource><PMID Version="1">21974800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2012 Apr;31(4):541-6</RefSource><PMID Version="1">21899442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(4):e35970</RefSource><PMID Version="1">22540013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2012 Apr;133(4):127-32</RefSource><PMID Version="1">22019847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chim Acta. 2012 Oct 9;413(19-20):1519-24</RefSource><PMID Version="1">22687647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2012 Sep;138(9):1443-8</RefSource><PMID Version="1">22526153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2012;13(5):1803-8</RefSource><PMID Version="1">22901126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dig Dis Sci. 2012 Sep;57(9):2451-7</RefSource><PMID Version="1">22565339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2012 Nov;28(5):1859-68</RefSource><PMID Version="1">22922830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathol Oncol Res. 2012 Oct;18(4):1015-20</RefSource><PMID Version="1">22544315</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018095" MajorTopicYN="Y">Germ-Line Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26089588</ArticleId><ArticleId IdType="doi">10.1155/2015/690878</ArticleId><ArticleId IdType="pmc">PMC4452349</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26081414</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1791-2423</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of oncology</Title><ISOAbbreviation>Int. J. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.</ArticleTitle><Pagination><MedlinePgn>610-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/ijo.2015.3048</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1, Ape1) is a multifunctional protein that is upregulated in human pancreatic cancer. Ape1 redox domain plays an essential role in regulating the effects of reactive oxygen species (ROS) generated during physiological metabolism and pathological stress. In the present study, we explored whether Ape1 and ROS affect WNT/β-catenin signaling. We used E3330, a small molecule inhibitor of the redox activity of Ape1, and a siRNA approach to knock down Ape1, in two human pancreatic cancer cell lines. Inhibition of Ape1 resulted in growth suppression of pancreatic cancer cells, increased ROS levels, upregulation of β-catenin and c-myc and downregulation of cyclin D1. Consistent with these data, overexpression of Ape1 in pancreatic cancer cells reduced ROS and c-myc levels and increased cyclin D1 levels. Moreover, treatment of pancreatic cancer cells with H2O2 to induce oxidative stress resulted in upregulated ROS levels, decreased Ape1 at both the mRNA and protein level, and alterations in WNT/β-catenin pathway components. Finally, treatment of pancreatic cancer cells with the WNT/β-catenin inhibitor IWR-1 resulted in growth inhibition, which was greatly enhanced when combined with E3330 treatment. In summary, our results demonstrate that ROS is an important intracellular messenger that can modulate WNT/β‑catenin signaling. The present study provides interesting new insight into crosstalk between the redox function of Ape1 and WNT/β-catenin signaling in cancer cells. Furthermore, our data show that the combination of Ape1 and WNT inhibitors enhanced the inhibition of pancreatic cell proliferation. These results provide a promising novel therapeutic strategy for treating pancreatic cancer in future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Shaojie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Haimei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Miaofeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhihua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Xin Hua Hospital, Shanghai Key Laboratory for Pediatrics Gastroenterology and Nutrition, Shanghai Institute for Pediatrics Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fei</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Baosan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Gang-Ming</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Xin Hua Hospital, Shanghai Key Laboratory for Pediatrics Gastroenterology and Nutrition, Shanghai Institute for Pediatrics Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Int J Oncol</MedlineTA><NlmUniqueID>9306042</NlmUniqueID><ISSNLinking>1019-6439</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016227">Benzoquinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C585534">IWR-1 compound</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007094">Imides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011422">Propionates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011804">Quinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>136164-66-4</RegistryNumber><NameOfSubstance UI="C075569">E 3330</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016227" MajorTopicYN="N">Benzoquinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007094" MajorTopicYN="N">Imides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011422" MajorTopicYN="N">Propionates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060449" MajorTopicYN="Y">Wnt Signaling Pathway</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>04</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26081414</ArticleId><ArticleId IdType="doi">10.3892/ijo.2015.3048</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26063178</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2199</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><PubDate><Year>2015</Year><Month>Jun</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC molecular biology</Title><ISOAbbreviation>BMC Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>SIRT6 protein deacetylase interacts with MYH DNA glycosylase, APE1 endonuclease, and Rad9-Rad1-Hus1 checkpoint clamp.</ArticleTitle><Pagination><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12867-015-0041-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">SIRT6, a member of the NAD(+)-dependent histone/protein deacetylase family, regulates genomic stability, metabolism, and lifespan. MYH glycosylase and APE1 are two base excision repair (BER) enzymes involved in mutation avoidance from oxidative DNA damage. Rad9-Rad1-Hus1 (9-1-1) checkpoint clamp promotes cell cycle checkpoint signaling and DNA repair. BER is coordinated with the checkpoint machinery and requires chromatin remodeling for efficient repair. SIRT6 is involved in DNA double-strand break repair and has been implicated in BER. Here we investigate the direct physical and functional interactions between SIRT6 and BER enzymes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We show that SIRT6 interacts with and stimulates MYH glycosylase and APE1. In addition, SIRT6 interacts with the 9-1-1 checkpoint clamp. These interactions are enhanced following oxidative stress. The interdomain connector of MYH is important for interactions with SIRT6, APE1, and 9-1-1. Mutagenesis studies indicate that SIRT6, APE1, and Hus1 bind overlapping but different sequence motifs on MYH. However, there is no competition of APE1, Hus1, or SIRT6 binding to MYH. Rather, one MYH partner enhances the association of the other two partners to MYH. Moreover, APE1 and Hus1 act together to stabilize the MYH/SIRT6 complex. Within human cells, MYH and SIRT6 are efficiently recruited to confined oxidative DNA damage sites within transcriptionally active chromatin, but not within repressive chromatin. In addition, Myh foci induced by oxidative stress and Sirt6 depletion are frequently localized on mouse telomeres.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although SIRT6, APE1, and 9-1-1 bind to the interdomain connector of MYH, they do not compete for MYH association. Our findings indicate that SIRT6 forms a complex with MYH, APE1, and 9-1-1 to maintain genomic and telomeric integrity in mammalian cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Bor-Jang</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. BHwang@som.umaryland.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. jinjin1681@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA. yig10@pitt.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Tsinghua University, No.1 Tsinghua Yuan, Haidian District, Beijing, 100084, China. yig10@pitt.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Guoli</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. gshi001@son.umaryland.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Maryland School of Nursing, 655 West Lombard Street, Baltimore, MD, 21201, USA. gshi001@son.umaryland.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madabushi</LastName><ForeName>Amrita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. amadabushi@bccc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Natural and Physical Sciences, Life Sciences Institute, Baltimore City Community College, 801 West Baltimore Street, Baltimore, MD, 21201, USA. amadabushi@bccc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. ay.savethetigers@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. xin0709@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zalzman</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. MZalzman@som.umaryland.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otorhinolaryngology-Head and Neck Surgery, University of Maryland School of Medicine, 16 South Eutaw Street, Baltimore, MD, 21201, USA. MZalzman@som.umaryland.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakajima</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA. san48@pitt.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, 450 Technology Drive, Pittsburgh, PA, 15219, USA. san48@pitt.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lan</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA. lilyrisa2@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, 450 Technology Drive, Pittsburgh, PA, 15219, USA. lilyrisa2@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>A-Lien</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. alu-chang@som.umaryland.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD, 21201, USA. alu-chang@som.umaryland.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>S10 OD011969</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10-OD011969</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA078391</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21-AG045545</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-CA78391</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG045545</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Mol Biol</MedlineTA><NlmUniqueID>100966983</NlmUniqueID><ISSNLinking>1471-2199</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002843">Chromatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>139691-42-2</RegistryNumber><NameOfSubstance UI="C069930">rad9 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.31</RegistryNumber><NameOfSubstance UI="C501860">Sirt6 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D005092">Exonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C061738">mutY adenine glycosylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="C516592">SIRT6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.-</RegistryNumber><NameOfSubstance UI="D037761">Sirtuins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Jun 21;447(7147):941-50</RefSource><PMID Version="1">17581577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2009 Aug 15;8(16):2664-6</RefSource><PMID Version="1">19625767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 Jun 17;332(6036):1443-6</RefSource><PMID Version="1">21680843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 Jan 27;124(2):315-29</RefSource><PMID Version="1">16439206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2009 Jun 30;48(25):6022-33</RefSource><PMID Version="1">19449863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1994;63:915-48</RefSource><PMID Version="1">7979257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2002 Feb;30(2):227-32</RefSource><PMID Version="1">11818965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Mar 27;452(7186):492-6</RefSource><PMID Version="1">18337721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Oct 3;278(40):38121-4</RefSource><PMID Version="1">12917422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Biosci. 2006;11:3062-80</RefSource><PMID Version="1">16720376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Biol. 2000 Mar;7(3):176-8</RefSource><PMID Version="1">10700268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jun 15;29(12):2666-74</RefSource><PMID Version="1">11410677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2006 Nov 15;400(1):53-62</RefSource><PMID Version="1">16879101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Sep 10;329(5997):1348-53</RefSource><PMID Version="1">20829486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Dec 8;4(12):1442-9</RefSource><PMID Version="1">16199212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Mar 1;6(3):317-28</RefSource><PMID Version="1">17126083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e51555</RefSource><PMID Version="1">23240041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2014;5:5011</RefSource><PMID Version="1">25247314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Jun 3;280(22):21313-20</RefSource><PMID Version="1">15795229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2596-608</RefSource><PMID Version="1">17426133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2002 Jul;27(7):339-44</RefSource><PMID Version="1">12114022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1993 May;299(3-4):277-87</RefSource><PMID Version="1">7683095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2007 Feb;39(2):243-50</RefSource><PMID Version="1">17237781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2013 Aug 22;51(4):454-68</RefSource><PMID Version="1">23911928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr;41(7):4093-103</RefSource><PMID Version="1">23460202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2011 Jan 21;405(3):653-65</RefSource><PMID Version="1">21110984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2005 Mar 11;346(5):1259-74</RefSource><PMID Version="1">15713479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Jan 1;66(1):113-24</RefSource><PMID Version="1">16397223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17844-9</RefSource><PMID Version="1">24127576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Mar 2;4(3):315-25</RefSource><PMID Version="1">15661655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Nov 21;283(47):32680-90</RefSource><PMID Version="1">18805789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2014 Feb;39(2):72-81</RefSource><PMID Version="1">24438746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2004;73:39-85</RefSource><PMID Version="1">15189136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2010 May;6(5):e1000951</RefSource><PMID Version="1">20485567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Genet. 2013 Feb 28;4:18</RefSource><PMID Version="1">23450852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2015;14(2):269-76</RefSource><PMID Version="1">25607651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1997 Jun 15;25(12):2495-500</RefSource><PMID Version="1">9171104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aging (Albany NY). 2009 Jan;1(1):109-21</RefSource><PMID Version="1">20157594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12754-7</RefSource><PMID Version="1">9398071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2013 Nov 15;456(1):89-98</RefSource><PMID Version="1">23952905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Feb;42(4):2330-45</RefSource><PMID Version="1">24293652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2000 Jun 30;476(1-2):73-7</RefSource><PMID Version="1">10878254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Feb 23;276(8):5547-55</RefSource><PMID Version="1">11092888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Feb 1;29(3):743-52</RefSource><PMID Version="1">11160897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Jan 2;10(1):34-44</RefSource><PMID Version="1">20951653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2010 Oct 29;403(3):351-70</RefSource><PMID Version="1">20816984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Dec;12(12):1043-52</RefSource><PMID Version="1">24209961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1995 Feb;15(2):989-96</RefSource><PMID Version="1">7823963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2006 Aug 8;16(15):1551-8</RefSource><PMID Version="1">16890531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Apr 4;496(7443):110-3</RefSource><PMID Version="1">23552949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1999 Jun 25;453(3):365-8</RefSource><PMID Version="1">10405177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2014 Jan;13:10-21</RefSource><PMID Version="1">24315136</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059447" MajorTopicYN="Y">Cell Cycle Checkpoints</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002843" MajorTopicYN="N">Chromatin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005092" MajorTopicYN="N">Exonucleases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037761" MajorTopicYN="N">Sirtuins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016615" MajorTopicYN="N">Telomere</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26063178</ArticleId><ArticleId IdType="doi">10.1186/s12867-015-0041-9</ArticleId><ArticleId IdType="pii">10.1186/s12867-015-0041-9</ArticleId><ArticleId IdType="pmc">PMC4464616</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26045303</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2180</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk.</ArticleTitle><Pagination><MedlinePgn>982-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/carcin/bgv082</ELocationID><Abstract><AbstractText>The key role of DNA repair in removing DNA damage and minimizing mutations makes it an attractive target for cancer risk assessment and prevention. Here we describe the development of a robust assay for apurinic/apyrimidinic (AP) endonuclease 1 (APE1; APEX1), an essential enzyme involved in the repair of oxidative DNA damage. APE1 DNA repair enzymatic activity was measured in peripheral blood mononuclear cell protein extracts using a radioactivity-based assay, and its association with lung cancer was determined using conditional logistic regression with specimens from a population-based case-control study with 96 lung cancer cases and 96 matched control subjects. The mean APE1 enzyme activity in case patients was 691 [95% confidence interval (CI) = 655-727] units/ng protein, significantly lower than in control subjects (mean = 793, 95% CI = 751-834 units/ng protein, P = 0.0006). The adjusted odds ratio for lung cancer associated with 1 SD (211 units) decrease in APE1 activity was 2.0 (95% CI = 1.3-3.1; P = 0.002). Comparison of radioactivity- and fluorescence-based assays showed that the two are equivalent, indicating no interference by the fluorescent tag. The APE1Asp148Glu SNP was associated neither with APE1 enzyme activity nor with lung cancer risk. Taken together, our results indicate that low APE1 activity is associated with lung cancer risk, consistent with the hypothesis that 'bad DNA repair', rather than 'bad luck', is involved in cancer etiology. Such assays may be useful, along with additional DNA repair biomarkers, for risk assessment of lung cancer and perhaps other cancers, and for selecting individuals to undergo early detection techniques such as low-dose CT.</AbstractText><CopyrightInformation>© The Author 2015. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sevilya</LastName><ForeName>Ziv</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel, Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel, Department of General Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel and Biostatistics Unit, Gertner Institute for Epidemiology and Public Health Policy Research, Sheba Medical Center, Tel Hashomer 52621, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leitner-Dagan</LastName><ForeName>Yael</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel, Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel, Department of General Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel and Biostatistics Unit, Gertner Institute for Epidemiology and Public Health Policy Research, Sheba Medical Center, Tel Hashomer 52621, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinchev</LastName><ForeName>Mila</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kremer</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elinger</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel, Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel, Department of General Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel and Biostatistics Unit, Gertner Institute for Epidemiology and Public Health Policy Research, Sheba Medical Center, Tel Hashomer 52621, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lejbkowicz</LastName><ForeName>Flavio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rennert</LastName><ForeName>Hedy S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freedman</LastName><ForeName>Laurence S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Gertner Institute for Epidemiology and Public Health Policy Research, Sheba Medical Center, Tel Hashomer 52621, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rennert</LastName><ForeName>Gad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paz-Elizur</LastName><ForeName>Tamar</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel, Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel, Department of General Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel and Biostatistics Unit, Gertner Institute for Epidemiology and Public Health Policy Research, Sheba Medical Center, Tel Hashomer 52621, Israel zvi.livneh@weizmann.ac.il tamar.paz-elizur@weizmann.ac.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livneh</LastName><ForeName>Zvi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel, Department of Community Medicine and Epidemiology, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Clalit Health Services National Cancer Control Center, Haifa, Israel, Department of General Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel and Biostatistics Unit, Gertner Institute for Epidemiology and Public Health Policy Research, Sheba Medical Center, Tel Hashomer 52621, Israel zvi.livneh@weizmann.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1 U01 CA111219</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2012 Apr 1;732(1-2):43-6</RefSource><PMID Version="1">22266085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Dec 17;361(25):2449-60</RefSource><PMID Version="1">20018966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):14-35</RefSource><PMID Version="1">22122462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Aug 7;690(1-2):3-11</RefSource><PMID Version="1">20223251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Mar 4;144(5):646-74</RefSource><PMID Version="1">21376230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2011 May 1;128(9):1999-2009</RefSource><PMID Version="1">21387284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2012 Nov 21;104(22):1765-9</RefSource><PMID Version="1">23104324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Biol. 2013 Apr;5(4):a012583</RefSource><PMID Version="1">23545420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oxid Med Cell Longev. 2013;2013:387014</RefSource><PMID Version="1">24382987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Prev Res (Phila). 2014 Apr;7(4):398-406</RefSource><PMID Version="1">24356339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Apr;35(4):3597-603</RefSource><PMID Version="1">24310503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2015 Jan 2;347(6217):78-81</RefSource><PMID Version="1">25554788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2014 Dec;35(12):2763-70</RefSource><PMID Version="1">25355292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Chemother Pharmacol. 2014 Oct;74(4):777-86</RefSource><PMID Version="1">25107571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2015 Jun;54 Suppl 1:E103-11</RefSource><PMID Version="1">25156607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2000 Nov 1;92(21):1764-72</RefSource><PMID Version="1">11058619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jan 15;29(2):430-8</RefSource><PMID Version="1">11139613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2000;36(4):312-24</RefSource><PMID Version="1">11152564</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2001 Apr;10(7):705-13</RefSource><PMID Version="1">11257103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 May 17;411(6835):366-74</RefSource><PMID Version="1">11357144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Jan 10;415(6868):183-7</RefSource><PMID Version="1">11805838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Jun 21;277(25):22605-15</RefSource><PMID Version="1">11960995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Aug 1;63(15):4351-7</RefSource><PMID Version="1">12907604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Aug 15;63(16):4899-902</RefSource><PMID Version="1">12941813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2003 Sep 3;95(17):1312-9</RefSource><PMID Version="1">12953085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2004 Aug;10(8):789-99</RefSource><PMID Version="1">15286780</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Apr 22;362(6422):709-15</RefSource><PMID Version="1">8469282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1994 Dec 23;266(5193):1959-60</RefSource><PMID Version="1">7801122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 Jul 7;270(27):16002-7</RefSource><PMID Version="1">7608159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Dec;25(12):2433-41</RefSource><PMID Version="1">15333465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Jan 19;97(2):127-32</RefSource><PMID Version="1">15657342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(7):2204-9</RefSource><PMID Version="1">15831793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1585-7</RefSource><PMID Version="1">16030087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(15):4711-24</RefSource><PMID Version="1">16113242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Dec 15;66(24):11683-9</RefSource><PMID Version="1">17178863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Mar 1;6(3):274-9</RefSource><PMID Version="1">17161978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Apr 15;67(8):3493-5</RefSource><PMID Version="1">17440053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2008 May;60(2):277-84</RefSource><PMID Version="1">18061304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2008 Jul 18;266(1):60-72</RefSource><PMID Version="1">18374480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3081-9</RefSource><PMID Version="1">18990748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 Jan 7;101(1):24-36</RefSource><PMID Version="1">19116388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2009 Dec;66(3):298-304</RefSource><PMID Version="1">19324449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):3-13</RefSource><PMID Version="1">22122461</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26045303</ArticleId><ArticleId IdType="pii">bgv082</ArticleId><ArticleId IdType="doi">10.1093/carcin/bgv082</ArticleId><ArticleId IdType="pmc">PMC4552243</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26032169</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Free radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic. Biol. Med.</ISOAbbreviation></Journal><ArticleTitle>Genistein induces apoptosis by stabilizing intracellular p53 protein through an APE1-mediated pathway.</ArticleTitle><Pagination><MedlinePgn>209-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2015.05.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0891-5849(15)00253-1</ELocationID><Abstract><AbstractText>Genistein (GEN) has been previously shown to have a proapoptotic effect on cancer cells through a p53-dependent pathway, the mechanism of which remains unclear. One of its intracellular targets, APE1, protects against apoptosis under genotoxic stress and interacts with p53. In this current study, we explored the mechanism of the proapoptotic effect of GEN by examining the APE1-p53 protein-protein interaction. We initially showed that the p53 protein level was elevated in GEN-treated human non-small lung cancer A549 cells and cervical cancer HeLa cells. By examining both protein synthesis and degradation, we found that GEN enhances p53 intracellular stability by interfering with the interaction of APE1 and p53, which provided a plausible explanation for how GEN initiates apoptosis. Furthermore, we found that the interaction between APE1 and p53 is important for the degradation of p53 and is dependent on the redox domain of APE1 by utilizing the redox domain mutant APE1 C65A. Our data suggest that the degradation of wild-type p53 is blocked when the redox domain of APE1 is masked or interrupted. Based on this evidence, we hereby report a novel mechanism of p53 degradation through an APE1-mediated, redox-dependent pathway. </AbstractText><CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jianwu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xiaolin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China. Electronic address: mengxia.li@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhenzhou</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China. Electronic address: yangzz1970@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495901">TP53 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance></Chemical><Chemical><RegistryNumber>DH2M523P0H</RegistryNumber><NameOfSubstance UI="D019833">Genistein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019833" MajorTopicYN="N">Genistein</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055550" MajorTopicYN="N">Protein Stability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Genistein</Keyword><Keyword MajorTopicYN="N">Stability</Keyword><Keyword MajorTopicYN="N">Wild-type p53</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>05</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26032169</ArticleId><ArticleId IdType="pii">S0891-5849(15)00253-1</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.05.030</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26020771</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Mammalian Base Excision Repair: Functional Partnership between PARP-1 and APE1 in AP-Site Repair.</ArticleTitle><Pagination><MedlinePgn>e0124269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0124269</ELocationID><Abstract><AbstractText>The apurinic/apyrimidinic- (AP-) site in genomic DNA arises through spontaneous base loss and base removal by DNA glycosylases and is considered an abundant DNA lesion in mammalian cells. The base excision repair (BER) pathway repairs the AP-site lesion by excising and replacing the site with a normal nucleotide via template directed gap-filling DNA synthesis. The BER pathway is mediated by a specialized group of proteins, some of which can be found in multiprotein complexes in cultured mouse fibroblasts. Using a DNA polymerase (pol) β immunoaffinity-capture technique to isolate such a complex, we identified five tightly associated and abundant BER factors in the complex: PARP-1, XRCC1, DNA ligase III, PNKP, and Tdp1. AP endonuclease 1 (APE1), however, was not present. Nevertheless, the complex was capable of BER activity, since repair was initiated by PARP-1's AP lyase strand incision activity. Addition of purified APE1 increased the BER activity of the pol β complex. Surprisingly, the pol β complex stimulated the strand incision activity of APE1. Our results suggested that PARP-1 was responsible for this effect, whereas other proteins in the complex had no effect on APE1 strand incision activity. Studies of purified PARP-1 and APE1 revealed that PARP-1 was able to stimulate APE1 strand incision activity. These results illustrate roles of PARP-1 in BER including a functional partnership with APE1. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Rajendra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyrkheeva</LastName><ForeName>Nadezhda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Epigenetics and Stem Cell Biology Laboratory, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Genome Integrity and Structural Biology Laboratory, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z01ES050158</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01ES050159</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="C499321">Parp1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="D000071137">Poly (ADP-Ribose) Polymerase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="D011065">Poly(ADP-ribose) Polymerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D019951">DNA Polymerase beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2009;15(25):2908-14</RefSource><PMID Version="1">19754367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(2):510-21</RefSource><PMID Version="1">19910369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Dec 24;285(52):40479-88</RefSource><PMID Version="1">20952393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22090-5</RefSource><PMID Version="1">21127267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Oct;52(8):623-35</RefSource><PMID Version="1">21786338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1998 Jun;407(3):203-15</RefSource><PMID Version="1">9653447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Aug 14;273(33):21203-9</RefSource><PMID Version="1">9694877</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1999 Jun 1;59(11):2522-6</RefSource><PMID Version="1">10363965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 2001 May;23(5):447-55</RefSource><PMID Version="1">11340626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Jul;24(3):218-29</RefSource><PMID Version="1">11403571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Jul 6;276(27):25541-8</RefSource><PMID Version="1">11340072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Aug 23;277(34):31115-23</RefSource><PMID Version="1">12063248</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2003 Jan 2;2(1):27-48</RefSource><PMID Version="1">12509266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1985 Mar;40(3):483-4</RefSource><PMID Version="1">2982494</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1986 Apr 22;25(8):2212-20</RefSource><PMID Version="1">2423122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 1987 Mar 1;242(2):565-72</RefSource><PMID Version="1">2439070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 1989 Sep 1;262(2):581-9</RefSource><PMID Version="1">2679549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1990 Feb 5;265(4):2124-31</RefSource><PMID Version="1">2404980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1990 Sep-Nov;236(2-3):173-201</RefSource><PMID Version="1">1697933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 1994;48:315-70</RefSource><PMID Version="1">7938553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1995 Jan 10;34(1):128-38</RefSource><PMID Version="1">7819187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1995 Aug 4;269(5224):699-702</RefSource><PMID Version="1">7624801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 1995 Oct;20(10):391-7</RefSource><PMID Version="1">8533150</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 1995;262:98-107</RefSource><PMID Version="1">8594388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1995 Dec 11;23(23):4836-43</RefSource><PMID Version="1">8532526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1996 Jan 11;379(6561):183-6</RefSource><PMID Version="1">8538772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1996 Apr 19;271(16):9573-8</RefSource><PMID Version="1">8621631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1996 Jun 7;271(23):13816-20</RefSource><PMID Version="1">8662731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1996 Jul 5;271(27):16000-7</RefSource><PMID Version="1">8663274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1996 Jul 26;271(30):17811-5</RefSource><PMID Version="1">8663612</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Jan 10;272(2):1302-7</RefSource><PMID Version="1">8995436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1997 Apr 24;14(16):1911-21</RefSource><PMID Version="1">9150358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7166-9</RefSource><PMID Version="1">9207062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1997 Jun 2;16(11):3341-8</RefSource><PMID Version="1">9214649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Jan 9;273(2):898-902</RefSource><PMID Version="1">9422747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1998 Mar 17;37(11):3575-80</RefSource><PMID Version="1">9530283</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Jun;18(6):3563-71</RefSource><PMID Version="1">9584196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1990 Aug 7;29(31):7156-9</RefSource><PMID Version="1">2207097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Apr 22;362(6422):709-15</RefSource><PMID Version="1">8469282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Cell Biol. 1993 Jun;5(3):424-33</RefSource><PMID Version="1">8352959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1994 Jan;14(1):310-7</RefSource><PMID Version="1">8264597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1994 Jan;14(1):68-76</RefSource><PMID Version="1">8264637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Mar 22;288(12):8445-55</RefSource><PMID Version="1">23355472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2013;(78):e50695</RefSource><PMID Version="1">23995844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2013 Oct 29;52(43):7669-77</RefSource><PMID Version="1">24079850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2014 May;25(10):1641-52</RefSource><PMID Version="1">24648491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jun;42(10):6337-51</RefSource><PMID Version="1">24771347</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2014 Jul;71(13):2451-65</RefSource><PMID Version="1">24496644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Mar 15;29(6):1285-92</RefSource><PMID Version="1">11238994</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Sep 28;4(10):1099-110</RefSource><PMID Version="1">16051529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2006 Jan;5(1):144-56</RefSource><PMID Version="1">16219938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Feb 2;282(5):2976-86</RefSource><PMID Version="1">17148452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(5):1569-77</RefSource><PMID Version="1">17289756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 May 4;282(18):13532-41</RefSource><PMID Version="1">17355977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2596-608</RefSource><PMID Version="1">17426133</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2007 Sep 7;27(5):829-41</RefSource><PMID Version="1">17803946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(17):e112</RefSource><PMID Version="1">17720705</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Oct 19;282(42):30577-85</RefSource><PMID Version="1">17724035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Nov 9;287(46):39233-44</RefSource><PMID Version="1">22992732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Dec;40(22):11571-82</RefSource><PMID Version="1">23042675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Jun 3;3(6):581-91</RefSource><PMID Version="1">15135726</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 May 16;289(20):13996-4008</RefSource><PMID Version="1">24695738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2014 Aug;12(8):1128-39</RefSource><PMID Version="1">24770870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13300-5</RefSource><PMID Version="1">10557315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1999 Dec 3;286(5446):1897-905</RefSource><PMID Version="1">10583946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2000 Feb;153(2):186-95</RefSource><PMID Version="1">10629618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Jan 21;275(3):2211-8</RefSource><PMID Version="1">10636928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Apr;462(2-3):129-35</RefSource><PMID Version="1">10767624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2001 Jan 12;104(1):107-17</RefSource><PMID Version="1">11163244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2003 Feb;31(Pt 1):247-51</RefSource><PMID Version="1">12546695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2003 Oct 7;2(10):1087-100</RefSource><PMID Version="1">13679147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):231-51</RefSource><PMID Version="1">14637258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Jul 2;3(7):703-10</RefSource><PMID Version="1">15177179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2004 Jul 23;15(2):209-20</RefSource><PMID Version="1">15260972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13738-43</RefSource><PMID Version="1">15365186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1972 Sep 12;11(19):3610-8</RefSource><PMID Version="1">4626532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1982;51:61-87</RefSource><PMID Version="1">6287922</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019951" MajorTopicYN="N">DNA Polymerase beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071137" MajorTopicYN="N">Poly (ADP-Ribose) Polymerase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011065" MajorTopicYN="N">Poly(ADP-ribose) Polymerases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26020771</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0124269</ArticleId><ArticleId IdType="pii">PONE-D-15-02289</ArticleId><ArticleId IdType="pmc">PMC4447435</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25976310</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>16</Issue><PubDate><Year>2015</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum. Mol. Genet.</ISOAbbreviation></Journal><ArticleTitle>Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.</ArticleTitle><Pagination><MedlinePgn>4516-29</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddv183</ELocationID><Abstract><AbstractText>Ataxia oculomotor apraxia type 1 (AOA1) is an autosomal recessive disease caused by mutations in APTX, which encodes the DNA strand-break repair protein aprataxin (APTX). CoQ10 deficiency has been identified in fibroblasts and muscle of AOA1 patients carrying the common W279X mutation, and aprataxin has been localized to mitochondria in neuroblastoma cells, where it enhances preservation of mitochondrial function. In this study, we show that aprataxin deficiency impairs mitochondrial function, independent of its role in mitochondrial DNA repair. The bioenergetics defect in AOA1-mutant fibroblasts and APTX-depleted Hela cells is caused by decreased expression of SDHA and genes encoding CoQ biosynthetic enzymes, in association with reductions of APE1, NRF1 and NRF2. The biochemical and molecular abnormalities in APTX-depleted cells are recapitulated by knockdown of APE1 in Hela cells and are rescued by overexpression of NRF1/2. Importantly, pharmacological upregulation of NRF1 alone by 5-aminoimidazone-4-carboxamide ribonucleotide does not rescue the phenotype, which, in contrast, is reversed by the upregulation of NRF2 by rosiglitazone. Accordingly, we propose that the lack of aprataxin causes reduction of the pathway APE1/NRF1/NRF2 and their target genes. Our findings demonstrate a critical role of APTX in transcription regulation of mitochondrial function and the pathogenesis of AOA1 via a novel pathomechanistic pathway, which may be relevant to other neurodegenerative diseases. </AbstractText><CopyrightInformation>© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia-Diaz</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barca</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, UOC of Neurology and Neuromuscular Disorders, Department of Neuroscience, University of Messina, Messina 98100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balreira</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Luis C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute of Biotechnology, Biomedical Research Center (CIBM), Health Science Technological Park (PTS), University of Granada, Armilla, Granada 18100, Spain and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadesse</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishna</LastName><ForeName>Sindhu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naini</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unitâ di Genetica delle Malattie Neurodegenerative e Metaboliche, Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Milan 20126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellotti</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Unitâ di Genetica delle Malattie Neurodegenerative e Metaboliche, Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Milan 20126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinzii</LastName><ForeName>Catarina M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Neurology, cmq2101@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5K23 HD065871</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NIH P01 HD080642-01</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C438188">APTX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495635">NFE2L2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495633">NRF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051266">Nuclear Respiratory Factor 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Apr 18;283(16):10967-77</RefSource><PMID Version="1">18252725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Mar 30;282(13):9469-74</RefSource><PMID Version="1">17276982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2006 Dec;79(6):1125-9</RefSource><PMID Version="1">17186472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2015 Feb 16;208(4):429-42</RefSource><PMID Version="1">25688136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 Oct 20;127(2):397-408</RefSource><PMID Version="1">17055439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurogenetics. 2011 Aug;12(3):193-201</RefSource><PMID Version="1">21465257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2013 Feb;27(2):612-21</RefSource><PMID Version="1">23150520</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2009 Nov 1;18(21):4102-17</RefSource><PMID Version="1">19643912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2003 Mar 11;60(5):868-70</RefSource><PMID Version="1">12629250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>IUBMB Life. 2014 Feb;66(2):63-70</RefSource><PMID Version="1">24470391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2003 Dec;126(Pt 12):2761-72</RefSource><PMID Version="1">14506070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2011 Apr 15;435(2):297-312</RefSource><PMID Version="1">21726199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2011 May;134(Pt 5):1387-99</RefSource><PMID Version="1">21486904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2001 Feb;27(2):181-6</RefSource><PMID Version="1">11175786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Mar;29(5):1354-62</RefSource><PMID Version="1">19103743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Orphanet J Rare Dis. 2006;1:47</RefSource><PMID Version="1">17112370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2013 May;57(5):2037-48</RefSource><PMID Version="1">22961760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 May 19;281(20):13939-48</RefSource><PMID Version="1">16547001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Child Neurol. 2008 Aug;23(8):895-900</RefSource><PMID Version="1">18403580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2002 Mar 6;286(1):81-9</RefSource><PMID Version="1">11943463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2001 Oct;29(2):184-8</RefSource><PMID Version="1">11586299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2005 Feb;62(4):485-91</RefSource><PMID Version="1">15719174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Nov 2;3(11):1493-502</RefSource><PMID Version="1">15380105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2014 May 8;157(4):882-96</RefSource><PMID Version="1">24813611</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2008 Mar;82(3):661-72</RefSource><PMID Version="1">18319074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2009 Feb;9(4):1058-74</RefSource><PMID Version="1">19180539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Syndromol. 2014 Jul;5(3-4):119-40</RefSource><PMID Version="1">25126045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Oct 12;443(7112):713-6</RefSource><PMID Version="1">16964241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2014 May 1;23(9):2400-15</RefSource><PMID Version="1">24334768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Neurobiol. 2010 Jun;41(2-3):187-96</RefSource><PMID Version="1">20411356</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2007 Feb;61(2):162-74</RefSource><PMID Version="1">17315206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rinsho Shinkeigaku. 1992 Oct;32(10):1067-74</RefSource><PMID Version="1">1297549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2006 Jul 15;15(14):2239-49</RefSource><PMID Version="1">16777843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2007 Jan 23;68(4):295-7</RefSource><PMID Version="1">17242337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2010 Oct;24(10):3733-43</RefSource><PMID Version="1">20495179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 May 3;108(18):7437-42</RefSource><PMID Version="1">21502511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2009 Jun 4;8(6):760-6</RefSource><PMID Version="1">19303373</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2004 Feb;55(2):241-9</RefSource><PMID Version="1">14755728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2001 Apr 10;56(7):849-55</RefSource><PMID Version="1">11294920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2001 Oct;29(2):189-93</RefSource><PMID Version="1">11586300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2013 Mar 15;22(6):1233-48</RefSource><PMID Version="1">23255162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2005 Jun 1;66(3):562-73</RefSource><PMID Version="1">15914121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol. 1997 Dec;273(6 Pt 1):E1107-12</RefSource><PMID Version="1">9435525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2004 May 15;13(10):1081-93</RefSource><PMID Version="1">15044383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2008 Dec;1147:321-34</RefSource><PMID Version="1">19076454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Jul 18;278(29):26597-603</RefSource><PMID Version="1">12734177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2005 Feb 8;64(3):539-41</RefSource><PMID Version="1">15699391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2006 Feb;78(2):345-9</RefSource><PMID Version="1">16400613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Jul 15;53(2):237-48</RefSource><PMID Version="1">22580151</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001259" MajorTopicYN="N">Ataxia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="Y">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030342" MajorTopicYN="N">Genetic Diseases, Inborn</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051266" MajorTopicYN="N">Nuclear Respiratory Factor 1</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>03</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>05</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25976310</ArticleId><ArticleId IdType="pii">ddv183</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddv183</ArticleId><ArticleId IdType="pmc">PMC4512623</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25976295</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1791-2431</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Oncology reports</Title><ISOAbbreviation>Oncol. Rep.</ISOAbbreviation></Journal><ArticleTitle>Lentiviral-mediated short hairpin RNA silencing of APE1 suppresses hepatocellular carcinoma proliferation and migration: A potential therapeutic target for hepatoma treatment.</ArticleTitle><Pagination><MedlinePgn>95-102</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/or.2015.3976</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease-1 (APE1) is a protein involved in DNA repair and transcriptional regulation of gene expression. APE1 expression was reported to be correlated with poor prognosis in hepatocellular carcinoma (HCC) patients. Based on our previous study, we hypothesized that APE1 may be involved in the metastatic progression of HCC. Thus, the present study aimed to investigate the knockdown effect of APE1 using shRNA in HCC and demonstrate that silencing of APE1 in MHCC97-H cells can decrease the oncogenic transforming potential in vitro and reduce the growth of HCC tumor xenografts in vivo. Silencing of APE1 expression decreased the cell proliferation and survival, reduced the cell adhesion ability in Matrigel or fibronectin-coated plates and suppressed the cell migration and invasion in a Transwell assay of HCC cells. In the xenograft study, tumor growth was markedly inhibited in the APE1-silenced group. Silencing of APE1 in MHCC97-H cells decreased the oncogenic transforming potential in vitro and reduced the growth of HCC tumor xenografts in vivo. Inhibition of APE1 may present a novel therapeutic approach for the treatment of HCC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhi-Hua</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Department of Pathology, Quanzhou Medical College, Quanzhou, Fujian 362100, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pathology and Institute of Oncology, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Institute of Oncology, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Mei-Qin</ForeName><Initials>MQ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Institute of Oncology, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ai-Min</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pathology and Institute of Oncology, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jing-Feng</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian 350025, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Oncol Rep</MedlineTA><NlmUniqueID>9422756</NlmUniqueID><ISSNLinking>1021-335X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020868" MajorTopicYN="N">Gene Silencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="Y">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25976295</ArticleId><ArticleId IdType="doi">10.3892/or.2015.3976</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25956655</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2015</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res.</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial translocation of APE1 relies on the MIA pathway.</ArticleTitle><Pagination><MedlinePgn>5451-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkv433</ELocationID><Abstract><AbstractText>APE1 is a multifunctional protein with a fundamental role in repairing nuclear and mitochondrial DNA lesions caused by oxidative and alkylating agents. Unfortunately, comprehensions of the mechanisms regulating APE1 intracellular trafficking are still fragmentary and contrasting. Recent data demonstrate that APE1 interacts with the mitochondrial import and assembly protein Mia40 suggesting the involvement of a redox-assisted mechanism, dependent on the disulfide transfer system, to be responsible of APE1 trafficking into the mitochondria. The MIA pathway is an import machinery that uses a redox system for cysteine enriched proteins to drive them in this compartment. It is composed by two main proteins: Mia40 is the oxidoreductase that catalyzes the formation of the disulfide bonds in the substrate, while ALR reoxidizes Mia40 after the import. In this study, we demonstrated that: (i) APE1 and Mia40 interact through disulfide bond formation; and (ii) Mia40 expression levels directly affect APE1's mitochondrial translocation and, consequently, play a role in the maintenance of mitochondrial DNA integrity. In summary, our data strongly support the hypothesis of a redox-assisted mechanism, dependent on Mia40, in controlling APE1 translocation into the mitochondrial inner membrane space and thus highlight the role of this protein transport pathway in the maintenance of mitochondrial DNA stability and cell survival. </AbstractText><CopyrightInformation>© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barchiesi</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical and Biological Sciences, University of Udine, Udine 33100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasilewski</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Institute of Molecular and Cell Biology, Warsaw, 02-109, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chacinska</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Institute of Molecular and Cell Biology, Warsaw, 02-109, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tell</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Biological Sciences, University of Udine, Udine 33100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vascotto</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical and Biological Sciences, University of Udine, Udine 33100, Italy carlo.vascotto@uniud.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004220">Disulfides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507282">MIA40 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033681">Mitochondrial Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Microbiol. 2007 Sep;65(5):1360-73</RefSource><PMID Version="1">17680986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Mar 7;485(2):143-52</RefSource><PMID Version="1">11182545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Aug 25;643(1-2):54-63</RefSource><PMID Version="1">18579163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006;34(7):2067-76</RefSource><PMID Version="1">16617147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 May 1;32(9):804-12</RefSource><PMID Version="1">11978482</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2001 Nov-Dec;21(6A):4041-9</RefSource><PMID Version="1">11911289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2012 Jun;29(2):1265-71</RefSource><PMID Version="1">21479902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2012 Feb;122(2):600-11</RefSource><PMID Version="1">22214851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Mar 11;280(10):8901-5</RefSource><PMID Version="1">15632148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2008 Jul-Aug;129(7-8):383-90</RefSource><PMID Version="1">18417187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1997 Nov 3;16(21):6548-58</RefSource><PMID Version="1">9351835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Dec 28;282(52):37461-70</RefSource><PMID Version="1">17959605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):23-7</RefSource><PMID Version="1">7506414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2011 Oct;22(20):3887-901</RefSource><PMID Version="1">21865600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2002 Mar 6;286(1):127-34</RefSource><PMID Version="1">11943468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2014 Aug 1;588(15):2484-95</RefSource><PMID Version="1">24866464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2014 Jan 13;28(1):30-42</RefSource><PMID Version="1">24360785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2009 Dec;66(3):298-304</RefSource><PMID Version="1">19324449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2010 Jun 1;12(11):1247-69</RefSource><PMID Version="1">19764832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2004 Oct 1;23(19):3735-46</RefSource><PMID Version="1">15359280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2007 Jan 19;365(3):612-20</RefSource><PMID Version="1">17095012</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1993 Sep;13(9):5370-6</RefSource><PMID Version="1">8355688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17356-61</RefSource><PMID Version="1">24101517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 1990;8(6):523-39</RefSource><PMID Version="1">2193852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1988 Sep;85(17):6465-7</RefSource><PMID Version="1">3413108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cell Biol. 2013;2013:742923</RefSource><PMID Version="1">24348563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):3957-69</RefSource><PMID Version="1">22918950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2012 Jan 25;134(3):1442-5</RefSource><PMID Version="1">22224850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20190-5</RefSource><PMID Version="1">21059946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2010 Feb 26;37(4):516-28</RefSource><PMID Version="1">20188670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):651-68</RefSource><PMID Version="1">18715143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2007 Jan-Feb;13(1-2):89-96</RefSource><PMID Version="1">17515960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2009 Nov;35(5):1069-79</RefSource><PMID Version="1">19787261</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2014;14:11</RefSource><PMID Version="1">24400589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 May 14;285(20):14871-81</RefSource><PMID Version="1">20231292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2009 Feb;9(4):1058-74</RefSource><PMID Version="1">19180539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2014 Mar;98(3):402-7</RefSource><PMID Version="1">24385289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2012 May;103(5):882-8</RefSource><PMID Version="1">22329793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2012;920:111-32</RefSource><PMID Version="1">22941600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(7):2181-92</RefSource><PMID Version="1">15107486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2005 Oct 28;353(3):517-28</RefSource><PMID Version="1">16185709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4811-6</RefSource><PMID Version="1">21383138</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004220" MajorTopicYN="N">Disulfides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033681" MajorTopicYN="N">Mitochondrial Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055550" MajorTopicYN="N">Protein Stability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25956655</ArticleId><ArticleId IdType="pii">gkv433</ArticleId><ArticleId IdType="doi">10.1093/nar/gkv433</ArticleId><ArticleId IdType="pmc">PMC4477663</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25917483</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2584</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International urology and nephrology</Title><ISOAbbreviation>Int Urol Nephrol</ISOAbbreviation></Journal><ArticleTitle>The association of ApE1 -656T&gt;G and 1349T&gt;G polymorphisms and idiopathic male infertility risk.</ArticleTitle><Pagination><MedlinePgn>921-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11255-015-0979-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In spite of variety studies in understanding of human reproductive and fertility, the underlying causes of male infertility remains undefined in about 50 % of cases. The polymorphism studies have a crucial role in diseases recognizing. Human apurinic/apyrimidinic endonuclease 1 (ApE1) is a multifunctional protein that has an important role in the base excision repair pathway. The present study was aimed to evaluate whether two polymorphisms -656T&gt;G and 1349T&gt;G ApE1 are related with the susceptibility to idiopathic male infertility.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Samples were collected from 180 patients diagnosed with idiopathic male infertility and 120 control subjects and genotyped by tetra-primer amplification refractory mutation system PCR.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed a significant difference in genotype distributions of -656T&gt;G ApE1 polymorphism between infertile patients and controls (P = 0.0001). Our findings indicated individuals with the variant TG genotypes had a significant increased risk of idiopathic male infertility (OR 1.84, 95 % CI 1.09-3.11, P = 0.021), whereas the significant association between the 1349T&gt;G polymorphism and idiopathic male infertility risk was not observed (P = 0.2).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data suggest that the -656T&gt;G ApE1 polymorphism may be associated with increased risk of idiopathic male infertility. Larger studies with more patients and controls are needed to confirm the results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yousefi</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Sciences, University of Guilan, P.O. Box 1914, Rasht, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salehi</LastName><ForeName>Zivar</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Mashayekhi</LastName><ForeName>Farhad</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Bahadori</LastName><ForeName>Mohammad Hadi</ForeName><Initials>MH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Urol Nephrol</MedlineTA><NlmUniqueID>0262521</NlmUniqueID><ISSNLinking>0301-1623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 May 16;278(20):18289-96</RefSource><PMID Version="1">12624104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(12):e28971</RefSource><PMID Version="1">22205985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2006 Jan;1762(1):17-28</RefSource><PMID Version="1">16297602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Reprod Toxicol. 2006 Aug;22(2):133-41</RefSource><PMID Version="1">16806807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011 Mar 23;11:104</RefSource><PMID Version="1">21429202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Jan 1;161(1):1-14</RefSource><PMID Version="1">15615908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fertil Steril. 2009 Nov;92(5):1520-4</RefSource><PMID Version="1">19828144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Jun;22(6):917-22</RefSource><PMID Version="1">11375899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Balkan J Med Genet. 2012 Dec;15(Suppl):31-4</RefSource><PMID Version="1">24052740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Feb 16;291(5507):1284-9</RefSource><PMID Version="1">11181991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2004 Jun;83(6):970-9</RefSource><PMID Version="1">15177551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Reprod. 2008 Dec;23(12):2663-8</RefSource><PMID Version="1">18757447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2013 Jun;30(2):505</RefSource><PMID Version="1">23430444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):160-4</RefSource><PMID Version="1">19592152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Androl. 2009 Feb;32(1):46-56</RefSource><PMID Version="1">19076252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011 Dec 18;11:521</RefSource><PMID Version="1">22176746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Apr;7(4):824-30</RefSource><PMID Version="1">11309329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Feb 15;61(4):1354-7</RefSource><PMID Version="1">11245433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Urol. 2012;2012:384520</RefSource><PMID Version="1">22046184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 Nov 15;531(1):97-100</RefSource><PMID Version="1">23994194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2006 May 26;312(5777):1215-7</RefSource><PMID Version="1">16728641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Jan;40(1):171-6</RefSource><PMID Version="1">23143180</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007248" MajorTopicYN="N">Infertility, Male</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25917483</ArticleId><ArticleId IdType="doi">10.1007/s11255-015-0979-z</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25916209</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0380</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</Title><ISOAbbreviation>Tumour Biol.</ISOAbbreviation></Journal><ArticleTitle>XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions.</ArticleTitle><Pagination><MedlinePgn>7569-79</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13277-015-3472-5</ELocationID><Abstract><AbstractText>In the present study, we investigated the effect of the DNA repair gene polymorphisms XPD Asp312Asn (G&gt;A), APE1 Asp148Glu (T&gt;G), and MUTYH Tyr165Cys (G&gt;A) on the risk for head and neck cancer (HNC) in association with tobacco use in a population of Northeast India. The study subjects comprised of 80 HNC patients and 92 healthy controls. Genotyping was performed using amplification refractory mutation system-PCR (ARMS-PCR) for XPD Asp312Asn (G&gt;A) and PCR using confronting two-pair primers (PCR-CTPP) for APE1 Asp148Glu (T&gt;G) and MUTYH Tyr165Cys (G&gt;A). The XPD Asp/Asn genotype increased the risk for HNC by 2-fold (odds ratio, OR = 2.072; 95 % CI, 1.025-4.190; p &lt; 0.05). Interaction between APE1 Asp/Asp and XPD Asp/Asn as well as MUTYH Tyr/Tyr and XPD Asp/Asn genotypes further increased the risk by 2.9 (OR = 2.97; 95 % CI, 1.16-7.61; p &lt; 0.05) and 2.3 (OR = 2.37; 95 % CI, 1.11-5.10; p &lt; 0.05) folds, respectively. The risk was further increased in heavy smokers with the XPD Asp/Asn genotype and heavy tobacco chewers with XPD Asn/Asn genotype by 7.7-fold (OR = 7.749; 95 % CI, 2.53-23.70; p &lt; 0.05) and 10-fold (OR = 10; 95 % CI, 1.26-79.13; p &lt; 0.05), respectively. We thus conclude that the XPD Asp312Asn and APE1 Asp148Glu polymorphisms increase the risk for HNC in association with smoking and/or tobacco chewing in the population under study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Sambuddha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhowmik</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharjee</LastName><ForeName>Abhinandan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of ENT, Silchar Medical College and Hospital, Silchar, 788014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Biswadeep</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Silchar Medical College and Hospital, Silchar, 788014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naiding</LastName><ForeName>Momota</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Silchar Medical College and Hospital, Silchar, 788014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laskar</LastName><ForeName>Agniv Kr</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Sankar Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Yashmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Assam University, Silchar, 788011, India. yashminchoudhury@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Tumour Biol</MedlineTA><NlmUniqueID>8409922</NlmUniqueID><ISSNLinking>1010-4283</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C061738">mutY adenine glycosylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="D051759">Xeroderma Pigmentosum Group D Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.99.-</RegistryNumber><NameOfSubstance UI="C497292">ERCC2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 May 10;28(14):2445-51</RefSource><PMID Version="1">20385987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2014 Aug;31(8):67</RefSource><PMID Version="1">24958516</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="N">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051759" MajorTopicYN="N">Xeroderma Pigmentosum Group D Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Head and neck cancer</Keyword><Keyword MajorTopicYN="N">MUTYH</Keyword><Keyword MajorTopicYN="N">Polymorphism</Keyword><Keyword MajorTopicYN="N">XPD</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>04</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25916209</ArticleId><ArticleId IdType="doi">10.1007/s13277-015-3472-5</ArticleId><ArticleId IdType="pii">10.1007/s13277-015-3472-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25865359</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-2744</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Molecular carcinogenesis</Title><ISOAbbreviation>Mol. Carcinog.</ISOAbbreviation></Journal><ArticleTitle>Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.</ArticleTitle><Pagination><MedlinePgn>688-704</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mc.22313</ELocationID><Abstract><AbstractText>The apurinic/apyrimidinic endonuclease 1 (APE1) is a protein central to the base excision DNA repair pathway and operates in the modulation of gene expression through redox-dependent and independent mechanisms. Aberrant expression and localization of APE1 in tumors are recurrent hallmarks of aggressiveness and resistance to therapy. We identified and characterized the molecular association between APE1 and nucleophosmin (NPM1), a multifunctional protein involved in the preservation of genome stability and rRNA maturation. This protein-protein interaction modulates subcellular localization and endonuclease activity of APE1. Moreover, we reported a correlation between APE1 and NPM1 expression levels in ovarian cancer, with NPM1 overexpression being a marker of poor prognosis. These observations suggest that tumors that display an augmented APE1/NPM1 association may exhibit increased aggressiveness and resistance. Therefore, targeting the APE1/NPM1 interaction might represent an innovative strategy for the development of anticancer drugs, as tumor cells relying on higher levels of APE1 and NPM1 for proliferation and survival may be more sensitive than untransformed cells. We set up a chemiluminescence-based high-throughput screening assay in order to find small molecules able to interfere with the APE1/NPM1 interaction. This screening led to the identification of a set of bioactive compounds that impair the APE1/NPM1 association in living cells. Interestingly, some of these molecules display anti-proliferative activity and sensitize cells to therapeutically relevant genotoxins. Given the prognostic significance of APE1 and NPM1, these compounds might prove effective in the treatment of tumors that show abundant levels of both proteins, such as ovarian or hepatic carcinomas.</AbstractText><CopyrightInformation>© 2015 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poletto</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical and Biological Sciences, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malfatti</LastName><ForeName>Matilde C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Medical and Biological Sciences, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorjsuren</LastName><ForeName>Dorjbal</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scognamiglio</LastName><ForeName>Pasqualina L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, CIRPEB (Centro Interuniversitario di Ricerca sui Peptidi Bioattivi), University of Naples 'Federico II', Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Biomaterials for Healthcare@CRIB, Istituto Italiano di Tecnologia (IIT), Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marasco</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, CIRPEB (Centro Interuniversitario di Ricerca sui Peptidi Bioattivi), University of Naples 'Federico II', Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vascotto</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical and Biological Sciences, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jadhav</LastName><ForeName>Ajit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloney</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simeonov</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tell</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Biological Sciences, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z99 TR999999</GrantID><Acronym>NULL</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54MH08468</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Carcinog</MedlineTA><NlmUniqueID>8811105</NlmUniqueID><ISSNLinking>0899-1987</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance></Chemical><Chemical><RegistryNumber>117896-08-9</RegistryNumber><NameOfSubstance UI="C029739">nucleophosmin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2012 Apr 12;55(7):3101-12</RefSource><PMID Version="1">22455312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JALA Charlottesv Va. 2008 Apr;13(2):79-89</RefSource><PMID Version="1">18496600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(2):701-11</RefSource><PMID Version="1">21933813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Pathol. 2014 Mar;141(3):404-14</RefSource><PMID Version="1">24515769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 1989 Apr;35(4):428-32</RefSource><PMID Version="1">2468077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2012 Jun;29(2):1265-71</RefSource><PMID Version="1">21479902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2002 Nov 15;95(10):2243-51</RefSource><PMID Version="1">12412180</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(10):3303-12</RefSource><PMID Version="1">15942031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol. 2014 Sep 18;21(9):1102-14</RefSource><PMID Version="1">25237857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2000 Mar;18(3):304-8</RefSource><PMID Version="1">10700146</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2009 Nov 1;240(3):348-54</RefSource><PMID Version="1">19632256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chem. 2008 Jul;54(7):1218-25</RefSource><PMID Version="1">18499900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2008 Mar;8(3):193-204</RefSource><PMID Version="1">18256616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):4079-96</RefSource><PMID Version="1">22918947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(1):73-81</RefSource><PMID Version="1">14704345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Feb 18;286(7):4968-77</RefSource><PMID Version="1">21081487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1998 Apr;77(7):1169-73</RefSource><PMID Version="1">9569057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Pharmacol. 2000 Nov 3;407(3):227-35</RefSource><PMID Version="1">11068018</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 1988 Mar;175(1):184-91</RefSource><PMID Version="1">3345800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pharmacol Toxicol. 2014;54:435-56</RefSource><PMID Version="1">24160698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1990 Dec;87(23):9373-7</RefSource><PMID Version="1">1701259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2012 Jul 20;424(1):34-9</RefSource><PMID Version="1">22713458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2011 Jun 9;30(23):2595-609</RefSource><PMID Version="1">21278791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2007 Jan-Feb;13(1-2):89-96</RefSource><PMID Version="1">17515960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 2001 Jul;86(7):3250-6</RefSource><PMID Version="1">11443197</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2012;19(23):3922-36</RefSource><PMID Version="1">22788768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Apr 16;285(16):12416-25</RefSource><PMID Version="1">20159984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(7):1834-54</RefSource><PMID Version="1">19188445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3621-31</RefSource><PMID Version="1">20809131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Mar 1;12(3):188-95</RefSource><PMID Version="1">23276627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2009 Feb;9(4):1058-74</RefSource><PMID Version="1">19180539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2014 May 29;33(22):2876-87</RefSource><PMID Version="1">23831574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1998 Oct 21;409(1):17-29</RefSource><PMID Version="1">9806499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Dec;38(22):8239-56</RefSource><PMID Version="1">20699270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Mar 1;61(5):2220-5</RefSource><PMID Version="1">11280790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2007 Aug;6(8):2303-9</RefSource><PMID Version="1">17699725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Proteomics. 2010 Jan;9(1):178-83</RefSource><PMID Version="1">19864249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(6):e5740</RefSource><PMID Version="1">19484131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2013 Jun 15;452(3):545-57</RefSource><PMID Version="1">23544830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(8):e70909</RefSource><PMID Version="1">23967134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(6):e66362</RefSource><PMID Version="1">23840452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 2001;68:41-54</RefSource><PMID Version="1">11554312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(15):4711-24</RefSource><PMID Version="1">16113242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2007 Feb 12;96(3):477-84</RefSource><PMID Version="1">17245342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3589-608</RefSource><PMID Version="1">20706766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2011 May;43(5):470-5</RefSource><PMID Version="1">21441929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Feb 1;109(3):874-85</RefSource><PMID Version="1">17008539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">NPM1</Keyword><Keyword MajorTopicYN="N">combination therapy</Keyword><Keyword MajorTopicYN="N">protein/protein interaction</Keyword><Keyword MajorTopicYN="N">small molecule</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>08</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25865359</ArticleId><ArticleId IdType="doi">10.1002/mc.22313</ArticleId><ArticleId IdType="pmc">PMC4600639</ArticleId><ArticleId IdType="mid">NIHMS668166</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25847273</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2015</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-135X</ISSN><JournalIssue CitedMedium="Internet"><Volume>766-767</Volume><PubDate><MedlineDate>2014 Aug-Sep</MedlineDate></PubDate></JournalIssue><Title>Mutation research</Title><ISOAbbreviation>Mutat. Res.</ISOAbbreviation></Journal><ArticleTitle>Direct observation of preferential processing of clustered abasic DNA damages with APE1 in TATA box and CpG island by reaction kinetics and fluorescence dynamics.</ArticleTitle><Pagination><MedlinePgn>56-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrfmmm.2014.06.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0027-5107(14)00110-9</ELocationID><Abstract><AbstractText>Sequences like the core element of TATA box and CpG island are frequently encountered in the genome and related to transcription. The fate of repair of clustered abasic sites in such sequences of genomic importance is largely unknown. This prompted us to investigate the sequence dependence of cleavage efficiency of APE1 enzyme at abasic sites within the core sequences of TATA box and CpG island using fluorescence dynamics and reaction kinetics. Simultaneous molecular dynamics study through steady state and time resolved fluorescence spectroscopy using unique ethidium bromide dye release assay confirmed an elevated amount of abasic site cleavage of the TATA box sequence as compared to the core CpG island. Reaction kinetics showed that catalytic efficiency of APE1 for abasic site cleavage of core CpG island sequence was ∼4 times lower as compared to that of the TATA box. Higher value of Km was obtained from the core CpG island sequence than the TATA box sequence. This suggests a greater binding effect of APE1 enzyme on TATA sequence that signifies a prominent role of the sequence context of the DNA substrate. Evidently, a faster response from APE1 was obtained for clustered abasic damage repair of TATA box core sequences than CpG island consensus sequences. The neighboring bases of the abasic sites in the complementary DNA strand were found to have significant contribution in addition to the flanking bases in modulating APE1 activity. The repair refractivity of the bistranded clustered abasic sites arise from the slow processing of the second abasic site, consequently resulting in decreased overall production of potentially lethal double strand breaks. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Vandana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Govt. Polytechnic Campus, Patliputra Colony, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumari</LastName><ForeName>Bhavini</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Govt. Polytechnic Campus, Patliputra Colony, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maity</LastName><ForeName>Banibrata</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Govt. Polytechnic Campus, Patliputra Colony, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seth</LastName><ForeName>Debabrata</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Govt. Polytechnic Campus, Patliputra Colony, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Prolay</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Govt. Polytechnic Campus, Patliputra Colony, Patna 800013, Bihar, India. Electronic address: prolay@iitp.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002384" MajorTopicYN="N">Catalysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018899" MajorTopicYN="Y">CpG Islands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013050" MajorTopicYN="N">Spectrometry, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016385" MajorTopicYN="Y">TATA Box</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Abasic site</Keyword><Keyword MajorTopicYN="N">CpG island</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">TATA box</Keyword><Keyword MajorTopicYN="N">Time resolved fluorescence spectroscopy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25847273</ArticleId><ArticleId IdType="pii">S0027-5107(14)00110-9</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2014.06.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25847267</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2015</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-135X</ISSN><JournalIssue CitedMedium="Internet"><Volume>766-767</Volume><PubDate><MedlineDate>2014 Aug-Sep</MedlineDate></PubDate></JournalIssue><Title>Mutation research</Title><ISOAbbreviation>Mutat. Res.</ISOAbbreviation></Journal><ArticleTitle>Impact of abasic site orientation within nucleosomes on human APE1 endonuclease activity.</ArticleTitle><Pagination><MedlinePgn>19-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrfmmm.2014.05.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0027-5107(14)00103-1</ELocationID><Abstract><AbstractText>Glycosylases responsible for recognizing DNA lesions and initiating Base Excision Repair (BER) are impeded by the presence of histones, which are essential for compaction of the genetic material in the nucleus. Abasic sites are an abundant mutagenic lesion in the DNA, arising spontaneously and as the product of glycosylase activity, making it a common intermediate in BER. The apurinic/apyrimidinic endonuclease 1 (APE1) recognizes abasic sites and cleaves the DNA backbone adjacent to the lesion, creating the single-strand break essential for the subsequent steps of BER. In this study the endonuclease activity of human APE1 was measured on reconstituted nucleosome core particles (NCPs) with DNA containing enzymatically created abasic sites (AP) or the abasic site analog tetrahydrofuran (TF) at different rotational positions relative to the histone core surface. The presence of histones on the DNA reduced APE1 activity overall, and the magnitude was greatly influenced by differences in orientation of the lesions along the DNA gyre relative to the histone core. Abasic moieties oriented with their phosphate backbones adjacent to the underlying histones (In) were cleaved less efficiently than those oriented away from the histone core (Out) or between the In and Out orientations (Mid). The impact on APE1 at each orientation was very similar between the AP and TF lesions, highlighting the dependability of the TF abasic analog in APE1 activity measurements in nucleosomes. Measurement of APE1 binding to the NCP substrates reveals a substantial reduction in its interaction with nucleosomes compared to naked DNA, also in a lesion orientation-dependent manner, reinforcing the concept that reduction in APE1 activity on nucleosomes is due to occlusion from its abasic DNA substrate by the histones. These results suggest that APE1 activity in nucleosomes, like BER glycosylases, is primarily regulated by its chance interactions with transiently exposed lesions. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hinz</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>School of Molecular Biosciences, Washington State University, Pullman, WA 99164-7520, United States. Electronic address: jmhinz@wsu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ES004106</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES02095</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009707">Nucleosomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="Y">Nucleic Acid Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009707" MajorTopicYN="N">Nucleosomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1 endonuclease</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">Histone</Keyword><Keyword MajorTopicYN="N">Nucleosome</Keyword><Keyword MajorTopicYN="N">Tetrahydrofuran</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25847267</ArticleId><ArticleId IdType="pii">S0027-5107(14)00103-1</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2014.05.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25790058</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2015</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0844</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cell biochemistry and function</Title><ISOAbbreviation>Cell Biochem. Funct.</ISOAbbreviation></Journal><ArticleTitle>A review on protein-protein interaction network of APE1/Ref-1 and its associated biological functions.</ArticleTitle><Pagination><MedlinePgn>101-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cbf.3100</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1 (APE1) is a classic example of functionally variable protein. Besides its well-known role in (i) DNA repair of oxidative base damage, APE1 also plays a critical role in (ii) redox regulation of transcription factors controlling gene expression for cell survival pathways, for which it is also known as redox effector factor 1 (Ref-1), and recent evidences advocates for (iii) coordinated control of other non-canonical protein-protein interaction(s) responsible for significant biological functions in mammalian cells. The diverse functions of APE1 can be ascribed to its ability to interact with different protein partners, owing to the attainment of unfolded domains during evolution. Association of dysregulation of APE1 with various human pathologies, such as cancer, cardiovascular diseases and neurodegeneration, is attributable to its multifunctional nature, and this makes APE1 a potential therapeutic target. This review covers the important aspects of APE1 in terms of its significant protein-protein interaction(s), and this knowledge is required to understand the onset and development of human pathologies and to design or improve the strategies to target such interactions for treatment and management of various human diseases.</AbstractText><CopyrightInformation>Copyright © 2015 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Biosciences, School of Basic and Applied Sciences, Central University of Punjab, Bathinda, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhiman</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tell</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Mantha</LastName><ForeName>A K</ForeName><Initials>AK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Biochem Funct</MedlineTA><NlmUniqueID>8305874</NlmUniqueID><ISSNLinking>0263-6484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.5.1.-</RegistryNumber><NameOfSubstance UI="D045643">DNA Repair Enzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D045643" MajorTopicYN="N">DNA Repair Enzymes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1/Ref-1</Keyword><Keyword MajorTopicYN="N">BER-pathway</Keyword><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">redox regulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>02</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25790058</ArticleId><ArticleId IdType="doi">10.1002/cbf.3100</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25733810</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1177-8881</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Drug design, development and therapy</Title><ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation></Journal><ArticleTitle>Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer.</ArticleTitle><Pagination><MedlinePgn>901-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S75152</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Gastric cancer is a fatal malignancy with a rising incidence rate. Effective methods for early diagnosis, monitoring metastasis, and prognosis are currently unavailable for gastric cancer. In this study, we examined the association of programmed death ligand-1 (PD-L1) and apurinic/apyrimidinic endonuclease 1 (APE1) expression with the prognosis of gastric cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The expressions of PD-L1 and APE1 were detected by immunohistochemistry in 107 cases of human gastric carcinoma. The correlation of PD-L1 and APE1 expression with the clinicopathologic features of gastric carcinoma was analyzed by SPSS version 19.0.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The positive expression rates of PD-L1 and APE1 in gastric cancer tissues were 50.5% (54/107) and 86.9% (93/107), respectively. PD-L1 and APE1 positive expressions were significantly associated with depth of invasion, lymph node metastasis, pathological type, overall survival, and higher T stage. Furthermore, the expression of PD-L1 in highly differentiated gastric cancers was higher than that in poorly differentiated cancers (P=0.008). Moreover, the expression of APE1 and PD-L1 in gastric cancers was positively correlated (r=0.336, P&lt;0.01). Multivariate analysis showed that the depth of invasion was a significant prognostic factor (risk ratio 19.91; P=0.000), but there was no significant relationship with PD-L1, APE1, prognosis, and other characteristics.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The deregulation of PD-L1 and APE1 might contribute to the development and the poor prognosis of gastric cancer. Our findings suggest that high expression of PD-L1 and APE1 is a risk factor of gastric cancer and a new biomarker to predict the prognosis of gastric cancer. Furthermore, our findings suggest that targeting the PD-L1 and APE1 signaling pathways may be a new strategy for cancer immune therapy and targeted therapy for gastric cancer, especially in patients with deep invasion and lymph node metastasis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Gao-Lei</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Urological Surgery, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yu-Xin</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Xiao-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shu-Feng</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Des Devel Ther</MedlineTA><NlmUniqueID>101475745</NlmUniqueID><ISSNLinking>1177-8881</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060890">B7-H1 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C423236">CD274 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Mar 1;109(5):1917-22</RefSource><PMID Version="1">17053053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 1999 Dec;5(12):1365-9</RefSource><PMID Version="1">10581077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Dermatol Res. 2014 Aug;306(6):511-9</RefSource><PMID Version="1">24615548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Cell Mol Biol. 2001 Dec;25(6):664-7</RefSource><PMID Version="1">11726389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2002 Feb;2(2):116-26</RefSource><PMID Version="1">11910893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2002 Aug;8(8):793-800</RefSource><PMID Version="1">12091876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7</RefSource><PMID Version="1">12218188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2002 Nov 15;169(10):5538-45</RefSource><PMID Version="1">12421930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2003 Apr 1;170(7):3637-44</RefSource><PMID Version="1">12646628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Med (Berl). 2003 May;81(5):281-7</RefSource><PMID Version="1">12721664</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastric Cancer. 2002;5 Suppl 1:5-11</RefSource><PMID Version="1">12772880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2003 Oct;112(7):989-98</RefSource><PMID Version="1">14523036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Oct 1;63(19):6501-5</RefSource><PMID Version="1">14559843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Mar 1;67(5):2141-9</RefSource><PMID Version="1">17332344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Aug 15;121(4):751-8</RefSource><PMID Version="1">17415709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Immunol. 2008 Jan;45(1):76-86</RefSource><PMID Version="1">17599408</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2007 Dec;98(12):1993-2001</RefSource><PMID Version="1">17892509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Immunol. 2008 Mar;45(5):1470-6</RefSource><PMID Version="1">17920123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2008 Sep 8;268(1):98-109</RefSource><PMID Version="1">18486325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2008 Sep 1;112(5):2149-55</RefSource><PMID Version="1">18577709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Autoimmun Rev. 2010 Jun;9(8):583-7</RefSource><PMID Version="1">20433954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2010 Jun;51(5):417-26</RefSource><PMID Version="1">20544882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Markers. 2010;29(1):47-53</RefSource><PMID Version="1">20826917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2011 Jul;102(7):1272-80</RefSource><PMID Version="1">21466615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(12):e28971</RefSource><PMID Version="1">22205985</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2012 Jun 1;188(11):5227-37</RefSource><PMID Version="1">22508931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47462</RefSource><PMID Version="1">23094050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2014 Feb 21;20(7):1657-66</RefSource><PMID Version="1">24587645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2014 Jul;40(6):770-80</RefSource><PMID Version="1">24656976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2014 Jul;140(7):1117-24</RefSource><PMID Version="1">24752338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Chin Med Assoc. 2014 Jul;77(7):345-53</RefSource><PMID Version="1">24907022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncology. 2000 Feb;58(2):126-36</RefSource><PMID Version="1">10705239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Nov 1;63(21):7462-7</RefSource><PMID Version="1">14612546</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2004 Aug 1;10(15):5094-100</RefSource><PMID Version="1">15297412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17174-9</RefSource><PMID Version="1">15569934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Apr 15;11(8):2947-53</RefSource><PMID Version="1">15837746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43</RefSource><PMID Version="1">15824325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Apr 1;66(7):3381-5</RefSource><PMID Version="1">16585157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasia. 2006 Mar;8(3):190-8</RefSource><PMID Version="1">16611412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2006 Apr 17;203(4):883-95</RefSource><PMID Version="1">16606670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Histochem. 2006;108(1):19-24</RefSource><PMID Version="1">16530813</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060890" MajorTopicYN="N">B7-H1 Antigen</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063646" MajorTopicYN="N">Carcinogenesis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">gastric carcinoma</Keyword><Keyword MajorTopicYN="N">immunohistochemistry</Keyword><Keyword MajorTopicYN="N">potential targets</Keyword><Keyword MajorTopicYN="N">prognostic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25733810</ArticleId><ArticleId IdType="doi">10.2147/DDDT.S75152</ArticleId><ArticleId IdType="pii">dddt-9-901</ArticleId><ArticleId IdType="pmc">PMC4338255</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25733688</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5549</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>Molecular and cellular biology</Title><ISOAbbreviation>Mol. Cell. Biol.</ISOAbbreviation></Journal><ArticleTitle>Interaction with OGG1 is required for efficient recruitment of XRCC1 to base excision repair and maintenance of genetic stability after exposure to oxidative stress.</ArticleTitle><Pagination><MedlinePgn>1648-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/MCB.00134-15</ELocationID><Abstract><AbstractText>XRCC1 is an essential protein required for the maintenance of genomic stability through its implication in DNA repair. The main function of XRCC1 is associated with its role in the single-strand break (SSB) and base excision repair (BER) pathways that share several enzymatic steps. We show here that the polymorphic XRCC1 variant R194W presents a defect in its interaction with the DNA glycosylase OGG1 after oxidative stress. While proficient for single-strand break repair (SSBR), this variant does not colocalize with OGG1, reflecting a defect in its involvement in BER. Consistent with a role of XRCC1 in the coordination of the BER pathway, induction of oxidative base damage in XRCC1-deficient cells complemented with the R194W variant results in increased genetic instability as revealed by the accumulation of micronuclei. These data identify a specific molecular role for the XRCC1-OGG1 interaction in BER and provide a model for the effects of the R194W variant identified in molecular cancer epidemiology studies. </AbstractText><CopyrightInformation>Copyright © 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campalans</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CEA, Institute of Cellular and Molecular Radiobiology, Fontenay-aux-Roses, France INSERM, U967, Fontenay-aux-Roses, France Université Paris Diderot, U967, Fontenay-aux-Roses, France Université Paris Sud, U967, Fontenay-aux-Roses, France anna.campalans@cea.fr pablo.radicella@cea.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moritz</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Pharmacy and Biochemistry, University of Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kortulewski</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CEA, Institute of Cellular and Molecular Radiobiology, Fontenay-aux-Roses, France INSERM, U967, Fontenay-aux-Roses, France Université Paris Diderot, U967, Fontenay-aux-Roses, France Université Paris Sud, U967, Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biard</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CEA, DSV, iMETI, SEPIA, Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epe</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Pharmacy and Biochemistry, University of Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radicella</LastName><ForeName>J Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>CEA, Institute of Cellular and Molecular Radiobiology, Fontenay-aux-Roses, France INSERM, U967, Fontenay-aux-Roses, France Université Paris Diderot, U967, Fontenay-aux-Roses, France Université Paris Sud, U967, Fontenay-aux-Roses, France anna.campalans@cea.fr pablo.radicella@cea.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell Biol</MedlineTA><NlmUniqueID>8109087</NlmUniqueID><ISSNLinking>0270-7306</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Microsc. 2006 Dec;224(Pt 3):213-32</RefSource><PMID Version="1">17210054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 2004;38:445-76</RefSource><PMID Version="1">15568983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2003 Feb;31(Pt 1):247-51</RefSource><PMID Version="1">12546695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Nov 15;20(22):6530-9</RefSource><PMID Version="1">11707423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Feb 4;6(2):254-64</RefSource><PMID Version="1">17118717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(8):2550-5</RefSource><PMID Version="1">15141024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Aug;38(15):5023-35</RefSource><PMID Version="1">20385586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8010-5</RefSource><PMID Version="1">9223305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1976 Oct 19;15(21):4629-37</RefSource><PMID Version="1">9979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Mar 1;41(5):3115-29</RefSource><PMID Version="1">23355608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Oct 20;275(42):32635-41</RefSource><PMID Version="1">10924509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Biol. 2000 Mar;7(3):176-8</RefSource><PMID Version="1">10700268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2005 Aug 1;170(3):341-7</RefSource><PMID Version="1">16061690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2003 Sep 18;2(9):955-69</RefSource><PMID Version="1">12967653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2005 Apr 4;582(1-2):135-45</RefSource><PMID Version="1">15781218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 1999 Apr 15;208(2):513-29</RefSource><PMID Version="1">10191063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1996 Nov 15;24(22):4387-94</RefSource><PMID Version="1">8948628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2003 Jan;124(1):27-32</RefSource><PMID Version="1">12618003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(8):2512-20</RefSource><PMID Version="1">15867196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Jun;23(11):3974-81</RefSource><PMID Version="1">12748298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1994 Mar 14;341(1):59-64</RefSource><PMID Version="1">8137923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2007 Jan 1;120(Pt 1):23-32</RefSource><PMID Version="1">17148573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Mar-Apr;658(3):215-33</RefSource><PMID Version="1">18037339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 1998 Jul 16;8(15):877-80</RefSource><PMID Version="1">9705932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2009 Nov;19(11):617-29</RefSource><PMID Version="1">19819145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Jul 12;4(7):826-35</RefSource><PMID Version="1">15927541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1995 Jan 16;358(1):1-3</RefSource><PMID Version="1">7821417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1992 Sep 7;309(2):193-8</RefSource><PMID Version="1">1324197</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jun;21(6):1135-41</RefSource><PMID Version="1">10837001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Nov;35(11):10665-76</RefSource><PMID Version="1">25062722</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1998 Jun;18(6):3563-71</RefSource><PMID Version="1">9584196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Apr;39(8):3166-75</RefSource><PMID Version="1">21183466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(1):298-306</RefSource><PMID Version="1">15647512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2007 Jul;48(6):491-500</RefSource><PMID Version="1">17603793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Mol Biol. 2007;8:81</RefSource><PMID Version="1">17880707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 May 15;28(10):2049-59</RefSource><PMID Version="1">10773072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Feb 16;459(1):1-18</RefSource><PMID Version="1">10677679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1996 Dec 2;15(23):6662-70</RefSource><PMID Version="1">8978692</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Nov;35(11):10677-97</RefSource><PMID Version="1">25064613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13738-43</RefSource><PMID Version="1">15365186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Sep 19;272(38):23970-5</RefSource><PMID Version="1">9295348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1994 Jan;14(1):68-76</RefSource><PMID Version="1">8264637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2005 Sep;3(9):519-29</RefSource><PMID Version="1">16179499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Oct;52(8):623-35</RefSource><PMID Version="1">21786338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 1997 Nov;18(11):2225-31</RefSource><PMID Version="1">9395225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Biol. 2000 Dec;7(12):1087-9</RefSource><PMID Version="1">11101884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2003 Nov 7;278(45):44068-74</RefSource><PMID Version="1">12933815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1995 Dec 11;23(23):4836-43</RefSource><PMID Version="1">8532526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1997 Apr 29;36(17):5207-11</RefSource><PMID Version="1">9136882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Oct 1;31(19):5526-33</RefSource><PMID Version="1">14500814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 May;38(9):2878-90</RefSource><PMID Version="1">20071746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2001 Jul;8(1):213-24</RefSource><PMID Version="1">11511374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2008 Dec 3;27(23):3140-50</RefSource><PMID Version="1">18971944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2014 Jul 7;206(1):29-43</RefSource><PMID Version="1">24982429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 Jan;20(2):735-40</RefSource><PMID Version="1">10611252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1999 Mar 8;424(1-2):9-21</RefSource><PMID Version="1">10064846</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017353" MajorTopicYN="N">Gene Deletion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>02</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25733688</ArticleId><ArticleId IdType="pii">MCB.00134-15</ArticleId><ArticleId IdType="doi">10.1128/MCB.00134-15</ArticleId><ArticleId IdType="pmc">PMC4387214</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25731027</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0016-6758</ISSN><JournalIssue CitedMedium="Print"><Volume>50</Volume><Issue>8</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Genetika</Title><ISOAbbreviation>Genetika</ISOAbbreviation></Journal><ArticleTitle>[The polymorphism of DNA repair genes XPD, XRCC1, OGG1, and ERCC6, life expectancy, and the inclination to smoke].</ArticleTitle><Pagination><MedlinePgn>975-85</MedlinePgn></Pagination><Abstract><AbstractText>The polymorphism of excision repair genes XPD Asp312Asn, XRCC1 Arg399Gln, OGG1 Ser326Cys, and ERCC6 Met1097Val was analyzed by PCR-RFLP in 370 representatives of the Belarusian population of average, old, and elderly ages. Correlation analysis showed that the frequencies of wild-type homozygous combinations significantly increase with age in the group of subjects over 70 years old in the case of the interaction of two genes, XPD 312 and XRCC1399, or three genes, XPD312, XRCC1399, and ERCC6 1097. In a subgroup of the long-lived, this relationship is manifested in case of a pairwise interaction of gene XPD 312 with XRCC1 399 or ERCC6 1097, as well as an interaction of three genes, XPD 312, XRCC1 399, and ERCC6 1097. The data suggest that the optimum activity of repair processes may favor longevity. It is shown that the frequency of the Asp/Asp genotype is reduced, and the frequency of the Asn allele of the XPD 312 gene is increased in the subgroup of smokers as compared with nonsmokers, which apparently indicates an association of this gene polymorphism with an inclination to smoke. The problem requires further study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romaniuk</LastName><ForeName>O P</ForeName><Initials>OP</Initials></Author><Author ValidYN="Y"><LastName>Nikitchenko</LastName><ForeName>N V</ForeName><Initials>NV</Initials></Author><Author ValidYN="Y"><LastName>Savina</LastName><ForeName>N V</ForeName><Initials>NV</Initials></Author><Author ValidYN="Y"><LastName>Kuzhir</LastName><ForeName>T D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Goncharova</LastName><ForeName>R I</ForeName><Initials>RI</Initials></Author></AuthorList><Language>rus</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Russia (Federation)</Country><MedlineTA>Genetika</MedlineTA><NlmUniqueID>0047354</NlmUniqueID><ISSNLinking>0016-6758</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075223">Poly-ADP-Ribose Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="C078673">ERCC6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="D051759">Xeroderma Pigmentosum Group D Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.99.-</RegistryNumber><NameOfSubstance UI="C497292">ERCC2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.5.1.-</RegistryNumber><NameOfSubstance UI="D045643">DNA Repair Enzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045643" MajorTopicYN="N">DNA Repair Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075223" MajorTopicYN="N">Poly-ADP-Ribose Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051759" MajorTopicYN="N">Xeroderma Pigmentosum Group D Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25731027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25711499</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-3804</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Mutagenesis</Title><ISOAbbreviation>Mutagenesis</ISOAbbreviation></Journal><ArticleTitle>Wood dust exposure induces cell transformation through EGFR-mediated OGG1 inhibition.</ArticleTitle><Pagination><MedlinePgn>487-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/mutage/gev007</ELocationID><Abstract><AbstractText>A high risk of neoplastic transformation of nasal and paranasal sinuses mucosa is related to the occupational exposure to wood dust. However, the role of occupational exposures in the aetiology of the airway cancers remains largely unknown. Here, an in vitro model was performed to investigate the carcinogenic effect of wood dusts. Human bronchial epithelial cells were incubated with hard and soft wood dusts and the DNA damage and response to DNA damage evaluated. Wood dust exposure induced accumulation of oxidised DNA bases, which was associated with a delay in DNA repair activity. By exposing cells to wood dust at a prolonged time, wood dust-initiated cells were obtained. Initiated-cells were able to form colonies in soft agar, and to induce blood vessel formation. These cells showed extensive autophagy, reduced DNA repair, which was associated with reduced OGG1 expression and oxidised DNA base accumulation. These events were found related to the activation of EGFR/AKT/mTOR pathway, through phosphorylation and subsequent inactivation of tuberin. The persistence in the tissue of wood dusts, their repetitious binding with EGFR may continually trigger the activation switch, leading to chronic down-regulation of genes involved in DNA repair, leading to cell transformation and proliferation. </AbstractText><CopyrightInformation>© The Author 2015. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Staffolani</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzella</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strafella</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nocchi</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bracci</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciarapica</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amati</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubini</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Re</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Polytechnic University of Marche, via Tronto, 10A, 60020 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugnaloni</LastName><ForeName>Armanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasquini</LastName><ForeName>Ernesto</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UOC-ORL Budrio-Metropolitan Hospital Via Benni, 44, Budrio 40054, Bologna, Italy and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarchini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of E.N.T. Polyclinic 'Sant'Orsola Malpighi' Otolaryngology Clinic, University of Bologna Via Pietro Albertoni, 15, 40138, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentino</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomasetti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science, m.tomasetti@univpm.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santarelli</LastName><ForeName>Lory</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Science.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mutagenesis</MedlineTA><NlmUniqueID>8707812</NlmUniqueID><ISSNLinking>0267-8357</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004391">Dust</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>4JG2LF96VF</RegistryNumber><NameOfSubstance UI="C090570">tuberous sclerosis complex 2 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C512478">EGFR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011958">Receptor, Epidermal Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C494918">AKT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001980" MajorTopicYN="N">Bronchi</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004391" MajorTopicYN="Y">Dust</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018919" MajorTopicYN="N">Neovascularization, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016273" MajorTopicYN="N">Occupational Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011958" MajorTopicYN="N">Receptor, Epidermal Growth Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025521" MajorTopicYN="N">Tumor Suppressor Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014934" MajorTopicYN="N">Wood</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25711499</ArticleId><ArticleId IdType="pii">gev007</ArticleId><ArticleId IdType="doi">10.1093/mutage/gev007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25672588</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2005-9256</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cancer research and treatment : official journal of Korean Cancer Association</Title><ISOAbbreviation>Cancer Res Treat</ISOAbbreviation></Journal><ArticleTitle>APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.</ArticleTitle><Pagination><MedlinePgn>823-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4143/crt.2014.074</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein that shows elevated expression in a number of cancers. We attempted to determine whether serum APE1/Ref-1 is elevated in patients with bladder cancer.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Serum APE1/Ref-1 levels were determined using enzyme-linked immunosorbent assay in serum from patients with bladder cancer who had not received chemotherapy or radiotherapy (n=51) and non-tumor controls (n=55). The area under the receiver operating characteristic area under the curve was applied to determine the correlation between clinical factors and the serum levels of APE1/Ref-1.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Serum levels of APE1/Ref-1 in bladder cancer patients were significantly elevated compared to those of the control group (3.548 ± 0.333 ng/100 μL [n=51] for bladder cancer vs. 1.547 ± 0.319 ng/100 μL [n=55] for the control group), with a sensitivity and specificity of 93% and 59%, respectively. Serum APE1/Ref-1 levels are associated with tumor stage, grade, muscle invasion, and recurrence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Serum APE1/Ref-1 might be useful as a potential serologic biomarker for bladder cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Ju Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infection Signaling Network Research Center, Research Institute of Medical Sciences, Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yu Ran</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Infection Signaling Network Research Center, Research Institute of Medical Sciences, Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Myoung Soo</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Infection Signaling Network Research Center, Research Institute of Medical Sciences, Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Yong Gil</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irani</LastName><ForeName>Kaikobad</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Do</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Infection Signaling Network Research Center, Research Institute of Medical Sciences, Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jin Bong</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Infection Signaling Network Research Center, Research Institute of Medical Sciences, Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin Man</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Pathology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Jae Sung</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Urology, Chungnam National University Hospital, Daejeon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeong Hwa</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Infection Signaling Network Research Center, Research Institute of Medical Sciences, Department of Physiology, Chungnam National University School of Medicine, Daejeon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Cancer Res Treat</MedlineTA><NlmUniqueID>101155137</NlmUniqueID><ISSNLinking>1598-2998</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Sep;110(5):699-708</RefSource><PMID Version="1">22313585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2012 Jul-Aug;62(4):220-41</RefSource><PMID Version="1">22700443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 14;435(4):621-6</RefSource><PMID Version="1">23685156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2005 Feb 16;293(7):810-6</RefSource><PMID Version="1">15713770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Mar 19;140(6):883-99</RefSource><PMID Version="1">20303878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 Jun 7;435(3):403-7</RefSource><PMID Version="1">23665318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2000 Apr;163(4):1124-9</RefSource><PMID Version="1">10737480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Verh Dtsch Ges Pathol. 2002;86:57-66</RefSource><PMID Version="1">12647352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol. 2011 Apr;35(2):126-31</RefSource><PMID Version="1">20952269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Pathol. 2007 Jun;127(6):946-53</RefSource><PMID Version="1">17509992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2522-32</RefSource><PMID Version="1">17403694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2010 Nov;49(8):1283-7</RefSource><PMID Version="1">20843171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2009 Nov;35(5):1069-79</RefSource><PMID Version="1">19787261</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull Am Coll Surg. 2002 Jul;87(7):13-5</RefSource><PMID Version="1">17387902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Pathol. 2009 Nov;132(5):785-93</RefSource><PMID Version="1">19846822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biom J. 2005 Aug;47(4):458-72</RefSource><PMID Version="1">16161804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Urol. 2009 Mar;16(3):234-43</RefSource><PMID Version="1">19298346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(3):e58001</RefSource><PMID Version="1">23472128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2010 Aug;76(2):514.e6-11</RefSource><PMID Version="1">20346489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2002 Jan-Feb;9(1):11-7</RefSource><PMID Version="1">11748448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Rep. 2012 Feb;32(1):1-15</RefSource><PMID Version="1">21981137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3589-608</RefSource><PMID Version="1">20706766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res Treat. 2011 Mar;43(1):1-11</RefSource><PMID Version="1">21509157</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apurinic/apyrimidinic endonuclease 1/redox factor-1</Keyword><Keyword MajorTopicYN="N">Biological markers</Keyword><Keyword MajorTopicYN="N">Enzyme-linked immunosorbent assay</Keyword><Keyword MajorTopicYN="N">Urinary bladder neoplasms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25672588</ArticleId><ArticleId IdType="doi">10.4143/crt.2014.074</ArticleId><ArticleId IdType="pii">crt.2014.074</ArticleId><ArticleId IdType="pmc">PMC4614188</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25588927</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-131X</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Medical oncology (Northwood, London, England)</Title><ISOAbbreviation>Med. Oncol.</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.</ArticleTitle><Pagination><MedlinePgn>472</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12032-014-0472-z</ELocationID><Abstract><AbstractText>The oxyguanine glycosylase 1 (OGG1) gene has an important role in DNA repair, and the polymorphism of the gene may alter cancer susceptibility. This study aims to examine the association between the OGG1 Ser326Cys polymorphism and cancer risk based on meta-analysis. Relevant studies were identified through a search of PubMed and Weipu databases, and a total of 109 studies including 111 comparisons containing 34,041 cases and 42,730 controls were enrolled. Overall, significant association was observed between OGG1 Ser326Cys polymorphism and cancer risk in all genetic models except for heterozygote model (Cys/Cys + Cys/Ser vs Ser/Ser: OR 1.071, 95 % CI 1.019-1.125; Cys/Cys vs Cys/Ser + Ser/Ser: OR 1.159, 95 % CI 1.076-1.248; Cys/Cys vs Ser/Ser: OR 1.202, 95 % CI 1.105-1.308). In stratified analysis by cancer type, significantly increased cancer risk was observed in digestive system cancer, head and neck cancer and lung cancer. For gynecologic cancer, significantly increased cancer risk was also observed in homozygote model (OR 1.974, 95 % CI 1.254-3.107). In addition, in stratified analysis by ethnicities, increased cancer risk was found in Asians (Cys/Cys vs Cys/Ser + Ser/Ser: OR 1.195, 95 % CI 1.088-1.313; Cys/Cys + Cys/Ser vs Ser/Ser: OR 1.115, 95 % CI 1.045-1.190; Cys/Cys vs Ser/Ser: OR 1.273, 95 % CI 1.149-1.410). The OGG1 Ser326Cys polymorphism may be a risk factor for cancers of lung, digestive system and head and neck. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ping-Ting</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai, 200438, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng-Meng</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Chun-Fang</ForeName><Initials>CF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Oncol</MedlineTA><NlmUniqueID>9435512</NlmUniqueID><ISSNLinking>1357-0560</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Apr;35(4):3495-502</RefSource><PMID Version="1">24402573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2001 May 20;95(3):140-3</RefSource><PMID Version="1">11307145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Dec 24;726(2):227-33</RefSource><PMID Version="1">21986195</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2012;135:64-71</RefSource><PMID Version="1">22382185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):170-1</RefSource><PMID Version="1">12582029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Genet. 2004 Dec;42(11-12):453-60</RefSource><PMID Version="1">15587988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 1999 Aug;8(8):669-74</RefSource><PMID Version="1">10744126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:67-72</RefSource><PMID Version="1">21414327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hum Genet. 2009 Dec;54(12):739-45</RefSource><PMID Version="1">19881468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Rep. 2013 Jul;1(4):679-683</RefSource><PMID Version="1">24649009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2013 Dec;20 Suppl 3:S379-88</RefSource><PMID Version="1">22941157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2006 Aug;97(8):724-8</RefSource><PMID Version="1">16800823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2013 May-Jun;745-746:6-15</RefSource><PMID Version="1">23618615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2008 Jan;29(1):100-5</RefSource><PMID Version="1">17984110</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1984 Feb 24;12(4):2137-45</RefSource><PMID Version="1">6701097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2011 Nov-Dec;29(6):641-6</RefSource><PMID Version="1">19914098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Jun 15;68(12):4928-35</RefSource><PMID Version="1">18544627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Res. 2006 Aug;40(8):885-91</RefSource><PMID Version="1">17015267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2009 Jan 22;28:10</RefSource><PMID Version="1">19161591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacogenetics. 2004 Feb;14(2):103-9</RefSource><PMID Version="1">15077011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2010 Feb;21(2):289-300</RefSource><PMID Version="1">19902366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1993 Mar 15;53(6):1269-72</RefSource><PMID Version="1">8383005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Dec 15;648(1-2):65-72</RefSource><PMID Version="1">18977234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Exp Med Biol. 1999;459:179-93</RefSource><PMID Version="1">10335376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2008;59(4):201-4</RefSource><PMID Version="1">19391486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12 ):3384-8</RefSource><PMID Version="1">19959686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2012 Jul;103(7):1215-20</RefSource><PMID Version="1">22463382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2010 Aug;14(4):559-64</RefSource><PMID Version="1">20649433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:21-31</RefSource><PMID Version="1">21376741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006 Mar 20;34(5):1620-32</RefSource><PMID Version="1">16549874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2008 Jul 1;123(1):51-5</RefSource><PMID Version="1">18366059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2008 Dec;37(6):1316-25</RefSource><PMID Version="1">18641418</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2007 Mar;28(3):665-71</RefSource><PMID Version="1">17040931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2004 Dec;95(12):977-83</RefSource><PMID Version="1">15596047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2006 Oct 10;601(1-2):83-91</RefSource><PMID Version="1">16843501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Jun;16(6):1695-703</RefSource><PMID Version="1">19266243</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arh Hig Rada Toksikol. 2008 Dec;59(4):241-50</RefSource><PMID Version="1">19064361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 May;27(5):997-1007</RefSource><PMID Version="1">16308313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2011 Aug;73(2):138-46</RefSource><PMID Version="1">21195504</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2010 Sep 21;16(35):4476-82</RefSource><PMID Version="1">20845517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1994 Jan 22;343(8891):243-4</RefSource><PMID Version="1">7904707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2007 Jul 28;631(2):101-10</RefSource><PMID Version="1">17531525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Sep;111(2):279-88</RefSource><PMID Version="1">17922186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 Jun;27(6):1245-50</RefSource><PMID Version="1">16364924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(1):59-62</RefSource><PMID Version="1">12779082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1971 May;60(5):913-21</RefSource><PMID Version="1">4931955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Biosci. 2003 May 01;8:d963-81</RefSource><PMID Version="1">12700077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):409-12</RefSource><PMID Version="1">11927502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Feb 1;638(1-2):146-53</RefSource><PMID Version="1">17991492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2009 Sep 15;170(6):695-702</RefSource><PMID Version="1">19671832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dig Dis Sci. 2012 Sep;57(9):2451-7</RefSource><PMID Version="1">22565339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2012 Apr;31(4):541-6</RefSource><PMID Version="1">21899442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Mar;17(3):760-71</RefSource><PMID Version="1">20183911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):736-9</RefSource><PMID Version="1">18349297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2011 Feb 1;117(3):440-5</RefSource><PMID Version="1">20862743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Nov;25(6):569-75</RefSource><PMID Version="1">20817763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jun;29(6):535-9</RefSource><PMID Version="1">19040031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2000 Dec 15;88(6):932-7</RefSource><PMID Version="1">11093817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2008 Sep 30;27:49</RefSource><PMID Version="1">18823566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2005 Oct;99(1):43-9</RefSource><PMID Version="1">15990162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1991 Jan 31;349(6308):431-4</RefSource><PMID Version="1">1992344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jan;35(1):513-7</RefSource><PMID Version="1">23975367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(11):e27545</RefSource><PMID Version="1">22114677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2006 Nov;16(6):233-9</RefSource><PMID Version="1">17085873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2010;11(1):165-8</RefSource><PMID Version="1">20593951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Oncol. 2005 Nov;27(5):1315-20</RefSource><PMID Version="1">16211227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Dec;35(12):12627-33</RefSource><PMID Version="1">25227662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-8</RefSource><PMID Version="1">16492928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1994 Feb 12;343(8894):418</RefSource><PMID Version="1">7905571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Oct 15;69(20):7994-8000</RefSource><PMID Version="1">19826048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thorac Oncol. 2011 Apr;6(4):813-7</RefSource><PMID Version="1">21623257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2004 Nov;4(11):850-60</RefSource><PMID Version="1">15516958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2011 Apr;42(3):226-34</RefSource><PMID Version="1">21722819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Genet. 2007 Apr;121(2):233-42</RefSource><PMID Version="1">17203305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2010 Dec 06;29:157</RefSource><PMID Version="1">21134244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2010 Jul;31(7):1259-63</RefSource><PMID Version="1">20453000</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3642-9</RefSource><PMID Version="1">19351836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Cancer Res. 1998 Aug;89(8):825-8</RefSource><PMID Version="1">9765618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Nov;38(8):5379-86</RefSource><PMID Version="1">21390502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Oct 15;27(20):4001-7</RefSource><PMID Version="1">10497264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3167-73</RefSource><PMID Version="1">21037106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):730-8</RefSource><PMID Version="1">12163326</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2001 Sep 10;170(1):53-61</RefSource><PMID Version="1">11448535</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1959 Apr;22(4):719-48</RefSource><PMID Version="1">13655060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathol Oncol Res. 2012 Oct;18(4):1015-20</RefSource><PMID Version="1">22544315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2003 May;9(5):956-60</RefSource><PMID Version="1">12717837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 May 1;519(2):231-7</RefSource><PMID Version="1">23454624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Prev Med Public Health. 2006 Mar;39(2):130-4</RefSource><PMID Version="1">16615267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hum Genet. 2006 Mar;78(3):464-79</RefSource><PMID Version="1">16465622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Jul 1;116(13):3160-9</RefSource><PMID Version="1">20564624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Sep;40(9):5261-73</RefSource><PMID Version="1">23673479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jun;115(3):623-7</RefSource><PMID Version="1">18553220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2010 Apr;136(4):631-6</RefSource><PMID Version="1">20140625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Mar 1;639(1-2):45-54</RefSource><PMID Version="1">18155253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8</RefSource><PMID Version="1">16609022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2011;62(2):89-94</RefSource><PMID Version="1">21866464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Clin Oncol. 2008 Mar;38(3):186-91</RefSource><PMID Version="1">18272472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1999 Mar;79(7-8):1283-7</RefSource><PMID Version="1">10098773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2010 Apr;75(4):779-85</RefSource><PMID Version="1">19914697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Sep;25(5):463-71</RefSource><PMID Version="1">20534734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Jul;23(7):1229-34</RefSource><PMID Version="1">12117782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1997 Sep 13;315(7109):629-34</RefSource><PMID Version="1">9310563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):403-4</RefSource><PMID Version="1">16492938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 May 12;664(1-2):13-9</RefSource><PMID Version="1">19428376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 1966 Oct;7(5):427-32</RefSource><PMID Version="1">5929252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Gastroenterol. 2000 Jun;95(6):1402-10</RefSource><PMID Version="1">10894571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2002 Apr 15;62(8):2253-7</RefSource><PMID Version="1">11956079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2002 May;12(3):258-65</RefSource><PMID Version="1">12164330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2009 Jan 15;15(2):740-6</RefSource><PMID Version="1">19147782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2011 Aug;32(8):1223-30</RefSource><PMID Version="1">21622940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomarkers. 2014 Sep;19(6):509-16</RefSource><PMID Version="1">25089939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):811-5</RefSource><PMID Version="1">16614128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2013 Oct;34(5):2843-8</RefSource><PMID Version="1">23700156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(4):e35970</RefSource><PMID Version="1">22540013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Aug 12;8(8):e71157</RefSource><PMID Version="1">23951099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2007 Sep;17(5):156-60</RefSource><PMID Version="1">17827862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2005 Nov 8;229(1):85-91</RefSource><PMID Version="1">15946795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Feb;38(2):1163-70</RefSource><PMID Version="1">20602259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Gastroenterol. 2011 Jun 14;11:74</RefSource><PMID Version="1">21672255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2005 Apr 20;97(8):567-76</RefSource><PMID Version="1">15840879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Feb;23(2):401-5</RefSource><PMID Version="1">21515665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2003 Dec;170(6 Pt 1):2471-4</RefSource><PMID Version="1">14634453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Nov-Dec;680(1-2):56-63</RefSource><PMID Version="1">19815090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2005 Jan;65(1):70-5</RefSource><PMID Version="1">15667866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2012 Apr;133(4):127-32</RefSource><PMID Version="1">22019847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Nov;25(11):2177-81</RefSource><PMID Version="1">15284179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 May 17;411(6835):366-74</RefSource><PMID Version="1">11357144</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25588927</ArticleId><ArticleId IdType="doi">10.1007/s12032-014-0472-z</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27350816</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1880-7046</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Genes and environment : the official journal of the Japanese Environmental Mutagen Society</Title><ISOAbbreviation>Genes Environ</ISOAbbreviation></Journal><ArticleTitle>An active alternative splicing isoform of human mitochondrial 8-oxoguanine DNA glycosylase (OGG1).</ArticleTitle><Pagination><MedlinePgn>21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41021-015-0021-9</ELocationID><Abstract><AbstractText>Eight alternatively spliced isoforms of human 8-oxoguanine DNA glycosylase (OGG1) (OGG1-1a, -1b, -1c, -2a, -2b, -2c, -2d and -2e) are registered at the National Center for Biotechnology Information (NCBI). OGG1-1a is present in the nucleus, whereas the other seven isoforms are present in the mitochondria. Recombinant OGG1-1a has been purified and enzyme kinetics determined. OGG1(s) in mitochondria have not been fully characterized biochemically until recently. The major mitochondrial OGG1 isoform, OGG1-2a (also named β-OGG1), has also been expressed and purified; however, its activity is unresolved. Recently, we purified recombinant mitochondrial OGG1-1b and found that it was an active OGG1 enzyme. We reported its enzyme kinetics and compared the results with those of OGG1-1a. The reaction rate constant of OGG1-1b 8-oxoG glycosylase activity (k g) was 8-oxoG:C &gt; &gt; 8-oxoG:T &gt; &gt; 8-oxoG:G &gt; 8-oxoG:A and was similar to that of OGG1-1a under single-turnover conditions ([E] &gt; [S]). Both OGG1-1b and OGG1-1a showed high specificity towards 8-oxoG:C. The reaction rate constant of OGG1-1b N-glycosylase/DNA lyase activity (k gl) was 8-oxoG:C &gt; 8-oxoG:T ≃ 8-oxoG:G &gt; &gt; 8-oxoG:A and that of OGG1-1a was 8-oxoG:C &gt; 8-oxoG:T, 8-oxoG:G and 8-oxoG:A. The k gl of OGG1-1b and OGG1-1a is one order of magnitude lower than the corresponding k g value. OGG1-1b showed an especially low k gl towards 8-oxoG:A. Comparable expression of OGG1-1a and OGG1-1b was detected by RT-PCR in normal human lung tissue and lung cell lines. These results suggest that OGG1-1b is associated with 8-oxoG cleavage in human lung mitochondria and that the mechanism of this repair is similar to that of nuclear OGG1-1a. Currently, the other five mitochondrial OGG1 isoforms have not been isolated. I summarize information on OGG1 isoform mRNAs, coding DNA sequences and amino acid sequences that are archived by the National Center for Biotechnology Information. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Furihata</LastName><ForeName>Chie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Science and Engineering, Aoyama Gakuin University, Sagamihara, Kanagawa 252-5258 Japan ; Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, Setagayaku, Tokyo 158-8501 Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genes Environ</MedlineTA><NlmUniqueID>101285347</NlmUniqueID><ISSNLinking>1880-7046</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Oct 19;32(18):5596-608</RefSource><PMID Version="1">15494448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2013 Sep 17;587(18):3129-34</RefSource><PMID Version="1">23954288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8016-20</RefSource><PMID Version="1">9223306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Aug 9;486(3):207-16</RefSource><PMID Version="1">11459633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2002 Mar 22;317(2):171-7</RefSource><PMID Version="1">11902834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 1999 May;10(5):1637-52</RefSource><PMID Version="1">10233168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1998 Jun 15;26(12):2917-22</RefSource><PMID Version="1">9611236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2009 Jul 15;131(27):9506-15</RefSource><PMID Version="1">19537786</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Oct 4;288(40):28936-47</RefSource><PMID Version="1">23955443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2009 Nov;28(11):579-88</RefSource><PMID Version="1">19630534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gan. 1984 Dec;75(12):1037-9</RefSource><PMID Version="1">6526216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biochem Mol Toxicol. 2015 Feb;29(2):49-56</RefSource><PMID Version="1">25196052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1997 Jun 1;57(11):2151-6</RefSource><PMID Version="1">9187114</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2013 Jan;54(1):54-64</RefSource><PMID Version="1">23055259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2009 Sep 15;47(6):750-9</RefSource><PMID Version="1">19524665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2012 Jan 25;134(3):1653-61</RefSource><PMID Version="1">22175854</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Human 8-oxoguanine DNA glycosylase</Keyword><Keyword MajorTopicYN="N">Mitochondrial OGG1</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">OGG1-1a</Keyword><Keyword MajorTopicYN="N">OGG1-1b</Keyword><Keyword MajorTopicYN="N">OGG1-2a</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>08</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27350816</ArticleId><ArticleId IdType="doi">10.1186/s41021-015-0021-9</ArticleId><ArticleId IdType="pii">21</ArticleId><ArticleId IdType="pmc">PMC4917946</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25534136</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-7856</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>DNA repair</Title><ISOAbbreviation>DNA Repair (Amst.)</ISOAbbreviation></Journal><ArticleTitle>Inactivation of a common OGG1 variant by TNF-alpha in mammalian cells.</ArticleTitle><Pagination><MedlinePgn>15-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dnarep.2014.11.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-7864(14)00282-1</ELocationID><Abstract><AbstractText>Reactive oxygen species threaten genomic integrity by inducing oxidative DNA damage. One common form of oxidative DNA damage is the mutagenic lesion 8-oxoguanine (8-oxodG). One driver of oxidative stress that can induce 8-oxodG is inflammation, which can be initiated by the cytokine tumor necrosis factor alpha (TNF-α). Oxidative DNA damage is primarily repaired by the base excision repair pathway, initiated by glycosylases targeting specific DNA lesions. 8-oxodG is excised by 8-oxoguanine glycosylase 1 (OGG1). A common Ogg1 allelic variant is S326C-Ogg1, prevalent in Asian and Caucasian populations. S326C-Ogg1 is associated with various forms of cancer, and is inactivated by oxidation. However, whether oxidative stress caused by inflammatory cytokines compromises OGG1 variant repair activity remains unknown. We addressed whether TNF-α causes oxidative stress that both induces DNA damage and inactivates S326C-OGG1 via cysteine 326 oxidation. In mouse embryonic fibroblasts, we found that S326C-OGG1 was inactivated only after exposure to H2O2 or TNF-α. Treatment with the antioxidant N-acetylcysteine prior to oxidative stress rescued S326C-OGG1 activity, demonstrated by in vitro and cellular repair assays. In contrast, S326C-OGG1 activity was unaffected by potassium bromate, which induces oxidative DNA damage without causing oxidative stress, and presumably cysteine oxidation. This study reveals that Cys326 is vulnerable to oxidation that inactivates S326C-OGG1. Physiologically relevant levels of TNF-α simultaneously induce 8-oxodG and inactivate S326C-OGG1. These results suggest a mechanism that could contribute to increased risk of cancer among S326C-Ogg1 homozygous individuals. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morreall</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA; Graduate Program in Genetics and Molecular Biology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limpose</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA; Graduate Program in Cancer Biology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheppard</LastName><ForeName>Clayton</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kow</LastName><ForeName>Yoke Wah</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werner</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doetsch</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA; Emory Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, 30322, USA. Electronic address: medpwd@emory.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA120288</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA120288</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>DNA Repair (Amst)</MedlineTA><NlmUniqueID>101139138</NlmUniqueID><ISSNLinking>1568-7856</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1997;76(2):206-10</RefSource><PMID Version="1">9231920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 May 1;273(18):11069-74</RefSource><PMID Version="1">9556591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2013 Oct;63:401-9</RefSource><PMID Version="1">23726996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2013 Sep 17;587(18):3129-34</RefSource><PMID Version="1">23954288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Nov 27;284(48):33400-8</RefSource><PMID Version="1">19679659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2010 Aug 15;123(Pt 16):2834-43</RefSource><PMID Version="1">20663918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2010 Sep;17(9):1420-34</RefSource><PMID Version="1">20203691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2010 Nov;53(5):797-804</RefSource><PMID Version="1">20801537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2010 Dec 1;49(11):1603-16</RefSource><PMID Version="1">20840865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2011 Mar 4;144(5):646-74</RefSource><PMID Version="1">21376230</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2011 Oct;123(2):471-9</RefSource><PMID Version="1">21778470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Jan 1;52(1):118-25</RefSource><PMID Version="1">22019439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2012 Apr 1;16(7):649-57</RefSource><PMID Version="1">21967570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Feb 23;119(8):e45-56</RefSource><PMID Version="1">22096246</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2012 Jul;27(4):501-10</RefSource><PMID Version="1">22451681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Toxicol. 2012 Oct;27(10):590-7</RefSource><PMID Version="1">21254323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2014 Jun;35(6):1426-33</RefSource><PMID Version="1">24632493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13300-5</RefSource><PMID Version="1">10557315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 1999 Dec;26(4):254-60</RefSource><PMID Version="1">10569802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Feb 24;403(6772):859-66</RefSource><PMID Version="1">10706276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Jul 15;28(14):2672-8</RefSource><PMID Version="1">10908322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2698-702</RefSource><PMID Version="1">11226302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 2001 Jun;14(6):678-85</RefSource><PMID Version="1">11409938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Jul;23(7):1229-34</RefSource><PMID Version="1">12117782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2003 Aug;33(8):2297-306</RefSource><PMID Version="1">12884305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2003 Sep 3;95(17):1312-9</RefSource><PMID Version="1">12953085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2004 Jan 9;116(1):99-107</RefSource><PMID Version="1">14718170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2004 May;19(3):169-85</RefSource><PMID Version="1">15123782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 1979 Jun;30:185-9</RefSource><PMID Version="1">446450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol Methods. 1983 Dec 16;65(1-2):55-63</RefSource><PMID Version="1">6606682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 1989;6(6):593-7</RefSource><PMID Version="1">2546864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1993 May 1;53(9):1982-5</RefSource><PMID Version="1">8481899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915-22</RefSource><PMID Version="1">8367443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1994 Mar 1;305(2):253-64</RefSource><PMID Version="1">7510036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 1994 Dec;102 Suppl 10:5-12</RefSource><PMID Version="1">7705305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 1997;15:351-69</RefSource><PMID Version="1">9143692</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 1997 Jun 1;7(6):397-407</RefSource><PMID Version="1">9197244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(11):e81162</RefSource><PMID Version="1">24260552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2014 Feb;14:17-26</RefSource><PMID Version="1">24382305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2014 Apr 25;447(1):12-8</RefSource><PMID Version="1">24680828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Oct 15;27(20):4001-7</RefSource><PMID Version="1">10497264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Nov;25(11):2177-81</RefSource><PMID Version="1">15284179</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W230-2</RefSource><PMID Version="1">15980459</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Nov 15;162(10):925-42</RefSource><PMID Version="1">16221808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006;34(5):1620-32</RefSource><PMID Version="1">16549874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2006 Apr;387(4):373-9</RefSource><PMID Version="1">16606334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Res. 2006 May;16(5):567-75</RefSource><PMID Version="1">16651663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2006 May;21(3):185-90</RefSource><PMID Version="1">16597659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2006 Aug;20(10):1589-98</RefSource><PMID Version="1">16873882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2006 Nov 8;5(11):1337-45</RefSource><PMID Version="1">16861056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Signal. 2007 Jul;19(7):1419-33</RefSource><PMID Version="1">17317104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2007 Nov;117(11):3283-95</RefSource><PMID Version="1">17960249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Gerontol. 2008 Apr;43(4):353-9</RefSource><PMID Version="1">18289818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3081-9</RefSource><PMID Version="1">18990748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18877-82</RefSource><PMID Version="1">19020090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3642-9</RefSource><PMID Version="1">19351836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Agromedicine. 2009;14(2):206-14</RefSource><PMID Version="1">19437279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Jun 25;360(26):2719-29</RefSource><PMID Version="1">19516027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2009 Sep;276(18):5149-62</RefSource><PMID Version="1">19674107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2009 Oct;119(10):3011-23</RefSource><PMID Version="1">19741298</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002461" MajorTopicYN="N">Cell Line, Transformed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="Y">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">8-oxodG</Keyword><Keyword MajorTopicYN="N">Cys326-Ogg1</Keyword><Keyword MajorTopicYN="N">H(2)O(2)</Keyword><Keyword MajorTopicYN="N">ROS</Keyword><Keyword MajorTopicYN="N">S326C-Ogg1</Keyword><Keyword MajorTopicYN="N">TNF-α</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25534136</ArticleId><ArticleId IdType="pii">S1568-7864(14)00282-1</ArticleId><ArticleId IdType="doi">10.1016/j.dnarep.2014.11.007</ArticleId><ArticleId IdType="pmc">PMC4308426</ArticleId><ArticleId IdType="mid">NIHMS651201</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25526641</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>PARP-1 expression is increased in colon adenoma and carcinoma and correlates with OGG1.</ArticleTitle><Pagination><MedlinePgn>e115558</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0115558</ELocationID><Abstract><AbstractText>The ethiology of colon cancer is largely dependent on inflammation driven oxidative stress. The analysis of 8-oxodeoxyguanosine (8-oxodGuo) level in leukocyte DNA of healthy controls (138 individuals), patients with benign adenomas (AD, 137 individuals) and with malignant carcinomas (CRC, 169 individuals) revealed a significant increase in the level of 8-oxodGuo in leukocyte DNA of AD and CRC patients in comparison to controls. The counteracting mechanism is base excision repair, in which OGG1 and PARP-1 play a key role. We investigated the level of PARP-1 and OGG1 mRNA and protein in diseased and marginal, normal tissues taken from AD and CRC patients and in leukocytes taken from the patients as well as from healthy subjects. In colon tumors the PARP-1 mRNA level was higher than in unaffected colon tissue and in polyp tissues. A high positive correlation was found between PARP-1 and OGG1 mRNA levels in all investigated tissues. This suggests reciprocal influence of PARP-1 and OGG1 on their expression and stability, and may contribute to progression of colon cancer. PARP-1 and OGG1 proteins level was several fold higher in polyps and CRC in comparison to normal colon tissues. Individuals bearing the Cys326Cys genotype of OGG1 were characterized by higher PARP-1 protein level in diseased tissues than the Ser326Cys and Ser326Ser genotypes. Aforementioned result may suggest that the diseased cells with polymorphic OGG1 recruit more PARP protein, which is necessary to remove 8-oxodGuo. Thus, patients with decreased activity of OGG1/polymorphism of the OGG1 gene and higher 8-oxodGuo level may be more susceptible to treatment with PARP-1 inhibitors. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dziaman</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Collegium Medicum, Nicolaus Copernicus University, Karlowicza 24, PO-85-092 Bydgoszcz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludwiczak</LastName><ForeName>Hubert</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, PO-02-106 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciesla</LastName><ForeName>Jaroslaw M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, PO-02-106 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banaszkiewicz</LastName><ForeName>Zbigniew</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, Collegium Medicum, Nicolaus Copernicus University, Ujejskiego 75, Bydgoszcz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winczura</LastName><ForeName>Alicja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, PO-02-106 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chmielarczyk</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, PO-02-106 Warsaw, Poland; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, PO-02-106 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wisniewska</LastName><ForeName>Ewa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathomorphology, Collegium Medicum, Nicolaus Copernicus University, Sklodowskiej-Curie 9, PO-85-092 Bydgoszcz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marszalek</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathomorphology, Collegium Medicum, Nicolaus Copernicus University, Sklodowskiej-Curie 9, PO-85-092 Bydgoszcz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tudek</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, PO-02-106 Warsaw, Poland; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, PO-02-106 Warsaw, Poland; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, PO-02-106 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olinski</LastName><ForeName>Ryszard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Collegium Medicum, Nicolaus Copernicus University, Karlowicza 24, PO-85-092 Bydgoszcz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="C499320">PARP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="D000071137">Poly (ADP-Ribose) Polymerase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="D011065">Poly(ADP-ribose) Polymerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Sep 15;31(18):5332-7</RefSource><PMID Version="1">12954769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Apr 15;63(8):1727-30</RefSource><PMID Version="1">12702551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2003 Dec;170(6 Pt 1):2471-4</RefSource><PMID Version="1">14634453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):177-90</RefSource><PMID Version="1">14637254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2004 Apr 10;109(3):317-21</RefSource><PMID Version="1">14961567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2004 Apr;18(6):690-2</RefSource><PMID Version="1">14766804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2004 Oct;12(4):821-5</RefSource><PMID Version="1">15375506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1983 Jul;43(7):3441-6</RefSource><PMID Version="1">6406058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathologe. 1987 May;8(3):138-40</RefSource><PMID Version="1">3303008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hematol. 1991 Aug;37(4):223-7</RefSource><PMID Version="1">1907096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 1994 Mar 14;341(1):59-64</RefSource><PMID Version="1">8137923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 1997 Jun 7;1332(3):F127-47</RefSource><PMID Version="1">9196022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8010-5</RefSource><PMID Version="1">9223305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 1996 Jul;2(7):1163-7</RefSource><PMID Version="1">9816283</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechniques. 2005 Feb;38(2):287-93</RefSource><PMID Version="1">15727135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2005 Jun;128(7):1919-36</RefSource><PMID Version="1">15940627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Apoptosis. 2006 Jan;11(1):131-9</RefSource><PMID Version="1">16374543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chim Acta. 2006 Mar;365(1-2):30-49</RefSource><PMID Version="1">16214123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2006 Apr 5;98(7):472-82</RefSource><PMID Version="1">16595783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2006 Sep;42(14):2374-81</RefSource><PMID Version="1">16809031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2006;6:208</RefSource><PMID Version="1">16914027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Jan 4;6(1):45-60</RefSource><PMID Version="1">16982217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2007;14(11):1179-87</RefSource><PMID Version="1">17504138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2007 Sep;99(1):277-88</RefSource><PMID Version="1">17578862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2007 Dec 15;585(Pt 3):741-58</RefSource><PMID Version="1">17947304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):27-47</RefSource><PMID Version="1">18166975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2008 Dec;19(10):1051-64</RefSource><PMID Version="1">18543072</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2010 Sep 15;49(6):1064-71</RefSource><PMID Version="1">20600828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Sep;25(5):463-71</RefSource><PMID Version="1">20534734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2010 Aug 1;9(15):3002-4</RefSource><PMID Version="1">20714214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 10;709-710:21-31</RefSource><PMID Version="1">21376741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Jun 10;286(23):20335-44</RefSource><PMID Version="1">21518760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Mar 1;639(1-2):45-54</RefSource><PMID Version="1">18155253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2008 Nov 15;123(10):2460-4</RefSource><PMID Version="1">18729200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Dec 30;286(52):44679-90</RefSource><PMID Version="1">22057269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Jan 19;481(7381):287-94</RefSource><PMID Version="1">22258607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):88-101</RefSource><PMID Version="1">22122466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(8):e42690</RefSource><PMID Version="1">22880082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2012 Nov 2;586(21):3771-7</RefSource><PMID Version="1">23022557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2014 Feb;42(1):82-8</RefSource><PMID Version="1">24450632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diagn Pathol. 2013;8:144</RefSource><PMID Version="1">23971971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2012 Dec;12(12):801-17</RefSource><PMID Version="1">23175119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2014 Jan 15;134(2):376-83</RefSource><PMID Version="1">23832862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2014 Feb-Mar;103(2-3):211-21</RefSource><PMID Version="1">24316131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2002 Jun 4;12(11):912-8</RefSource><PMID Version="1">12062055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Jul 15;33(2):192-200</RefSource><PMID Version="1">12106815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2002 Oct 1;101(4):395-7</RefSource><PMID Version="1">12209966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Jun 2;477(1-2):7-21</RefSource><PMID Version="1">11376682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2001 Aug;3(4):597-609</RefSource><PMID Version="1">11554447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods. 2001 Dec;25(4):402-8</RefSource><PMID Version="1">11846609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1100-4</RefSource><PMID Version="1">14578150</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018256" MajorTopicYN="N">Adenomatous Polyps</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071137" MajorTopicYN="N">Poly (ADP-Ribose) Polymerase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011065" MajorTopicYN="N">Poly(ADP-ribose) Polymerases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>07</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25526641</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0115558</ArticleId><ArticleId IdType="pii">PONE-D-14-32536</ArticleId><ArticleId IdType="pmc">PMC4272268</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25498387</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1089-8638</ISSN><JournalIssue CitedMedium="Internet"><Volume>427</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of molecular biology</Title><ISOAbbreviation>J. Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>Human apurinic/apyrimidinic endonuclease 1 (APE1) has 3' RNA phosphatase and 3' exoribonuclease activities.</ArticleTitle><Pagination><MedlinePgn>298-311</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmb.2014.12.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-2836(14)00617-2</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1 (APE1) is the predominant mammalian enzyme in DNA base excision repair pathway that cleaves the DNA backbone immediately 5' to abasic sites. In addition to its abasic endonuclease activity, APE1 has 3' phosphatase and 3'-5' exonuclease activities against DNA. We recently identified APE1 as an endoribonuclease that preferentially cleaves at UA, UG, and CA sites in single-stranded regions of RNAs and can regulate c-myc mRNA level and half-life in cells. APE1 can also endonucleolytically cleave abasic single-stranded RNA. Here, we show for the first time that the human APE1 has 3' RNA phosphatase and 3' exoribonuclease activities. Using three distinct RNA substrates, we show that APE1, but not RNase A, can remove the phosphoryl group from the 3' end of RNA decay products. Studies using various site-directed APE1 mutant proteins (H309N, H309S, D283N, N68A, D210N, Y171F, D308A, F266A, and D70A) suggest that the 3' RNA phosphatase activity shares the same active center as its other known nuclease activities. A number of APE1 variants previously identified in the human population, including the most common D148E variant, have greater than 80% reduction in the 3' RNA phosphatase activity. APE1 can remove a ribonucleotide from the 3' overhang of RNA decay product, but its 3'-5' exoribonuclease activity against unstructured poly(A), poly(C), and poly(U) RNAs is relatively weak. This study further underscores the significance of understanding the role of APE1 in RNA metabolism in vivo. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chohan</LastName><ForeName>Manbir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chemistry Program, University of Northern British Columbia, 3333 University Way, Prince George, British Columbia, V2N 4Z9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackedenski</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chemistry Program, University of Northern British Columbia, 3333 University Way, Prince George, British Columbia, V2N 4Z9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wai-Ming</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Chemistry Program, University of Northern British Columbia, 3333 University Way, Prince George, British Columbia, V2N 4Z9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chow H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Chemistry Program, University of Northern British Columbia, 3333 University Way, Prince George, British Columbia, V2N 4Z9, Canada. Electronic address: chow.lee@unbc.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Mol Biol</MedlineTA><NlmUniqueID>2985088R</NlmUniqueID><ISSNLinking>0022-2836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016227">Benzoquinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006898">Hydroxylamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011422">Propionates</NameOfSubstance></Chemical><Chemical><RegistryNumber>136164-66-4</RegistryNumber><NameOfSubstance UI="C075569">E 3330</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>76XC01FTOJ</RegistryNumber><NameOfSubstance UI="C040015">myricetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9TZH4WY30J</RegistryNumber><NameOfSubstance UI="C005214">methoxyamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004722">Endoribonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D005095">Exoribonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.2</RegistryNumber><NameOfSubstance UI="D010744">Phosphoric Monoester Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016227" MajorTopicYN="N">Benzoquinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004722" MajorTopicYN="N">Endoribonucleases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005095" MajorTopicYN="N">Exoribonucleases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006207" MajorTopicYN="N">Half-Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006898" MajorTopicYN="N">Hydroxylamines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010744" MajorTopicYN="N">Phosphoric Monoester Hydrolases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011422" MajorTopicYN="N">Propionates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3′ RNA phosphatase</Keyword><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">RNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>09</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>12</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>12</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25498387</ArticleId><ArticleId IdType="pii">S0022-2836(14)00617-2</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2014.12.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25492865</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>290</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.</ArticleTitle><Pagination><MedlinePgn>3057-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.621995</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) (henceforth referred to as Ref-1) is a multifunctional protein that in addition to its base excision DNA repair activity exerts redox control of multiple transcription factors, including nuclear factor κ-light chain enhancer of activated B cells (NF-κB), STAT3, activator protein-1 (AP-1), hypoxia-inducible factor-1 (HIF-1), and tumor protein 53 (p53). In recent years, Ref-1 has emerged as a promising therapeutic target in cancer, particularly in pancreatic ductal carcinoma. Although a significant amount of research has centered on Ref-1, no wide-ranging approach had been performed on the effects of Ref-1 inhibition and transcription factor activity perturbation. Starting with a broader approach, we identified a previously unsuspected effect on the nuclear factor erythroid-related factor 2 (NRF2), a critical regulator of cellular defenses against oxidative stress. Based on genetic and small molecule inhibitor-based methodologies, we demonstrated that repression of Ref-1 potently activates NRF2 and its downstream targets in a dose-dependent fashion, and that the redox, rather than the DNA repair function of Ref-1 is critical for this effect. Intriguingly, our results also indicate that this pathway does not involve reactive oxygen species. The link between Ref-1 and NRF2 appears to be present in all cells tested in vitro, noncancerous and cancerous, including patient-derived tumor samples. In particular, we focused on understanding the implications of the novel interaction between these two pathways in primary pancreatic ductal adenocarcinoma tumor cells and provide the first evidence that this mechanism has implications for overcoming the resistance against experimental drugs targeting Ref-1 activity, with clear translational implications. </AbstractText><CopyrightInformation>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fishel</LastName><ForeName>Melissa L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Wells Center for Pediatric Research, Pharmacology and Toxicology, mfishel@iu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Microbiology and Immunology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devlin</LastName><ForeName>Cecilia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logsdon</LastName><ForeName>Derek P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Pharmacology and Toxicology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yanlin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Wells Center for Pediatric Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Meihua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Wells Center for Pediatric Research, Pharmacology and Toxicology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Wells Center for Pediatric Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhangsheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Biostatistics, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biostatistics, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipking</LastName><ForeName>Kelsey P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maitra</LastName><ForeName>Anirban</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>the Departments of Oncology and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajeshkumar</LastName><ForeName>N V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>the Departments of Oncology and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandura</LastName><ForeName>Glenda</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>From the Departments of Pediatrics, Wells Center for Pediatric Research, Pharmacology and Toxicology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivan</LastName><ForeName>Mircea</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Microbiology and Immunology, Medicine, mivan@iu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01 CA155332-01</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA121168S1</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA155332</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495635">NFE2L2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2008 Oct;135(4):1358-1368, 1368.e1-4</RefSource><PMID Version="1">18692501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1853-67</RefSource><PMID Version="1">18627350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2009;8:37</RefSource><PMID Version="1">19508729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2010 Feb 11;53(3):1200-10</RefSource><PMID Version="1">20067291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2010 May 1;244(3):291-9</RefSource><PMID Version="1">20083128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pancreas. 2010 May;39(4):463-72</RefSource><PMID Version="1">20118824</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Nov;28(9):885-95</RefSource><PMID Version="1">20919954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Hematol. 2010 Dec;38(12):1178-88</RefSource><PMID Version="1">20826193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 Apr 15;14(8):1387-401</RefSource><PMID Version="1">20874257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry (Mosc). 2011 Apr;76(4):407-22</RefSource><PMID Version="1">21585316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Biol Interact. 2011 Jun 30;192(1-2):37-45</RefSource><PMID Version="1">20932822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2011 Sep;10(9):1698-708</RefSource><PMID Version="1">21700832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 17;51(2):695-705</RefSource><PMID Version="1">22148505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2011 Jan 11;50(1):82-92</RefSource><PMID Version="1">21117647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47462</RefSource><PMID Version="1">23094050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(11):e50521</RefSource><PMID Version="1">23209767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2013;19(15):2765-70</RefSource><PMID Version="1">23092325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2013 Apr 30;52(17):2955-66</RefSource><PMID Version="1">23597102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 May 14;110(20):E1857-66</RefSource><PMID Version="1">23630282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(7):e68467</RefSource><PMID Version="1">23874636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Sep 26;321(5897):1801-6</RefSource><PMID Version="1">18772397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioorg Med Chem. 2013 Sep 1;21(17):5145-53</RefSource><PMID Version="1">23867390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2013;20(30):3711-32</RefSource><PMID Version="1">23746277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2013 Oct;32(40):4825-35</RefSource><PMID Version="1">23108405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Dec 22;275(51):40134-41</RefSource><PMID Version="1">11013233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care Med. 2001 Oct;29(10):1962-71</RefSource><PMID Version="1">11588462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2002 Sep 20;297(2):346-52</RefSource><PMID Version="1">12237125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2003 Feb;4(2):145-53</RefSource><PMID Version="1">12524539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1982 Jul 10;257(13):7778-85</RefSource><PMID Version="1">6806282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Apr;26(7):2845-56</RefSource><PMID Version="1">16537925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2006;7:85</RefSource><PMID Version="1">16504059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 May 15;11(10):3790-8</RefSource><PMID Version="1">15897578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</RefSource><PMID Version="1">17560642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2008 Feb 1;7(2):177-86</RefSource><PMID Version="1">17974506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2008 Mar;5(3):253-60</RefSource><PMID Version="1">18297081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2008 Jul;7(7):2012-21</RefSource><PMID Version="1">18645011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Planta Med. 2008 Oct;74(13):1526-39</RefSource><PMID Version="1">18937164</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1/Ref-1</Keyword><Keyword MajorTopicYN="N">HMOX1</Keyword><Keyword MajorTopicYN="N">Hypoxia</Keyword><Keyword MajorTopicYN="N">Nuclear Factor 2 (Erythroid-derived 2-like Factor) (NFE2L2) (Nrf2)</Keyword><Keyword MajorTopicYN="N">Pancreatic Adenocarcinoma</Keyword><Keyword MajorTopicYN="N">Reactive Oxygen Species (ROS)</Keyword><Keyword MajorTopicYN="N">Redox Signaling</Keyword><Keyword MajorTopicYN="N">Transcription Factor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25492865</ArticleId><ArticleId IdType="pii">M114.621995</ArticleId><ArticleId IdType="doi">10.1074/jbc.M114.621995</ArticleId><ArticleId IdType="pmc">PMC4317024</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25463392</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2014</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-7856</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>DNA repair</Title><ISOAbbreviation>DNA Repair (Amst.)</ISOAbbreviation></Journal><ArticleTitle>The repair of oxidized purines in the DNA of human lymphocytes requires an activation involving NF-YA-mediated upregulation of OGG1.</ArticleTitle><Pagination><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dnarep.2014.10.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-7864(14)00262-6</ELocationID><Abstract><AbstractText>8-Oxoguanine DNA glycosylase (OGG1), which initiates the repair of DNA purine modifications such as 8-oxo-7,8-dihydroguanine (8-oxoG), is often regarded as a house keeping protein ubiquitously active in mammalian cells. We have analysed the repair rates of oxidized purines generated by photosensitization in peripheral human lymphocytes and observed that the cells were virtually unable to remove these lesions (less than 10% removal within 24h). However, stimulation of the lymphocytes with phytohemagglutinin (PHA) strongly accelerated the repair so that ∼30% of the lesions were repaired within 4h. Within 24h following PHA stimulation and preceding the induction of cell proliferation, Western blots revealed an approximately 4-fold up-regulation of OGG1. The levels of OGG1 mRNA were 4-fold increased already after 6h. Chromatin immunoprecipitation analysis indicated that the up-regulation of OGG1 was associated with increased binding of the transcription factor NF-YA to the promoter of the OGG1 gene. The binding of NF-YA and subsequent induction of OGG1 was inhibited in the presence of an inhibitor of Jun kinase, indicating an activation of the corresponding signalling pathway as the mechanism underlying this transcriptional up-regulation. Our results reveal a strict control of base excision repair in cells of the human immune system. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von der Lippen</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Pharmacy and Biochemistry, University of Mainz, Staudingerweg 5, D-55099 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahu</LastName><ForeName>Sanjeeb</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology, D-55218 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seifermann</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Pharmacy and Biochemistry, University of Mainz, Staudingerweg 5, D-55099 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Vijay K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology, D-55218 Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epe</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Pharmacy and Biochemistry, University of Mainz, Staudingerweg 5, D-55099 Mainz, Germany. Electronic address: epe@uni-mainz.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>DNA Repair (Amst)</MedlineTA><NlmUniqueID>101139138</NlmUniqueID><ISSNLinking>1568-7856</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023081">CCAAT-Binding Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492061">NFYA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010835">Phytohemagglutinins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011687">Purines</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D023081" MajorTopicYN="N">CCAAT-Binding Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002461" MajorTopicYN="N">Cell Line, Transformed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010835" MajorTopicYN="N">Phytohemagglutinins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011687" MajorTopicYN="N">Purines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Base excision repair</Keyword><Keyword MajorTopicYN="N">NF-YA</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Oxidatively generated DNA damage</Keyword><Keyword MajorTopicYN="N">Phytohemagglutinin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25463392</ArticleId><ArticleId IdType="pii">S1568-7864(14)00262-6</ArticleId><ArticleId IdType="doi">10.1016/j.dnarep.2014.10.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25452143</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2014</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Free radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic. Biol. Med.</ISOAbbreviation></Journal><ArticleTitle>APE1 promotes antioxidant capacity by regulating Nrf-2 function through a redox-dependent mechanism.</ArticleTitle><Pagination><MedlinePgn>11-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2014.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0891-5849(14)00455-9</ELocationID><Abstract><AbstractText>APE1 is a multifunctional protein that has recently been implicated in protecting cells from oxidative stress. In the current study, we confirmed that APE1׳s effect on cellular antioxidant capacity is related to its redox activity through the use of an APE1 functional mutant, and we investigated the mechanism through which this multifunctional protein affects the function of the transcription factor Nrf-2 in regulating oxidative stress-induced genes. Using a pair of mutants for both the redox activity and the acetylation-regulated activity of APE1, in vitro assays showed that the redox activity of APE1 is crucial for its nuclear association with Nrf-2 and subsequent activation of Nrf-2׳s transcription of several downstream genes during oxidative challenge. Important oxidative stress genes are affected by APE1 redox activity, including Hmox1, Gstm1, and Txnrd1. In addition, utilizing human non-small-cell lung cancer sample tissue as well as a nude mouse xenograft model, we determined that APE1 expression levels are inversely correlated to oxidative stress in vivo. These findings indicated that interference with these crucial functions of APE1 shows promise in preventing resistance to certain radiotherapies and that further research is necessary to understand APE1׳s complex roles in regulating both the basal redox status and the oxidative stress state of the cellular environment. </AbstractText><CopyrightInformation>Crown Copyright © 2014. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Jin-Lu</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Hai-Tao</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Meng-Xia</ForeName><Initials>MX</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jian-Wu</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ge</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xue-Qin</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiration, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Hua-Liang</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Pathology, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Wei-Dong</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>Department of General surgery, Research Institute of Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhen-Zhou</ForeName><Initials>ZZ</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, People׳s Republic of China. Electronic address: yangzhenzhou@sohu.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495635">NFE2L2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012516" MajorTopicYN="N">Osteosarcoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Antioxidant capacity</Keyword><Keyword MajorTopicYN="N">Nrf-2</Keyword><Keyword MajorTopicYN="N">Redox</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25452143</ArticleId><ArticleId IdType="pii">S0891-5849(14)00455-9</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.10.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25404348</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>48</Issue><PubDate><Year>2014</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination.</ArticleTitle><Pagination><MedlinePgn>17242-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1420221111</ELocationID><Abstract><AbstractText>Activation-induced cytidine deaminase (AID) is essential for antibody diversification, namely somatic hypermutation (SHM) and class switch recombination (CSR). The deficiency of apurinic/apyrimidinic endonuclease 1 (Ape1) in CH12F3-2A B cells reduces CSR to ∼20% of wild-type cells, whereas the effect of APE1 loss on SHM has not been examined. Here we show that, although APE1's endonuclease activity is important for CSR, it is dispensable for SHM as well as IgH/c-myc translocation. Importantly, APE1 deficiency did not show any defect in AID-induced S-region break formation, but blocked both the recruitment of repair protein Ku80 to the S region and the synapse formation between Sμ and Sα. Knockdown of end-processing factors such as meiotic recombination 11 homolog (MRE11) and carboxy-terminal binding protein (CtBP)-interacting protein (CtIP) further reduced the remaining CSR in Ape1-null CH12F3-2A cells. Together, our results show that APE1 is dispensable for SHM and AID-induced DNA breaks and may function as a DNA end-processing enzyme to facilitate the joining of broken ends during CSR. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jianliang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>Afzal</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Wenjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honjo</LastName><ForeName>Tasuku</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida Sakyo-ku, Kyoto 606-8501, Japan honjo@mfour.med.kyoto-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Maki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501070">CtIP protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007143">Immunoglobulin Heavy Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C512689">Mre11a protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016271">Proto-Oncogene Proteins c-myc</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D000076228">MRE11 Homologue Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.4.-</RegistryNumber><NameOfSubstance UI="C438563">AICDA (activation-induced cytidine deaminase)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.4.5</RegistryNumber><NameOfSubstance UI="D003564">Cytidine Deaminase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.5.1.-</RegistryNumber><NameOfSubstance UI="D045643">DNA Repair Enzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2022-7</RefSource><PMID Version="1">15684068</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2002 Sep;3(9):815-21</RefSource><PMID Version="1">12145648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Immunol. 2007;94:1-36</RefSource><PMID Version="1">17560270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Mar 2;440(7080):105-9</RefSource><PMID Version="1">16400328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2003 Jul 25;330(5):1027-37</RefSource><PMID Version="1">12860125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Sep 1;102(5):565-75</RefSource><PMID Version="1">11007475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2007;76:1-22</RefSource><PMID Version="1">17328676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2010 Mar;42(3):245-9</RefSource><PMID Version="1">20118933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Aug 20;305(5687):1160-3</RefSource><PMID Version="1">15326357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2014 Jun;17(6):813-21</RefSource><PMID Version="1">24793032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Oct 9;284(41):28084-92</RefSource><PMID Version="1">19666469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2005 Jan 17;201(2):189-94</RefSource><PMID Version="1">15657289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2013 Jun 15;190(12):5949-60</RefSource><PMID Version="1">23667108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11534-9</RefSource><PMID Version="1">8876170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2752-7</RefSource><PMID Version="1">19202054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 May 10;485(4):283-307</RefSource><PMID Version="1">11585362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2012 Apr 15;188(8):3559-66</RefSource><PMID Version="1">22492685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1999 Jun 25;274(26):18470-6</RefSource><PMID Version="1">10373455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2007 Nov 26;204(12):3017-26</RefSource><PMID Version="1">18025127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Apr 5;484(7392):69-74</RefSource><PMID Version="1">22314321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2007 Mar;128(3):259-66</RefSource><PMID Version="1">17224176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Immunol. 2007;94:157-214</RefSource><PMID Version="1">17560275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2011 Sep 2;411(5):960-71</RefSource><PMID Version="1">21762700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Nov 27;532(1-2):173-203</RefSource><PMID Version="1">14643436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2012 Jun 1;188(11):5528-37</RefSource><PMID Version="1">22547703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2009 Jan 16;33(1):117-23</RefSource><PMID Version="1">19150433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Apr 13;287(16):12848-57</RefSource><PMID Version="1">22375014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2002 Feb 18;195(4):529-34</RefSource><PMID Version="1">11854365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):E1016-24</RefSource><PMID Version="1">24591630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Nov 22;450(7169):509-14</RefSource><PMID Version="1">17965729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Jun 19;54(6):1012-21</RefSource><PMID Version="1">24837675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1993 Sep;13(9):5370-6</RefSource><PMID Version="1">8355688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1998 Apr 15;17(8):2404-11</RefSource><PMID Version="1">9545251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19305-10</RefSource><PMID Version="1">22080610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2012 Jun 4;209(6):1075-81</RefSource><PMID Version="1">22615128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Jul 4;418(6893):99-103</RefSource><PMID Version="1">12097915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(17):5134-46</RefSource><PMID Version="1">15459284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Dec 6;414(6864):660-5</RefSource><PMID Version="1">11740565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ISRN Mol Biol. 2012;2012:null</RefSource><PMID Version="1">24236237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(12):3531-6</RefSource><PMID Version="1">15247342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22375-80</RefSource><PMID Version="1">20018730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 2009 Aug;21(8):947-55</RefSource><PMID Version="1">19556307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2013 Apr;33(7):1468-73</RefSource><PMID Version="1">23382073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2002 Oct;32(2):267-72</RefSource><PMID Version="1">12244316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2007 Nov 1;179(9):6064-71</RefSource><PMID Version="1">17947680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Sep 27;449(7161):478-82</RefSource><PMID Version="1">17713479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2008;26:261-92</RefSource><PMID Version="1">18370922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Jun 19;54(6):1022-33</RefSource><PMID Version="1">24837676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2004 Jul;4(7):541-52</RefSource><PMID Version="1">15229473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Jul 3;55(1):97-110</RefSource><PMID Version="1">24954901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Sep 1;102(5):553-63</RefSource><PMID Version="1">11007474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Jul 9;460(7252):231-6</RefSource><PMID Version="1">19587764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2002;20:165-96</RefSource><PMID Version="1">11861601</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Dec 12;135(6):1028-38</RefSource><PMID Version="1">19070574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003564" MajorTopicYN="N">Cytidine Deaminase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045643" MajorTopicYN="N">DNA Repair Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017578" MajorTopicYN="N">Immunoglobulin Class Switching</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007143" MajorTopicYN="N">Immunoglobulin Heavy Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016393" MajorTopicYN="N">Lymphoma, B-Cell</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076228" MajorTopicYN="N">MRE11 Homologue Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016271" MajorTopicYN="N">Proto-Oncogene Proteins c-myc</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011995" MajorTopicYN="Y">Recombination, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D027041" MajorTopicYN="N">Somatic Hypermutation, Immunoglobulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA cleavage</Keyword><Keyword MajorTopicYN="N">DNA synapse formation</Keyword><Keyword MajorTopicYN="N">class switch recombination</Keyword><Keyword MajorTopicYN="N">end processing</Keyword><Keyword MajorTopicYN="N">somatic hypermutation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25404348</ArticleId><ArticleId IdType="pii">1420221111</ArticleId><ArticleId IdType="doi">10.1073/pnas.1420221111</ArticleId><ArticleId IdType="pmc">PMC4260585</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25384510</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0380</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</Title><ISOAbbreviation>Tumour Biol.</ISOAbbreviation></Journal><ArticleTitle>Letter regarding Shen et al. entitled "The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis".</ArticleTitle><Pagination><MedlinePgn>12775-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13277-014-2804-1</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of liver surgery, West China Hospital of Sichuan University, 37 Guo Xue Road, Chengdu, 610041, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yong-Gang</ForeName><Initials>YG</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wen-Tao</ForeName><Initials>WT</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Tumour Biol</MedlineTA><NlmUniqueID>8409922</NlmUniqueID><ISSNLinking>1010-4283</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Tumour Biol. 2014 Mar;35(3):2529-35</RefSource><PMID Version="1">24254302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Feb 1;67(3):1395-404</RefSource><PMID Version="1">17283177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2008 Sep 30;27:49</RefSource><PMID Version="1">18823566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Mar;35(3):2529-35</RefSource><PMID Version="1">24254302</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25384510</ArticleId><ArticleId IdType="doi">10.1007/s13277-014-2804-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25356934</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1364-5528</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>24</Issue><PubDate><Year>2014</Year><Month>Dec</Month><Day>21</Day></PubDate></JournalIssue><Title>The Analyst</Title><ISOAbbreviation>Analyst</ISOAbbreviation></Journal><ArticleTitle>Signal-on electrochemical immunoassay for APE1 using ionic liquid doped Au nanoparticle/graphene as a nanocarrier and alkaline phosphatase as enhancer.</ArticleTitle><Pagination><MedlinePgn>6563-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1039/c4an01712a</ELocationID><Abstract><AbstractText>In this paper, the Au nanoparticles decorated graphene nanosheets (AuNPs/Gr) were prepared as nanocarriers using ionic liquid (IL) as linker reagent. Then the alkaline phosphatase (ALP) and the ferrocene tagged detection antibodies (Fc-Ab2) were loaded on the IL doped AuNPs/Gr as a trace label for ultrasensitive measurements of human apurinic/apyrimidinic endonuclease 1 (APE1), which is a multifunctional protein in the DNA base excision repair pathway relating to various types of cancer. Several labeling protocols were investigated for the determination of the APE1 protein concentration and improved analytical features were obtained with the proposed carriers of IL doped AuNPs/Gr which were labeled with Fc-Ab2 and ALP (ALP/Fc-Ab2/AuNPs/IL/Gr). The reason may be that the IL doped AuNPs/Gr carriers (AuNPs/IL/Gr) could not only enhance the immobilized amount of ALP and Fc-Ab2, but also promote the electron transfer rate. Thus, through the specific recognition of antigen-antibody, numerous ALP/Fc-Ab2/AuNPs/IL/Gr, which are captured onto every single immunocomplex, could further catalyze the ascorbic acid 2-phosphate (AA-p) reaction to amplify the electrochemical signal. Transmission electron microscopy (TEM) images of the AuNPs/IL/Gr nanocomposites revealed the formation of a functionalized surface network structure. The resulting immunosensor exhibited a linear response to APE1 in the concentration range of 0.1-80 pg mL(-1) with a detection limit of 0.04 pg mL(-1), indicating potential applications in clinical diagnostics. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaoyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, P.R. China. dongwang64@hotmail.com zhongzhaoyang08@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Nan</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Analyst</MedlineTA><NlmUniqueID>0372652</NlmUniqueID><ISSNLinking>0003-2654</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055910">Antibodies, Immobilized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004800">Enzymes, Immobilized</NameOfSubstance></Chemical><Chemical><RegistryNumber>7440-57-5</RegistryNumber><NameOfSubstance UI="D006046">Gold</NameOfSubstance></Chemical><Chemical><RegistryNumber>7782-42-5</RegistryNumber><NameOfSubstance UI="D006108">Graphite</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.1</RegistryNumber><NameOfSubstance UI="D000469">Alkaline Phosphatase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000469" MajorTopicYN="N">Alkaline Phosphatase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055910" MajorTopicYN="N">Antibodies, Immobilized</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055664" MajorTopicYN="N">Electrochemical Techniques</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057075" MajorTopicYN="N">Enzyme Assays</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004800" MajorTopicYN="N">Enzymes, Immobilized</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006046" MajorTopicYN="N">Gold</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006108" MajorTopicYN="N">Graphite</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057230" MajorTopicYN="N">Limit of Detection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053768" MajorTopicYN="N">Metal Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25356934</ArticleId><ArticleId IdType="doi">10.1039/c4an01712a</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25354798</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0738</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Archives of toxicology</Title><ISOAbbreviation>Arch. Toxicol.</ISOAbbreviation></Journal><ArticleTitle>Deficient DNA repair exacerbates ethanol-initiated DNA oxidation and embryopathies in ogg1 knockout mice: gender risk and protection by a free radical spin trapping agent.</ArticleTitle><Pagination><MedlinePgn>415-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00204-014-1397-1</ELocationID><Abstract><AbstractText>Reactive oxygen species (ROS) have been implicated in the teratogenicity of alcohol (ethanol, EtOH). To determine the involvement of embryonic oxidative DNA damage, DNA repair-deficient oxoguanine glycosylase 1 (ogg1) knockout embryos were exposed in culture to EtOH (2 or 4 mg/ml), with or without pretreatment with the free radical spin trap phenylbutylnitrone (PBN) (0.125 mM). Visceral yolk sacs were used to genotype embryos for DNA repair status and gender. EtOH caused a concentration-dependent decrease in anterior neuropore closure (ANPC), somite development, turning, crown-rump length (CRL), yolk sac diameter (YSD) and head length (HL) (p &lt; 0.001) in all 3 ogg1 genotypes. There was a further ogg1 gene dose-dependent decrease from +/+ to -/- embryos in ANPC, somite development, turning, CRL and HL (p &lt; 0.05), and a gene-dependent correlation between HL and ANPC (p &lt; 0.01). Female embryos exhibited lesser ANPC and turning than males (p &lt; 0.05), suggesting underlying gender-dependent target-specific determinants. PBN pretreatment increased ANPC, somite development, turning, CRL, YSD and HL (p &lt; 0.001), although this protection against EtOH was slightly less effective in -/- embryos. Oxidatively damaged DNA determined as 8-oxo-2'-deoxyguanosine (8-oxodGuo), which is repaired by OGG1, was measured in single embryos in vivo after maternal EtOH treatment (4 g/kg i.p). EtOH increased embryonic 8-oxodGuo in an ogg1 gene-dependent fashion, with the highest levels in -/- embryos. These results show that embryonic DNA repair status and gender are determinants of risk. ROS-initiated embryonic DNA oxidation is involved in EtOH embryopathies. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller-Pinsler</LastName><ForeName>Lutfiya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Southern Research Institute, 2000 9th Avenue South, Birmingham, AL, 35205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wells</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada. pg.wells@utoronto.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biomolecular Sciences, Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, ON, M5S 3M2, Canada. pg.wells@utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010654">Phenylbutyrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>3K9958V90M</RegistryNumber><NameOfSubstance UI="D000431">Ethanol</NameOfSubstance></Chemical><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>90-26-6</RegistryNumber><NameOfSubstance UI="C010416">phenylbutyramide</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049914" MajorTopicYN="N">DNA Repair-Deficiency Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046149" MajorTopicYN="N">Embryo Culture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004622" MajorTopicYN="N">Embryo, Mammalian</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000431" MajorTopicYN="N">Ethanol</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010654" MajorTopicYN="N">Phenylbutyrates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019097" MajorTopicYN="N">Spin Trapping</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA oxidation</Keyword><Keyword MajorTopicYN="N">Embryo culture</Keyword><Keyword MajorTopicYN="N">Ethanol</Keyword><Keyword MajorTopicYN="N">Ogg1 mice</Keyword><Keyword MajorTopicYN="N">PBN</Keyword><Keyword MajorTopicYN="N">Reactive oxygen species</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>08</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25354798</ArticleId><ArticleId IdType="doi">10.1007/s00204-014-1397-1</ArticleId><ArticleId IdType="pii">10.1007/s00204-014-1397-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25308545</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3592</ISSN><JournalIssue CitedMedium="Internet"><Volume>772</Volume><PubDate><Year>2014</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Mutation research. Genetic toxicology and environmental mutagenesis</Title><ISOAbbreviation>Mutat Res Genet Toxicol Environ Mutagen</ISOAbbreviation></Journal><ArticleTitle>Single cell gel electrophoresis (SCGE) and Pig-a mutation assay in vivo-tools for genotoxicity testing from a regulatory perspective: a study of benzo[a]pyrene in Ogg1(-/-) mice.</ArticleTitle><Pagination><MedlinePgn>34-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mrgentox.2014.07.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1383-5718(14)00214-9</ELocationID><Abstract><AbstractText>The OECD has developed test guidelines (TG) to identify agents with genotoxic effects. The in vivo alkaline single cell gel electrophoresis (SCGE) assay is currently being prepared to become such a TG. The performance of a combined SCGE/Pig-a gene mutation study was evaluated with the prototypical genotoxicant benzo[a]pyrene (BaP) at an exposure level known to induce germ cell mutation. We aimed to better understand (i) the strengths and weaknesses of the two methods applied in blood and their potential to predict germ cell mutagenicity, and (ii) the involvement of reactive oxygen species (ROS) following in vivo BaP-exposure. To explore the involvement of ROS on BaP genotoxicity, we utilised a mouse model deficient in a DNA glycosylase. Specifically, C57BL/6 mice (Ogg1(+/+) and Ogg1(-/-)) were treated for three consecutive days with 50 mg BaP/kg/day. DNA damage in nucleated blood cells was measured four hours after the last treatment with the SCGE assay, with and without formamidopyrimidine DNA glycosylase (Fpg). Pig-a mutant phenotype blood erythrocytes were analysed two and four weeks after treatment. BaP-induced DNA lesions were not significantly increased in either version of the SCGE assay. The phenotypic mutation frequencies for immature and mature erythrocytes were significantly increased after two weeks. These effects were not affected by genotype, suggesting oxidative damage may have a minor role in BaP genotoxicity, at least in the acute exposure situation studied here. While both assays are promising tools for risk assessment, these results highlight the necessity of understanding the limitations regarding each assay's ability to detect chemicals' genotoxic potential.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Graupner</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemicals and Radiation, Norwegian Institute of Public Health, Oslo 0403, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Instanes</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Chemicals and Radiation, Norwegian Institute of Public Health, Oslo 0403, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dertinger</LastName><ForeName>Stephen D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Litron Laboratories, Rochester, NY 14623, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Jill Mari</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Chemicals and Radiation, Norwegian Institute of Public Health, Oslo 0403, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindeman</LastName><ForeName>Birgitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Chemicals and Radiation, Norwegian Institute of Public Health, Oslo 0403, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rongved</LastName><ForeName>Tonje Danielsen</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Chemicals and Radiation, Norwegian Institute of Public Health, Oslo 0403, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunborg</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Chemicals and Radiation, Norwegian Institute of Public Health, Oslo 0403, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Ann-Karin</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Chemicals and Radiation, Norwegian Institute of Public Health, Oslo 0403, Norway. Electronic address: ann.karin.olsen@fhi.no.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R44 ES018017</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R44ES018017</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res Genet Toxicol Environ Mutagen</MedlineTA><NlmUniqueID>101632149</NlmUniqueID><ISSNLinking>1383-5718</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009153">Mutagens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C080086">phosphatidylinositol glycan-class A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>3417WMA06D</RegistryNumber><NameOfSubstance UI="D001564">Benzo(a)pyrene</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13300-5</RefSource><PMID Version="1">10557315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2013 May;28(3):333-40</RefSource><PMID Version="1">23462850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Feb 15;31(4):1351-63</RefSource><PMID Version="1">12582255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1988 Feb 5;263(4):1814-20</RefSource><PMID Version="1">3276678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 1988 Mar;175(1):184-91</RefSource><PMID Version="1">3345800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1990 Mar 5;265(7):3916-22</RefSource><PMID Version="1">1689309</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4690-4</RefSource><PMID Version="1">2052552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1992 Jan 14;31(1):106-10</RefSource><PMID Version="1">1731864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 1996;27(1):19-29</RefSource><PMID Version="1">8625944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 1996 Jan-Feb;9(1):84-92</RefSource><PMID Version="1">8924621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5209-14</RefSource><PMID Version="1">10220445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2006 Apr;387(4):373-9</RefSource><PMID Version="1">16606334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2008 May;23(3):143-51</RefSource><PMID Version="1">18283046</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 May 13;105(19):6846-51</RefSource><PMID Version="1">18474869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Jul 31;654(2):114-32</RefSource><PMID Version="1">18585956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Dec 8;657(2):122-6</RefSource><PMID Version="1">18790079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Feb 19;673(1):21-8</RefSource><PMID Version="1">19073277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Jun-Jul;677(1-2):86-92</RefSource><PMID Version="1">19501187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Feb;696(1):55-61</RefSource><PMID Version="1">20026424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2010 Jun;115(2):401-11</RefSource><PMID Version="1">20202993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010;5(6):e11349</RefSource><PMID Version="1">20596530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Toxicol. 2010 Jul;30(5):402-10</RefSource><PMID Version="1">20186696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2010 Oct;117(2):381-92</RefSource><PMID Version="1">20624995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2010 Oct-Dec;51(8-9):825-35</RefSource><PMID Version="1">20857433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Apr 3;721(2):163-70</RefSource><PMID Version="1">21277384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 May 18;722(1):7-19</RefSource><PMID Version="1">21356328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Dec;52(9):784-94</RefSource><PMID Version="1">21826740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Dec;52(9):690-8</RefSource><PMID Version="1">21910140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Dec;52(9):685-9</RefSource><PMID Version="1">21976154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Dec;52(9):756-65</RefSource><PMID Version="1">21976233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Dec;52(9):731-7</RefSource><PMID Version="1">22052432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2011 Dec;52(9):681-4</RefSource><PMID Version="1">22167884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharm Stat. 2011 Nov-Dec;10(6):485-93</RefSource><PMID Version="1">22127874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2012 Apr;53(3):166-72</RefSource><PMID Version="1">22351488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2012 Jun;12(11):1731-55</RefSource><PMID Version="1">22623321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2012 Dec;130(2):328-48</RefSource><PMID Version="1">22923490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Metab Rev. 2001 Feb;33(1):1-35</RefSource><PMID Version="1">11270659</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001564" MajorTopicYN="N">Benzo(a)pyrene</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="Y">DNA Glycosylases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004586" MajorTopicYN="N">Electrophoresis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004913" MajorTopicYN="N">Erythrocytes, Abnormal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009153" MajorTopicYN="N">Mutagens</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alkaline single cell gel electrophoresis (SCGE)</Keyword><Keyword MajorTopicYN="N">Benzo[a]pyrene (BaP)</Keyword><Keyword MajorTopicYN="N">Genotoxicity</Keyword><Keyword MajorTopicYN="N">Hazard identification</Keyword><Keyword MajorTopicYN="N">Pig-a mutation assay</Keyword><Keyword MajorTopicYN="N">Risk assessment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>07</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25308545</ArticleId><ArticleId IdType="pii">S1383-5718(14)00214-9</ArticleId><ArticleId IdType="doi">10.1016/j.mrgentox.2014.07.010</ArticleId><ArticleId IdType="pmc">PMC4196198</ArticleId><ArticleId IdType="mid">NIHMS620047</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25280182</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2014</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4804</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>24</Issue><PubDate><Year>2014</Year><Month>Dec</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of medicinal chemistry</Title><ISOAbbreviation>J. Med. Chem.</ISOAbbreviation></Journal><ArticleTitle>DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.</ArticleTitle><Pagination><MedlinePgn>10241-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/jm500865u</ELocationID><Abstract><AbstractText>The apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a multifunctional enzyme involved in DNA repair and activation of transcription factors through its redox function. The evolutionarily conserved C- and N-termini are involved in these functions independently. It is also reported that the activity of APE1/Ref-1 abruptly increases several-fold in various human cancers. The control over the outcomes of these two functions is emerging as a new strategy to combine enhanced DNA damage and chemotherapy in order to tackle the major hurdle of increased cancer cell growth and proliferation. Studies have targeted these two domains individually for the design and development of inhibitors for APE1/Ref-1. Here, we have made, for the first time, an attempt at a comparative analysis of APE1/Ref-1 inhibitors that target both DNA repair and redox activities simultaneously. We further discuss their scope and limitations with respect to the development of potential anticancer agents. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Gagandeep</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory for Drug Design and Synthesis, Centre for Chemical and Pharmaceutical Sciences, School of Basic and Applied Sciences, Central University of Punjab , Bathinda, 151001, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholia</LastName><ForeName>Ravi P</ForeName><Initials>RP</Initials></Author><Author ValidYN="Y"><LastName>Mantha</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Raj</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Chem</MedlineTA><NlmUniqueID>9716531</NlmUniqueID><ISSNLinking>0022-2623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015195" MajorTopicYN="Y">Drug Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25280182</ArticleId><ArticleId IdType="doi">10.1021/jm500865u</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25268610</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Effect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.</ArticleTitle><Pagination><MedlinePgn>17333-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms151017333</ELocationID><Abstract><AbstractText>It has been hypothesized that genetic variation in base excision repair (BER) might modify colorectal adenoma risk. Thus, we evaluated the influence of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in normal and tumor samples from patients with colorectal cancer. The results indicate a downregulation of OGG1 and an upregulation of XRCC1 expression in tumor tissue. Regarding the anatomical location of APE1, OGG1 and PARP-1, a decrease in gene expression was observed among patients with cancer in the rectum. In patients with or without some degree of tumor invasion, a significant downregulation in OGG1 was observed in tumor tissue. Interestingly, when taking into account the tumor stage, patients with more advanced grades (III and IV) showed a significant repression for APE1, OGG1 and PARP-1. XRCC1 expression levels were significantly enhanced in tumor samples and were correlated with all clinical and histopathological data. Concerning the polymorphism T2197G, GG genotype carriers exhibited a significantly reduced expression of genes of the BER repair system (APE1, XRCC1 and PARP1). In summary, our data show that patients with colorectal cancer present expression changes in several BER genes, suggesting a role for APE1, XRCC1, PARP1 and OGG1 and APE1 polymorphism in colorectal carcinogenesis. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Juliana C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology and Molecular Biology, Clinical Pharmacology and Gastroenterology Unit, Sao Francisco University Medical School, Bragança Paulista, SP. 12916-900, Brazil. ju_carvalho_s@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funck</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology and Molecular Biology, Clinical Pharmacology and Gastroenterology Unit, Sao Francisco University Medical School, Bragança Paulista, SP. 12916-900, Brazil. afunck1@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Fernandes</LastName><ForeName>Isabelle J L</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Forensic Medicine, Federal University of Ceará, Fortaleza, CE. 60020-181, Brazil. isabellejoyce@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabenhorst</LastName><ForeName>Silvia H B</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Pathology and Forensic Medicine, Federal University of Ceará, Fortaleza, CE. 60020-181, Brazil. srabenhorst@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Carlos A R</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology and Molecular Biology, Clinical Pharmacology and Gastroenterology Unit, Sao Francisco University Medical School, Bragança Paulista, SP. 12916-900, Brazil. caomartinez@uol.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Marcelo L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology and Molecular Biology, Clinical Pharmacology and Gastroenterology Unit, Sao Francisco University Medical School, Bragança Paulista, SP. 12916-900, Brazil. marcelo.ribeiro@usf.edu.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="C499320">PARP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="D000071137">Poly (ADP-Ribose) Polymerase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.2.30</RegistryNumber><NameOfSubstance UI="D011065">Poly(ADP-ribose) Polymerases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</RefSource><PMID Version="1">21296855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Sep;25(5):463-71</RefSource><PMID Version="1">20534734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Cancer Drug Targets. 2012 May;12(4):356-71</RefSource><PMID Version="1">22385513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e40131</RefSource><PMID Version="1">22792228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2012 Aug 1;736(1-2):82-92</RefSource><PMID Version="1">22561673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2012 Jun;63(2):87-92</RefSource><PMID Version="1">22864776</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2012 Sep 15;106(4):448-55</RefSource><PMID Version="1">22374853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Nov 1;18(21):5878-87</RefSource><PMID Version="1">22966016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2013 Jun;30(2):505</RefSource><PMID Version="1">23430444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Pathol. 2014 Feb;45(2):268-75</RefSource><PMID Version="1">24289972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Chir Belg. 2013 Nov-Dec;113(6):385-90</RefSource><PMID Version="1">24494463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 1999 Nov;20(11):2125-9</RefSource><PMID Version="1">10545415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Gastrointest Dis. 2000 Oct;11(4):229-37</RefSource><PMID Version="1">11057950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2001 Jan 12;104(1):107-17</RefSource><PMID Version="1">11163244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Dermatol Sci. 2001 Oct;27(2):121-9</RefSource><PMID Version="1">11532376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2002 Mar 1;62(5):1377-81</RefSource><PMID Version="1">11888908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2004 Mar 15;18(6):602-16</RefSource><PMID Version="1">15075289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2004 Jun;83(6):970-9</RefSource><PMID Version="1">15177551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 1990 Jun 1;61(5):759-67</RefSource><PMID Version="1">2188735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1992 Jan 5;267(1):166-72</RefSource><PMID Version="1">1730583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Sep;11(9):3323-35</RefSource><PMID Version="1">1380454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11759-63</RefSource><PMID Version="1">1465394</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1999 Jun 2;91(11):916-32</RefSource><PMID Version="1">10359544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chromosome Res. 2006;14(1):27-37</RefSource><PMID Version="1">16506094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8</RefSource><PMID Version="1">16609022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2006 Jul;7(7):517-28</RefSource><PMID Version="1">16829982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Sep 1;12(17):5104-11</RefSource><PMID Version="1">16951227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2006 Sep;42(14):2374-81</RefSource><PMID Version="1">16809031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2006;6:208</RefSource><PMID Version="1">16914027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Feb 1;638(1-2):146-53</RefSource><PMID Version="1">17991492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2008 Jul 18;266(1):60-72</RefSource><PMID Version="1">18374480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2008;27:49</RefSource><PMID Version="1">18823566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):501-5</RefSource><PMID Version="1">18990028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathologe. 2009 Dec;30 Suppl 2:193-9</RefSource><PMID Version="1">19960300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Genet. 2010;51(3):343-52</RefSource><PMID Version="1">20720310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071137" MajorTopicYN="N">Poly (ADP-Ribose) Polymerase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011065" MajorTopicYN="N">Poly(ADP-ribose) Polymerases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>08</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>09</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>09</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25268610</ArticleId><ArticleId IdType="pii">ijms151017333</ArticleId><ArticleId IdType="doi">10.3390/ijms151017333</ArticleId><ArticleId IdType="pmc">PMC4227165</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25234162</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1617-4623</ISSN><JournalIssue CitedMedium="Internet"><Volume>290</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Molecular genetics and genomics : MGG</Title><ISOAbbreviation>Mol. Genet. Genomics</ISOAbbreviation></Journal><ArticleTitle>The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.</ArticleTitle><Pagination><MedlinePgn>281-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00438-014-0916-3</ELocationID><Abstract><AbstractText>The apurinic/apyrimidinic endonuclease 1 (APE1) plays important roles in the repair of DNA damage and adducts. However, previous case-control studies on the association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility have shown contradictory results, this meta-analysis was performed to draw a more precise estimation of the relationship. A total of seven case-control studies including 1,294 cases and 1,762 controls were included for analysis. In overall, no significant associations were found in all genetic models (GG vs. TT: OR = 1.16, 95 % CI 0.89-1.52; TG vs. TT: OR = 1.04, 95 % CI 0.81-1.35; the dominant model GG + TG vs. TT: OR = 1.12, 95 % CI 0.96-1.30; the recessive model GG vs. TG + TT: OR = 0.90, 95 % CI 0.77-1.04); in the subgroup by source of control, we found a significant association for the dominant model in Hospital-based subgroup (OR = 1.34, 95 % CI 1.08-1.68), no significant associations were found in other models in the subgroups. This meta-analysis suggested that the APE1 Asp148Glu polymorphism was a risk factor for prostate cancer susceptibility in Hospital-based population. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Guangjun</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Mingzhen</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ning</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yajie</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chuan</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Mol Genet Genomics</MedlineTA><NlmUniqueID>101093320</NlmUniqueID><ISSNLinking>1617-4623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2012;135:64-71</RefSource><PMID Version="1">22382185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biometrics. 1994 Dec;50(4):1088-101</RefSource><PMID Version="1">7786990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2006 Jan;175(1):108-12; discussion 112</RefSource><PMID Version="1">16406883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300</RefSource><PMID Version="1">20610543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource><PMID Version="1">3802833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci Suppl. 1995;19:73-7</RefSource><PMID Version="1">8655650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108</RefSource><PMID Version="1">15761078</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Mar;38(3):1585-91</RefSource><PMID Version="1">20852942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2008 Feb;37(1):120-32</RefSource><PMID Version="1">17898028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prostate. 2010 Feb 1;70(2):113-9</RefSource><PMID Version="1">19760636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2012;13(8):3931-6</RefSource><PMID Version="1">23098495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2008 Feb;37(1):136-46</RefSource><PMID Version="1">18037675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Jun;22(6):917-22</RefSource><PMID Version="1">11375899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2004;44(1):74-82</RefSource><PMID Version="1">15199549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2004 Jun;83(6):970-9</RefSource><PMID Version="1">15177551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jan;35(1):667-73</RefSource><PMID Version="1">23975370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jul 04;8(7):e68634</RefSource><PMID Version="1">23861929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Decis Making. 2005 Nov-Dec;25(6):646-54</RefSource><PMID Version="1">16282215</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Apr 22;362(6422):709-15</RefSource><PMID Version="1">8469282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1997 Sep 13;315(7109):629-34</RefSource><PMID Version="1">9310563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36</RefSource><PMID Version="1">21685461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lab. 2013;59(1-2):163-8</RefSource><PMID Version="1">23505922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2004 Nov 15;101(10 Suppl):2371-490</RefSource><PMID Version="1">15495199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1992 Sep 11;20(17):4417-21</RefSource><PMID Version="1">1383925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2012 Apr;133(4):127-32</RefSource><PMID Version="1">22019847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Epidemiol. 2010 Sep;25(9):603-5</RefSource><PMID Version="1">20652370</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnic Groups</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018740" MajorTopicYN="N">Genetic Heterogeneity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>06</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25234162</ArticleId><ArticleId IdType="doi">10.1007/s00438-014-0916-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25222230</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2014</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1676-5680</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>Genetics and molecular research : GMR</Title><ISOAbbreviation>Genet. Mol. Res.</ISOAbbreviation></Journal><ArticleTitle>Association of c.461G&gt;A genetic variant of OGG1 gene with pancreatic cancer susceptibility in Chinese.</ArticleTitle><Pagination><MedlinePgn>7256-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4238/2014.September.5.10</ELocationID><Abstract><AbstractText>This study aimed to evaluate the potential association of single nucleotide polymorphisms of the 8-oxoguanine DNA glycosylase gene (OGG1) with susceptibility to pancreatic cancer (PC). A total of 764 Chinese Han subjects were recruited in this study. The polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing methods were used to detect the genotype of c.461G&gt;A genetic variant of OGG1. The genotype and allele frequencies were statistically different in PC patients compared with cancer-free controls. The AA genotype was statistically associated with increased PC susceptibility compared to GG wild genotype (AA vs GG, OR=2.62, 95%CI=1.48-4.63, χ2=11.46, P=0.001). Allele A could contribute to the increased risk of PC (A vs G, OR=1.35, 95%CI=1.08-1.69, χ2=6.86, P=0.009). Our data indicated that the c.461G&gt;A genetic variant of the OGG1 gene was associated with susceptibility to PC in a Chinese Han population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Z M</ForeName><Initials>ZM</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, The Chinese PLA General Hospital, Beijing, China zhi_ming_zhao@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>C G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, The Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>M G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, The Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>G D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, The Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, The Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Genet Mol Res</MedlineTA><NlmUniqueID>101169387</NlmUniqueID><ISSNLinking>1676-5680</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25222230</ArticleId><ArticleId IdType="pii">gmr3583</ArticleId><ArticleId IdType="doi">10.4238/2014.September.5.10</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25210033</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>289</Volume><Issue>44</Issue><PubDate><Year>2014</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation></Journal><ArticleTitle>Distinct roles of Ape1 protein, an enzyme involved in DNA repair, in high or low linear energy transfer ionizing radiation-induced cell killing.</ArticleTitle><Pagination><MedlinePgn>30635-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.604959</ELocationID><Abstract><AbstractText>High linear energy transfer (LET) radiation from space heavy charged particles or a heavier ion radiotherapy machine kills more cells than low LET radiation, mainly because high LET radiation-induced DNA damage is more difficult to repair. Relative biological effectiveness (RBE) is the ratio of the effects generated by high LET radiation to low LET radiation. Previously, our group and others demonstrated that the cell-killing RBE is involved in the interference of high LET radiation with non-homologous end joining but not homologous recombination repair. This effect is attributable, in part, to the small DNA fragments (≤40 bp) directly produced by high LET radiation, the size of which prevents Ku protein from efficiently binding to the two ends of one fragment at the same time, thereby reducing non-homologous end joining efficiency. Here we demonstrate that Ape1, an enzyme required for processing apurinic/apyrimidinic (known as abasic) sites, is also involved in the generation of small DNA fragments during the repair of high LET radiation-induced base damage, which contributes to the higher RBE of high LET radiation-induced cell killing. This discovery opens a new direction to develop approaches for either protecting astronauts from exposure to space radiation or benefiting cancer patients by sensitizing tumor cells to high LET radiotherapy. </AbstractText><CopyrightInformation>© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guangnan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiangming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiaobing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Dongkyoo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cucinotta</LastName><ForeName>Francis A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>the Department of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, Nevada 89154.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Xingming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dynan</LastName><ForeName>William S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doetsch</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>From the Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 and ywang94@emory.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA138292</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30CA138292</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C512689">Mre11a protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D000076228">MRE11 Homologue Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.5.1.-</RegistryNumber><NameOfSubstance UI="D045643">DNA Repair Enzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1999 Oct 15;13(20):2633-8</RefSource><PMID Version="1">10541549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2009 Dec 3;8(12):1343-54</RefSource><PMID Version="1">19800300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Dec 15;27(24):4679-86</RefSource><PMID Version="1">10572166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):103-8</RefSource><PMID Version="1">10618378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2012;(66):e4168</RefSource><PMID Version="1">22895410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 May 31;340(6136):1080-4</RefSource><PMID Version="1">23723233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2014 Jan 9;53(1):7-18</RefSource><PMID Version="1">24316220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2001 Mar;27(3):247-54</RefSource><PMID Version="1">11242102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Apr 15;29(8):1653-60</RefSource><PMID Version="1">11292837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2010 Jan;173(1):27-39</RefSource><PMID Version="1">20041757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jun;38(10):3245-51</RefSource><PMID Version="1">20150414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Feb 18;286(7):4968-77</RefSource><PMID Version="1">21081487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 May 17;108(20):8293-8</RefSource><PMID Version="1">21527720</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13300-5</RefSource><PMID Version="1">10557315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Aug 9;412(6847):607-14</RefSource><PMID Version="1">11493912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Prot Dosimetry. 2001;97(1):25-31</RefSource><PMID Version="1">11763354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Aug;23(16):5706-15</RefSource><PMID Version="1">12897142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2003 Sep;160(3):366-75</RefSource><PMID Version="1">12926995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(18):5609-20</RefSource><PMID Version="1">15494449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Feb;37(2):135-67</RefSource><PMID Version="1">6966263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 1981 May;86(2):185-95</RefSource><PMID Version="1">7015409</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Biol Relat Stud Phys Chem Med. 1987 May;51(5):779-90</RefSource><PMID Version="1">3496288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Biol. 1992 Jun;61(6):737-48</RefSource><PMID Version="1">1351522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):23-7</RefSource><PMID Version="1">7506414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 1994 Aug;139(2):133-41</RefSource><PMID Version="1">8052688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1995 Mar 15;55(6):1232-4</RefSource><PMID Version="1">7882314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1996 Aug 8;382(6591):551-5</RefSource><PMID Version="1">8700231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5061-6</RefSource><PMID Version="1">9560228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1999 Jul 9;290(2):447-57</RefSource><PMID Version="1">10390343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 1999 Jul 1;9(13):699-702</RefSource><PMID Version="1">10395545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2005 Feb;202(2):492-502</RefSource><PMID Version="1">15389585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2006 Jan;165(1):59-67</RefSource><PMID Version="1">16392963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Struct Mol Biol. 2006 May;13(5):451-7</RefSource><PMID Version="1">16622404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2008 May 3;7(5):725-33</RefSource><PMID Version="1">18325854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Oct 3;135(1):85-96</RefSource><PMID Version="1">18854157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2008 Oct 3;135(1):97-109</RefSource><PMID Version="1">18854158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1236-41</RefSource><PMID Version="1">19545789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2012 Mar 1;72(5):1221-8</RefSource><PMID Version="1">22237628</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053903" MajorTopicYN="Y">DNA Breaks, Double-Stranded</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059766" MajorTopicYN="Y">DNA End-Joining Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053938" MajorTopicYN="N">DNA Fragmentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045643" MajorTopicYN="N">DNA Repair Enzymes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018499" MajorTopicYN="N">Linear Energy Transfer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076228" MajorTopicYN="N">MRE11 Homologue Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011833" MajorTopicYN="N">Radiation Injuries, Experimental</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014965" MajorTopicYN="N">X-Rays</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ape1</Keyword><Keyword MajorTopicYN="N">DNA Damage</Keyword><Keyword MajorTopicYN="N">DNA Damage Response</Keyword><Keyword MajorTopicYN="N">DNA Enzyme</Keyword><Keyword MajorTopicYN="N">DNA Repair</Keyword><Keyword MajorTopicYN="N">DNA-binding Protein</Keyword><Keyword MajorTopicYN="N">High LET</Keyword><Keyword MajorTopicYN="N">Radiation Biology</Keyword><Keyword MajorTopicYN="N">Radiosensitivity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25210033</ArticleId><ArticleId IdType="pii">M114.604959</ArticleId><ArticleId IdType="doi">10.1074/jbc.M114.604959</ArticleId><ArticleId IdType="pmc">PMC4215242</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25196052</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0461</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of biochemical and molecular toxicology</Title><ISOAbbreviation>J. Biochem. Mol. Toxicol.</ISOAbbreviation></Journal><ArticleTitle>Enzyme kinetics of an alternative splicing isoform of mitochondrial 8-oxoguanine DNA glycosylase, ogg1-1b, and compared with the nuclear ogg1-1a.</ArticleTitle><Pagination><MedlinePgn>49-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jbt.21605</ELocationID><Abstract><AbstractText>Eight alternatively spliced isoforms of human 8-oxoguanine DNA glycosylase (OGG1) (OGG1-1a to -1c and -2a to -2e) are registered in the National Center for Biotechnology Information. OGG1(s) in mitochondria have not yet been fully characterized biochemically. In this study, we purified mitochondrial recombinant OGG1-1b protein and compared its activity with nuclear OGG1-1a protein. The reaction rate constant (kg ) of the 7,8-dihydro-8-oxoguanine (8-oxoG) glycosylase activity of OGG1-1b was 8-oxoG:C &gt; 8-oxoG:T &gt; 8-oxoG:G &gt; 8-oxoG:A (7.96, 0.805, 0.070, and 0.015 min(-1) , respectively) and that of the N-glycosylase/DNA lyase activity (kgl ) of OGG1-1b was 8-oxoG:C &gt; 8-oxoG:T ≃8-oxoG:G &gt; 8-oxoG:A (0.286, 0.079, 0.040, and negligible min(-1) , respectively). These reaction rate constants were similar to those of OGG1-1a except for kgl against 8-oxoG:A. APEX nuclease 1 was required to promote DNA strand breakage by OGG1-1b. These results suggest that OGG1-1b is associated with 8-oxoG cleavage in human mitochondria and that the mechanism of this repair is similar to that of nuclear OGG1-1a. </AbstractText><CopyrightInformation>© 2014 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Functional Genomics Laboratory, School of Science and Engineering, Aoyama Gakuin University, Sagamihara, Kanagawa, 252-5258, Japan. chiefurihata@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Shoji</LastName><ForeName>Sayaka</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Furihata</LastName><ForeName>Chie</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biochem Mol Toxicol</MedlineTA><NlmUniqueID>9717231</NlmUniqueID><ISSNLinking>1095-6670</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017398" MajorTopicYN="N">Alternative Splicing</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enzyme Activity</Keyword><Keyword MajorTopicYN="N">Mitochondrial OGG1-1b</Keyword><Keyword MajorTopicYN="N">Multiple-turnover Condition</Keyword><Keyword MajorTopicYN="N">Nuclear OGG1-1a</Keyword><Keyword MajorTopicYN="N">Single-turnover Condition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>08</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25196052</ArticleId><ArticleId IdType="doi">10.1002/jbt.21605</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25188410</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>9</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy.</ArticleTitle><Pagination><MedlinePgn>e106485</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0106485</ELocationID><Abstract><AbstractText>Although chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of platinum drugs, the mechanisms of this toxicity remain unknown. Previous work in our laboratory suggests that cisplatin-induced CIPN is secondary to DNA damage which is susceptible to base excision repair (BER). To further examine this hypothesis, we studied the effects of cisplatin, oxaliplatin, and carboplatin on cell survival, DNA damage, ROS production, and functional endpoints in rat sensory neurons in culture in the absence or presence of reduced expression of the BER protein AP endonuclease/redox factor-1 (APE1). Using an in situ model of peptidergic sensory neuron function, we examined the effects of the platinum drugs on hind limb capsaicin-evoked vasodilatation. Exposing sensory neurons in culture to the three platinum drugs caused a concentration-dependent increase in apoptosis and cell death, although the concentrations of carboplatin were 10 fold higher than cisplatin. As previously observed with cisplatin, oxaliplatin and carboplatin also increased DNA damage as indicated by an increase in phospho-H2AX and reduced the capsaicin-evoked release of CGRP from neuronal cultures. Both cisplatin and oxaliplatin increased the production of ROS as well as 8-oxoguanine DNA adduct levels, whereas carboplatin did not. Reducing levels of APE1 in neuronal cultures augmented the cisplatin and oxaliplatin induced toxicity, but did not alter the effects of carboplatin. Using an in vivo model, systemic injection of cisplatin (3 mg/kg), oxaliplatin (3 mg/kg), or carboplatin (30 mg/kg) once a week for three weeks caused a decrease in capsaicin-evoked vasodilatation, which was delayed in onset. The effects of cisplatin on capsaicin-evoked vasodilatation were attenuated by chronic administration of E3330, a redox inhibitor of APE1 that serendipitously enhances APE1 DNA repair activity in sensory neurons. These outcomes support the importance of the BER pathway, and particularly APE1, in sensory neuropathy caused by cisplatin and oxaliplatin, but not carboplatin and suggest that augmenting DNA repair could be a therapeutic target for CIPN. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, Indiana, United States of America; Department of Pharmacology &amp; Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yanlin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Chunlu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>April</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Hongdi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasko</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA121168S1</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009944">Organoplatinum Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>04ZR38536J</RegistryNumber><NameOfSubstance UI="C030110">oxaliplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>BG3F62OND5</RegistryNumber><NameOfSubstance UI="D016190">Carboplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Peripher Nerv Syst. 2008 Mar;13(1):27-46</RefSource><PMID Version="1">18346229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 1999 Dec;20(6):883-7</RefSource><PMID Version="1">10693969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 Jun 21;447(7147):941-50</RefSource><PMID Version="1">17581577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rejuvenation Res. 2011 Jun;14(3):293-308</RefSource><PMID Version="1">21595514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2004 Jul-Aug;24(4):2127-34</RefSource><PMID Version="1">15330152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2013 Apr 30;52(17):2955-66</RefSource><PMID Version="1">23597102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Feb;23(2):341-9</RefSource><PMID Version="1">11872643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2010 Mar 17;30(11):3933-46</RefSource><PMID Version="1">20237264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2002 Sep;302(3):839-45</RefSource><PMID Version="1">12183638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 2011 Jan;32(1):140-9</RefSource><PMID Version="1">20932997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):3-13</RefSource><PMID Version="1">22122461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2007 Aug;28(8):1629-37</RefSource><PMID Version="1">17389610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Otol. 1997 Sep;18(5):559-71</RefSource><PMID Version="1">9303151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 1998 Oct;9(10):1053-71</RefSource><PMID Version="1">9834817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pain. 2010;6:76</RefSource><PMID Version="1">21050491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1985 May 15;55(10):2303-l6</RefSource><PMID Version="1">3886121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Oncol. 2002 Oct;29(5 Suppl 15):21-33</RefSource><PMID Version="1">12422305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Sep 5;10(9):942-52</RefSource><PMID Version="1">21741887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 2007 Apr 14;145(4):1260-6</RefSource><PMID Version="1">17045754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2006 Aug;32(5):390-7</RefSource><PMID Version="1">16781082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 Jun 15;14(12):2465-77</RefSource><PMID Version="1">20812782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2011 Jan 11;50(1):82-92</RefSource><PMID Version="1">21117647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Mar 2;4(3):367-79</RefSource><PMID Version="1">15661660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95</RefSource><PMID Version="1">17560642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2010 Sep 1;334(3):988-98</RefSource><PMID Version="1">20504914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Aug;12(8):685-90</RefSource><PMID Version="1">23684797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2005 Apr;4(4):307-20</RefSource><PMID Version="1">15789122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fundam Appl Toxicol. 1995 Jul;26(2):293-300</RefSource><PMID Version="1">7589918</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Neurol. 2011 Dec;232(2):154-61</RefSource><PMID Version="1">21907196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2005 Mar;18(2):305-13</RefSource><PMID Version="1">15686959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2011 Sep;10(9):1698-708</RefSource><PMID Version="1">21700832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Laryngoscope. 2001 Jul;111(7):1147-55</RefSource><PMID Version="1">11568534</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Inorg Biochem. 1999 Oct;77(1-2):105-10</RefSource><PMID Version="1">10626361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Nov;28(9):885-95</RefSource><PMID Version="1">20919954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1998 May;64(5):667-9</RefSource><PMID Version="1">9598687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Cancer Drug Targets. 2010 Nov;10(7):670-82</RefSource><PMID Version="1">20578989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Aug 1;68(15):6425-34</RefSource><PMID Version="1">18676868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2007 Jan 3;614(1-2):24-36</RefSource><PMID Version="1">16879837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2009 Jan;8(1):10-6</RefSource><PMID Version="1">19139108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 17;51(2):695-705</RefSource><PMID Version="1">22148505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Colorectal Cancer. 2011 Jun;10(2):126-33</RefSource><PMID Version="1">21859566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2012 Nov 15;131(10):2433-44</RefSource><PMID Version="1">22377908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotoxicology. 2006 Dec;27(6):992-1002</RefSource><PMID Version="1">16797073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2010 Feb 11;53(3):1200-10</RefSource><PMID Version="1">20067291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2011 Jan;29(1):21-8</RefSource><PMID Version="1">21166495</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytokine. 2004 Feb 7;25(3):94-102</RefSource><PMID Version="1">14698135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurol. 2010 Dec;6(12):657-66</RefSource><PMID Version="1">21060341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microvasc Res. 1998 Jan;55(1):3-13</RefSource><PMID Version="1">9473405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2014 Jun 20;32(18):1941-67</RefSource><PMID Version="1">24733808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Feb 15;104(4):653-63</RefSource><PMID Version="1">21266972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1992 May;10(5):795-803</RefSource><PMID Version="1">1569451</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1988 Mar;24(3):739-68</RefSource><PMID Version="1">3288903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Metallomics. 2009;1(4):280-91</RefSource><PMID Version="1">20046924</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Muscle Nerve. 1999 Mar;22(3):329-40</RefSource><PMID Version="1">10086893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):651-68</RefSource><PMID Version="1">18715143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chemother Res Pract. 2011;2011:843019</RefSource><PMID Version="1">22312559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1999 Jan;17(1):409-22</RefSource><PMID Version="1">10458260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1998 Jun 15;101(12):2842-50</RefSource><PMID Version="1">9637718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Apr 1;20(7):1767-74</RefSource><PMID Version="1">11919233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2009 Nov 2;8(11):1273-82</RefSource><PMID Version="1">19726241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Pathol. 1992;6(1-2):65-74</RefSource><PMID Version="1">1625039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Muscle Nerve. 2004 Mar;29(3):387-92</RefSource><PMID Version="1">14981738</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2001 Dec;8(6):1027-35</RefSource><PMID Version="1">11741398</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 1998 Apr;9(4):443-7</RefSource><PMID Version="1">9636837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(15):4711-24</RefSource><PMID Version="1">16113242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pain. 2011 Feb;152(2):308-13</RefSource><PMID Version="1">21145656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(6):1812-21</RefSource><PMID Version="1">17329374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Aug;41(15):7332-43</RefSource><PMID Version="1">23761438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Muscle Nerve. 2005 Jul;32(1):51-60</RefSource><PMID Version="1">15880395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Aug 29;27(35):9451-7</RefSource><PMID Version="1">17728458</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016190" MajorTopicYN="N">Carboplatin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009944" MajorTopicYN="N">Organoplatinum Compounds</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010523" MajorTopicYN="N">Peripheral Nervous System Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011984" MajorTopicYN="N">Sensory Receptor Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>08</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25188410</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0106485</ArticleId><ArticleId IdType="pii">PONE-D-14-11622</ArticleId><ArticleId IdType="pmc">PMC4154694</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25169084</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1001-9391</ISSN><JournalIssue CitedMedium="Print"><Volume>32</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases</Title><ISOAbbreviation>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Effects of polymorphisms in XRCC1 and APE1 on vinyl chloride-induced chromosome damage].</ArticleTitle><Pagination><MedlinePgn>321-6</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the effects of polymorphisms in XRCC1 and APE1 genes on vinyl chloride (VC)-induced chromosomal damage in peripheral lymphocytes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, 317 workers occupationally exposed to VC were recruited from a factory in Shandong Province, China. The micronucleus (MN) frequency in peripheral lymphocytes was used as an indicator of chromosomal damage. Polymerase chain reaction-restriction fragment length polymorphism and created restriction site combined with restriction fragment length polymorphism were used to determine the five single nucleotide polymorphisms in XRCC1 and APE1 genes in the base excision repair pathway. The association of chromosomal damage with these polymorphisms and the haplotype of XRCC1 was analyzed using Poisson regression and PHASE 2.0.2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">It was found that among the VC-exposed workers, individuals with XRCC1 polymorphisms (-77C/T, Arg194Trp, Arg280His, and Arg399Gln) had a significantly higher MN frequency than those with homozygous wild-type genotypes, with frequency ratios (FR) as follows, respectively: FR = 1.21, 95%CI: 1.05∼1.39 (P &lt; 0.05); FR = 1.14, 95%CI: 1.00∼1.38 (P &lt; 0.05); FR = 1.26, 95%CI: 1.11∼1.44 (P &lt; 0.05); FR = 1.23, 95%CI: 1.08∼1.46 (P &lt; 0.05). APE1 Asp148Glu was found of no significant relationship with MN frequency. Haplotype analysis of XRCC1 demonstrated that the MN frequencies in subjects with CTAA/CTAA and CCAA/CTAA were significantly higher than that in those with TCGG/TCGG (FR = 1.19, 95%CI: 1.02∼1.32, P &lt; 0.05; FR = 1.41, 95%CI: 1.02∼1.87, P &lt; 0.05). Furthermore, association was found between accumulated exposure to VC and XRCC1 polymorphisms (-77C/T, Arg194Trp, Arg280His, and Arg399Gln) after adjustment for age, sex, drinking, and smoking.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">VC can induce chromosomal damage even when the exposure level is lower than the national occupational health standard of China (PC-TWA: 10 mg/m(3)); the polymorphisms in XRCC1 and APE1 are associated with chromosomal damage induced by VC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Occupational Health and Toxicity, School of Pubic Health, Fudan University, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiaowen</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fang</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Hongshan</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Nannan</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lifang</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Yunjie</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Hua</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhaolin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>E-mail: zlxia@shmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi</MedlineTA><NlmUniqueID>8410840</NlmUniqueID><ISSNLinking>1001-9391</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>WD06X94M2D</RegistryNumber><NameOfSubstance UI="D014752">Vinyl Chloride</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048629" MajorTopicYN="N">Micronuclei, Chromosome-Defective</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016273" MajorTopicYN="N">Occupational Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012150" MajorTopicYN="Y">Polymorphism, Restriction Fragment Length</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014752" MajorTopicYN="N">Vinyl Chloride</DescriptorName><QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25169084</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25108836</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2014</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-7856</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>DNA repair</Title><ISOAbbreviation>DNA Repair (Amst.)</ISOAbbreviation></Journal><ArticleTitle>Functional variants of human APE1 rescue the DNA repair defects of the yeast AP endonuclease/3'-diesterase-deficient strain.</ArticleTitle><Pagination><MedlinePgn>53-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dnarep.2014.07.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-7864(14)00196-7</ELocationID><Abstract><AbstractText>Human APE1 is an essential enzyme performing functions in DNA repair and transcription. It possesses four distinct repair activities acting on a variety of base and sugar derived DNA lesions. APE1 has seven cysteine residues and Cys65, and to a lesser extent Cys93 and Cys99, is uniquely involved in maintaining a subset of transcription factors in the reduced and active state. Four of the cysteines Cys93, 99, 208 and 310 of APE1 are located proximal to its active site residues Glu96, Asp210 and His309 involved in processing damaged DNA, raising the possibility that missense mutation of these cysteines could alter the enzyme DNA repair functions. An earlier report documented that serine substitution of the individual cysteine residues did not affect APE1 ability to cleave an abasic site oligonucleotide substrate in vitro, except for Cys99Ser, although any consequences of these variants in the repair of in vivo DNA lesions were not tested. Herein, we mutated all seven cysteines of APE1, either singly or in combination, to alanine and show that none of the resulting variants interfered with the enzyme DNA repair functions. Cross-specie complementation analysis reveals that these APE1 cysteine variants fully rescued the yeast DNA repair deficient strain YW778, lacking AP endonucleases and 3'-diesterases, from toxicities caused by DNA damaging agents. Moreover, the elevated spontaneous mutations arising in strain YW778 from the lack of the DNA repair activities were completely suppressed by the APE1 cysteine variants. These findings suggest that the cysteine residues of APE1 are unlikely to play a role in the DNA repair functions of the enzyme in vivo. We also examine other APE1 missense mutations and provide the first evidence that the variant Asp308Ala with normal AP endonuclease, but devoid of 3'→5' exonuclease, displays hypersensitivity to the anticancer drug bleomycin, and not to other agents, suggesting that it has a defect in processing unique DNA lesions. Molecular modeling reveals that Asp308Ala cannot make proper contact with Mg(2+) and may alter the enzyme ability to cleave or disassociate from specific DNA lesions. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal 5415 Boul. de l' Assomption, Montréal, Québec, Canada H1T 2M4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayoub</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal 5415 Boul. de l' Assomption, Montréal, Québec, Canada H1T 2M4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazouzi</LastName><ForeName>Abdelghani</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal 5415 Boul. de l' Assomption, Montréal, Québec, Canada H1T 2M4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grin</LastName><ForeName>Inga</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Groupe Réparation de l'ADN, Université Paris Sud, Laboratoire Stabilité Génétique et Oncogenèse CNRS, UMR 8200, Gustave-Roussy Cancer Center, F-94805 Villejuif Cedex, France; SB RAS Institute of Chemical Biology and Fundamental Medicine, 8 Lavrentieva Ave. , Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishchenko</LastName><ForeName>Alexander A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Groupe Réparation de l'ADN, Université Paris Sud, Laboratoire Stabilité Génétique et Oncogenèse CNRS, UMR 8200, Gustave-Roussy Cancer Center, F-94805 Villejuif Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Jinjiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Institute of the McGill University Health Centre and Department of Medicine, McGill University, 1650 Cedar Avenue, Montreal, QC H3G 1A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal 5415 Boul. de l' Assomption, Montréal, Québec, Canada H1T 2M4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harihar</LastName><ForeName>Taramatti</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal 5415 Boul. de l' Assomption, Montréal, Québec, Canada H1T 2M4.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saparbaev</LastName><ForeName>Murat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Groupe Réparation de l'ADN, Université Paris Sud, Laboratoire Stabilité Génétique et Oncogenèse CNRS, UMR 8200, Gustave-Roussy Cancer Center, F-94805 Villejuif Cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramotar</LastName><ForeName>Dindial</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Maisonneuve-Rosemont Hospital, Research Center, Université de Montréal 5415 Boul. de l' Assomption, Montréal, Québec, Canada H1T 2M4. Electronic address: dindial.ramotar@umontreal.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>DNA Repair (Amst)</MedlineTA><NlmUniqueID>101139138</NlmUniqueID><ISSNLinking>1568-7856</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Base-excision repair</Keyword><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">Human AP endonuclease</Keyword><Keyword MajorTopicYN="N">Mutations</Keyword><Keyword MajorTopicYN="N">Oxidative DNA damage</Keyword><Keyword MajorTopicYN="N">Yeast</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25108836</ArticleId><ArticleId IdType="pii">S1568-7864(14)00196-7</ArticleId><ArticleId IdType="doi">10.1016/j.dnarep.2014.07.010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25107571</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0843</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cancer chemotherapy and pharmacology</Title><ISOAbbreviation>Cancer Chemother. Pharmacol.</ISOAbbreviation></Journal><ArticleTitle>Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.</ArticleTitle><Pagination><MedlinePgn>777-86</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00280-014-2562-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Drug resistance is not only one of the major obstacles to treatment but also a poor prognosis in advanced non-small cell lung cancer (NSCLC) patients. The aim of this study was to evaluate the predictive value of APE1, BRCA1, ERCC1 and TUBB3 in advanced NSCLC patients who received platinum-paclitaxel treatment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">One hundred and thirty-six advanced NSCLC patients, who were treated with first-line platinum-paclitaxel chemotherapy, were enrolled in this study. The protein expression levels of APE1, BRCA1, ERCC1 and TUBB3 were assessed by immunohistochemistry and analyzed for the association with response to chemotherapy and progression-free survival (PFS) and overall survival (OS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with negative expression of APE1, ERCC1 or TUBB3 benefited from platinum plus paclitaxel regimen chemotherapy. ERCC1-negative patients had better PFS (P = 0.016) and OS (P = 0.030) compared with positive patients. Similarly, the APE1-negative patients showed better PFS (P = 0.004) and longer OS though statistically insignificant. Multivariate analysis showed that APE1 and ERCC1 were independent predictor for PFS (HR 2.07; P = 0.004 and HR 1.66; P = 0.016) and OS (HR 1.99; P = 0.008 and HR 1.64; P = 0.040). Moreover, patients with both APE1- and ERCC1-negative or both APE1- and TUBB3-negative tumors had significantly higher response rate, longer median PFS and OS following treatment with platinum and paclitaxel (P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The data indicate that APE1, ERCC1 and TUBB3 could be a useful biomarker to predict clinical outcome in patients with advanced NSCLC receiving first-line platinum-paclitaxel chemotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, The Third Military Medical University, No. 10 Changjiang Zhi Rd., Yuzhong District, Chongqing, 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yu</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shiheng</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Yanli</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Cancer Chemother Pharmacol</MedlineTA><NlmUniqueID>7806519</NlmUniqueID><ISSNLinking>0344-5704</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019313">BRCA1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498585">TUBB3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014404">Tubulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="C071447">ERCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004720">Endonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>P88XT4IS4D</RegistryNumber><NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019313" MajorTopicYN="N">BRCA1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="Y">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="Y">Cisplatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004354" MajorTopicYN="N">Drug Screening Assays, Antitumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004720" MajorTopicYN="N">Endonucleases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017239" MajorTopicYN="Y">Paclitaxel</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25107571</ArticleId><ArticleId IdType="doi">10.1007/s00280-014-2562-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25089939</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1366-5804</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals</Title><ISOAbbreviation>Biomarkers</ISOAbbreviation></Journal><ArticleTitle>Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus.</ArticleTitle><Pagination><MedlinePgn>509-16</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/1354750X.2014.943291</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">The study of DNA base and nucleotide excision repair gene polymorphisms in bladder cancer seems to have a predictive value because of the evident relationship between the DNA damage response induced by environmental mutagens and cancer predisposition.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective was to determine OGG1 Ser326Cys, XRCC1 Arg399Gln, XPD Asp312Asn, and ERCC6 Met1097Val polymorphisms in bladder cancer patients as compared to controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Both groups were predominantly represented by Belarusians and Eastern Slavs. DNA samples from 336 patients and 370 controls were genotyped using a PCR-RFLP method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The genotype distributions were in agreement with the Hardy-Weinberg equilibrium. The minor allele frequencies in the control population were in the range of those in Caucasians in contrast to Asians. The OGG1 326 Ser/Cys and XPD 312 Asp/Asn heterozygous genotypes were inversely associated with cancer risk (OR [95% CI] = 0.69 [0.50-0.95] and 1.35 [1.0-1.82], respectively). The contrasting effects of these genotypes were potentiated due to their interactions with smoking habit or age.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among four DNA repair gene polymorphisms, the OGG1 326 Ser/Cys and XPD 312 Asp/Asn heterozygous genotypes might be recognized as potential genetic markers modifying susceptibility to bladder cancer in Belarus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramaniuk</LastName><ForeName>Volha P</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>Institute of Genetics and Cytology, National Academy of Sciences of Belarus , Minsk , Republic of Belarus .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikitchenko</LastName><ForeName>Nataliya V</ForeName><Initials>NV</Initials></Author><Author ValidYN="Y"><LastName>Savina</LastName><ForeName>Nataliya V</ForeName><Initials>NV</Initials></Author><Author ValidYN="Y"><LastName>Kuzhir</LastName><ForeName>Tatyana D</ForeName><Initials>TD</Initials></Author><Author ValidYN="Y"><LastName>Rolevich</LastName><ForeName>Alexander I</ForeName><Initials>AI</Initials></Author><Author ValidYN="Y"><LastName>Krasny</LastName><ForeName>Sergei A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Sushinsky</LastName><ForeName>Vadim E</ForeName><Initials>VE</Initials></Author><Author ValidYN="Y"><LastName>Goncharova</LastName><ForeName>Roza I</ForeName><Initials>RI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biomarkers</MedlineTA><NlmUniqueID>9606000</NlmUniqueID><ISSNLinking>1354-750X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075223">Poly-ADP-Ribose Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="C078673">ERCC6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="D051759">Xeroderma Pigmentosum Group D Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.99.-</RegistryNumber><NameOfSubstance UI="C497292">ERCC2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.5.1.-</RegistryNumber><NameOfSubstance UI="D045643">DNA Repair Enzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002295" MajorTopicYN="N">Carcinoma, Transitional Cell</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045643" MajorTopicYN="N">DNA Repair Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075223" MajorTopicYN="N">Poly-ADP-Ribose Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002094" MajorTopicYN="N">Republic of Belarus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001749" MajorTopicYN="N">Urinary Bladder Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051759" MajorTopicYN="N">Xeroderma Pigmentosum Group D Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bladder cancer</Keyword><Keyword MajorTopicYN="N">DNA repair gene polymorphisms</Keyword><Keyword MajorTopicYN="N">ERCC6</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">XPD</Keyword><Keyword MajorTopicYN="N">XRCC1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25089939</ArticleId><ArticleId IdType="doi">10.3109/1354750X.2014.943291</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25086253</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0006-3002</ISSN><JournalIssue CitedMedium="Print"><Volume>1840</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Biochimica et biophysica acta</Title><ISOAbbreviation>Biochim. Biophys. Acta</ISOAbbreviation></Journal><ArticleTitle>Pre-steady-state fluorescence analysis of damaged DNA transfer from human DNA glycosylases to AP endonuclease APE1.</ArticleTitle><Pagination><MedlinePgn>3042-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbagen.2014.07.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0304-4165(14)00261-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">DNA glycosylases remove the modified, damaged or mismatched bases from the DNA by hydrolyzing the N-glycosidic bonds. Some enzymes can further catalyze the incision of a resulting abasic (apurinic/apyrimidinic, AP) site through β- or β,δ-elimination mechanisms. In most cases, the incision reaction of the AP-site is catalyzed by special enzymes called AP-endonucleases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Here, we report the kinetic analysis of the mechanisms of modified DNA transfer from some DNA glycosylases to the AP endonuclease, APE1. The modified DNA contained the tetrahydrofurane residue (F), the analogue of the AP-site. DNA glycosylases AAG, OGG1, NEIL1, MBD4(cat) and UNG from different structural superfamilies were used.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that all DNA glycosylases may utilise direct protein-protein interactions in the transient ternary complex for the transfer of the AP-containing DNA strand to APE1.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We hypothesize a fast "flip-flop" exchange mechanism of damaged and undamaged DNA strands within this complex for monofunctional DNA glycosylases like MBD4(cat), AAG and UNG. Bifunctional DNA glycosylase NEIL1 creates tightly specific complex with DNA containing F-site thereby efficiently competing with APE1. Whereas APE1 fast displaces other bifunctional DNA glycosylase OGG1 on F-site thereby induces its shifts to undamaged DNA regions.</AbstractText><AbstractText Label="GENERAL SIGNIFICANCE" NlmCategory="CONCLUSIONS">Kinetic analysis of the transfer of DNA between human DNA glycosylases and APE1 allows us to elucidate the critical step in the base excision repair pathway.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuznetsova</LastName><ForeName>Alexandra A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuznetsov</LastName><ForeName>Nikita A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Novosibirsk 630090, Russia; Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia. Electronic address: nikita.kuznetsov@niboch.nsc.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishchenko</LastName><ForeName>Alexander A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Groupe «Réparation de l'ADN», Université Paris-Sud XI, UMR8200 CNRS, Institut Gustave Roussy, Villejuif Cedex F-94805, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saparbaev</LastName><ForeName>Murat K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Groupe «Réparation de l'ADN», Université Paris-Sud XI, UMR8200 CNRS, Institut Gustave Roussy, Villejuif Cedex F-94805, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedorova</LastName><ForeName>Olga S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology and Fundamental Medicine, Novosibirsk 630090, Russia; Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia. Electronic address: fedorova@niboch.nsc.ru.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biochim Biophys Acta</MedlineTA><NlmUniqueID>0217513</NlmUniqueID><ISSNLinking>0006-3002</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AP endonuclease</Keyword><Keyword MajorTopicYN="N">Base excision repair</Keyword><Keyword MajorTopicYN="N">Coordination of DNA repair process</Keyword><Keyword MajorTopicYN="N">DNA glycosylase</Keyword><Keyword MajorTopicYN="N">Protein–protein interaction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>07</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25086253</ArticleId><ArticleId IdType="pii">S0304-4165(14)00261-X</ArticleId><ArticleId IdType="doi">10.1016/j.bbagen.2014.07.016</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">25083139</PMID><DateRevised><Year>2017</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-135X</ISSN><JournalIssue CitedMedium="Internet"><Volume>766-767</Volume><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Mutation research</Title><ISOAbbreviation>Mutat. Res.</ISOAbbreviation></Journal><ArticleTitle>Impact of abasic site orientation within nucleosomes on human APE1 endonuclease activity.</ArticleTitle><Pagination><MedlinePgn>19-24</MedlinePgn></Pagination><Abstract><AbstractText>Glycosylases responsible for recognizing DNA lesions and initiating Base Excision Repair (BER) are impeded by the presence of histones, which are essential for compaction of the genetic material in the nucleus. Abasic sites are an abundant mutagenic lesion in the DNA, arising spontaneously and as the product of glycosylase activity, making it a common intermediate in BER. The apurinic/apyrimidinic endonuclease 1 (APE1) recognizes abasic sites and cleaves the DNA backbone adjacent to the lesion, creating the single-strand break essential for the subsequent steps of BER. In this study the endonuclease activity of human APE1 was measured on reconstituted nucleosome core particles (NCPs) with DNA containing enzymatically-created abasic sites (AP) or the abasic site analog tetrahydrofuran (TF) at different rotational positions relative to the histone core surface. The presence of histones on the DNA reduced APE1 activity overall, and the magnitude was greatly influenced by differences in orientation of the lesions along the DNA gyre relative to the histone core. Abasic moieties oriented with their phosphate backbones adjacent to the underlying histones (In) were cleaved less efficiently than those oriented away from the histone core (Out) or between the In and Out orientations (Mid). The impact on APE1 at each orientation was very similar between the AP and TF lesions, highlighting the dependability of the TF abasic analog in APE1 activity measurements in nucleosomes. Measurement of APE1 binding to the NCP substrates reveals a substantial reduction in its interaction with nucleosomes compared to naked DNA, also in a lesion orientation-dependent manner, reinforcing the concept that reduction in APE1 activity on nucleosomes is due to occlusion from its abasic DNA substrate by the histones. These results suggest that APE1 activity in nucleosomes, like BER glycosylases, is primarily regulated by its chance interactions with transiently exposed lesions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hinz</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>School of Molecular Biosciences, Washington State University, Pullman, WA 99164-7520.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 ES004106</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 ES020955</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mutat Res</MedlineTA><NlmUniqueID>0400763</NlmUniqueID><ISSNLinking>0027-5107</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1987 Jul 25;262(21):10171-9</RefSource><PMID Version="1">2440861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2007 Aug 17;371(3):649-68</RefSource><PMID Version="1">17586522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1999 Jul 20;38(29):9485-94</RefSource><PMID Version="1">10413526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Rev Biochem Mol Biol. 2008 Jul-Aug;43(4):239-76</RefSource><PMID Version="1">18756381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2007 Dec;27(24):8442-53</RefSource><PMID Version="1">17923696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2009 Mar;66(6):981-93</RefSource><PMID Version="1">19153658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2013 Feb;228(2):258-66</RefSource><PMID Version="1">22718094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 May 10;288(19):13863-75</RefSource><PMID Version="1">23543741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2010 Feb 4;9(2):134-43</RefSource><PMID Version="1">20005182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Basic Life Sci. 1986;38:341-7</RefSource><PMID Version="1">3741336</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Symp Quant Biol. 2000;65:127-33</RefSource><PMID Version="1">12760027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Jul;22(7):987-98</RefSource><PMID Version="1">11408341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Dec 2;280(48):40051-7</RefSource><PMID Version="1">16210312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Enzymol Relat Areas Mol Biol. 1987;60:1-34</RefSource><PMID Version="1">2444076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1989 Oct;86(19):7418-22</RefSource><PMID Version="1">2798415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2002;71:17-50</RefSource><PMID Version="1">12045089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2008 May 23;379(1):17-27</RefSource><PMID Version="1">18439621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 2002;71:133-63</RefSource><PMID Version="1">12045093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Jan 22;285(4):2876-85</RefSource><PMID Version="1">19933279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1996 Nov 7;384(6604):87-92</RefSource><PMID Version="1">8900285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1998 Feb 13;276(1):19-42</RefSource><PMID Version="1">9514715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2002 Nov 1;21(21):5943-52</RefSource><PMID Version="1">12411511</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4646-51</RefSource><PMID Version="1">20176960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7465-70</RefSource><PMID Version="1">12799467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):27-47</RefSource><PMID Version="1">18166975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1995 Aug;15(8):4375-84</RefSource><PMID Version="1">7623832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(2):692-700</RefSource><PMID Version="1">21930508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Feb 3;4(2):203-9</RefSource><PMID Version="1">15590328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1980 Aug 25;8(16):3517-34</RefSource><PMID Version="1">7433098</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 1990 Nov 5;216(1):69-84</RefSource><PMID Version="1">2172553</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43</RefSource><PMID Version="1">15824325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 1991 Oct 15;30(41):9931-40</RefSource><PMID Version="1">1911785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Jul 1;18(13):3712-23</RefSource><PMID Version="1">10393186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2011 Nov;31(22):4623-32</RefSource><PMID Version="1">21930793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Apr 1;6(4):398-409</RefSource><PMID Version="1">17129767</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1 endonuclease</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">histone</Keyword><Keyword MajorTopicYN="N">nucleosome</Keyword><Keyword MajorTopicYN="N">tetrahydrofuran</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25083139</ArticleId><ArticleId IdType="doi">10.1016/j.mrfmmm.2014.05.008</ArticleId><ArticleId IdType="pmc">PMC4112536</ArticleId><ArticleId IdType="mid">NIHMS603296</ArticleId><ArticleId IdType="pii">S0027-5107(14)00103-1</ArticleId></ArticleIdList><?nihms?></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25048946</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1298</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Chemosphere</Title><ISOAbbreviation>Chemosphere</ISOAbbreviation></Journal><ArticleTitle>Processing of abasic site damaged lesions by APE1 enzyme on DNA adsorbed over normal and organomodified clay.</ArticleTitle><Pagination><MedlinePgn>503-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chemosphere.2014.05.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0045-6535(14)00646-8</ELocationID><Abstract><AbstractText>The efficiency of the apurinic/apyrimidinic endonuclease (APE1) DNA repair enzyme in the processing of abasic site DNA damage lesions at precise location in DNA oligomer duplexes that are adsorbed on clay surfaces was evaluated. Three different forms of clay namely montmorillonite, quaternary ammonium salt modified montmorillonite and its boiled counterpart i.e. partially devoid of organic moiety were used for a comparative study of adsorption, desorption and DNA repair efficiency on their surfaces. The interaction between the DNA and the clay was analysed by X-ray diffraction, Atomic force microscopy, UV-Vis spectroscopy and Infrared spectroscopy. The abasic site cleavage efficiency of APE1 enzyme was quantitatively evaluated by polyacrylamide gel electrophoresis. Apart from the difference in the DNA adsorption or desorption capacity of the various forms of clay, substantial variation in the repair efficiency of abasic sites initiated by the APE1 enzyme on the clay surfaces was observed. The incision efficiency of APE1 enzyme at abasic sites was found to be greatly diminished, when the DNA was adsorbed over organomodified montmorillonite. The reduced repair activity indicates an important role of the pendant surfactant groups on the clay surfaces in directing APE1 mediated cleavage of abasic site DNA damage lesions. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kumari</LastName><ForeName>Bhavini</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Shib Shankar</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Materials Science and Engineering, Indian Institute of Technology Patna, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Vandana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Prolay</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology Patna, Patna 800013, Bihar, India. Electronic address: prolay@iitp.ac.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhowmick</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Materials Science and Engineering, Indian Institute of Technology Patna, Patna 800013, Bihar, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Chemosphere</MedlineTA><NlmUniqueID>0320657</NlmUniqueID><ISSNLinking>0045-6535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000644">Quaternary Ammonium Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>1302-78-9</RegistryNumber><NameOfSubstance UI="D001546">Bentonite</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000327" MajorTopicYN="N">Adsorption</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001546" MajorTopicYN="N">Bentonite</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053837" MajorTopicYN="N">DNA Cleavage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016296" MajorTopicYN="N">Mutagenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="Y">Nucleic Acid Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000644" MajorTopicYN="N">Quaternary Ammonium Compounds</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013499" MajorTopicYN="N">Surface Properties</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014961" MajorTopicYN="N">X-Ray Diffraction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Abasic site</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">Montmorillonite</Keyword><Keyword MajorTopicYN="N">Organomodified montmorillonite</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>05</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25048946</ArticleId><ArticleId IdType="pii">S0045-6535(14)00646-8</ArticleId><ArticleId IdType="doi">10.1016/j.chemosphere.2014.05.022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25038572</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2014</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1568-7856</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><PubDate><Year>2014</Year><Month>Sep</Month></PubDate></JournalIssue><Title>DNA repair</Title><ISOAbbreviation>DNA Repair (Amst.)</ISOAbbreviation></Journal><ArticleTitle>The role of Asn-212 in the catalytic mechanism of human endonuclease APE1: stopped-flow kinetic study of incision activity on a natural AP site and a tetrahydrofuran analogue.</ArticleTitle><Pagination><MedlinePgn>43-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dnarep.2014.06.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-7864(14)00186-4</ELocationID><Abstract><AbstractText>Mammalian AP endonuclease 1 is a pivotal enzyme of the base excision repair pathway acting on apurinic/apyrimidinic sites. Previous structural and biochemical studies showed that the conserved Asn-212 residue is important for the enzymatic activity of APE1. Here, we report a comprehensive pre-steady-state kinetic analysis of two APE1 mutants, each containing amino acid substitutions at position 212, to ascertain the role of Asn-212 in individual steps of the APE1 catalytic mechanism. We applied the stopped-flow technique for detection of conformational transitions in the mutant proteins and DNA substrates during the catalytic cycle, using fluorophores that are sensitive to the micro-environment. Our data indicate that Asn-212 substitution by Asp reduces the rate of the incision step by ∼550-fold, while Ala substitution results in ∼70,000-fold decrease. Analysis of the binding steps revealed that both mutants continued to rapidly and efficiently bind to abasic DNA containing the natural AP site or its tetrahydrofuran analogue (F). Moreover, transient kinetic analysis showed that N212A APE1 possessed a higher binding rate and a higher affinity for specific substrates compared to N212D APE1. Molecular dynamics (MD) simulation revealed a significant dislocation of the key catalytic residues of both mutant proteins relative to wild-type APE1. The analysis of the model structure of N212D APE1 provides evidence for alternate hydrogen bonding between Asn-212 and Asp-210 residues, whereas N212A possesses an extended active site pocket due to Asn removal. Taken together, these biochemical and MD simulation results indicate that Asn-212 is essential for abasic DNA incision, but is not crucial for effective recognition/binding. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanazhevskaya</LastName><ForeName>Lyubov Yu</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology &amp; Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrentyev Ave., 8, Novosibirsk 630090, Russia; Novosibirsk State University, Pirogova St., 2, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koval</LastName><ForeName>Vladimir V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology &amp; Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrentyev Ave., 8, Novosibirsk 630090, Russia; Novosibirsk State University, Pirogova St., 2, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomzov</LastName><ForeName>Alexander A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology &amp; Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrentyev Ave., 8, Novosibirsk 630090, Russia; Novosibirsk State University, Pirogova St., 2, Novosibirsk 630090, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedorova</LastName><ForeName>Olga S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Institute of Chemical Biology &amp; Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrentyev Ave., 8, Novosibirsk 630090, Russia; Novosibirsk State University, Pirogova St., 2, Novosibirsk 630090, Russia. Electronic address: fedorova@niboch.nsc.ru.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>DNA Repair (Amst)</MedlineTA><NlmUniqueID>101139138</NlmUniqueID><ISSNLinking>1568-7856</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005663">Furans</NameOfSubstance></Chemical><Chemical><RegistryNumber>3N8FZZ6PY4</RegistryNumber><NameOfSubstance UI="C018674">tetrahydrofuran</NameOfSubstance></Chemical><Chemical><RegistryNumber>7006-34-0</RegistryNumber><NameOfSubstance UI="D001216">Asparagine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001216" MajorTopicYN="N">Asparagine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020134" MajorTopicYN="N">Catalytic Domain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005663" MajorTopicYN="N">Furans</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="Y">Molecular Dynamics Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2-Aminopurine</Keyword><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">Abasic site</Keyword><Keyword MajorTopicYN="N">Base excision repair</Keyword><Keyword MajorTopicYN="N">MD simulations</Keyword><Keyword MajorTopicYN="N">Pre-steady-state kinetics</Keyword><Keyword MajorTopicYN="N">Stopped-flow method</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25038572</ArticleId><ArticleId IdType="pii">S1568-7864(14)00186-4</ArticleId><ArticleId IdType="doi">10.1016/j.dnarep.2014.06.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25033834</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2092-6413</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><PubDate><Year>2014</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Experimental &amp; molecular medicine</Title><ISOAbbreviation>Exp. Mol. Med.</ISOAbbreviation></Journal><ArticleTitle>APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions.</ArticleTitle><Pagination><MedlinePgn>e106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/emm.2014.42</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional enzyme involved in the base excision repair (BER) pathway, which repairs oxidative base damage caused by endogenous and exogenous agents. APE1 acts as a reductive activator of many transcription factors (TFs) and has also been named redox effector factor 1, Ref-1. For example, APE1 activates activator protein-1, nuclear factor kappa B, hypoxia-inducible factor 1α, paired box gene 8, signal transducer activator of transcription 3 and p53, which are involved in apoptosis, inflammation, angiogenesis and survival pathways. APE1/Ref-1 maintains cellular homeostasis (redox) via the activation of TFs that regulate various physiological processes and that crosstalk with redox balancing agents (for example, thioredoxin, catalase and superoxide dismutase) by controlling levels of reactive oxygen and nitrogen species. The efficiency of APE1/Ref-1's function(s) depends on pairwise interaction with participant protein(s), the functions regulated by APE1/Ref-1 include the BER pathway, TFs, energy metabolism, cytoskeletal elements and stress-dependent responses. Thus, APE1/Ref-1 acts as a 'hub-protein' that controls pathways that are important for cell survival. In this review, we will discuss APE1/Ref-1's versatile nature in various human etiologies, including neurodegeneration, cancer, cardiovascular and other diseases that have been linked with alterations in the expression, subcellular localization and activities of APE/Ref-1. APE1/Ref-1 can be targeted for therapeutic intervention using natural plant products that modulate the expression and functions of APE1/Ref-1. In addition, studies focusing on translational applications based on APE1/Ref-1-mediated therapeutic interventions are discussed. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Shweta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Biosciences, School of Basic and Applied Sciences, Central University of Punjab, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarkar</LastName><ForeName>Bibekananda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Biosciences, School of Basic and Applied Sciences, Central University of Punjab, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholia</LastName><ForeName>Ravi P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Center for Biosciences, School of Basic and Applied Sciences, Central University of Punjab, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gautam</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Environmental Science and Technology, School of Environment and Earth Sciences, Central University of Punjab, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhiman</LastName><ForeName>Monisha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Genetic Diseases and Molecular Medicine, School of Emerging Life Science Technologies, Central University of Punjab, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantha</LastName><ForeName>Anil K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>1] Center for Biosciences, School of Basic and Applied Sciences, Central University of Punjab, Punjab, India [2] Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Mol Med</MedlineTA><NlmUniqueID>9607880</NlmUniqueID><ISSNLinking>1226-3613</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Food Chem Toxicol. 2009 Mar;47(3):625-32</RefSource><PMID Version="1">19146912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2010 Jun;12(6):563-71</RefSource><PMID Version="1">20473298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Open Neurosci J. 2009 Jan 1;3:26-34</RefSource><PMID Version="1">19898678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1853-67</RefSource><PMID Version="1">18627350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2004 Jul-Aug;24(4):2127-34</RefSource><PMID Version="1">15330152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2006 Oct 1;41(7):1113-23</RefSource><PMID Version="1">16962936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Dec;10(12):2023-33</RefSource><PMID Version="1">18759561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2013 Apr 30;52(17):2955-66</RefSource><PMID Version="1">23597102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2005 Dec;4(12):1923-35</RefSource><PMID Version="1">16373707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neoplasma. 2003;50(4):291-5</RefSource><PMID Version="1">12937843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2006 Jul;7(7):473-83</RefSource><PMID Version="1">16829979</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14548-53</RefSource><PMID Version="1">12357032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Aug 25;643(1-2):54-63</RefSource><PMID Version="1">18579163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2000 Dec 1;60(23):6688-95</RefSource><PMID Version="1">11118054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2003 Feb;24(2):155-7</RefSource><PMID Version="1">12584162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Nov 15;20(22):6530-9</RefSource><PMID Version="1">11707423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Hypertens. 2010 Feb;23(2):186-91</RefSource><PMID Version="1">20010699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2013 May;29(5):1983-90</RefSource><PMID Version="1">23483203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nutr Biochem. 2005 Nov;16(11):641-9</RefSource><PMID Version="1">16169201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22090-5</RefSource><PMID Version="1">21127267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2011 Jan;1215:22-33</RefSource><PMID Version="1">21261638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2000;926:64-78</RefSource><PMID Version="1">11193042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Biochem. 1994;63:915-48</RefSource><PMID Version="1">7979257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2012 Jun 1;16(11):1285-94</RefSource><PMID Version="1">22117613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2004 Mar;3(3):205-14</RefSource><PMID Version="1">15031734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vision Res. 2011 Jan;51(1):93-100</RefSource><PMID Version="1">20937296</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2010 Feb 16;102(4):704-9</RefSource><PMID Version="1">20087352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915-22</RefSource><PMID Version="1">8367443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2005;12(10):1161-208</RefSource><PMID Version="1">15892631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2004 Oct 29;95(9):902-10</RefSource><PMID Version="1">15472121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Pharmacol. 2008 Dec 28;601(1-3):50-60</RefSource><PMID Version="1">18996367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicology. 2013 Mar 8;305:120-9</RefSource><PMID Version="1">23370007</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2009 Jan;65 Suppl 1:S3-9</RefSource><PMID Version="1">19191304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2006 Feb 1;69(2):520-6</RefSource><PMID Version="1">16325162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Neurosci. 2013;14:26</RefSource><PMID Version="1">23497276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2002 Feb;21(2):71-5</RefSource><PMID Version="1">12102499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Sep 1;11(17):6205-11</RefSource><PMID Version="1">16144922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2011 Oct;39(18):8017-28</RefSource><PMID Version="1">21727086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2001 Nov-Dec;21(6A):4041-9</RefSource><PMID Version="1">11911289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Biochem. 1993 Jul 15;215(2):213-9</RefSource><PMID Version="1">7688300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Agents Med Chem. 2008 May;8(4):417-25</RefSource><PMID Version="1">18473726</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2011 Jan 27;30(4):482-93</RefSource><PMID Version="1">20856196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(10):3303-12</RefSource><PMID Version="1">15942031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):83-108</RefSource><PMID Version="1">11018583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2011 Jan 11;50(1):82-92</RefSource><PMID Version="1">21117647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1987 Jun 1;47(11):3012-31</RefSource><PMID Version="1">3105872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2010 Feb;24(2):391-401</RefSource><PMID Version="1">20032196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2003 Dec;10(23):2495-505</RefSource><PMID Version="1">14529465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2003 Jul;17(10):1195-214</RefSource><PMID Version="1">12832285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1997 Mar 1;11(5):558-70</RefSource><PMID Version="1">9119221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1997 Nov 3;16(21):6548-58</RefSource><PMID Version="1">9351835</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2009 Mar;5(3):e1000327</RefSource><PMID Version="1">19266025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 Sep 15;15(6):1655-67</RefSource><PMID Version="1">21194382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pak J Biol Sci. 2008 Apr 15;11(8):1114-9</RefSource><PMID Version="1">18819549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Mar 2;4(3):367-79</RefSource><PMID Version="1">15661660</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):23-7</RefSource><PMID Version="1">7506414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Apr;30(4):1359-64</RefSource><PMID Version="1">20530453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Jul-Aug;659(1-2):4-14</RefSource><PMID Version="1">18083609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1998 Nov;78(9):1128-33</RefSource><PMID Version="1">9820167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Lett. 2009 Dec 11;466(3):124-7</RefSource><PMID Version="1">19782121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2010 Sep 1;334(3):988-98</RefSource><PMID Version="1">20504914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jul 15;29(14):3116-22</RefSource><PMID Version="1">11452037</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2007 Oct 19;282(42):30577-85</RefSource><PMID Version="1">17724035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Aug;12(8):685-90</RefSource><PMID Version="1">23684797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2005 Apr 28;24(19):3110-20</RefSource><PMID Version="1">15735682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2011 Oct;22(20):3887-901</RefSource><PMID Version="1">21865600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Feb 1;65(3):1035-44</RefSource><PMID Version="1">15705905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2006 Jan;175(1):108-12; discussion 112</RefSource><PMID Version="1">16406883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2011 Nov;50(11):863-70</RefSource><PMID Version="1">21538578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 Aug;36(13):4327-36</RefSource><PMID Version="1">18586825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Planta Med. 1998 May;64(4):353-6</RefSource><PMID Version="1">9619120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7166-9</RefSource><PMID Version="1">9207062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 1991 Sep 30;91(3C):14S-22S</RefSource><PMID Version="1">1928205</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nutr. 2002 Jul;132(7):2076-81</RefSource><PMID Version="1">12097696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1989 Mar 24;243(4898):1576-83</RefSource><PMID Version="1">2538923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2013 Apr;17(4):307-13</RefSource><PMID Version="1">23368530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biother Radiopharm. 2013 Mar;28(2):169-76</RefSource><PMID Version="1">23268706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2011 Sep;10(9):1698-708</RefSource><PMID Version="1">21700832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2011 Aug 1;91(3):502-9</RefSource><PMID Version="1">21467074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):395-403</RefSource><PMID Version="1">16677086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2009 Jan;30(1):2-10</RefSource><PMID Version="1">18978338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2012 Oct;23(20):4079-96</RefSource><PMID Version="1">22918947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Dec 1;22(23):6299-309</RefSource><PMID Version="1">14633989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1999 Jun 10;52(9):1899-901</RefSource><PMID Version="1">10371543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Feb 18;280(7):5892-901</RefSource><PMID Version="1">15590663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2013 Apr;52:84-93</RefSource><PMID Version="1">23220414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biochem Mol Toxicol. 2012 Nov;26(11):477-85</RefSource><PMID Version="1">23132811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1997 Dec 15;57(24):5457-9</RefSource><PMID Version="1">9407949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pediatr Hematol Oncol. 2001 May;23(4):234-9</RefSource><PMID Version="1">11846302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2001 Jul-Aug;21(4B):2895-900</RefSource><PMID Version="1">11712783</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Dec;28(23):7066-80</RefSource><PMID Version="1">18809583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1991 Nov 11;19(21):5907-14</RefSource><PMID Version="1">1719484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Apr 11;283(15):9925-32</RefSource><PMID Version="1">18263880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2012 May;30(5):917-25</RefSource><PMID Version="1">22441348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Toxicol. 2010 Apr;30(3):254-9</RefSource><PMID Version="1">19847787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Oct 1;53(7):1478-88</RefSource><PMID Version="1">22709585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 1997 Jul 1;325 ( Pt 1):1-16</RefSource><PMID Version="1">9224623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1995 Jan 15;55(2):259-66</RefSource><PMID Version="1">7812955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbiol Rev. 1992 Mar;56(1):1-11</RefSource><PMID Version="1">1579104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5061-6</RefSource><PMID Version="1">9560228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fertil Steril. 2011 Nov;96(5):1252-8</RefSource><PMID Version="1">21907337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Nutr. 2001;21:381-406</RefSource><PMID Version="1">11375442</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Biochem Cell Biol. 2000 Sep;32(9):925-9</RefSource><PMID Version="1">11084372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2006 Jul;166(1 Pt 1):73-80</RefSource><PMID Version="1">16808622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroreport. 1997 Apr 14;8(6):1337-40</RefSource><PMID Version="1">9172131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Mar 1;67(5):2141-9</RefSource><PMID Version="1">17332344</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 17;51(2):695-705</RefSource><PMID Version="1">22148505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 1993 Sep;13(9):5370-6</RefSource><PMID Version="1">8355688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry (Mosc). 2011 Jan;76(1):147-56</RefSource><PMID Version="1">21568846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Mol Biol Int. 1998 Feb;44(2):217-24</RefSource><PMID Version="1">9530505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Top Med Chem. 2001 Dec;1(6):483-95</RefSource><PMID Version="1">11895125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2001 Nov 15;20(52):7597-609</RefSource><PMID Version="1">11753638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2002 Jul;9(7):717-25</RefSource><PMID Version="1">12058277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Aug;10(8):1343-74</RefSource><PMID Version="1">18522489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2002 Jun;16(8):889-90</RefSource><PMID Version="1">12039869</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):96-101</RefSource><PMID Version="1">15539619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phytochemistry. 2003 Jan;62(2):121-5</RefSource><PMID Version="1">12482446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci Res. 2012 Jun;90(6):1230-9</RefSource><PMID Version="1">22488727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2012 Jun;16(6):504-7</RefSource><PMID Version="1">22224629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2001 Mar-Apr;21(2A):873-8</RefSource><PMID Version="1">11396178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Physiol. 1997 Mar;82(2):291-5</RefSource><PMID Version="1">9129943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(8):2522-32</RefSource><PMID Version="1">17403694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2007 Aug;1768(8):1976-90</RefSource><PMID Version="1">17433250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1990 Sep-Nov;236(2-3):173-201</RefSource><PMID Version="1">1697933</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Jan;432(3-4):53-9</RefSource><PMID Version="1">11465542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2004 Oct 29;95(9):849-51</RefSource><PMID Version="1">15514165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thorac Oncol. 2011 Apr;6(4):688-98</RefSource><PMID Version="1">21325978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Nucleic Acid Res Mol Biol. 2001;68:57-74</RefSource><PMID Version="1">11554313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2001 Jan 12;104(1):107-17</RefSource><PMID Version="1">11163244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(8):2264-77</RefSource><PMID Version="1">19188437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2003 May;247(1-2):219-22</RefSource><PMID Version="1">12841651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1990 Sep 7;249(4973):1157-61</RefSource><PMID Version="1">2118682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroreport. 1998 Dec 21;9(18):4015-8</RefSource><PMID Version="1">9926839</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Nov 1;277(44):41715-24</RefSource><PMID Version="1">12200445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jul 16;17(2):173-8</RefSource><PMID Version="1">9674701</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nutr Cancer. 1999;34(2):160-6</RefSource><PMID Version="1">10578483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bioessays. 1995 Aug;17(8):713-9</RefSource><PMID Version="1">7661852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Nov;7(11):3510-8</RefSource><PMID Version="1">11705870</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(4):1222-9</RefSource><PMID Version="1">15731342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e55313</RefSource><PMID Version="1">23418439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2009 Apr 1;124(7):1675-84</RefSource><PMID Version="1">19101986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):651-68</RefSource><PMID Version="1">18715143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2009 Oct 21;28(20):3207-15</RefSource><PMID Version="1">19713937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2007 Jan-Feb;13(1-2):89-96</RefSource><PMID Version="1">17515960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Agric Food Chem. 2012 Sep 26;60(38):9603-8</RefSource><PMID Version="1">22957812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Aug 23;277(34):30417-20</RefSource><PMID Version="1">12097317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2003 Oct 15;552(Pt 2):335-44</RefSource><PMID Version="1">14561818</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3609-20</RefSource><PMID Version="1">20711647</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ScientificWorldJournal. 2011;11:1679-91</RefSource><PMID Version="1">22125427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Aging. 2003 Nov;24(7):953-68</RefSource><PMID Version="1">12928056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3204-9</RefSource><PMID Version="1">20133634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2005 Jan 3;565(2):105-12</RefSource><PMID Version="1">15661608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Oct 15;18(20):5609-21</RefSource><PMID Version="1">10523305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Biochem Biophys. 2011 Dec;61(3):561-72</RefSource><PMID Version="1">21769563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Apr;29(7):1834-54</RefSource><PMID Version="1">19188445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 1986;20:201-30</RefSource><PMID Version="1">3545059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):231-51</RefSource><PMID Version="1">14637258</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Sci. 2012;13(12):16929-44</RefSource><PMID Version="1">23443128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 2007;14(28):2968-75</RefSource><PMID Version="1">18220733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Mol Biol Transl Sci. 2012;110:123-53</RefSource><PMID Version="1">22749145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroscience. 1999;93(4):1465-73</RefSource><PMID Version="1">10501471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2008 May;60(2):277-84</RefSource><PMID Version="1">18061304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuromolecular Med. 2002;2(1):47-60</RefSource><PMID Version="1">12230304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 1998 Nov 9;252(1):178-83</RefSource><PMID Version="1">9813166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Dec;38(22):8239-56</RefSource><PMID Version="1">20699270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2001 Oct 23;40(42):12639-44</RefSource><PMID Version="1">11601988</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Structure. 1996 May 15;4(5):613-20</RefSource><PMID Version="1">8736558</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1999 Apr 1;18(7):1905-14</RefSource><PMID Version="1">10202154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2003 Jun;23(12):4257-66</RefSource><PMID Version="1">12773568</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2013 May 3;434(2):185-90</RefSource><PMID Version="1">23485469</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Res. 2008 Jan;18(1):27-47</RefSource><PMID Version="1">18166975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Sep;11(9):3323-35</RefSource><PMID Version="1">1380454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Life Sci. 2006 Oct 19;79(21):2056-68</RefSource><PMID Version="1">16857214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mitochondrion. 2014 May;16:38-49</RefSource><PMID Version="1">24220222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Nov 7;283(45):30632-41</RefSource><PMID Version="1">18776186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Apr 1;70(7):2799-808</RefSource><PMID Version="1">20332233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Exp Biol. 2011 Nov;49(11):848-56</RefSource><PMID Version="1">22126016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Res. 2005 Mar;39(3):269-81</RefSource><PMID Version="1">15788231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2003 Jan-Feb;23(1A):363-98</RefSource><PMID Version="1">12680238</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2010 Jan;30(2):366-71</RefSource><PMID Version="1">19901076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2001 May 10;166(1):65-9</RefSource><PMID Version="1">11295288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3633-8</RefSource><PMID Version="1">9108029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Feb 7;415(6872):655-9</RefSource><PMID Version="1">11832948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2005 Feb 24;24(9):1641-7</RefSource><PMID Version="1">15674341</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J R Soc Health. 1991 Oct;111(5):172-7</RefSource><PMID Version="1">1795351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Sep 10;285(37):28812-25</RefSource><PMID Version="1">20622253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Mar 23;276(12):9532-6</RefSource><PMID Version="1">11133992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Sep 3;285(36):28191-9</RefSource><PMID Version="1">20573957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2000 Aug;18(8):877-81</RefSource><PMID Version="1">10932159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Pathol. 2002 Nov-Dec;30(6):620-50</RefSource><PMID Version="1">12512863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 Mar;36(5):1555-66</RefSource><PMID Version="1">18208837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2138-43</RefSource><PMID Version="1">17488730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Mar 1;28(5):1099-105</RefSource><PMID Version="1">10666449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2010 Aug 3;49(30):6451-61</RefSource><PMID Version="1">20575528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharm Res. 2010 Jun;27(6):1115-27</RefSource><PMID Version="1">20309614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2000 Aug 11;275(32):24840-6</RefSource><PMID Version="1">10823822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2004 Apr 1;64(7):2350-6</RefSource><PMID Version="1">15059885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2012;22(6):537-42</RefSource><PMID Version="1">23038158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2001;38(2-3):180-90</RefSource><PMID Version="1">11746753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jul;37(12):3946-58</RefSource><PMID Version="1">19401441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Oct 1;31(19):5526-33</RefSource><PMID Version="1">14500814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2004 Jul 23;15(2):209-20</RefSource><PMID Version="1">15260972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2003 May;24(5):791-802</RefSource><PMID Version="1">12771022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2006 Dec 1;177(11):7990-9</RefSource><PMID Version="1">17114472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Structure. 1995 Mar 15;3(3):289-97</RefSource><PMID Version="1">7788295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2001 Nov 1;21(21):8370-7</RefSource><PMID Version="1">11606625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1049-54</RefSource><PMID Version="1">16445570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Diet Suppl. 2011 Jun;8(2):169-88</RefSource><PMID Version="1">22432688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2009 Jun;136(7):2258-69</RefSource><PMID Version="1">19505426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2012 Jan 3;125(1):188-97</RefSource><PMID Version="1">22215894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Learn Mem. 2003 Jan;79(1):11-8</RefSource><PMID Version="1">12482674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Oct 15;11(20):7405-14</RefSource><PMID Version="1">16243814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2005 Dec 2;123(5):773-86</RefSource><PMID Version="1">16325574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1999 Jan 28;18(4):1033-40</RefSource><PMID Version="1">10023679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(10):e25224</RefSource><PMID Version="1">22022384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2002 Sep;8(9):3008-18</RefSource><PMID Version="1">12231548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Mol Med. 2010 Sep;14(9):2235-9</RefSource><PMID Version="1">20716127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2009 Apr 2;28(13):1616-25</RefSource><PMID Version="1">19219073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):27-36</RefSource><PMID Version="1">11316543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2012 Apr;133(4):157-68</RefSource><PMID Version="1">22313689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Mar 1;109(5):1917-22</RefSource><PMID Version="1">17053053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1999 Sep 24;274(39):27891-7</RefSource><PMID Version="1">10488136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47462</RefSource><PMID Version="1">23094050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biosci Biotechnol Biochem. 2011;75(3):434-42</RefSource><PMID Version="1">21389625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Agric Food Chem. 2010 Jun 23;58(12):7465-71</RefSource><PMID Version="1">20486687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Biochem Biophys. 2004 Mar 1;423(1):12-22</RefSource><PMID Version="1">14989259</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Jan;40(1):171-6</RefSource><PMID Version="1">23143180</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058990" MajorTopicYN="Y">Molecular Targeted Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064209" MajorTopicYN="N">Phytochemicals</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25033834</ArticleId><ArticleId IdType="pii">emm201442</ArticleId><ArticleId IdType="doi">10.1038/emm.2014.42</ArticleId><ArticleId IdType="pmc">PMC4119211</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25029857</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1009-3591</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Zhonghua nan ke xue = National journal of andrology</Title><ISOAbbreviation>Zhonghua Nan Ke Xue</ISOAbbreviation></Journal><ArticleTitle>[Association of 8-hydroxyguanine glycosidase OGG1 Ser326Cys polymorphism with male infertility].</ArticleTitle><Pagination><MedlinePgn>518-22</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the association of 8-hydroxyguanine glycosidase OGG1 Ser326Cys polymorphism with semen quality and the risk of male infertility.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This case-control study included 620 idiopathic infertile patients and 385 normal fertile controls. We determined their genotypes by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and analyzed their semen quality by computer-aided semen analysis (CASA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The individuals with OGG1 326 Cys/Cys showed significantly lower sperm motility and concentration ([52.1 +/- 26.7]% and (3.75 +/- 0.91) x 10(6)/ml, ln transformed value) than the Ser/Ser carriers ([59.0 +/- 21.8] % and (4.12 +/- 0.88) x 10(6)/ml, ln transformed value) (P &lt; 0.05). The risk of male infertility increased 69% in the OGG1 326Cys allele carriers as compared with the Ser carriers (OR = 1.69, 95% CI: 1.24 -2.31).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">OGG1 326 Ser/Cys polymorphism might contribute to the risk of male infertility in the southern Chinese population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jian-Zhong</ForeName><Initials>JZ</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Sheng-Min</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Gui-Xiang</ForeName><Initials>GX</Initials></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Ai-Hua</ForeName><Initials>AH</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Nan Ke Xue</MedlineTA><NlmUniqueID>101093592</NlmUniqueID><ISSNLinking>1009-3591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007248" MajorTopicYN="N">Infertility, Male</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055101" MajorTopicYN="N">Semen Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25029857</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25024628</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2219-2840</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>26</Issue><PubDate><Year>2014</Year><Month>Jul</Month><Day>14</Day></PubDate></JournalIssue><Title>World journal of gastroenterology</Title><ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation></Journal><ArticleTitle>APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.</ArticleTitle><Pagination><MedlinePgn>8700-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v20.i26.8700</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To study the association between four base excision repair gene polymorphisms and colorectal cancer risk in a Chinese population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two hundred forty-seven colorectal cancer (CRC) patients and three hundred cancer-free controls were enrolled in this study. Four polymorphisms (OGG1 Ser326Cys, APE1 Asp148Glu, -141T/G in the promoter region, and XRCC1 Arg399Gln) in components of the base excision repair pathway were determined in patient blood samples using polymerase chain reaction with confronting two-pair primers. The baseline information included age, gender, family history of cancer, and three behavioral factors [smoking status, alcohol consumption, and body mass index (BMI)]. χ(2) tests were used to assess the Hardy-Weinberg equilibrium, the distributions of baseline characteristics, and the four gene polymorphisms between the cases and controls. Multivariate logistic regression analyses were conducted to analyze the correlations between the four polymorphisms and CRC risk, adjusted by the baseline characteristics. Likelihood ratio tests were performed to analyze the gene-behavior interactions of smoking status, alcohol consumption, and BMI on polymorphisms and CRC susceptibility.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The APE1 148 Glu/Glu genotype was significantly associated with an increased risk of colorectal cancer (OR = 2.411, 95%CI: 1.497-3.886, P &lt; 0.001 relative to Asp/Asp genotype). There were no associations between OGG1, XRCC1, or APE1 promoter polymorphisms and CRC risk. A multivariate analysis including three behavioral factors showed that the APE1 148 Glu/Glu genotype was associated with an increased risk for CRC among both smokers and non-smokers, non-drinkers and individuals with a BMI ≥ 25 kg/m(2) (ORs = 2.356, 3.299, 2.654, and 2.581, respectively). The XRCC1 399 Arg/Gln genotype was associated with a decreased risk of CRC among smokers and drinkers (OR = 0.289, 95%CI: 0.152-0.548, P &lt; 0.001, and OR = 0.327, 95%CI: 0.158-0.673, P &lt; 0.05, respectively). The APE1 promoter polymorphism -141 T/G genotype was associated with a reduced risk of colorectal cancer among subjects with a BMI &lt; 25 kg/m(2) (OR = 0.214, 95%CI: 0.069-0.660, P &lt; 0.05 relative to T/T genotype). There were significant gene-behavior interactions between smoking status and XRCC1 Arg399Gln, as well as BMI and APE1 -141T/G polymorphism (all P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">APE1 Asp148Glu is associated with increased CRC risk and smoking alters the association between XRCC1 Arg399Gln and CRC risk in the Chinese Han population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shi-Heng</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin-Ang</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cun</LastName><ForeName>Yan-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Yan-Li</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Shi-Heng Zhang, Lin-Ang Wang, Zheng Li, Yu Peng, Yan-Ping Cun, Nan Dai, Yi Cheng, He Xiao, Yan-Li Xiong, Dong Wang, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Gastroenterol</MedlineTA><NlmUniqueID>100883448</NlmUniqueID><ISSNLinking>1007-9327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2010;16:991-6</RefSource><PMID Version="1">20577654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3384-8</RefSource><PMID Version="1">19959686</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2011 Jun 3;711(1-2):100-12</RefSource><PMID Version="1">21167187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2012 Jul;27(4):501-10</RefSource><PMID Version="1">22451681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011;11:104</RefSource><PMID Version="1">21429202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2010 May;101(5):1247-54</RefSource><PMID Version="1">20331623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2013 Feb;34(1):555-63</RefSource><PMID Version="1">23188703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol. 2011 Oct;35(5):e38-41</RefSource><PMID Version="1">21612998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Lett. 2013 Mar;5(3):959-963</RefSource><PMID Version="1">23426866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2009 Jan;30(1):2-10</RefSource><PMID Version="1">18978338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arh Hig Rada Toksikol. 2011 Sep;62(3):207-14</RefSource><PMID Version="1">21971103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Diagn. 2002 May;4(2):103-7</RefSource><PMID Version="1">11986401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2007 Jun-Aug;28(3-4):258-75</RefSource><PMID Version="1">17628657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Sep;25(9):1689-94</RefSource><PMID Version="1">15073047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Feb 1;638(1-2):146-53</RefSource><PMID Version="1">17991492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Jun;22(6):917-22</RefSource><PMID Version="1">11375899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Colorectal Dis. 2011 Dec;26(12):1525-30</RefSource><PMID Version="1">21695387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Cancer Res. 2000 Sep;91(9):865-8</RefSource><PMID Version="1">11011111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2012 Mar;27(2):219-23</RefSource><PMID Version="1">22294770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2012;13(2):665-9</RefSource><PMID Version="1">22524842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2012;22(1):64-71</RefSource><PMID Version="1">22186158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2011 Apr;42(3):226-34</RefSource><PMID Version="1">21722819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3167-73</RefSource><PMID Version="1">21037106</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Mol Biol Transl Sci. 2012;110:123-53</RefSource><PMID Version="1">22749145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2002;39(2-3):208-15</RefSource><PMID Version="1">11921191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2010 Dec 15;127(12):2893-917</RefSource><PMID Version="1">21351269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2012 Oct;31(10):981-1005</RefSource><PMID Version="1">23023028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8</RefSource><PMID Version="1">16609022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2010 Sep;25(5):463-71</RefSource><PMID Version="1">20534734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2008;27:49</RefSource><PMID Version="1">18823566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2009 Oct;23(10):3459-69</RefSource><PMID Version="1">19541747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90</RefSource><PMID Version="1">21296855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2012 Oct 3;104(19):1433-57</RefSource><PMID Version="1">23019048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2001 Aug;3(4):671-83</RefSource><PMID Version="1">11554453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lab. 2013;59(1-2):163-8</RefSource><PMID Version="1">23505922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2005 Nov 8;229(1):85-91</RefSource><PMID Version="1">15946795</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Genet. 2010;51(3):343-52</RefSource><PMID Version="1">20720310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3589-608</RefSource><PMID Version="1">20706766</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000428" MajorTopicYN="N">Alcohol Drinking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="N">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apurinic endonuclease 1</Keyword><Keyword MajorTopicYN="N">Base excision repair</Keyword><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Single nucleotide polymorphisms</Keyword><Keyword MajorTopicYN="N">X-ray repair cross-complementing groups</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25024628</ArticleId><ArticleId IdType="doi">10.3748/wjg.v20.i26.8700</ArticleId><ArticleId IdType="pmc">PMC4093723</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25023401</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0380</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</Title><ISOAbbreviation>Tumour Biol.</ISOAbbreviation></Journal><ArticleTitle>Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis.</ArticleTitle><Pagination><MedlinePgn>10111-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13277-014-2115-6</ELocationID><Abstract><AbstractText>APE1 T1349G polymorphism was considered to be associated with risk of cancer, but studies on the association between APE1 T1349G polymorphism and risk of prostate cancer remained inconclusive. A meta-analysis of published studies was performed to precisely assess the association between APE1 Asp148Glu polymorphism and prostate cancer risk. PubMed, Embase, and Wanfang databases were searched for published case-control studies investigating the association between APE1 T1349G polymorphism and prostate cancer risk. Odds ratios (ORs) and 95 % confidence intervals (95 % CIs) were used to assess the strength of the association. Overall, seven studies with a total of 3,063 individuals were finally included into the meta-analysis. The heterogeneity analysis did not find obvious heterogeneity among those included studies. Meta-analysis of total seven studies did not find an obvious association between APE1 T1349G polymorphism and prostate cancer risk (G vs T OR (95 % CI) = 1.11 (0.99-1.24); GG vs TT OR (95 % CI) = 1.25 (0.96-1.62); TG vs TT OR (95 % CI) = 1.11 (0.95-1.30); GG/TG vs T OR (95 % CI) = 1.13 (0.97-1.32); GG vs TT/TG OR (95 % CI) = 1.16 (0.91-1.48)). Subgroup analyses by ethnicity showed that APE1 T1349G polymorphism was associated with increased risk of prostate cancer in Caucasians (G vs T OR (95 % CI) = 1.26 (1.02-1.56), P = 0.033; TG vs TT OR (95 % CI) = 1.44 (1.06-1.94), P = 0.019; GG/TG vs T OR (95 % CI) = 1.45 (1.08-1.94), P = 0.013). The meta-analysis suggests that APE1 T1349G polymorphism is associated with increased risk of prostate cancer, especially in Caucasians. More studies are needed to further identify the obvious association above.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Urinary Surgery, General Hospital of Shenyang Military Region, Shenyang, 110840, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Geng</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Huai</LastName><ForeName>Yong-Jun</ForeName><Initials>YJ</Initials></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Zhi-Qiang</ForeName><Initials>ZQ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016441">Retracted Publication</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Tumour Biol</MedlineTA><NlmUniqueID>8409922</NlmUniqueID><ISSNLinking>1010-4283</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="RetractionIn"><RefSource>Tumour Biol. 2017 Apr 20;:</RefSource><PMID Version="1">28792236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2012;135:64-71</RefSource><PMID Version="1">22382185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Mar 15;366(11):981-90</RefSource><PMID Version="1">22417251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jun 21;8(6):e66999</RefSource><PMID Version="1">23805288</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2010 Feb;21(2):289-300</RefSource><PMID Version="1">19902366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2008 May 17;371(9625):1710-21</RefSource><PMID Version="1">18486743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2006 Jan;175(1):108-12; discussion 112</RefSource><PMID Version="1">16406883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource><PMID Version="1">3802833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Mar;38(3):1585-91</RefSource><PMID Version="1">20852942</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prostate. 2010 Feb 1;70(2):113-9</RefSource><PMID Version="1">19760636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Jan 15;161(2):147-52</RefSource><PMID Version="1">15632264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2003 Sep 6;327(7414):557-60</RefSource><PMID Version="1">12958120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Nov 15;162(10):925-42</RefSource><PMID Version="1">16221808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2009;471:305-33</RefSource><PMID Version="1">19109787</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2009 Nov;24(6):507-12</RefSource><PMID Version="1">19762350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2006 Dec 9;5(12 ):1439-48</RefSource><PMID Version="1">16982218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 Mar;27(3):560-7</RefSource><PMID Version="1">16195237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1959 Apr;22(4):719-48</RefSource><PMID Version="1">13655060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jul;35(7):6665-71</RefSource><PMID Version="1">24705777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jul 04;8(7):e68634</RefSource><PMID Version="1">23861929</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2012 Oct;31(10):981-1005</RefSource><PMID Version="1">23023028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2012 Jul;33(7):1259-69</RefSource><PMID Version="1">22523086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1997 Sep 13;315(7109):629-34</RefSource><PMID Version="1">9310563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011 Dec 18;11:521</RefSource><PMID Version="1">22176746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2010 Jul 1;10(1):13-8</RefSource><PMID Version="1">20495366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lab. 2013;59(1-2):163-8</RefSource><PMID Version="1">23505922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genet Test Mol Biomarkers. 2013 Dec;17(12):926-31</RefSource><PMID Version="1">24093803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2012 Apr;133(4):127-32</RefSource><PMID Version="1">22019847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2013 Jan;40(1):171-6</RefSource><PMID Version="1">23143180</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25023401</ArticleId><ArticleId IdType="doi">10.1007/s13277-014-2115-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24976129</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2014</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3336</ISSN><JournalIssue CitedMedium="Internet"><Volume>278</Volume><PubDate><Year>2014</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of hazardous materials</Title><ISOAbbreviation>J. Hazard. Mater.</ISOAbbreviation></Journal><ArticleTitle>Effects of CEES and LPS synergistically stimulate oxidative stress inactivates OGG1 signaling in macrophage cells.</ArticleTitle><Pagination><MedlinePgn>236-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhazmat.2014.05.096</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0304-3894(14)00451-8</ELocationID><Abstract><AbstractText>2-chloroethyl ethyl sulphide (CEES), a monofunctional analogue of sulfur mustard, is a strong vesicant and an alkylating chemical warfare agent. We studied the molecular mechanism of oxidative stress triggered signaling cascades in murine macrophages exposed to CEES with lipopolysaccharide (LPS). Exposure of CEES with specific dose of LPS stimulates oxidative stress caused increasing level of intracellular ROS and RNS, decreased antioxidant enzymes, increasing bimolecular damage, reduced cell viability, and cell cycle arrest. Synergistic exposure of CEES and LPS provoked significant increase in phosphorylation of MAPKs, Akt, tuberin, that down regulate OGG1 expression and 8-OHdG accumulations. Treatment with Akt and ERK1/2 inhibitors, the cells with constitutively active inhibiting activity of Akt and ERK1/2MAPK significant reduce CEES and LPS challenge tuberin but not the OGG1. In addition, the N-acetylcysteine inhibited ROS/RNS generation, elevation of antioxidants level, expression of ERK1/2, Akt, tuberin phosphorylation, resulted in deceased 8-OHdG accumulation and upregulation of OGG1 protein expression suggesting no involvement of Akt and ERK1/2MAPK pathways after CEES and LPS challenge. Collectively, our results indicate that exposure of CEES and LPS induces oxidative stress and the activation of tuberin, and 8-OHdG accumulation via upstream signaling pathways including Akt and ERK1/2MAPK pathway in macrophages but not the down regulation of OGG1. </AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sagar</LastName><ForeName>Satish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Biotechnology, KIIT University, Campus 11, Bhubaneswar 751024, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Premranjan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Biotechnology, KIIT University, Campus 11, Bhubaneswar 751024, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behera</LastName><ForeName>Reena Rani</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>School of Biotechnology, KIIT University, Campus 11, Bhubaneswar 751024, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Arttatrana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Biotechnology, KIIT University, Campus 11, Bhubaneswar 751024, India. Electronic address: arttatrana@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Hazard Mater</MedlineTA><NlmUniqueID>9422688</NlmUniqueID><ISSNLinking>0304-3894</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002619">Chemical Warfare Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026361">Reactive Nitrogen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>4JG2LF96VF</RegistryNumber><NameOfSubstance UI="C090570">tuberous sclerosis complex 2 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>693-07-2</RegistryNumber><NameOfSubstance UI="C031278">2-chloroethyl ethyl sulfide</NameOfSubstance></Chemical><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.6</RegistryNumber><NameOfSubstance UI="D002374">Catalase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C485990">Ogg1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>T8KEC9FH9P</RegistryNumber><NameOfSubstance UI="D009151">Mustard Gas</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002374" MajorTopicYN="N">Catalase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002619" MajorTopicYN="N">Chemical Warfare Agents</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009151" MajorTopicYN="N">Mustard Gas</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026361" MajorTopicYN="N">Reactive Nitrogen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025521" MajorTopicYN="N">Tumor Suppressor Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">8-OHdG</Keyword><Keyword MajorTopicYN="N">CEES</Keyword><Keyword MajorTopicYN="N">LPS</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Signaling</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>05</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24976129</ArticleId><ArticleId IdType="pii">S0304-3894(14)00451-8</ArticleId><ArticleId IdType="doi">10.1016/j.jhazmat.2014.05.096</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24970265</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1552-5783</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jun</Month><Day>26</Day></PubDate></JournalIssue><Title>Investigative ophthalmology &amp; visual science</Title><ISOAbbreviation>Invest. Ophthalmol. Vis. Sci.</ISOAbbreviation></Journal><ArticleTitle>Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.</ArticleTitle><Pagination><MedlinePgn>4461-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1167/iovs.14-14451</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The redox function of APE1/Ref-1 is a key regulator in pathological angiogenesis, such as retinal neovascularization and tumor growth. In this study, we examined whether inhibition of APE1/Ref-1 redox function by a small molecule inhibitor E3330 suppresses experimental choroidal neovascularization (CNV) in vitro and in vivo.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Primate choroid endothelial cells (CECs) received treatment of 0 to 100 μM E3330 alone or cotreatment of E3330 and 500 μg/mL anti-VEGF antibody bevacizumab. Choroid endothelial cell angiogenic function was examined by cell proliferation, migration, and tube formation assays. The effects of E3330 on NF-κB and STAT3 signaling pathways were determined by reporter gene assay, Western blot, and ELISA. Laser-induced CNV mouse model was used to test the effects of E3330 in vivo. Potential toxicity of E3330 was evaluated by TUNEL assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The E3330 of 25 to 100 μM dose-dependently suppressed CEC proliferation, migration, and tube formation, in the absence of noticeable cell toxicity. Lower doses of E3330 (10-20 μM) reduced the transcriptional activity of NF-κB and STAT3 without affecting protein phosphorylation of both molecules. At the same time, E3330 downregulated MCP-1 production in CECs. The antiangiogenic effect of E3330 was comparable and additive to bevacizumab. The E3330 effectively attenuated the progression of laser-induced CNV in mice after a single intravitreal injection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The APE1/Ref-1 redox function regulates multiple transcription factors and inflammatory molecules, and is essential for CEC angiogenesis. Specific inhibition of APE1/Ref-1 redox function with E3330 may represent a promising novel treatment for wet AMD.</AbstractText><CopyrightInformation>Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States Department of Ophthalmology, Shaanxi Maternity and Child Healthcare Hospital, Xi'an, Shaanxi, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiuli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Tongrong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Xiaoxi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R41 EY019784</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA121168</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA167291</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Invest Ophthalmol Vis Sci</MedlineTA><NlmUniqueID>7703701</NlmUniqueID><ISSNLinking>0146-0404</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016227">Benzoquinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011422">Propionates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494087">Stat3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>136164-66-4</RegistryNumber><NameOfSubstance UI="C075569">E 3330</NameOfSubstance></Chemical><Chemical><RegistryNumber>2S9ZZM9Q9V</RegistryNumber><NameOfSubstance UI="D000068258">Bevacizumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1839-43</RefSource><PMID Version="1">17389519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Redox Biol. 2014;2:485-94</RefSource><PMID Version="1">24624338</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Res Rev. 2008 Mar;28(2):185-200</RefSource><PMID Version="1">17457812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2005 Jul 14;11:509-17</RefSource><PMID Version="1">16052166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Ophthalmol. 2006 Jan;141(1):149-56</RefSource><PMID Version="1">16386991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 Oct 5;355(14):1419-31</RefSource><PMID Version="1">17021318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 Oct 5;355(14):1432-44</RefSource><PMID Version="1">17021319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2000 Mar;7(3):272-81</RefSource><PMID Version="1">10745272</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2000 Aug;18(8):877-81</RefSource><PMID Version="1">10932159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):83-108</RefSource><PMID Version="1">11018583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):E83-8</RefSource><PMID Version="1">11073859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2002 Apr 21;8:119-26</RefSource><PMID Version="1">11979237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2004 Apr;5(4):261-70</RefSource><PMID Version="1">15071551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Ophthalmol. 2004 Apr;122(4):564-72</RefSource><PMID Version="1">15078675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2004 Oct 29;95(9):902-10</RefSource><PMID Version="1">15472121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1991 May 15;88(10):4328-32</RefSource><PMID Version="1">1903539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Sep;11(9):3323-35</RefSource><PMID Version="1">1380454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1992 Aug 11;20(15):3821-30</RefSource><PMID Version="1">1508666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):23-7</RefSource><PMID Version="1">7506414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1994 Feb 1;179(2):503-12</RefSource><PMID Version="1">7507507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1996 Dec 13;271(50):32253-9</RefSource><PMID Version="1">8943284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1997 Mar 1;11(5):558-70</RefSource><PMID Version="1">9119221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1997 Apr 21;137(2):481-92</RefSource><PMID Version="1">9128257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1998 Jan 15;160(2):810-9</RefSource><PMID Version="1">9551916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1999 Feb;40(2):477-86</RefSource><PMID Version="1">9950608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Res. 2007 Jan;5(1):61-70</RefSource><PMID Version="1">17259346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Mar 1;109(5):1917-22</RefSource><PMID Version="1">17053053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2008 Jul;7(7):2012-21</RefSource><PMID Version="1">18645011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 Aug;36(13):4327-36</RefSource><PMID Version="1">18586825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1853-67</RefSource><PMID Version="1">18627350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2009 Jan;116(1):57-65.e5</RefSource><PMID Version="1">19118696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Biol Ther. 2008 Dec;7(12):1994-2003</RefSource><PMID Version="1">18981713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2009 Feb;50(2):844-50</RefSource><PMID Version="1">18936153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2009 Apr;219(1):209-18</RefSource><PMID Version="1">19097035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2009 Sep;23(9):1346-59</RefSource><PMID Version="1">19460860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):621-38</RefSource><PMID Version="1">18715144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2010 Feb 11;53(3):1200-10</RefSource><PMID Version="1">20067291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Pharmacol. 2010 Mar;159(6):1294-303</RefSource><PMID Version="1">20136831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2010 May;51(5):2697-704</RefSource><PMID Version="1">20007826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2010;340:c2459</RefSource><PMID Version="1">20538634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mediators Inflamm. 2010;2010. pii: 546826. doi: 10.1155/2010/546826</RefSource><PMID Version="1">20871825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Oct 15;70(20):8222-32</RefSource><PMID Version="1">20807804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):775-87</RefSource><PMID Version="1">20493977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neuroinflammation. 2010;7:87</RefSource><PMID Version="1">21126357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vision Res. 2011 Jan;51(1):93-100</RefSource><PMID Version="1">20937296</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Ophthalmol. 2011 May;22(3):199-204</RefSource><PMID Version="1">21427571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2011 May;52(6):3193-9</RefSource><PMID Version="1">21296829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 May 19;364(20):1897-908</RefSource><PMID Version="1">21526923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2012 Jan;227(1):116-26</RefSource><PMID Version="1">21374591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Ophthalmol. 2011 Dec;95(12):1631-7</RefSource><PMID Version="1">21546514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2012 Apr 6;287(15):12331-42</RefSource><PMID Version="1">22337883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2012 May 15;125(Pt 10):2407-15</RefSource><PMID Version="1">22357958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47462</RefSource><PMID Version="1">23094050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2008 Jan;49(1):407-15</RefSource><PMID Version="1">18172119</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016227" MajorTopicYN="N">Benzoquinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068258" MajorTopicYN="N">Bevacizumab</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002829" MajorTopicYN="N">Choroid</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020256" MajorTopicYN="N">Choroidal Neovascularization</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020287" MajorTopicYN="N">In Situ Nick-End Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058449" MajorTopicYN="N">Intravitreal Injections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011422" MajorTopicYN="N">Propionates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="N">STAT3 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1/Ref-1</Keyword><Keyword MajorTopicYN="N">antiangiogenesis</Keyword><Keyword MajorTopicYN="N">choroidal neovascularization</Keyword><Keyword MajorTopicYN="N">redox function</Keyword><Keyword MajorTopicYN="N">transcription factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24970265</ArticleId><ArticleId IdType="pii">iovs.14-14451</ArticleId><ArticleId IdType="doi">10.1167/iovs.14-14451</ArticleId><ArticleId IdType="pmc">PMC4106251</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">24944672</PMID><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1792-1074</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Oncology letters</Title><ISOAbbreviation>Oncol Lett</ISOAbbreviation></Journal><ArticleTitle>Aberrant expression of redox protein Ape1 in colon cancer stem cells.</ArticleTitle><Pagination><MedlinePgn>1078-1082</MedlinePgn></Pagination><Abstract><AbstractText>Ape1 is an important redox protein, essential for specific cytokine-induced signal transduction. Ape1 signaling is also important in regulating the growth of cancer cells, including colon cancer cells. The present study investigated whether Ape1 signaling plays a role in the regulation of colon cancer stem cell (CCSC) growth. The results showed that Ape1 was aberrantly expressed in CCSCs, as determined by quantitative (q)PCR assay. A laser confocal microscopy assay demonstrated that the Ape1 protein was mainly distributed in the nuclei, but not the cytoplasm, of the CSCs. Treatment of CCSCs with Ape1 redox inhibitor (E3330) significantly affected growth <i>in vitro</i>. In colon cancer xenograft mice, <i>in vivo</i> administration of E3330 enhanced tumor responses to the chemotherapeutic drug, 5-fluorouracil (5-FU). Furthermore, the combination of E3330 and 5-FU evidently increased the cytotoxicity of 5-FU in CSC growth. In the qPCR assay, the CCSCs were demonstrated to express the dominant ATP-binding cassette sub-family G member 2 (ABC-G2), but not the multidrug resistance 1, genes. Thus, we hypothesized that drug resistance in CCSCs is mediated by ABC-G2. Since CSCs are involved in cancer metastasis, the Ape1 inhibitor may be a potential agent in the inhibition of colon cancer growth and metastasis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lou</LastName><ForeName>Debao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Shanghai Eighth People's Hospital, Shanghai 200235, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Huawei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai 200240, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Hai-Yan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai 200240, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Gang-Ming</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai 200240, P.R. China ; Shanghai Institute for Pediatrics Research, Xin Hua Hospital, Shanghai Jiao Tong University Shanghai of Medicine, Shanghai 200092, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Oncol Lett</MedlineTA><NlmUniqueID>101531236</NlmUniqueID><ISSNLinking>1792-1074</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2013 Feb;31(2):97-102</RefSource><PMID Version="1">23245395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wien Med Wochenschr. 1988 Jun 30;138(11-12):288-92</RefSource><PMID Version="1">3051690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Sep 1;11(17):6205-11</RefSource><PMID Version="1">16144922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2001 Nov-Dec;21(6A):4041-9</RefSource><PMID Version="1">11911289</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2011 Jan 27;30(4):482-93</RefSource><PMID Version="1">20856196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2005 Apr;5(4):275-84</RefSource><PMID Version="1">15803154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2002 Jan 15;99(2):507-12</RefSource><PMID Version="1">11781231</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Histochem. 2012 Oct;114(6):594-602</RefSource><PMID Version="1">22154301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2011 Feb 18;286(7):4968-77</RefSource><PMID Version="1">21081487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2006 May;8(5):501-8</RefSource><PMID Version="1">16604061</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Growth Differ. 1994 Feb;5(2):125-31</RefSource><PMID Version="1">8180125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2010 Jun 4;6(6):603-15</RefSource><PMID Version="1">20569697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2008 Jul;7(7):2012-21</RefSource><PMID Version="1">18645011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Immunol. 2008 Aug;45(14):3731-9</RefSource><PMID Version="1">18617267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2009 Apr;219(1):209-18</RefSource><PMID Version="1">19097035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96</RefSource><PMID Version="1">18287387</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2012 Apr 13;420(3):628-34</RefSource><PMID Version="1">22450323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2011 Jan;140(1):297-309</RefSource><PMID Version="1">20951698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Mar 1;109(5):1917-22</RefSource><PMID Version="1">17053053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Pharmacol. 2010 Aug;10(4):362-8</RefSource><PMID Version="1">20627682</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-fluorouracil</Keyword><Keyword MajorTopicYN="N">ABC-G2</Keyword><Keyword MajorTopicYN="N">E3330</Keyword><Keyword MajorTopicYN="N">MDR1</Keyword><Keyword MajorTopicYN="N">Ref-1</Keyword><Keyword MajorTopicYN="N">colon cancer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>03</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24944672</ArticleId><ArticleId IdType="doi">10.3892/ol.2014.1864</ArticleId><ArticleId IdType="pii">ol-07-04-1078</ArticleId><ArticleId IdType="pmc">PMC3961307</ArticleId></ArticleIdList><?pmcsd?></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24935623</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-131X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Medical oncology (Northwood, London, England)</Title><ISOAbbreviation>Med. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Association between OGG1 gene single nucleotide polymorphisms and risk of pancreatic cancer in Chinese.</ArticleTitle><Pagination><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12032-014-0040-6</ELocationID><Abstract><AbstractText>Previous studies have suggested that the 8-oxoguanine DNA glycosylase gene (OGG1) has potentially influenced the risk of pancreatic cancer. The objective of this study was to assess the association between single nucleotide polymorphisms (SNPs) of OGG1 gene and risk of pancreatic cancer. A case-control study has been conducted in 370 pancreatic cancer patients and 395 healthy controls. Genotypes were determined using the polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing methods. The association analysis was evaluated by the unconditional logistic regression test. Our data suggested that the distributions of alleles and genotypes were statistically different between pancreatic cancer patients and healthy controls. The c.307G&gt;C SNP was associated with the decreased risk of pancreatic cancer (C vs. G: OR 0.73, 95 % CI 0.59-0.91, P = 0.006). As for c.828A&gt;G SNP, the significantly decreased risk of pancreatic cancer was detected (G vs. A: OR 0.74, 95 % CI 0.59-0.92, P = 0.006). The allele C of c.307G&gt;C and allele G of c.828A&gt;G SNPs might be associated with a protection from pancreatic cancer. Findings from this study indicate that OGG1 SNPs are associated with pancreatic cancer risk in Chinese Han population and could be useful molecular biomarkers for assessing the risk of pancreatic cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chengli</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary Surgery, The Air Force General Hospital of People's Liberation Army, No. 30 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China, chengli_liu@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cheng</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Yalin</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongyi</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Oncol</MedlineTA><NlmUniqueID>9435512</NlmUniqueID><ISSNLinking>1357-0560</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2011 Feb 15;117(4):744-51</RefSource><PMID Version="1">20922799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2008 Jun 15;68(12):4928-35</RefSource><PMID Version="1">18544627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1470-9</RefSource><PMID Version="1">18559563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pancreatology. 2003;3(1):1-7</RefSource><PMID Version="1">12683400</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2013 Dec;34(6):3417-21</RefSource><PMID Version="1">23807675</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 May 1;120(9):1993-8</RefSource><PMID Version="1">17266034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2001;2(4):271-280</RefSource><PMID Version="1">12718618</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Mar;35(3):2397-402</RefSource><PMID Version="1">24186001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JOP. 2010 May 05;11(3):203-12</RefSource><PMID Version="1">20442513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Causes Control. 2007 Aug;18(6):603-12</RefSource><PMID Version="1">17401636</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Jan;35(1):809-13</RefSource><PMID Version="1">23999824</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):197-209</RefSource><PMID Version="1">16549324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Epidemiol. 2012;22(6):477-83</RefSource><PMID Version="1">22850545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2009 Mar-Jun;681(2-3):299-307</RefSource><PMID Version="1">19150414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genomics Hum Genet. 2003;4:237-56</RefSource><PMID Version="1">14527303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mol Epidemiol Genet. 2011 Aug 30;2(3):236-44</RefSource><PMID Version="1">21915362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dig Dis. 2011;29(2):235-42</RefSource><PMID Version="1">21734390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2009 Jan 15;15(2):740-6</RefSource><PMID Version="1">19147782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Apr 15;120(8):1748-54</RefSource><PMID Version="1">17230526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Apr 10;24(11):1720-8</RefSource><PMID Version="1">16520463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Drug Targets. 2012 Jun;13(6):731-43</RefSource><PMID Version="1">22458519</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66</RefSource><PMID Version="1">17237035</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>04</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24935623</ArticleId><ArticleId IdType="doi">10.1007/s12032-014-0040-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24934622</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-313X</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Plant journal : for cell and molecular biology</Title><ISOAbbreviation>Plant J.</ISOAbbreviation></Journal><ArticleTitle>Arabidopsis ZDP DNA 3'-phosphatase and ARP endonuclease function in 8-oxoG repair initiated by FPG and OGG1 DNA glycosylases.</ArticleTitle><Pagination><MedlinePgn>824-34</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/tpj.12588</ELocationID><Abstract><AbstractText>Oxidation of guanine in DNA generates 7,8-dihydro-8-oxoguanine (8-oxoG), an ubiquitous lesion with mutagenic properties. 8-oxoG is primarily removed by DNA glycosylases distributed in two families, typified by bacterial Fpg proteins and eukaryotic Ogg1 proteins. Interestingly, plants possess both Fpg and Ogg1 homologs but their relative contributions to 8-oxoG repair remain uncertain. In this work we used Arabidopsis cell-free extracts to monitor 8-oxoG repair in wild-type and mutant plants. We found that both FPG and OGG1 catalyze excision of 8-oxoG in Arabidopsis cell extracts by a DNA glycosylase/lyase mechanism, and generate repair intermediates with blocked 3'-termini. An increase in oxidative damage is detected in both nuclear and mitochondrial DNA from double fpg ogg1 mutants, but not in single mutants, which suggests that a single deficiency in one of these DNA glycosylases may be compensated by the other. We also found that the DNA 3'-phosphatase ZDP (zinc finger DNA 3'-phosphoesterase) and the AP(apurinic/apyirmidinic) endonuclease ARP(apurinic endonuclease redox protein) are required in the 8-oxoG repair pathway to process the 3'-blocking ends generated by FPG and OGG1. Furthermore, deficiencies in ZDP and/or ARP decrease germination ability after seed deteriorating conditions. Altogether, our results suggest that Arabidopsis cells use both FPG and OGG1 to repair 8-oxoG in a pathway that requires ZDP and ARP in downstream steps. </AbstractText><CopyrightInformation>© 2014 The Authors The Plant Journal © 2014 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Córdoba-Cañero</LastName><ForeName>Dolores</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Genetics, University of Córdoba/Maimónides Institute for Research in Biomedicine of Córdoba (IMIBIC)/Reina Sofía University Hospital, 14071, Córdoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roldán-Arjona</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Ariza</LastName><ForeName>Rafael R</ForeName><Initials>RR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Plant J</MedlineTA><NlmUniqueID>9207397</NlmUniqueID><ISSNLinking>0960-7412</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C453560">7,8-dihydro-8-oxoguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029681">Arabidopsis Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>5614-64-2</RegistryNumber><NameOfSubstance UI="C024829">8-hydroxyguanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Z93L87A1R</RegistryNumber><NameOfSubstance UI="D006147">Guanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="C540283">Arp protein, Arabidopsis</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004720">Endonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.-</RegistryNumber><NameOfSubstance UI="D009708">Nucleotidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.34</RegistryNumber><NameOfSubstance UI="C039170">deoxynucleotide 3'-phosphatase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C500428">OGG1 protein, Arabidopsis</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017360" MajorTopicYN="N">Arabidopsis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029681" MajorTopicYN="N">Arabidopsis Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004720" MajorTopicYN="N">Endonucleases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018525" MajorTopicYN="N">Germination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006147" MajorTopicYN="N">Guanine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016254" MajorTopicYN="N">Mutagenesis, Insertional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009708" MajorTopicYN="N">Nucleotidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012639" MajorTopicYN="N">Seeds</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AP endonuclease</Keyword><Keyword MajorTopicYN="N">Arabidopsis thaliana</Keyword><Keyword MajorTopicYN="N">DNA glycosylase</Keyword><Keyword MajorTopicYN="N">DNA phosphatase</Keyword><Keyword MajorTopicYN="N">base-excision repair</Keyword><Keyword MajorTopicYN="N">oxidative DNA damage</Keyword><Keyword MajorTopicYN="N">seed vigor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>05</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24934622</ArticleId><ArticleId IdType="doi">10.1111/tpj.12588</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24927551</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>25</Issue><PubDate><Year>2014</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation></Journal><ArticleTitle>Differential expression of APE1 and APE2 in germinal centers promotes error-prone repair and A:T mutations during somatic hypermutation.</ArticleTitle><Pagination><MedlinePgn>9217-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1405590111</ELocationID><Abstract><AbstractText>Somatic hypermutation (SHM) of antibody variable region genes is initiated in germinal center B cells during an immune response by activation-induced cytidine deaminase (AID), which converts cytosines to uracils. During accurate repair in nonmutating cells, uracil is excised by uracil DNA glycosylase (UNG), leaving abasic sites that are incised by AP endonuclease (APE) to create single-strand breaks, and the correct nucleotide is reinserted by DNA polymerase β. During SHM, for unknown reasons, repair is error prone. There are two APE homologs in mammals and, surprisingly, APE1, in contrast to its high expression in both resting and in vitro-activated splenic B cells, is expressed at very low levels in mouse germinal center B cells where SHM occurs, and APE1 haploinsufficiency has very little effect on SHM. In contrast, the less efficient homolog, APE2, is highly expressed and contributes not only to the frequency of mutations, but also to the generation of mutations at A:T base pair (bp), insertions, and deletions. In the absence of both UNG and APE2, mutations at A:T bp are dramatically reduced. Single-strand breaks generated by APE2 could provide entry points for exonuclease recruited by the mismatch repair proteins Msh2-Msh6, and the known association of APE2 with proliferating cell nuclear antigen could recruit translesion polymerases to create mutations at AID-induced lesions and also at A:T bp. Our data provide new insight into error-prone repair of AID-induced lesions, which we propose is facilitated by down-regulation of APE1 and up-regulation of APE2 expression in germinal center B cells. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stavnezer</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linehan</LastName><ForeName>Erin K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Mikayla R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habboub</LastName><ForeName>Ghaith</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ucher</LastName><ForeName>Anna J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadungure</LastName><ForeName>Tatenda</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuchimoto</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakabeppu</LastName><ForeName>Yusaku</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrader</LastName><ForeName>Carol E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Physiological Systems, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester, MA 01655; and carol.schrader@umassmed.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI023283</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI23283</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI065639</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI088578</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AI092528</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI88578</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C102997">Msh6 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018809">Proliferating Cell Nuclear Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="C476886">Apex2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004720">Endonucleases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.3</RegistryNumber><NameOfSubstance UI="C497173">Msh2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.3</RegistryNumber><NameOfSubstance UI="D051718">MutS Homolog 2 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2000 Feb 7;191(3):579-84</RefSource><PMID Version="1">10662804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2014 Jul;44(7):1925-35</RefSource><PMID Version="1">24771041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Sep 1;102(5):565-75</RefSource><PMID Version="1">11007475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2000;36(4):312-24</RefSource><PMID Version="1">11152564</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2001 Jun 1;29(11):2349-60</RefSource><PMID Version="1">11376153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Jul 15;61(14):5552-7</RefSource><PMID Version="1">11454706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2001 Nov 15;20(22):6530-9</RefSource><PMID Version="1">11707423</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Feb 7;415(6872):655-9</RefSource><PMID Version="1">11832948</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2002 Feb 22;316(3):853-66</RefSource><PMID Version="1">11866537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2002 Jul 4;418(6893):99-103</RefSource><PMID Version="1">12097915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2002 Oct 18;277(42):39926-36</RefSource><PMID Version="1">12161446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 2002 Oct 15;12(20):1748-55</RefSource><PMID Version="1">12401169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2003 Jan;81(1):47-57</RefSource><PMID Version="1">12573260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2003 Aug 18;198(4):635-43</RefSource><PMID Version="1">12925679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2003 Sep 18;2(9):955-69</RefSource><PMID Version="1">12967653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2004 Feb;5(2):224-9</RefSource><PMID Version="1">14716311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Apr 30;279(18):18425-33</RefSource><PMID Version="1">14973123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2004 May 21;14(4):491-500</RefSource><PMID Version="1">15149598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23</RefSource><PMID Version="1">8799128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7166-9</RefSource><PMID Version="1">9207062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 1998 Jul;9(1):135-41</RefSource><PMID Version="1">9697843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2004 Dec 15;104(13):4097-103</RefSource><PMID Version="1">15319281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2005 Feb 4;17(3):463-70</RefSource><PMID Version="1">15694346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43</RefSource><PMID Version="1">15824325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2005 Jun 15;174(12):7781-6</RefSource><PMID Version="1">15944281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18361-6</RefSource><PMID Version="1">16344468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1166-71</RefSource><PMID Version="1">10655502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006;34(9):2508-15</RefSource><PMID Version="1">16687656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2007 Jan 22;204(1):17-23</RefSource><PMID Version="1">17190840</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2007 Jun 1;6(6):695-711</RefSource><PMID Version="1">17337257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2007;35(12):3879-92</RefSource><PMID Version="1">17537817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2007 Aug 6;204(8):1989-98</RefSource><PMID Version="1">17664295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2007 Nov 26;204(12):3017-26</RefSource><PMID Version="1">18025127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2008 Apr;8(4):302-12</RefSource><PMID Version="1">18340343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2008;26:481-511</RefSource><PMID Version="1">18304001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16248-53</RefSource><PMID Version="1">18854411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5593-8</RefSource><PMID Version="1">19307563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jul;37(13):4247-55</RefSource><PMID Version="1">19443450</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 2009 Aug;21(8):947-55</RefSource><PMID Version="1">19556307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2009 Sep;29(18):5148-57</RefSource><PMID Version="1">19596785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2009 Nov 23;206(12):2603-11</RefSource><PMID Version="1">19901081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jan;38(3):832-45</RefSource><PMID Version="1">19934257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Immunol. 2010;105:159-91</RefSource><PMID Version="1">20510733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010;5(6):e11182</RefSource><PMID Version="1">20567595</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2010 Dec;28(12):1248-50</RefSource><PMID Version="1">21139605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Feb 15;186(4):1943-50</RefSource><PMID Version="1">21228350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2011 Oct 24;208(11):2209-16</RefSource><PMID Version="1">21967769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Sep 13;120(11):2240-8</RefSource><PMID Version="1">22740445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2013 Apr;33(7):1468-73</RefSource><PMID Version="1">23382073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):E2470-9</RefSource><PMID Version="1">23754438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):E3695-703</RefSource><PMID Version="1">24023064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2013 Nov;14(11):1183-9</RefSource><PMID Version="1">24097111</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunity. 2013 Nov 14;39(5):912-24</RefSource><PMID Version="1">24184055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Dec;12(12):1087-93</RefSource><PMID Version="1">24084171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Jan 16;6(1):1-8</RefSource><PMID Version="1">24388753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2000 Sep 1;102(5):553-63</RefSource><PMID Version="1">11007474</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004720" MajorTopicYN="N">Endonucleases</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018858" MajorTopicYN="N">Germinal Center</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051718" MajorTopicYN="N">MutS Homolog 2 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018809" MajorTopicYN="N">Proliferating Cell Nuclear Antigen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027041" MajorTopicYN="N">Somatic Hypermutation, Immunoglobulin</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24927551</ArticleId><ArticleId IdType="pii">1405590111</ArticleId><ArticleId IdType="doi">10.1073/pnas.1405590111</ArticleId><ArticleId IdType="pmc">PMC4078814</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24914806</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Prognostic value of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in breast cancer.</ArticleTitle><Pagination><MedlinePgn>e99528</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0099528</ELocationID><Abstract><AbstractText>Human apurinic/apyrimidinic endonuclease 1 (APE1) is an essential protein for DNA base excision repair (BER) and redox regulation. The ability of cancer cells to recognize DNA damage and initiate DNA repair is an important mechanism for therapeutic resistance. Several recent studies have suggested that APE1 expression levels and/or subcellular dysregulation may be used to indicate the sensitivity of tumors to radiotherapy or chemotherapy. In this study, we assessed the prognostic significance of APE1 and differences in APE1 expression levels according to breast cancer molecular subtypes. We analyzed formalin-fixed, paraffin-embedded tumor tissue sections from 243 cases diagnosed as invasive breast cancer at Ewha Womans University Medical Center between January 2003 and December 2008. Immunohistochemistry was performed and the nuclear level of APE1 was scored by taking into account the percentage of positive cells. Medical records were reviewed to investigate clinicopathologic characteristics. We found that nuclear APE1 high-level expression (proportion ≥50%) in breast cancer showed a tendency towards unfavorable prognosis regarding disease-free survival (p = 0.093). However, there was no significant difference in overall survival between low and high-level expression groups (p = 0.294). Interestingly, within the Ki-67 low-level expression group, APE1 low-level expression was significantly associated with poor overall survival (p = 0.007). A significant positive correlation was observed between APE1 nuclear expression and estrogen receptor status (75.7% vs. 59.7%, p = 0.022). Also, the luminal A subtype was the most commonly observed breast cancer subtype in the APE1 high-level expression group (61.6% vs. 45.2%, p = 0.000). This study suggests that APE1 expression may be associated with breast cancer prognosis. In particular, its role as a prognostic factor would be significant for breast cancers with a low Ki-67 proliferation index. It is proposed that nuclear APE1 may be a novel target in breast cancer with a low proliferation rate to obtain better outcome. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Joohyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ewha Womans University School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Heejung</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology, Ewha Womans University School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Sun Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Pathology, Ewha Womans University School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Byung-In</ForeName><Initials>BI</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ewha Womans University School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Hyunsuk</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Plastic surgery, Ewha Womans University School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Woosung</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Surgery, Ewha Womans University School of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019394">Ki-67 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 1999 Nov;189(3):351-7</RefSource><PMID Version="1">10547596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Mar 1;61(5):2220-5</RefSource><PMID Version="1">11280790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):27-36</RefSource><PMID Version="1">11316543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2001 Aug;3(4):535-48</RefSource><PMID Version="1">11554443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2002 Jan-Feb;9(1):11-7</RefSource><PMID Version="1">11748448</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Apr 16;279(16):16875-82</RefSource><PMID Version="1">14761960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pathologe. 1987 May;8(3):138-40</RefSource><PMID Version="1">3303008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1991 Oct 25;19(20):5519-23</RefSource><PMID Version="1">1719477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1992 Sep 11;20(17):4417-21</RefSource><PMID Version="1">1383925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):23-7</RefSource><PMID Version="1">7506414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1994 Nov 25;22(23):4884-9</RefSource><PMID Version="1">7800476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1997 Oct 15;25(20):4035-40</RefSource><PMID Version="1">9321654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1998 Apr;77(7):1169-73</RefSource><PMID Version="1">9569057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2006 Sep;20(9):1982-95</RefSource><PMID Version="1">16690750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Med. 2007 Jan-Feb;13(1-2):89-96</RefSource><PMID Version="1">17515960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2009 May 20;101(10):736-50</RefSource><PMID Version="1">19436038</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2009 Sep;23(9):1346-59</RefSource><PMID Version="1">19460860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2009 Dec;66(3):298-304</RefSource><PMID Version="1">19324449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2010 Feb 16;102(4):704-9</RefSource><PMID Version="1">20087352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2011 Aug;22(8):1736-47</RefSource><PMID Version="1">21709140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2012 Jul 20;424(1):34-9</RefSource><PMID Version="1">22713458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2000 Feb;6(2):602-9</RefSource><PMID Version="1">10690545</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019394" MajorTopicYN="N">Ki-67 Antigen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24914806</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0099528</ArticleId><ArticleId IdType="pii">PONE-D-14-10745</ArticleId><ArticleId IdType="pmc">PMC4051707</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24911554</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2015</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2202</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Current eye research</Title><ISOAbbreviation>Curr. Eye Res.</ISOAbbreviation></Journal><ArticleTitle>The changes of 8-OHdG, hOGG1, APE1 and Pol β in lenses of patients with age-related cataract.</ArticleTitle><Pagination><MedlinePgn>378-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/02713683.2014.924148</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the changes of oxidative DNA damage (in the form of 8-OHdG) and three key DNA base-excision repair (BER) proteins, human 8-oxoguanine DNA glycosylase 1 (hOGG1), apurinic/apyrimidinic endonuclease 1 (APE1) and DNA polymerase β (Pol β), in lens epithelium cells (LECs), cortex and nucleus of lenses with age-related cataract (ARC) and age-matched controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 90 patients with ARC and 21 control subjects were enrolled. The samples included the anterior lens capsules (mainly composed of LECs) and various portions of lens. An ELISA assay was used to assess the 8-OHdG levels of genomic DNA extracted. Immunofluorescence and Western blot were used to analyze the localization and quantification of three BER proteins, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 8-OHdG levels in lenses with ARC were higher than those of controls, and were not different among ARC subtypes. The 8-OHdG levels were the highest in the nucleus, followed by the LECs and cortex. The repair proteins were predominantly detected in the cellular nuclei of the LECs and superficial cortical cells. In the LECs, the protein levels of the three BER enzymes were higher in ARC than in controls. In the cortex, a downward trend of the levels of three BER enzymes was found with the increasing opaque degrees. In the nucleus, no enzymes were detected.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings indicate that the oxidative DNA damage increases in lenses with ARC, and the three BER enzymes compensatively increase in the LECs, while decreasing in the opaque cortex. The results suggest that the oxidative DNA damage may be related ARC and the alteration of DNA repair enzyme levels in ARC is associated with the location and opaque degrees of lens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Biwei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Eye Institute, Affiliated Hospital of Nantong University , Nantong , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Lihua</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guowei</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Rongrong</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Mei</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Huaijin</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Eye Res</MedlineTA><NlmUniqueID>8104312</NlmUniqueID><ISSNLinking>0271-3683</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D019951">DNA Polymerase beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002386" MajorTopicYN="N">Cataract</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019951" MajorTopicYN="N">DNA Polymerase beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019084" MajorTopicYN="N">Fluorescent Antibody Technique, Indirect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007908" MajorTopicYN="N">Lens, Crystalline</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">8-OHdG</Keyword><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">Pol β</Keyword><Keyword MajorTopicYN="N">age-related cataract</Keyword><Keyword MajorTopicYN="N">hOGG1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24911554</ArticleId><ArticleId IdType="doi">10.3109/02713683.2014.924148</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24893568</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1746-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2014</Year><Month>Jun</Month><Day>03</Day></PubDate></JournalIssue><Title>Diagnostic pathology</Title><ISOAbbreviation>Diagn Pathol</ISOAbbreviation></Journal><ArticleTitle>Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.</ArticleTitle><Pagination><MedlinePgn>108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1746-1596-9-108</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The base excision repair (BER) pathway removes DNA damage caused by ionizing radiation, reactive oxidative species and methylating agents. OGG1 and APE1 are two important genes in the BER pathway. Many epidemiological studies have evaluated the association between polymorphisms in the two BER genes (OGG1 Ser326Cys and APE1 Asp148Glu) and breast cancer risk. However, the results are inconsistent.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched the electronic databases including PubMed, Embase and Cochrane library for all eligible studies for the period up to February 2014. Data were extracted by two independent authors and pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used to assess the strength of the association.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 17 studies including 9,040 cases and 10,042 controls were available for OGG1 Ser326Cys polymorphism and 7 studies containing 2,979 cases and 3,111 controls were included for APE1 Asp148Glu polymorphism. With respect to OGG1 Ser326Cys polymorphism, we did not find a significant association with breast cancer risk when all eligible studies were pooled into the meta-analysis. However, in subgroup analyses by ethnicity and menopausal status, statistical significant increased breast cancer risk was found in Asian populations (Cys/Cys vs. Ser/Ser: OR=1.157, 95% CI 1.013-1.321, P=0.011; Cys/Cys vs. Ser/Cys+Ser/Ser: OR=1.113, 95% CI 1.009-1.227, P=0.014) and postmenopausal patients (Cys/Cys vs. Ser/Cys+Ser/Ser: OR=1.162, 95% CI 1.003-1.346, P=0.024). In subgroup analysis according to quality score, source of control, and HWE in controls, no any significant association was detected. With respect to APE1 Asp148Glu polymorphism, no significant association with breast cancer risk was demonstrated in the overall and stratified analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present meta-analysis suggests that the OGG1 Ser326Cys polymorphism may be a risk factor for breast cancer in Asians and postmenopausal patients. Further large and well-designed studies are needed to confirm this association.</AbstractText><AbstractText Label="VIRTUAL SLIDES" NlmCategory="UNASSIGNED">The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1156934297124915.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Qiliu</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Lao</LastName><ForeName>Xianjun</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhiping</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ruolin</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Sui</LastName><ForeName>Jingzhe</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China. qinxue919@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shan</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diagn Pathol</MedlineTA><NlmUniqueID>101251558</NlmUniqueID><ISSNLinking>1746-1596</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Tumour Biol. 2014 Apr;35(4):3495-502</RefSource><PMID Version="1">24402573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diagn Pathol. 2013;8:172</RefSource><PMID Version="1">24143964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1999 Mar 8;424(1-2):107-15</RefSource><PMID Version="1">10064854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):170-1</RefSource><PMID Version="1">12582029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hum Genet. 2009 Dec;54(12):739-45</RefSource><PMID Version="1">19881468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Med. 2002 Jun 15;21(11):1539-58</RefSource><PMID Version="1">12111919</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Feb 3;684(1-2):43-8</RefSource><PMID Version="1">19962393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2005;7(1):21-32</RefSource><PMID Version="1">15642178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diagn Pathol. 2013;8:129</RefSource><PMID Version="1">23915145</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014;8(6):e64896</RefSource><PMID Version="1">23755158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacogenetics. 2004 Feb;14(2):103-9</RefSource><PMID Version="1">15077011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Rep. 2008 Apr;19(4):1033-8</RefSource><PMID Version="1">18357393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2008 Dec 15;648(1-2):65-72</RefSource><PMID Version="1">18977234</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol J Pathol. 2008;59(4):201-4</RefSource><PMID Version="1">19391486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2013 Oct;22(5):707-12</RefSource><PMID Version="1">23369609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 1990 Sep;11(9):1447-50</RefSource><PMID Version="1">2205403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 1998 Jan 15;24(2):341-8</RefSource><PMID Version="1">9433910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource><PMID Version="1">3802833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):835-42</RefSource><PMID Version="1">20058067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2004 Aug 23;23(38):6404-28</RefSource><PMID Version="1">15322514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Sep;111(2):279-88</RefSource><PMID Version="1">17922186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(1):59-62</RefSource><PMID Version="1">12779082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Chim Acta. 2005 Sep;359(1-2):150-5</RefSource><PMID Version="1">16002061</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dig Dis Sci. 2012 Sep;57(9):2451-7</RefSource><PMID Version="1">22565339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Mar;17(3):760-71</RefSource><PMID Version="1">20183911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Nov 15;162(10):925-42</RefSource><PMID Version="1">16221808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1109-15</RefSource><PMID Version="1">15279799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):353-8</RefSource><PMID Version="1">16492928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 Dec 15;532(2):192-6</RefSource><PMID Version="1">24076439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diagn Pathol. 2012;7:170</RefSource><PMID Version="1">23216981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2001 Feb 16;291(5507):1284-9</RefSource><PMID Version="1">11181991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12):e50857</RefSource><PMID Version="1">23272074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Aug 1;162(3):201-11</RefSource><PMID Version="1">15987731</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1959 Apr;22(4):719-48</RefSource><PMID Version="1">13655060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):536-42</RefSource><PMID Version="1">16537713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jun;115(3):623-7</RefSource><PMID Version="1">18553220</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Res Clin Oncol. 2010 Apr;136(4):631-6</RefSource><PMID Version="1">20140625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):403-4</RefSource><PMID Version="1">16492938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2008 Nov;29(11):2132-8</RefSource><PMID Version="1">18701435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Mar;21(3):361-70</RefSource><PMID Version="1">10688856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2011 Aug;32(8):1223-30</RefSource><PMID Version="1">21622940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):811-5</RefSource><PMID Version="1">16614128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Apr;7(4):824-30</RefSource><PMID Version="1">11309329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2011 Jul;27(7):1295-302</RefSource><PMID Version="1">21561390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Appl Genet. 2010;51(3):343-52</RefSource><PMID Version="1">20720310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Jul;122(2):527-31</RefSource><PMID Version="1">20054639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 May 17;411(6835):366-74</RefSource><PMID Version="1">11357144</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24893568</ArticleId><ArticleId IdType="pii">1746-1596-9-108</ArticleId><ArticleId IdType="doi">10.1186/1746-1596-9-108</ArticleId><ArticleId IdType="pmc">PMC4064811</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24872679</PMID><DateCompleted><Year>2014</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1177-8881</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Drug design, development and therapy</Title><ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation></Journal><ArticleTitle>Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor.</ArticleTitle><Pagination><MedlinePgn>485-96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S62963</ELocationID><Abstract><AbstractText>The human apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (APE1/Ref-1), an essential multifunctional protein involved in the repair of oxidative deoxyribonucleic acid (DNA) damage and transcriptional regulation, is often overexpressed in tumor tissues and cancer cells. Moreover, APE1/Ref-1 (APE1) overexpression has been linked to chemoresistance in human tumors. Thus, inhibiting APE1 function in cancer cells is considered a promising strategy to overcome resistance to therapeutic agents. Gossypol is a Bcl-2 homology 3 (BH3)-mimetic agent and is able to bind to the BH3 domain of B-cell lymphoma 2 (Bcl-2) family members. Other studies demonstrated that Bcl-2 directly interacted with APE1 via its BH domains. Using apurinic/apyrimidinic (AP) endonuclease assays, we found that gossypol inhibits the repair activity of APE1. Electrophoretic mobility shift assays and dual luciferase assays showed that gossypol could also inhibit the redox function of APE1. Using dual polarization interferometry technology, we show that gossypol can directly interact with APE1. Furthermore, addition of gossypol, in conjunction with APE1 overexpression, leads to cancer cell death. The addition of gossypol also enhances the cell killing effect of the laboratory alkylating agent methyl methanesulfonate and the clinical agent cisplatin (DDP). Administration of gossypol significantly inhibited the growth of xenografts. Furthermore, the combined treatment of gossypol and DDP resulted in a statistically higher antitumor activity compared with DDP alone in vivo. In conclusion, we have demonstrated that gossypol effectively inhibits the repair and redox activity of APE1 through a direct interaction. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sui</LastName><ForeName>Jiangdong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Des Devel Ther</MedlineTA><NlmUniqueID>101475745</NlmUniqueID><ISSNLinking>1177-8881</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>KAV15B369O</RegistryNumber><NameOfSubstance UI="D006072">Gossypol</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>In Vitro Cell Dev Biol. 1986 Oct;22(10):583-8</RefSource><PMID Version="1">3771439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 1984 Feb;44(2):768-71</RefSource><PMID Version="1">6581864</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1989 Mar;32(3):273-7</RefSource><PMID Version="1">2920946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1991 Oct 25;19(20):5519-23</RefSource><PMID Version="1">1719477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1991 Nov 11;19(21):5907-14</RefSource><PMID Version="1">1719484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11450-4</RefSource><PMID Version="1">1722334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1992 Feb;11(2):653-65</RefSource><PMID Version="1">1537340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Exp Med Biol. 1996;387:69-75</RefSource><PMID Version="1">8794196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1997 Mar 1;25(5):933-9</RefSource><PMID Version="1">9023101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Investig Drugs. 2005 Nov;14(11):1419-34</RefSource><PMID Version="1">16255680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2005 Dec;4(12):1923-35</RefSource><PMID Version="1">16373707</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cytokine Growth Factor Rev. 2006 Jun;17(3):147-56</RefSource><PMID Version="1">16516532</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2006 May-Jun;26(3A):1925-33</RefSource><PMID Version="1">16827126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Thorac Cardiovasc Surg. 2006 Dec;132(6):1356-62</RefSource><PMID Version="1">17140955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Chem. 2007 Apr 15;79(8):3023-31</RefSource><PMID Version="1">17367112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cancer. 2008 Mar;8(3):193-204</RefSource><PMID Version="1">18256616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2008 Apr 11;283(15):9925-32</RefSource><PMID Version="1">18263880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2008 Sep 1;45(5):592-601</RefSource><PMID Version="1">18515104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2008 Nov;10(11):1853-67</RefSource><PMID Version="1">18627350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proteomics. 2009 Feb;9(4):1058-74</RefSource><PMID Version="1">19180539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):601-20</RefSource><PMID Version="1">18976116</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2010 Feb 11;53(3):1200-10</RefSource><PMID Version="1">20067291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2010 Feb;9(2):461-70</RefSource><PMID Version="1">20124455</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2010 Feb 16;102(4):704-9</RefSource><PMID Version="1">20087352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2010;10:71</RefSource><PMID Version="1">20184742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2010 Jun 1;12(11):1247-69</RefSource><PMID Version="1">19764832</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):385-93</RefSource><PMID Version="1">21030352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2010 Nov 12;285(46):35418-27</RefSource><PMID Version="1">20837473</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2011 Apr 15;14(8):1387-401</RefSource><PMID Version="1">20874257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Cell. 2011 Oct;22(20):3887-901</RefSource><PMID Version="1">21865600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Endocrinol. 2011 Dec;25(12):2041-53</RefSource><PMID Version="1">22053001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):130-7</RefSource><PMID Version="1">21075552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):14-35</RefSource><PMID Version="1">22122462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):36-53</RefSource><PMID Version="1">22122463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2012 Jun;29(2):1265-71</RefSource><PMID Version="1">21479902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2012 Jul 15;53(2):237-48</RefSource><PMID Version="1">22580151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e55313</RefSource><PMID Version="1">23418439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2013 Jun;30(2):505</RefSource><PMID Version="1">23430444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2013 Dec;20 Suppl 3:S336-47</RefSource><PMID Version="1">22688662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 2004 Jun 15;329(2):190-8</RefSource><PMID Version="1">15158477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2000 Jan;20(1):402-15</RefSource><PMID Version="1">10594042</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2000 Aug;18(8):877-81</RefSource><PMID Version="1">10932159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2001 Mar 1;61(5):2220-5</RefSource><PMID Version="1">11280790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2001 Apr;7(4):824-30</RefSource><PMID Version="1">11309329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2001 Apr;66(3):239-48</RefSource><PMID Version="1">11510695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Res. 2002 Dec;46(6):551-5</RefSource><PMID Version="1">12457630</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2003 Sep 25;46(20):4259-64</RefSource><PMID Version="1">13678404</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2004 Jun;3(6):679-86</RefSource><PMID Version="1">15210853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(12):3531-6</RefSource><PMID Version="1">15247342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Contraception. 1987 Nov;36(5):581-92</RefSource><PMID Version="1">3447817</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006072" MajorTopicYN="N">Gossypol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BH3-mimetic</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">oxidative DNA damage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24872679</ArticleId><ArticleId IdType="doi">10.2147/DDDT.S62963</ArticleId><ArticleId IdType="pii">dddt-8-485</ArticleId><ArticleId IdType="pmc">PMC4026309</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24868140</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1090-0535</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Molecular vision</Title><ISOAbbreviation>Mol. Vis.</ISOAbbreviation></Journal><ArticleTitle>Polymorphisms of DNA repair genes OGG1 and XPD and the risk of age-related cataract in Egyptians.</ArticleTitle><Pagination><MedlinePgn>661-9</MedlinePgn></Pagination><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To analyze the association of the polymorphisms of xeroderma pigmentosum complementation group D (XPD) and 8-oxoguanine glycosylase-1 (OGG1) genes with the risk of age-related cataract (ARC) in an Egyptian population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This case-control study included 150 patients with ARC and 50 controls. Genotyping of XPD Asp³¹²Asn was performed by amplification refractory mutation system PCR assay and genotyping of OGG1 Ser³²⁶Cys was carried out by PCR including confronting two-pair primers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Asn/Asn genotype of XPD gene was significantly associated with increased risk of ARC (odds ratio [OR] = 2.74, 95% confidence interval [CI] = 1.01-7.43, p = 0.04) and cortical cataract (OR = 5.06, 95% CI = 1.70-15.05, p = 0.002). The Asn³¹² allele was significantly associated with an increased risk of ARC (OR = 1.75, 95% CI 1.06-2.89, p = 0.03) and cortical cataract (OR = 2.81, 95% CI = 1.56-5.08, p&lt;0.001). The OGG1 Cys/Cys genotype frequency was significantly higher in ARC (OR = 4.13, 95% CI = 0.93-18.21, p = 0.04) and the Cys(³²⁶ allele (OR = 1.85, 95% CI = 1.07-3.20, p = 0.03). Moreover, the Cys/Cys genotype of the OGG1 gene was significantly higher in cortical cataract (OR = 6.00, 95% CI = 1.24-28.99, p = 0.01) and the Cys³²⁶ allele was also significantly associated with cortical cataract (OR = 2.45, 95% CI = 1.30-4.63, p = 0.005).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results suggest that the Asn/Asn genotype and Asn³¹² allele of XPD polymorphism, as well as the Cys/Cys genotype and Cys³²⁶ allele of the OGG1 polymorphism, may be associated with increased risk of the development of ARC, particularly the cortical type, in the Egyptian population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gharib</LastName><ForeName>Amal F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabour</LastName><ForeName>Sherif A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etewa</LastName><ForeName>Rasha L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fouad</LastName><ForeName>Rania A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Vis</MedlineTA><NlmUniqueID>9605351</NlmUniqueID><ISSNLinking>1090-0535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="D051759">Xeroderma Pigmentosum Group D Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.99.-</RegistryNumber><NameOfSubstance UI="C497292">ERCC2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Radiat Res. 2003 Mar;44(1):31-5</RefSource><PMID Version="1">12841596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(1):59-62</RefSource><PMID Version="1">12779082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1916-21</RefSource><PMID Version="1">15161858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1979 Oct;18(10):1000-18</RefSource><PMID Version="1">225285</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 1987 Jul;94(7):875-80</RefSource><PMID Version="1">3309772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Ophthalmol. 1988 Dec;106(12):1683-7</RefSource><PMID Version="1">3058100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1990 Jan;240(1):35-45</RefSource><PMID Version="1">2152969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nippon Ganka Gakkai Zasshi. 1990 Feb;94(2):176-80</RefSource><PMID Version="1">2368644</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Ophthalmol. 1991 Feb;109(2):244-51</RefSource><PMID Version="1">1993036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1989 Feb;30(2):330-2</RefSource><PMID Version="1">2914761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):261-5</RefSource><PMID Version="1">1729695</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 1991 Nov;6(6):495-9</RefSource><PMID Version="1">1800897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 1992 Oct;174(20):6321-5</RefSource><PMID Version="1">1328155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Ophthalmol. 1993 Jun;111(6):831-6</RefSource><PMID Version="1">8512486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Eye Res. 1993 May;12(5):423-31</RefSource><PMID Version="1">8344066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1994 Jan;35(1):262-7</RefSource><PMID Version="1">8300354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1994 Sep 15;140(6):555-64</RefSource><PMID Version="1">8067349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1995 Jan;36(1):227-35</RefSource><PMID Version="1">7822150</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 1995 Sep;9(12):1173-82</RefSource><PMID Version="1">7672510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 1995 Oct;20(10):402-5</RefSource><PMID Version="1">8533152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 1996 May 15;10(10):1219-32</RefSource><PMID Version="1">8675009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1998 Feb;39(2):344-50</RefSource><PMID Version="1">9477992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 1994 Nov;59(5):557-64</RefSource><PMID Version="1">9492757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Mar 15;28(6):1355-64</RefSource><PMID Version="1">10684930</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Mar;21(3):453-60</RefSource><PMID Version="1">10688865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2000 Jun 30;476(1-2):73-7</RefSource><PMID Version="1">10878254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2001 Jan 1;15(1):15-23</RefSource><PMID Version="1">11156600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2001 Mar;42(3):601-5</RefSource><PMID Version="1">11222516</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1677-8</RefSource><PMID Version="1">11431427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 1998 Mar;39(3):544-52</RefSource><PMID Version="1">9501865</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 1998 May 25;400(1-2):15-24</RefSource><PMID Version="1">9685572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Oct 15;27(20):4001-7</RefSource><PMID Version="1">10497264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(6):1813-24</RefSource><PMID Version="1">15800211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2005 Oct;99(1):43-9</RefSource><PMID Version="1">15990162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2005 Nov 15;162(10):925-42</RefSource><PMID Version="1">16221808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4661-70</RefSource><PMID Version="1">16303963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Eye Res. 2007 Sep;85(3):328-34</RefSource><PMID Version="1">17637462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3642-9</RefSource><PMID Version="1">19351836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4732-7</RefSource><PMID Version="1">20375340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Vis. 2011;17:127-33</RefSource><PMID Version="1">21245954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ophthalmology. 2012 May;119(5):900-6</RefSource><PMID Version="1">22306120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2001 Aug 9;486(3):207-16</RefSource><PMID Version="1">11459633</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2001 Aug;3(4):597-609</RefSource><PMID Version="1">11554447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2001;38(2-3):180-90</RefSource><PMID Version="1">11746753</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Feb;23(2):295-9</RefSource><PMID Version="1">11872635</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Apr;23(4):599-603</RefSource><PMID Version="1">11960912</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2002 Apr;959:360-7</RefSource><PMID Version="1">11976210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2002 Jul 1;100(1):9-13</RefSource><PMID Version="1">12115580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2002 Aug 15;33(4):450-6</RefSource><PMID Version="1">12160927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Biol Med (Maywood). 2002 Oct;227(9):671-82</RefSource><PMID Version="1">12324649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2002 Nov 30;509(1-2):165-74</RefSource><PMID Version="1">12427537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Ageing Dev. 2003 Jan;124(1):27-32</RefSource><PMID Version="1">12618003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):23-9</RefSource><PMID Version="1">14744728</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002386" MajorTopicYN="N">Cataract</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051759" MajorTopicYN="N">Xeroderma Pigmentosum Group D Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>01</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24868140</ArticleId><ArticleId IdType="pmc">PMC4029483</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24861944</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2014</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8278</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Mitochondrion</Title><ISOAbbreviation>Mitochondrion</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial APE1/Ref-1 suppressed protein kinase C-induced mitochondrial dysfunction in mouse endothelial cells.</ArticleTitle><Pagination><MedlinePgn>42-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mito.2014.05.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1567-7249(14)00080-4</ELocationID><Abstract><AbstractText>Protein kinase C (PKC) induces mitochondrial dysfunction, which is an important pathological factor in cardiovascular diseases. The role of apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) on PKC-induced mitochondrial dysfunction has not been variously investigated. In this study, phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C, induced mitochondrial hyperpolarization and reactive oxygen species generation and also increased mitochondrial translocation of APE1/Ref-1. APE1/Ref-1 overexpression suppressed PMA-induced mitochondrial dysfunction. In contrast, gene silencing of APE1/Ref-1 increased the sensitivity of mitochondrial dysfunction. Moreover, mitochondrial targeting sequence (MTS)-fused APE1/Ref-1 more effectively suppressed PMA-induced mitochondrial dysfunctions. These results suggest that mitochondrial APE1/Ref-1 is contributed to the protective role to protein kinase C-induced mitochondrial dysfunction in endothelial cells. </AbstractText><CopyrightInformation>Copyright © 2014 © Elsevier B.V. and Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hee Kyoung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea; Infection Signaling Network Research Center, College of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yu Ran</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea; Infection Signaling Network Research Center, College of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Myoung Soo</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea; Infection Signaling Network Research Center, College of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sunga</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea; Infection Signaling Network Research Center, College of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kyoungsook</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>BioNano Health Guard Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Ki</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Sports Science, Chungnam National University, Daejeon 305-765, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Cuk-Seong</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jin Bong</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea; Infection Signaling Network Research Center, College of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeong Hwa</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea; Infection Signaling Network Research Center, College of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mitochondrion</MedlineTA><NlmUniqueID>100968751</NlmUniqueID><ISSNLinking>1567-7249</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1/Ref-1</Keyword><Keyword MajorTopicYN="N">Endothelial cell</Keyword><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">Mitochondrial membrane potential</Keyword><Keyword MajorTopicYN="N">Phorbol 12-myristate 13-acetate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24861944</ArticleId><ArticleId IdType="pii">S1567-7249(14)00080-4</ArticleId><ArticleId IdType="doi">10.1016/j.mito.2014.05.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24830350</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-2553</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>May</Month><Day>30</Day></PubDate></JournalIssue><Title>Oncotarget</Title><ISOAbbreviation>Oncotarget</ISOAbbreviation></Journal><ArticleTitle>Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy.</ArticleTitle><Pagination><MedlinePgn>3273-86</MedlinePgn></Pagination><Abstract><AbstractText>Phosphatase and tensin homolog (PTEN) loss is associated with genomic instability. APE1 is a key player in DNA base excision repair (BER) and an emerging drug target in cancer. We have developed small molecule inhibitors against APE1 repair nuclease activity. In the current study we explored a synthetic lethal relationship between PTEN and APE1 in melanoma. Clinicopathological significance of PTEN mRNA and APE1 mRNA expression was investigated in 191 human melanomas. Preclinically, PTEN-deficient BRAF-mutated (UACC62, HT144, and SKMel28), PTEN-proficient BRAF-wildtype (MeWo), and doxycycline-inducible PTEN-knockout BRAF-wildtype MeWo melanoma cells were DNA repair expression profiled and investigated for synthetic lethality using a panel of four prototypical APE1 inhibitors. In human tumours, low PTEN mRNA and high APE1 mRNA was significantly associated with reduced relapse free and overall survival. Pre-clinically, compared to PTEN-proficient cells, PTEN-deficient cells displayed impaired expression of genes involved in DNA double strand break (DSB) repair. Synthetic lethality in PTEN-deficient cells was evidenced by increased sensitivity, accumulation of DSBs and induction of apoptosis following treatment with APE1 inhibitors. We conclude that PTEN deficiency is not only a promising biomarker in melanoma, but can also be targeted by a synthetic lethality strategy using inhibitors of BER, such as those targeting APE1. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abbotts</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jewell</LastName><ForeName>Rosalyn</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Nsengimana</LastName><ForeName>Jérémie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Maloney</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Simeonov</LastName><ForeName>Anton</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Seedhouse</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Faye</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Laye</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Christy</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Jadhav</LastName><ForeName>Ajit</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Grabowska</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Poulam M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Newton-Bishop</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Suffix>3rd</Suffix></Author><Author ValidYN="Y"><LastName>Madhusudan</LastName><ForeName>Srinivasan</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA083115</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>C8216/A6129</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 CA83115</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>G0802123</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>C588/A10589</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>1 R03 MH086444-01</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>G1000252</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>C8216/A8168</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>C588/A4994</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>10589</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oncotarget</MedlineTA><NlmUniqueID>101532965</NlmUniqueID><ISSNLinking>1949-2553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.67</RegistryNumber><NameOfSubstance UI="D051059">PTEN Phosphohydrolase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.67</RegistryNumber><NameOfSubstance UI="C494929">PTEN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Exp Mol Pathol. 2012 Feb;92(1):20-6</RefSource><PMID Version="1">22019339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Chem. 2012 Apr 12;55(7):3101-12</RefSource><PMID Version="1">22455312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2012 May;69(9):1475-91</RefSource><PMID Version="1">22076652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2012 May;13(5):283-96</RefSource><PMID Version="1">22473468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2012 Jun;2(6):503-11</RefSource><PMID Version="1">22628410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Jul 10;30(20):2522-9</RefSource><PMID Version="1">22614978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2003 Jun 1;63(11):2881-90</RefSource><PMID Version="1">12782594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Cell Biol. 2003 Aug;5(8):741-7</RefSource><PMID Version="1">12855956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 Oct 29;531(1-2):157-63</RefSource><PMID Version="1">14637252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Investig Drugs. 2004 Jun;5(6):623-7</RefSource><PMID Version="1">15242251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2004 Nov 1;10(21):7252-9</RefSource><PMID Version="1">15534099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2005 Feb;7(2):193-204</RefSource><PMID Version="1">15710331</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Apr 14;434(7035):913-7</RefSource><PMID Version="1">15829966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Apr 14;434(7035):917-21</RefSource><PMID Version="1">15829967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(15):4711-24</RefSource><PMID Version="1">16113242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2007 Jan 12;128(1):157-70</RefSource><PMID Version="1">17218262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2009 May;41(5):544-52</RefSource><PMID Version="1">19282848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(6):e5740</RefSource><PMID Version="1">19484131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2009 Jul 15;8(14):2198-210</RefSource><PMID Version="1">19502790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Nov 10;27(32):5439-44</RefSource><PMID Version="1">19770375</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lung Cancer. 2009 Dec;66(3):298-304</RefSource><PMID Version="1">19324449</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2009 Mar;11(3):639-50</RefSource><PMID Version="1">18715151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2009 Sep;1(6-7):315-22</RefSource><PMID Version="1">20049735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2010 May;42(5):454-8</RefSource><PMID Version="1">20400965</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Jul 1;70(13):5457-64</RefSource><PMID Version="1">20530668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2010 Aug;36(5):425-35</RefSource><PMID Version="1">20056333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2010 Oct 13;2(53):53ra75</RefSource><PMID Version="1">20944090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3621-31</RefSource><PMID Version="1">20809131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2010 Nov;46(16):2889-95</RefSource><PMID Version="1">20724143</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2011 Feb 15;104(4):653-63</RefSource><PMID Version="1">21266972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2011 Apr 1;71(7):2750-60</RefSource><PMID Version="1">21317224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):240-8</RefSource><PMID Version="1">21481725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Jun 30;364(26):2507-16</RefSource><PMID Version="1">21639808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2012 Nov 15;131(10):2433-44</RefSource><PMID Version="1">22377908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Future Oncol. 2012 Sep;8(9):1109-20</RefSource><PMID Version="1">23030486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e47974</RefSource><PMID Version="1">23110144</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Dec 15;18(24):6792; author's reply p. 6793</RefSource><PMID Version="1">23169438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Jul 26;341(6144):395-9</RefSource><PMID Version="1">23888040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res. 2012;14(6):R142</RefSource><PMID Version="1">23116406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2011 Aug 1;71(15):5287-95</RefSource><PMID Version="1">21771908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2012 Feb 15;18(4):1015-27</RefSource><PMID Version="1">22114138</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2000 Oct 16;461(2):83-108</RefSource><PMID Version="1">11018583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2000 Oct;157(4):1123-8</RefSource><PMID Version="1">11021816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2001 Jan 5;84(1):106-12</RefSource><PMID Version="1">11139322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2002 Feb 15;11(4):445-50</RefSource><PMID Version="1">11854177</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020552" MajorTopicYN="N">Comet Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051059" MajorTopicYN="N">PTEN Phosphohydrolase</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24830350</ArticleId><ArticleId IdType="pii">1926</ArticleId><ArticleId IdType="pmc">PMC4102809</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.1926</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24794400</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-7856</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>DNA repair</Title><ISOAbbreviation>DNA Repair (Amst.)</ISOAbbreviation></Journal><ArticleTitle>Redox and epigenetic regulation of the APE1 gene in the hippocampus of piglets: The effect of early life exposures.</ArticleTitle><Pagination><MedlinePgn>52-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dnarep.2014.03.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-7864(14)00082-2</ELocationID><Abstract><AbstractText>Oxidative stress via redox reactions can regulate DNA repair pathways. The base excision repair (BER) enzyme apurinic/apyrimidinic endonuclease 1 (APE1) is a key player in the redox regulation of DNA repair. Environmental factors can alter the methylation of DNA repair genes, change their expression and thus modulate BER activity and susceptibility to oxidative DNA damage. Therefore, we hypothesized that epigenetic modifications play a role in the redox regulation of APE1 in hippocampi of newborns and investigated the effect of supplementation of pregnant sows with a diet enriched in antioxidants and other nutrients on oxidative stress, DNA methylation and DNA repair in their offspring. High levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and low levels of glutathione were detected in control piglets after birth compared with supplemented piglets, indicating the presence of oxidative stress. In control animals, this oxidative stress was associated with genomic DNA demethylation, decreased APE1 promoter methylation, increased APE1 expression and with slightly but not statistically significant increased BER-related DNA incision activity. Supplementation of piglets with antioxidants and other nutrients significantly lowered 8-oxodG levels compared to control animals, which was accompanied by overall lower APE1 promoter methylation and enhanced APE1 expression at day 7-28 after birth in supplemented piglets, although DNA incision activity was not significantly different between groups. Preliminary attempts to study the interaction between redox and epigenetic regulatory mechanisms revealed an inverse correlation between APE1 expression and methylation of CpG-sites 11 and 13 in the promoter region, which according to Genomatix "MatInspector" are located in the core binding sites of redox-sensitive transcription factors. We are the first to study methylation of the APE1 promoter and its role in mediating the functional effects of redox reactions induced by oxidative stress. Epigenetic and redox mechanisms may interact in regulating APE1-related DNA repair processes, involving redox-sensitive TFs.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Langie</LastName><ForeName>Sabine A S</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Centre for Brain Ageing and Vitality, Human Nutrition Research Centre, Institute for Ageing &amp; Health, Newcastle University, Campus for Ageing and Vitality, NE4 5PL Newcastle upon Tyne, UK. Electronic address: sabine.langie@newcastle.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalczyk</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Warsaw University of Life Sciences, Faculty of Agriculture and Biology, Department of Biochemistry, 02-787 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomaszewski</LastName><ForeName>Bartłomiej</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Brain Ageing and Vitality, Human Nutrition Research Centre, Institute for Ageing &amp; Health, Newcastle University, Campus for Ageing and Vitality, NE4 5PL Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasilaki</LastName><ForeName>Aphrodite</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, Faculty of Health &amp; Life Sciences, University of Liverpool, Liverpool L69 3GA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maas</LastName><ForeName>Lou M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Toxicology, Maastricht University, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moonen</LastName><ForeName>Edwin J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Toxicology, Maastricht University, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palagani</LastName><ForeName>Ajay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>PPES, Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godschalk</LastName><ForeName>Roger W L</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Toxicology, Maastricht University, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tudek</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Biophysics PAS, 02-106 Warsaw, Poland; Institute of Genetics and Biotechnology University of Warsaw, 02-106 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Schooten</LastName><ForeName>Frederik J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Toxicology, Maastricht University, 6200 MD Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berghe</LastName><ForeName>Wim Vanden</ForeName><Initials>WV</Initials><AffiliationInfo><Affiliation>PPES, Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabielski</LastName><ForeName>Romuald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, 02-766 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathers</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Centre for Brain Ageing and Vitality, Human Nutrition Research Centre, Institute for Ageing &amp; Health, Newcastle University, Campus for Ageing and Vitality, NE4 5PL Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BB/G007993/1</GrantID><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0700718</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>DNA Repair (Amst)</MedlineTA><NlmUniqueID>101139138</NlmUniqueID><ISSNLinking>1568-7856</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>88847-89-6</RegistryNumber><NameOfSubstance UI="C067134">8-oxo-7-hydrodeoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>G9481N71RO</RegistryNumber><NameOfSubstance UI="D003849">Deoxyguanosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber><NameOfSubstance UI="D005978">Glutathione</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018899" MajorTopicYN="N">CpG Islands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003849" MajorTopicYN="N">Deoxyguanosine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018507" MajorTopicYN="N">Gene Expression Regulation, Developmental</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Base excision repair</Keyword><Keyword MajorTopicYN="N">Developmental origin</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>04</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24794400</ArticleId><ArticleId IdType="pii">S1568-7864(14)00082-2</ArticleId><ArticleId IdType="doi">10.1016/j.dnarep.2014.03.011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24771875</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2018</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1460-2105</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of the National Cancer Institute</Title><ISOAbbreviation>J. Natl. Cancer Inst.</ISOAbbreviation></Journal><ArticleTitle>Re: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1093/jnci/dju086</ELocationID><ELocationID EIdType="pii" ValidYN="Y">dju086</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinnersley</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buch</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellví-Bel</LastName><ForeName>Sergi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrington</LastName><ForeName>Susan Mary</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsti</LastName><ForeName>Asta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hampe</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemminki</LastName><ForeName>Kari</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofstra</LastName><ForeName>Robert M W</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Northwood</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palles</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinheiro</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Ponte</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schafmayer</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Manuel R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westers</LastName><ForeName>Helga</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wezel</LastName><ForeName>Tom van</ForeName><Initials>Tv</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bishop</LastName><ForeName>D Timothy</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunlop</LastName><ForeName>Malcolm G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houlston</LastName><ForeName>Richard S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK (BK, RSH); Department of Medicine I, University Hospital Dresden, Dresden, Germany (SB); Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Catalonia, Spain (SCB); Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK (MGD, SMF); German Cancer Research Center, Heidelberg, Germany (AF, KH); Department of Internal Medicine I, Hospital Schleswig-Holstein, Kiel, Germany (JH); Leeds Cancer Research UK Centre, Section of Epidemiology and Biostatistics, Leeds Institute of Cancer Studies and Pathology, St James's University Hospital, Leeds, UK (EN, DTB); Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK (CP, IT); Department of Genetics, Portugese Oncology Institute, Porto, Portugal (MP, MRT); Galician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Rad de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain (CRP); Department of General and Thoraci Surgery, University Hospital Schleswig-Holstein, Kiel, Germany (CS); University of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen, The Netherlands (HW, RMWH); Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands (RMWH); Leiden Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands (TW). richard.houlston@icr.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CZB/4/449</GrantID><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G1001799</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_U127527198</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>12076</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_U127527198</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>090532</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CZD/16/6/4</GrantID><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>10589</GrantID><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L01629X/1</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Natl Cancer Inst</MedlineTA><NlmUniqueID>7503089</NlmUniqueID><ISSNLinking>0027-8874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Natl Cancer Inst. 2013 Aug 21;105(16):1249-53</RefSource><PMID Version="1">23852950</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Natl Cancer Inst. 2014 May;106(5). pii: dju087. doi: 10.1093/jnci/dju087</RefSource><PMID Version="1">24771876</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2013 Aug 21;105(16):1249-53</RefSource><PMID Version="1">23852950</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="Y">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24771875</ArticleId><ArticleId IdType="pii">dju086</ArticleId><ArticleId IdType="doi">10.1093/jnci/dju086</ArticleId><ArticleId IdType="pmc">PMC4677263</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24729390</PMID><DateCompleted><Year>2014</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0215</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>11</Issue><PubDate><Year>2014</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of cancer</Title><ISOAbbreviation>Int. J. Cancer</ISOAbbreviation></Journal><ArticleTitle>Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.</ArticleTitle><Pagination><MedlinePgn>2687-96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.28892</ELocationID><Abstract><AbstractText>Polymorphism of DNA base excision repair (BER) genes affects DNA repair capacity and may alter sensitivity to platinum-based chemotherapy regimens. This study investigated polymorphisms of OGG1 Ser326Cys, APE1 Asp148Glu APE1-141T/G and XRCC1 Arg399Gln for association with clinical outcome in 235 advanced inoperable nonsmall-cell lung cancer (NSCLC) patients after treatment with platinum-based chemotherapy. The multivariate analysis showed that OGG1 326 GC was associated with poor PFS [hazard ratio (HR) 1.730, p = 0.005], while XRCC1 399 GA, or GA+AA, was associated with poor OS in short-term period (HR 1.718, p = 0.003; HR 1.691, p = 0.003, respectively). Patients with OGG1 326/XRCC1 399 variant alleles had a higher risk to die early in short-term period (HR 1.929, p &lt; 0.001). Furthermore, patients with XRCC1 399 variant allele (GA+AA) had higher risk of hematologic toxicity (p = 0.009), whereas patients carrying the OGG1 326 variant (GG), or the APE1-141 GG variant, had reduced risk of gastrointestinal toxicity (p = 0.015 and p = 0.023, respectively). The data from the current study provide evidence that OGG1 Ser326Cys, XRCC1 Arg399Gln, APE1 Asp148Glu, and APE1-141T/G polymorphisms may be useful in predicting clinical outcomes in patients with advanced inoperable NSCLC that will undergo platinum-based chemotherapy.</AbstractText><CopyrightInformation>© 2014 UICC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Center, Daping Hospital and Research Institute of Surgery, The Third Military Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shiheng</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Yanli</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Cun</LastName><ForeName>Yanping</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Tao</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Cancer</MedlineTA><NlmUniqueID>0042124</NlmUniqueID><ISSNLinking>0020-7136</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043823">Taxoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076105">X-ray Repair Cross Complementing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000619371">XRCC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0W860991D6</RegistryNumber><NameOfSubstance UI="D003841">Deoxycytidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>15H5577CQD</RegistryNumber><NameOfSubstance UI="C067311">docetaxel</NameOfSubstance></Chemical><Chemical><RegistryNumber>B76N6SBZ8R</RegistryNumber><NameOfSubstance UI="C056507">gemcitabine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical><Chemical><RegistryNumber>P88XT4IS4D</RegistryNumber><NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003841" MajorTopicYN="N">Deoxycytidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017239" MajorTopicYN="N">Paclitaxel</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043823" MajorTopicYN="N">Taxoids</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076105" MajorTopicYN="N">X-ray Repair Cross Complementing Protein 1</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">base excision repair</Keyword><Keyword MajorTopicYN="N">chemotherapy</Keyword><Keyword MajorTopicYN="N">nonsmall-cell lung cancer</Keyword><Keyword MajorTopicYN="N">polymorphisms</Keyword><Keyword MajorTopicYN="N">toxicity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24729390</ArticleId><ArticleId IdType="doi">10.1002/ijc.28892</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24705777</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0380</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</Title><ISOAbbreviation>Tumour Biol.</ISOAbbreviation></Journal><ArticleTitle>Genetic polymorphism of APE1 rs1130409 can contribute to the risk of lung cancer.</ArticleTitle><Pagination><MedlinePgn>6665-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13277-014-1829-9</ELocationID><Abstract><AbstractText>Accumulative evidence suggests that polymorphism in the APE1 gene may have association with the etiology of lung cancer by modulating DNA repair capacity. Many studies have evaluated the association with great discrepancies in the results. The present meta-analysis was undertaken to clarify the effects of this polymorphism on lung cancer. A meta-analysis of 15 studies with 4,932 lung cancer patients and 6,555 cancer-free controls was conducted to evaluate the strength of the association using odds ratios (ORs) with 95 % confidence intervals (CIs). Overall, no significant association was found between APE1 polymorphism and lung cancer risk. We also did not observe any statistical evidence of modified lung cancer risk either in smokes or in nonsmokers. In the stratified analysis by ethnicity, however, it was found that the Glu/Clu genotype carriers had 1.16-fold higher risk of suffering lung cancer compared with the carriers of Arg/Glu + Arg/Arg genotypes in Asian population (OR = 1.16, 95 % CI = 1.01-1.32, P = 0.242). This meta-analysis provides statistical evidence for a potential association between APE1 polymorphism and an increased risk of lung cancer in Asian population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cancer Center, Research Institute of Surgery and Daping Hospital, Third Military Medical University, No.10 Changjiang Zhilu, Yuzhong District, Chongqing, 400042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Chengyuan</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Qing</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhimin</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ge</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Jinlu</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Nan</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Tumour Biol</MedlineTA><NlmUniqueID>8409922</NlmUniqueID><ISSNLinking>1010-4283</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Biochimie. 2003 Nov;85(11):1053-71</RefSource><PMID Version="1">14726013</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2002 Nov 30;509(1-2):165-74</RefSource><PMID Version="1">12427537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Cancer Prev. 2010;11(5):1181-6</RefSource><PMID Version="1">21198260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2013 Jun;33(6):2775-8</RefSource><PMID Version="1">23749940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2005 Jan-Feb;25(1B):537-42</RefSource><PMID Version="1">15816625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jul 11;8(7):e69018</RefSource><PMID Version="1">23874853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2001 Oct 15;94(2):153-6</RefSource><PMID Version="1">11668491</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Control Clin Trials. 1986 Sep;7(3):177-88</RefSource><PMID Version="1">3802833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2011 Oct;38(7):4537-43</RefSource><PMID Version="1">21132382</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Biochem Biophys. 2001;35(2):141-70</RefSource><PMID Version="1">11892789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Lett. 2003 Mar 10;191(2):171-8</RefSource><PMID Version="1">12618330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 May;27(5):997-1007</RefSource><PMID Version="1">16308313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Oncol. 2011 Sep;28(3):667-72</RefSource><PMID Version="1">20354815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2007 Jul 28;631(2):101-10</RefSource><PMID Version="1">17531525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2009 Jun;29(6):2417-20</RefSource><PMID Version="1">19528510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):689-98</RefSource><PMID Version="1">12917198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2003 Sep 6;327(7414):557-60</RefSource><PMID Version="1">12958120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Jul;21(7):1329-34</RefSource><PMID Version="1">10874010</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2002 Oct 7;21(45):6870-6</RefSource><PMID Version="1">12362269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Aug;25(8):1395-401</RefSource><PMID Version="1">15044328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2000 Nov 1;92(21):1764-72</RefSource><PMID Version="1">11058619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1054-64</RefSource><PMID Version="1">12376507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2011 Apr;42(3):226-34</RefSource><PMID Version="1">21722819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2006 Mar;27(3):560-7</RefSource><PMID Version="1">16195237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2004 Jun;83(6):970-9</RefSource><PMID Version="1">15177551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Oncol Clin N Am. 2011 Oct;20(4):605-18</RefSource><PMID Version="1">21986260</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2003 Oct 20;107(1):84-8</RefSource><PMID Version="1">12925960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1959 Apr;22(4):719-48</RefSource><PMID Version="1">13655060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Surg Oncol. 2012 Aug 24;10:170</RefSource><PMID Version="1">22917490</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Exp Toxicol. 2012 Oct;31(10):981-1005</RefSource><PMID Version="1">23023028</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Biol Rep. 2012 Dec;39(12):11249-62</RefSource><PMID Version="1">23065211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1997 Sep 13;315(7109):629-34</RefSource><PMID Version="1">9310563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2004 Dec;25(12):2433-41</RefSource><PMID Version="1">15333465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Pathol. 2010 Oct;38(6):849-55</RefSource><PMID Version="1">20805318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2009 Oct;23(10):3459-69</RefSource><PMID Version="1">19541747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2000 Jun;18(11):2309-15</RefSource><PMID Version="1">10829052</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2000 Oct 15;28(20):3871-9</RefSource><PMID Version="1">11024165</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian Continental Ancestry Group</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24705777</ArticleId><ArticleId IdType="doi">10.1007/s13277-014-1829-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24703901</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1089-8638</ISSN><JournalIssue CitedMedium="Internet"><Volume>426</Volume><Issue>11</Issue><PubDate><Year>2014</Year><Month>May</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of molecular biology</Title><ISOAbbreviation>J. Mol. Biol.</ISOAbbreviation></Journal><ArticleTitle>APE1 incision activity at abasic sites in tandem repeat sequences.</ArticleTitle><Pagination><MedlinePgn>2183-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmb.2014.03.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-2836(14)00159-4</ELocationID><Abstract><AbstractText>Repetitive DNA sequences, such as those present in microsatellites and minisatellites, telomeres, and trinucleotide repeats (linked to fragile X syndrome, Huntington disease, etc.), account for nearly 30% of the human genome. These domains exhibit enhanced susceptibility to oxidative attack to yield base modifications, strand breaks, and abasic sites; have a propensity to adopt non-canonical DNA forms modulated by the positions of the lesions; and, when not properly processed, can contribute to genome instability that underlies aging and disease development. Knowledge on the repair efficiencies of DNA damage within such repetitive sequences is therefore crucial for understanding the impact of such domains on genomic integrity. In the present study, using strategically designed oligonucleotide substrates, we determined the ability of human apurinic/apyrimidinic endonuclease 1 (APE1) to cleave at apurinic/apyrimidinic (AP) sites in a collection of tandem DNA repeat landscapes involving telomeric and CAG/CTG repeat sequences. Our studies reveal the differential influence of domain sequence, conformation, and AP site location/relative positioning on the efficiency of APE1 binding and strand incision. Intriguingly, our data demonstrate that APE1 endonuclease efficiency correlates with the thermodynamic stability of the DNA substrate. We discuss how these results have both predictive and mechanistic consequences for understanding the success and failure of repair protein activity associated with such oxidatively sensitive, conformationally plastic/dynamic repetitive DNA domains. </AbstractText><CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengxia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Gerontology, National Institute on Aging Intramural Research Program, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Völker</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, 610 Taylor Road, Piscataway, NJ 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breslauer</LastName><ForeName>Kenneth J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, 610 Taylor Road, Piscataway, NJ 08854, USA; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Laboratory of Molecular Gerontology, National Institute on Aging Intramural Research Program, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA. Electronic address: wilsonda@mail.nih.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CA47995</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM034469</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM023509</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA AG000743-12</GrantID><Acronym>NULL</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 CA047995</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Mol Biol</MedlineTA><NlmUniqueID>2985088R</NlmUniqueID><ISSNLinking>0022-2836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C085108">APEX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2010 Aug 1;429(3):573-82</RefSource><PMID Version="1">20528769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2010 May;6(5):e1000951</RefSource><PMID Version="1">20485567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Aug 15;10(8):887-96</RefSource><PMID Version="1">21727036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mutat. 2011 Oct;32(10):1075-99</RefSource><PMID Version="1">21853507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 Jan 10;51(1):52-62</RefSource><PMID Version="1">22148399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Mol Pharmacol. 2012 Jan;5(1):3-13</RefSource><PMID Version="1">22122461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2012 Apr 4;134(13):6033-44</RefSource><PMID Version="1">22397401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2012 May 8;51(18):3919-32</RefSource><PMID Version="1">22497302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry (Mosc). 2012 Mar;77(3):270-9</RefSource><PMID Version="1">22803944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Cycle. 2012 Mar 1;11(5):998-1007</RefSource><PMID Version="1">22336916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Mol Genet. 2012 Nov 15;21(22):4939-47</RefSource><PMID Version="1">22914735</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2013 Mar;123(3):996-1002</RefSource><PMID Version="1">23454763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(2):e56960</RefSource><PMID Version="1">23468897</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2013 Mar 6;77(5):825-43</RefSource><PMID Version="1">23473314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2013;9(7):e1003639</RefSource><PMID Version="1">23874233</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiat Res. 2013 Jul;180(1):100-9</RefSource><PMID Version="1">23682596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2013 Sep 20;288(38):27263-72</RefSource><PMID Version="1">23926102</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17844-9</RefSource><PMID Version="1">24127576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Apr 1;41(6):3483-90</RefSource><PMID Version="1">23408852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Jan 27;403(6768):451-6</RefSource><PMID Version="1">10667800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biochem Sci. 2002 Jul;27(7):339-44</RefSource><PMID Version="1">12114022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2004 Apr 13;43(14):4188-95</RefSource><PMID Version="1">15065862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2004 May 4;3(5):527-33</RefSource><PMID Version="1">15084314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2004 Jun 1;64(11):3830-7</RefSource><PMID Version="1">15172990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2004 Jun;1019:278-84</RefSource><PMID Version="1">15247029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004;32(17):5134-46</RefSource><PMID Version="1">15459284</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1980 Dec 25;255(24):11743-52</RefSource><PMID Version="1">6254980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Genet. 1986;20:201-30</RefSource><PMID Version="1">3545059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1987 Jul 25;262(21):10171-9</RefSource><PMID Version="1">2440861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biopolymers. 1987 Sep;26(9):1601-20</RefSource><PMID Version="1">3663875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 1993 Apr 22;362(6422):709-15</RefSource><PMID Version="1">8469282</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 1994;26:347-72</RefSource><PMID Version="1">7508801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1995 Jul 7;270(27):16002-7</RefSource><PMID Version="1">7608159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 1995 Nov 20;232(1):79-85</RefSource><PMID Version="1">8600837</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1997 Mar 1;25(5):933-9</RefSource><PMID Version="1">9023101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 May 23;272(21):13916-22</RefSource><PMID Version="1">9153253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6126-31</RefSource><PMID Version="1">9177181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1997 Jun 20;272(25):15650-5</RefSource><PMID Version="1">9188454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1998 Jun 1;26(11):2771-8</RefSource><PMID Version="1">9592167</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Dec 11;273(50):33406-13</RefSource><PMID Version="1">9837917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biopolymers. 1999 Sep;50(3):303-18</RefSource><PMID Version="1">10397791</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 1999 Oct;12(10):917-23</RefSource><PMID Version="1">10525266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2005 Feb 4;345(5):1003-14</RefSource><PMID Version="1">15644200</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(4):1230-9</RefSource><PMID Version="1">15731343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2005 Dec 8;4(12):1442-9</RefSource><PMID Version="1">16199212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2006 Jan 1;66(1):113-24</RefSource><PMID Version="1">16397223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2006 Feb 17;281(7):3889-98</RefSource><PMID Version="1">16356936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 2006 Sep;19(9):1215-20</RefSource><PMID Version="1">16978026</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2006 Oct 11;128(40):13034-5</RefSource><PMID Version="1">17017766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2007 Apr 25;129(16):5272-80</RefSource><PMID Version="1">17397164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2007 May 24;447(7143):447-52</RefSource><PMID Version="1">17450122</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2008 May;36(8):2717-27</RefSource><PMID Version="1">18353858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2008 May 23;379(1):17-27</RefSource><PMID Version="1">18439621</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Jun 5;284(23):15835-46</RefSource><PMID Version="1">19324873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2009 Jul 8;131(26):9354-60</RefSource><PMID Version="1">19566100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochemistry. 2009 Jul 21;48(28):6655-63</RefSource><PMID Version="1">19527055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Oct 9;284(41):28352-66</RefSource><PMID Version="1">19674974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Genet. 2009 Dec;5(12):e1000749</RefSource><PMID Version="1">19997493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biopolymers. 2010 Apr;93(4):355-69</RefSource><PMID Version="1">19890964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Chem Soc. 2010 Mar 31;132(12):4095-7</RefSource><PMID Version="1">20218680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2011 Jan 2;10(1):34-44</RefSource><PMID Version="1">20951653</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001482" MajorTopicYN="N">Base Composition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053837" MajorTopicYN="Y">DNA Cleavage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="Y">DNA Repair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020080" MajorTopicYN="Y">Tandem Repeat Sequences</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016615" MajorTopicYN="N">Telomere</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AP or abasic site</Keyword><Keyword MajorTopicYN="N">APEX1</Keyword><Keyword MajorTopicYN="N">tandem repeat</Keyword><Keyword MajorTopicYN="N">telomere</Keyword><Keyword MajorTopicYN="N">trinucleotide expansion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24703901</ArticleId><ArticleId IdType="pii">S0022-2836(14)00159-4</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2014.03.014</ArticleId><ArticleId IdType="pmc">PMC4034141</ArticleId><ArticleId IdType="mid">NIHMS582440</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24680828</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2104</ISSN><JournalIssue CitedMedium="Internet"><Volume>447</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Apr</Month><Day>25</Day></PubDate></JournalIssue><Title>Biochemical and biophysical research communications</Title><ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation></Journal><ArticleTitle>Cellular accumulation of Cys326-OGG1 protein complexes under conditions of oxidative stress.</ArticleTitle><Pagination><MedlinePgn>12-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2014.03.044</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0006-291X(14)00486-0</ELocationID><Abstract><AbstractText>The common Ser326Cys polymorphism in the base excision repair protein 8-oxoguanine glycosylase 1 is associated with a reduced capacity to repair oxidative DNA damage particularly under conditions of intracellular oxidative stress and there is evidence that Cys326-OGG1 homozygous individuals have increased susceptibility to specific cancer types. Indirect biochemical studies have shown that reduced repair capacity is related to OGG1 redox modification and also possibly OGG1 dimer formation. In the current study we have used bimolecular fluorescence complementation to study for the first time a component of the base excision repair pathway and applied it to visualise accumulation of Cys326-OGG1 protein complexes in the native cellular environment. Fluorescence was observed both within and around the cell nucleus, was shown to be specific to cells expressing Cys326-OGG1 and only occurred in cells under conditions of cellular oxidative stress following depletion of intracellular glutathione levels by treatment with buthionine sulphoximine. Furthermore, OGG1 complex formation was inhibited by incubation of cells with the thiol reducing agents β-mercaptoethanol and dithiothreitol and the antioxidant dimethylsulfoxide indicating a causative role for oxidative stress in the formation of OGG1 cellular complexes. In conclusion, this study has provided for the first time evidence of redox sensitive Cys326-OGG1 protein accumulation in cells under conditions of intracellular oxidative stress that may be related to the previously reported reduced repair capacity of Cys326-OGG1 specifically under conditions of oxidative stress.</AbstractText><CopyrightInformation>Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>M P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guggenheim</LastName><ForeName>E J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pulisciano</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbar</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kershaw</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodges</LastName><ForeName>N J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Electronic address: N.Hodges@bham.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochem Biophys Res Commun</MedlineTA><NlmUniqueID>0372516</NlmUniqueID><ISSNLinking>0006-291X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>5072-26-4</RegistryNumber><NameOfSubstance UI="D019328">Buthionine Sulfoximine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="D045647">DNA Glycosylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.2.-</RegistryNumber><NameOfSubstance UI="C479058">oxoguanine glycosylase 1, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>YOW8V9698H</RegistryNumber><NameOfSubstance UI="D004121">Dimethyl Sulfoxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13300-5</RefSource><PMID Version="1">10557315</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2012 Jan;40(2):701-11</RefSource><PMID Version="1">21933813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2000 Feb 24;403(6772):859-66</RefSource><PMID Version="1">10706276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Soc Trans. 2001 May;29(Pt 2):350-3</RefSource><PMID Version="1">11356181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2001 Sep;22(9):1459-63</RefSource><PMID Version="1">11532868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Jan;23(1):55-60</RefSource><PMID Version="1">11756223</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2002 Mar-Apr;383(3-4):467-75</RefSource><PMID Version="1">12033436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2002 Jun 1;30(11):2349-57</RefSource><PMID Version="1">12034821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2012 Jun;1820(6):730-5</RefSource><PMID Version="1">21571039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2012 Jul;27(4):501-10</RefSource><PMID Version="1">22451681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2013 Mar 1;12(3):227-37</RefSource><PMID Version="1">23332971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Free Radic Biol Med. 2013 Oct;63:401-9</RefSource><PMID Version="1">23726996</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1513-30</RefSource><PMID Version="1">12496039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2002 Dec;23(12):2005-10</RefSource><PMID Version="1">12507922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2003 Jun 11;2(6):707-18</RefSource><PMID Version="1">12767349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Biochem. 1976 Jul;74(1):214-26</RefSource><PMID Version="1">962076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Genet. 1993 Jul;9(7):246-9</RefSource><PMID Version="1">8379000</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chem Res Toxicol. 1993 Sep-Oct;6(5):690-700</RefSource><PMID Version="1">8292748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Biol. 1997 Jun 1;7(6):397-407</RefSource><PMID Version="1">9197244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Health Perspect. 1998 Feb;106 Suppl 1:289-95</RefSource><PMID Version="1">9539021</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 1998 Jun 25;16(25):3219-25</RefSource><PMID Version="1">9681819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1999 Oct 15;27(20):4001-7</RefSource><PMID Version="1">10497264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2005 Mar;42(3):127-41</RefSource><PMID Version="1">15584022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):497-505</RefSource><PMID Version="1">15734978</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(6):1813-24</RefSource><PMID Version="1">15800211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2005;33(10):3271-82</RefSource><PMID Version="1">15942030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Jul 15;65(14):6006-10</RefSource><PMID Version="1">16024598</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Mar;26(5):1654-65</RefSource><PMID Version="1">16478987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2006;34(5):1620-32</RefSource><PMID Version="1">16549874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2006 Oct;26(20):7430-6</RefSource><PMID Version="1">16923968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Repair (Amst). 2006 Nov 8;5(11):1337-45</RefSource><PMID Version="1">16861056</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Sci. 2007 Jan 1;120(Pt 1):23-32</RefSource><PMID Version="1">17148573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2007 May;22(3):189-94</RefSource><PMID Version="1">17284772</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2008 Feb 29;29(4):477-87</RefSource><PMID Version="1">18313385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Radiat Res. 2008 Jul;49(4):329-40</RefSource><PMID Version="1">18596371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem J. 2009 Jan 1;417(1):1-13</RefSource><PMID Version="1">19061483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2009 Apr 15;69(8):3642-9</RefSource><PMID Version="1">19351836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2009 Oct 21;28(20):3207-15</RefSource><PMID Version="1">19713937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2010 Mar 1;685(1-2):61-9</RefSource><PMID Version="1">19800894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Appl Pharmacol. 2011 Jan 1;250(1):19-28</RefSource><PMID Version="1">20934443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biochem Mol Toxicol. 2011 Jan-Feb;25(1):1-7</RefSource><PMID Version="1">21322094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Carcinogenesis. 2000 Mar;21(3):361-70</RefSource><PMID Version="1">10688856</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D019328" MajorTopicYN="N">Buthionine Sulfoximine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045647" MajorTopicYN="N">DNA Glycosylases</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004121" MajorTopicYN="N">Dimethyl Sulfoxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013050" MajorTopicYN="N">Spectrometry, Fluorescence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BiFC visualisation</Keyword><Keyword MajorTopicYN="N">Dimer</Keyword><Keyword MajorTopicYN="N">OGG1</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>03</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24680828</ArticleId><ArticleId IdType="pii">S0006-291X(14)00486-0</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2014.03.044</ArticleId><ArticleId IdType="pmc">PMC4005915</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24665350</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1837-9664</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Journal of Cancer</Title><ISOAbbreviation>J Cancer</ISOAbbreviation></Journal><ArticleTitle>Association between APE1 Single Nucleotide Polymorphism (rs1760944) and Cancer Risk: a Meta-Analysis Based on 6,419 Cancer Cases and 6,781 Case-free Controls.</ArticleTitle><Pagination><MedlinePgn>253-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/jca.8085</ELocationID><Abstract><AbstractText>Apurinic/apyrimidinic endonuclease 1 (APE1) is an essential enzyme in the base excision repair pathway. Epidemiological studies have suggested associations between APE1 rs1760944 polymorphism and cancer risk. This study was aimed to evaluate the relationship between APE1 rs1760944 polymorphism and cancer risk. We searched Pubmed, ISI Web of Knowledge, Embase, Chinese National Knowledge Infrastructure (CNKI) databases until September 2013 to identify eligible studies. Odds ratios (ORs) and 95 % confidence intervals (CIs) were used to estimate the strength of the associations. 12 studies from 11 articles on APE1 rs1760944 genotypes and cancer risk were identified, including a total of 6,419 cancer cases and 6,781 case-free controls. Overall, APE1 rs1760944 polymorphism was significantly associated with the decreased risk of cancer in any genetic models (G vs. T: OR = 0.86, 95% CI = 0.82-0.90; homozygote comparison: OR = 0.74, 95% CI = 0.67-0.82; heterozygote comparison: OR =0.88, 95%CI = 0.81-0.95; dominant model TG+GG vs. TT: OR = 0.82, 95% CI = 0.76-0.89; recessive model GG vs. TT+TG: OR = 0.81, 95%CI = 0.75-0.88). In the stratified analysis by populations, the effect was remain in studies of Asian population (homozygote comparison: OR = 0.71, 95%CI = 0.63-0.79; heterozygote comparison: OR = 0.86, 95 %CI = 0.79- 0.94; dominant model: OR = 0.80, 95% CI = 0.74 -0.87 and recessive model: OR = 0.78, 95%CI = 0.71-0.86). Moreover, a significantly decreased risk was found in lung cancer studies (homozygote comparison: OR = 0.68, 95% CI = 0.59-0.79; heterozygote comparison: OR = 0.86, 95%CI = 0.77- 0.98; dominant model: OR = 0.80, 95%CI = 0.72-0.90 and recessive model: OR= 0.77, 95% CI= 0.68-0.87). These findings support that APE1 rs1760944 polymorphism has a possible protective effect on cancer susceptibility particularly among Asians. Further studies based on different ethnicity and various cancer types are warranted to verify our findings. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Zhi-Jun</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xi-Jing</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>An-Jing</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>2. Department of Pathology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiao-Bin</ForeName><Initials>XB</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Wei-Li</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Peng-Tao</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Hua-Feng</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>1. Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China;</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Cancer</MedlineTA><NlmUniqueID>101535920</NlmUniqueID><ISSNLinking>1837-9664</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2007 Feb 1;67(3):1395-404</RefSource><PMID Version="1">17283177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Jul 11;8(7):e69018</RefSource><PMID Version="1">23874853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>DNA Cell Biol. 2010 Jun;29(6):303-11</RefSource><PMID Version="1">20218899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2005 Sep 4;577(1-2):275-83</RefSource><PMID Version="1">15922366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(4):e60607</RefSource><PMID Version="1">23577132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Carcinog. 2011 Nov;50(11):863-70</RefSource><PMID Version="1">21538578</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Obstet Gynecol. 2013 Oct;209(4):360.e1-7</RefSource><PMID Version="1">23871947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84</RefSource><PMID Version="1">15706084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011 Mar 23;11:104</RefSource><PMID Version="1">21429202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):223-9</RefSource><PMID Version="1">19124501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(12 ):e50857</RefSource><PMID Version="1">23272074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutagenesis. 2009 Nov;24(6):507-12</RefSource><PMID Version="1">19762350</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Sci. 2011 Jul;102(7):1293-7</RefSource><PMID Version="1">21615620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Med Res. 2011 Apr;42(3):226-34</RefSource><PMID Version="1">21722819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genomics. 2004 Jun;83(6):970-9</RefSource><PMID Version="1">15177551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antioxid Redox Signal. 2014 Feb 1;20(4):678-707</RefSource><PMID Version="1">23834463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS Lett. 2000 Jun 30;476(1-2):73-7</RefSource><PMID Version="1">10878254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Environ Mol Mutagen. 2002;39(2-3):208-15</RefSource><PMID Version="1">11921191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2009 Oct;23(10):3459-69</RefSource><PMID Version="1">19541747</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2011 Dec 18;11:521</RefSource><PMID Version="1">22176746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lab. 2013;59(1-2):163-8</RefSource><PMID Version="1">23505922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mutat Res. 2003 May 15;526(1-2):93-125</RefSource><PMID Version="1">12714187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Mol Life Sci. 2010 Nov;67(21):3589-608</RefSource><PMID Version="1">20706766</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gene. 2013 Nov 15;531(1):97-100</RefSource><PMID Version="1">23994194</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APE1</Keyword><Keyword MajorTopicYN="N">cancer susceptibility</Keyword><Keyword MajorTopicYN="N">meta-analysis.</Keyword><Keyword MajorTopicYN="N">single nucleotide polymorphism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>02</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24665350</ArticleId><ArticleId IdType="doi">10.7150/jca.8085</ArticleId><ArticleId IdType="pii">jcav05p0253</ArticleId><ArticleId IdType="pmc">PMC3963083</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24659138</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2014</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1559-0283</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cell biochemistry and biophysics</Title><ISOAbbreviation>Cell Biochem. Biophys.</ISOAbbreviation></Journal><ArticleTitle>Genistein alleviates radiation-induced pneumonitis by depressing Ape1/Ref-1 expression to down-regulate inflammatory cytokines.</ArticleTitle><Pagination><MedlinePgn>725-33</MedlinePgn></Pagination><Abstract><AbstractText>The aim of the study was to investigate the role of genistein in alleviating radiation-induced pneumonitis(RIP) through down-regulating levels of the inflammatory cytokines by inhibiting the expression of apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1). Fifty female C57BL/6J mice (8 weeks old) were randomly divided into a control group, a pure irradiation (IR) group and a genistein + IR group. At the four time points after IR, hematoxylin, and Masson’s trichrome stainings were used to examine the pathological changes and collagen fiber deposition. Flow cytometry was used to detect reactive oxygen system (ROS) changes, EMSA was used to estimate the nuclear factor kappa B (NF-κB) transcriptional activities and an ELISA assay was used to measure the levels of TGF-β1, IL-1β, TNF-α, and IL-6 in the serum and bronchoalveolar lavage fluid (BALF) 2 weeks after IR.The pathological detection results showed acute inflammatory/fibrinoid exudation of the thoracic tissue after IR,which was significantly alleviated with genistein. The IR inducedan APE1 protein expression increase and NF-jB was effectively suppressed by genistein (P &lt; 0.05). The induction of the inflammatory cytokines TGF-β1, IL-1β,TNF-α, and IL-6 by IR were in turn inhibited in the serum and BALF of the genistein-pretreated mice (P &lt; 0.05). In addition, the ROS production was significantly boosted in the A549 cells after IR, which could be down-regulated by the pretreatment of genistein. The results demonstrate that genistein alleviates RIP by attenuating the inflammatory response in the initiation of RIP. A possible target of genistein is the Ape1/ref-1, which regulates key inflammatory cytokines by activating the NF-κB.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guo-Dong</ForeName><Initials>GD</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jian-Wu</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Shan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Meng-Xia</ForeName><Initials>MX</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yong</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qian</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xue-Qin</ForeName><Initials>XQ</Initials></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Jin-Lu</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ge</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhen-Zhou</ForeName><Initials>ZZ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Biochem Biophys</MedlineTA><NlmUniqueID>9701934</NlmUniqueID><ISSNLinking>1085-9195</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011837">Radiation-Protective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>DH2M523P0H</RegistryNumber><NameOfSubstance UI="D019833">Genistein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="C486216">Apex1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.99.18</RegistryNumber><NameOfSubstance UI="D043603">DNA-(Apurinic or Apyrimidinic Site) Lyase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043603" MajorTopicYN="N">DNA-(Apurinic or Apyrimidinic Site) Lyase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019833" MajorTopicYN="N">Genistein</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017564" MajorTopicYN="N">Radiation Pneumonitis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011837" MajorTopicYN="N">Radiation-Protective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013909" MajorTopicYN="N">Thorax</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24659138</ArticleId><ArticleId IdType="doi">10.1007/s12013-014-9859-x</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>
